*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 69 ASP~? 7.42 O1 BME A 601 A 86 HIS A 66 HIS~? 3.42 MN MN A 604s A 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 7.88 51.22 19.98 7.64 49.14 20.25 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 3.21 51.23 16.81 3.87 52.43 15.22 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 69 ASP~? 7.42 O1 BME A 601 A 86 HIS A 66 HIS~? 3.42 MN MN A 604s A 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo 18.89 -28.09 25.11 19.05 -26.61 23.60 7.88 51.22 19.98 7.64 49.14 20.25 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 3.21 51.23 16.81 3.87 52.43 15.22 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 69 ASP~? 7.66 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s A 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 69 ASP~? 7.66 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s A 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o00 naa= 3 ULMN 5 1gpm_c08 GMP SYNTHETASE user 1 5 # 1 A 86 CYH A 21 CYH~? -2.28 S2 BME A 601s A 87 TYR A 58 TYR~? -4.88 S2 BME A 601s A 181 HIS A 22 HIS~? -3.40 MN MN A 604s A 183 GLU A 140 GLU~? -2.42 MN MN A 605s A 239 ASP B 145 ASP~? 15.01 MN MN B 607 coo 117.68 94.64 64.02 117.70 92.25 62.50 3.34 47.98 12.34 4.26 47.15 14.87 coo 117.29 94.86 70.32 116.72 95.97 72.82 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 119.92 89.03 61.19 119.18 89.32 63.12 3.18 53.06 10.64 3.66 54.63 11.95 coo 124.93 87.80 60.99 123.56 89.34 61.53 5.06 58.75 13.41 3.74 57.63 14.59 coo 142.16 73.72 70.58 140.27 74.30 69.85 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 5 1gpm_c08 GMP SYNTHETASE user 2 5 # 2 A 86 CYH A 21 CYH~? -2.28 S2 BME A 601s A 87 TYR A 58 TYR~? -4.88 S2 BME A 601s A 181 HIS A 22 HIS~? -3.40 MN MN A 604s A 183 GLU A 141 GLU~? 7.70 MN MN A 604 A 239 ASP B 145 ASP~? 15.01 MN MN B 607 coo 117.68 94.64 64.02 117.70 92.25 62.50 3.34 47.98 12.34 4.26 47.15 14.87 coo 117.29 94.86 70.32 116.72 95.97 72.82 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 119.92 89.03 61.19 119.18 89.32 63.12 3.18 53.06 10.64 3.66 54.63 11.95 coo 124.93 87.80 60.99 123.56 89.34 61.53 4.84 56.74 8.27 3.91 55.44 6.87 coo 142.16 73.72 70.58 140.27 74.30 69.85 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 5 1gpm_c08 GMP SYNTHETASE user 3 5 # 3 A 86 CYH B 21 CYH~? -2.10 S2 BME B 602s A 87 TYR B 58 TYR~? -4.91 S2 BME B 602s A 181 HIS B 22 HIS~? -3.40 MN MN B 607s A 183 GLU B 140 GLU~? -2.41 MN MN B 606s A 239 ASP A 145 ASP~? 14.76 MN MN A 604 coo 117.68 94.64 64.02 117.70 92.25 62.50 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 117.29 94.86 70.32 116.72 95.97 72.82 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 119.92 89.03 61.19 119.18 89.32 63.12 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 124.93 87.80 60.99 123.56 89.34 61.53 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 142.16 73.72 70.58 140.27 74.30 69.85 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 5 1gpm_c08 GMP SYNTHETASE user 4 5 # 4 A 86 CYH B 21 CYH~? -2.10 S2 BME B 602s A 87 TYR B 58 TYR~? -4.91 S2 BME B 602s A 181 HIS B 22 HIS~? -3.40 MN MN B 607s A 183 GLU B 141 GLU~? 7.71 MN MN B 607 A 239 ASP A 145 ASP~? 14.76 MN MN A 604 coo 117.68 94.64 64.02 117.70 92.25 62.50 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 117.29 94.86 70.32 116.72 95.97 72.82 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 119.92 89.03 61.19 119.18 89.32 63.12 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 124.93 87.80 60.99 123.56 89.34 61.53 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 142.16 73.72 70.58 140.27 74.30 69.85 12.32 59.45 6.26 13.32 58.94 4.48 1gpm_c08 source 1gpm GMP SYNTHETASE : 4 hits 1gpm_c08 naa= 5 ULMN 4 1aug_c00 PYROGLUTAMYL PEPTIDASE-1 user 1 4 # 1 A 81 GLU A 70 GLU~? -2.54 MN MN A 604s A 91 ARG A 26 ARG~? 9.60 MN MN A 604 A 144 CYH A 21 CYH~? -2.28 S2 BME A 601s A 168 HIS A 66 HIS~? 3.42 MN MN A 604s coo 28.87 6.96 30.67 27.64 7.06 28.97 6.20 55.25 17.70 4.45 55.72 16.64 coo 24.59 20.69 25.34 23.89 18.58 27.57 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 29.61 14.88 32.60 26.85 15.04 33.11 3.34 47.98 12.34 4.26 47.15 14.87 coo 25.29 9.73 31.76 26.04 11.54 31.12 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1aug_c00 PYROGLUTAMYL PEPTIDASE-1 user 2 4 # 2 A 81 GLU A 141 GLU~? 7.70 MN MN A 604 A 91 ARG A 27 ARG~? 11.42 S2 BME A 601 A 144 CYH A 21 CYH~? -2.28 S2 BME A 601s A 168 HIS A 22 HIS~? -3.40 MN MN A 604s coo 28.87 6.96 30.67 27.64 7.06 28.97 4.84 56.74 8.27 3.91 55.44 6.87 coo 24.59 20.69 25.34 23.89 18.58 27.57 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 29.61 14.88 32.60 26.85 15.04 33.11 3.34 47.98 12.34 4.26 47.15 14.87 coo 25.29 9.73 31.76 26.04 11.54 31.12 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1aug_c00 PYROGLUTAMYL PEPTIDASE-1 user 3 4 # 3 A 81 GLU B 70 GLU~? -2.57 MN MN B 607s A 91 ARG B 26 ARG~? 8.42 O2 GOL B 603 A 144 CYH B 21 CYH~? -2.10 S2 BME B 602s A 168 HIS B 66 HIS~? 3.43 MN MN B 607s coo 28.87 6.96 30.67 27.64 7.06 28.97 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 24.59 20.69 25.34 23.89 18.58 27.57 1.24 79.80 7.27 0.69 76.71 7.21 coo 29.61 14.88 32.60 26.85 15.04 33.11 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 25.29 9.73 31.76 26.04 11.54 31.12 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1aug_c00 PYROGLUTAMYL PEPTIDASE-1 user 4 4 # 4 A 81 GLU B 141 GLU~? 7.71 MN MN B 607 A 91 ARG B 27 ARG~? 11.60 C2 BME B 602 A 144 CYH B 21 CYH~? -2.10 S2 BME B 602s A 168 HIS B 22 HIS~? -3.40 MN MN B 607s coo 28.87 6.96 30.67 27.64 7.06 28.97 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 24.59 20.69 25.34 23.89 18.58 27.57 1.97 89.27 10.36 0.81 91.17 12.49 coo 29.61 14.88 32.60 26.85 15.04 33.11 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 25.29 9.73 31.76 26.04 11.54 31.12 -5.34 79.70 5.35 -6.67 78.07 5.35 1aug_c00 source 1aug PYROGLUTAMYL PEPTIDASE-1 : 4 hits 1aug_c00 naa= 4 ULMN 4 1aug_c01 PYROGLUTAMYL PEPTIDASE-1 user 1 4 # 1 B 291 GLU A 70 GLU~? -2.54 MN MN A 604s B 301 ARG A 26 ARG~? 9.60 MN MN A 604 B 354 CYH A 21 CYH~? -2.28 S2 BME A 601s B 378 HIS A 66 HIS~? 3.42 MN MN A 604s coo -5.92 11.02 9.25 -4.73 10.52 10.94 6.20 55.25 17.70 4.45 55.72 16.64 coo -1.70 21.74 19.55 -0.95 20.65 16.71 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -6.71 19.19 10.45 -3.88 19.54 10.05 3.34 47.98 12.34 4.26 47.15 14.87 coo -2.27 14.08 9.43 -3.22 15.49 10.57 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1aug_c01 PYROGLUTAMYL PEPTIDASE-1 user 2 4 # 2 B 291 GLU A 141 GLU~? 7.70 MN MN A 604 B 301 ARG A 27 ARG~? 11.42 S2 BME A 601 B 354 CYH A 21 CYH~? -2.28 S2 BME A 601s B 378 HIS A 22 HIS~? -3.40 MN MN A 604s coo -5.92 11.02 9.25 -4.73 10.52 10.94 4.84 56.74 8.27 3.91 55.44 6.87 coo -1.70 21.74 19.55 -0.95 20.65 16.71 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -6.71 19.19 10.45 -3.88 19.54 10.05 3.34 47.98 12.34 4.26 47.15 14.87 coo -2.27 14.08 9.43 -3.22 15.49 10.57 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1aug_c01 PYROGLUTAMYL PEPTIDASE-1 user 3 4 # 3 B 291 GLU B 70 GLU~? -2.57 MN MN B 607s B 301 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 354 CYH B 21 CYH~? -2.10 S2 BME B 602s B 378 HIS B 66 HIS~? 3.43 MN MN B 607s coo -5.92 11.02 9.25 -4.73 10.52 10.94 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -1.70 21.74 19.55 -0.95 20.65 16.71 1.24 79.80 7.27 0.69 76.71 7.21 coo -6.71 19.19 10.45 -3.88 19.54 10.05 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -2.27 14.08 9.43 -3.22 15.49 10.57 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1aug_c01 PYROGLUTAMYL PEPTIDASE-1 user 4 4 # 4 B 291 GLU B 141 GLU~? 7.71 MN MN B 607 B 301 ARG B 27 ARG~? 11.60 C2 BME B 602 B 354 CYH B 21 CYH~? -2.10 S2 BME B 602s B 378 HIS B 22 HIS~? -3.40 MN MN B 607s coo -5.92 11.02 9.25 -4.73 10.52 10.94 -3.60 76.13 2.85 -2.01 77.43 3.31 coo -1.70 21.74 19.55 -0.95 20.65 16.71 1.97 89.27 10.36 0.81 91.17 12.49 coo -6.71 19.19 10.45 -3.88 19.54 10.05 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -2.27 14.08 9.43 -3.22 15.49 10.57 -5.34 79.70 5.35 -6.67 78.07 5.35 1aug_c01 source 1aug PYROGLUTAMYL PEPTIDASE-1 : 4 hits 1aug_c01 naa= 4 ULMN 4 1aug_c02 PYROGLUTAMYL PEPTIDASE-1 user 1 4 # 1 C 501 GLU A 70 GLU~? -2.54 MN MN A 604s C 511 ARG A 26 ARG~? 9.60 MN MN A 604 C 564 CYH A 21 CYH~? -2.28 S2 BME A 601s C 588 HIS A 66 HIS~? 3.42 MN MN A 604s coo -7.75 5.44 26.59 -6.19 6.01 25.22 6.20 55.25 17.70 4.45 55.72 16.64 coo -1.59 -5.33 17.57 -1.47 -4.24 20.51 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -8.31 -2.65 25.36 -5.63 -2.95 26.36 3.34 47.98 12.34 4.26 47.15 14.87 coo -4.18 2.38 27.30 -4.81 0.94 26.02 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1aug_c02 PYROGLUTAMYL PEPTIDASE-1 user 2 4 # 2 C 501 GLU A 141 GLU~? 7.70 MN MN A 604 C 511 ARG A 27 ARG~? 11.42 S2 BME A 601 C 564 CYH A 21 CYH~? -2.28 S2 BME A 601s C 588 HIS A 22 HIS~? -3.40 MN MN A 604s coo -7.75 5.44 26.59 -6.19 6.01 25.22 4.84 56.74 8.27 3.91 55.44 6.87 coo -1.59 -5.33 17.57 -1.47 -4.24 20.51 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -8.31 -2.65 25.36 -5.63 -2.95 26.36 3.34 47.98 12.34 4.26 47.15 14.87 coo -4.18 2.38 27.30 -4.81 0.94 26.02 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1aug_c02 PYROGLUTAMYL PEPTIDASE-1 user 3 4 # 3 C 501 GLU B 70 GLU~? -2.57 MN MN B 607s C 511 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 564 CYH B 21 CYH~? -2.10 S2 BME B 602s C 588 HIS B 66 HIS~? 3.43 MN MN B 607s coo -7.75 5.44 26.59 -6.19 6.01 25.22 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -1.59 -5.33 17.57 -1.47 -4.24 20.51 1.24 79.80 7.27 0.69 76.71 7.21 coo -8.31 -2.65 25.36 -5.63 -2.95 26.36 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -4.18 2.38 27.30 -4.81 0.94 26.02 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1aug_c02 PYROGLUTAMYL PEPTIDASE-1 user 4 4 # 4 C 501 GLU B 141 GLU~? 7.71 MN MN B 607 C 511 ARG B 27 ARG~? 11.60 C2 BME B 602 C 564 CYH B 21 CYH~? -2.10 S2 BME B 602s C 588 HIS B 22 HIS~? -3.40 MN MN B 607s coo -7.75 5.44 26.59 -6.19 6.01 25.22 -3.60 76.13 2.85 -2.01 77.43 3.31 coo -1.59 -5.33 17.57 -1.47 -4.24 20.51 1.97 89.27 10.36 0.81 91.17 12.49 coo -8.31 -2.65 25.36 -5.63 -2.95 26.36 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -4.18 2.38 27.30 -4.81 0.94 26.02 -5.34 79.70 5.35 -6.67 78.07 5.35 1aug_c02 source 1aug PYROGLUTAMYL PEPTIDASE-1 : 4 hits 1aug_c02 naa= 4 ULMN 4 1aug_c03 PYROGLUTAMYL PEPTIDASE-1 user 1 4 # 1 D 711 GLU A 70 GLU~? -2.54 MN MN A 604s D 721 ARG A 26 ARG~? 9.60 MN MN A 604 D 774 CYH A 21 CYH~? -2.28 S2 BME A 601s D 798 HIS A 66 HIS~? 3.42 MN MN A 604s coo 30.61 8.40 12.47 29.08 8.31 13.97 6.20 55.25 17.70 4.45 55.72 16.64 coo 24.63 -5.13 16.78 24.42 -2.93 14.53 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 31.20 0.39 10.57 28.57 0.35 9.57 3.34 47.98 12.34 4.26 47.15 14.87 coo 27.09 5.86 10.69 27.61 4.00 11.36 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1aug_c03 PYROGLUTAMYL PEPTIDASE-1 user 2 4 # 2 D 711 GLU A 141 GLU~? 7.70 MN MN A 604 D 721 ARG A 27 ARG~? 11.42 S2 BME A 601 D 774 CYH A 21 CYH~? -2.28 S2 BME A 601s D 798 HIS A 22 HIS~? -3.40 MN MN A 604s coo 30.61 8.40 12.47 29.08 8.31 13.97 4.84 56.74 8.27 3.91 55.44 6.87 coo 24.63 -5.13 16.78 24.42 -2.93 14.53 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 31.20 0.39 10.57 28.57 0.35 9.57 3.34 47.98 12.34 4.26 47.15 14.87 coo 27.09 5.86 10.69 27.61 4.00 11.36 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1aug_c03 PYROGLUTAMYL PEPTIDASE-1 user 3 4 # 3 D 711 GLU B 70 GLU~? -2.57 MN MN B 607s D 721 ARG B 26 ARG~? 8.42 O2 GOL B 603 D 774 CYH B 21 CYH~? -2.10 S2 BME B 602s D 798 HIS B 66 HIS~? 3.43 MN MN B 607s coo 30.61 8.40 12.47 29.08 8.31 13.97 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 24.63 -5.13 16.78 24.42 -2.93 14.53 1.24 79.80 7.27 0.69 76.71 7.21 coo 31.20 0.39 10.57 28.57 0.35 9.57 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 27.09 5.86 10.69 27.61 4.00 11.36 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1aug_c03 PYROGLUTAMYL PEPTIDASE-1 user 4 4 # 4 D 711 GLU B 141 GLU~? 7.71 MN MN B 607 D 721 ARG B 27 ARG~? 11.60 C2 BME B 602 D 774 CYH B 21 CYH~? -2.10 S2 BME B 602s D 798 HIS B 22 HIS~? -3.40 MN MN B 607s coo 30.61 8.40 12.47 29.08 8.31 13.97 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 24.63 -5.13 16.78 24.42 -2.93 14.53 1.97 89.27 10.36 0.81 91.17 12.49 coo 31.20 0.39 10.57 28.57 0.35 9.57 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 27.09 5.86 10.69 27.61 4.00 11.36 -5.34 79.70 5.35 -6.67 78.07 5.35 1aug_c03 source 1aug PYROGLUTAMYL PEPTIDASE-1 : 4 hits 1aug_c03 naa= 4 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 1 4 # 1 A 133 HIS A 67 HIS~? -4.40 CL CL A 608s A 175 GLU A 70 GLU~? -2.54 MN MN A 604s A 204 ASP A 69 ASP~? 7.42 O1 BME A 601 A 236 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 7.06 3.02 44.15 5.29 1.89 44.11 0.35 54.22 20.29 -1.10 54.30 18.77 coo 5.26 3.96 48.13 7.21 3.45 47.51 6.20 55.25 17.70 4.45 55.72 16.64 coo 1.26 2.66 46.42 2.28 1.24 45.18 7.88 51.22 19.98 7.64 49.14 20.25 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 4 1bs0_c00 8-AMINO-7-OXONANOATE SYNTHASE user 2 4 # 2 A 133 HIS B 67 HIS~? -4.45 CL CL B 609s A 175 GLU B 70 GLU~? -2.57 MN MN B 607s A 204 ASP B 69 ASP~? 7.66 S2 BME B 602 A 236 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 7.06 3.02 44.15 5.29 1.89 44.11 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 5.26 3.96 48.13 7.21 3.45 47.51 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 1.26 2.66 46.42 2.28 1.24 45.18 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -3.23 86.22 8.94 -7.29 90.78 7.55 1bs0_c00 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 2 hits 1bs0_c00 naa= 4 ULMN 4 1cqq_c00 TYPE 2 RHINOVIRUS 3C PROTEASE user 1 4 # 1 A 40 HIS A 66 HIS~? 3.42 MN MN A 604s A 71 GLU A 70 GLU~? -2.54 MN MN A 604s A 145 GLY A 23 GLY~? 8.40 S2 BME A 601 A 147 CYH A 21 CYH~? -2.28 S2 BME A 601s coo 5.27 -2.35 33.27 6.82 -3.75 33.56 3.21 51.23 16.81 3.87 52.43 15.22 coo 8.33 0.95 29.83 6.39 0.91 30.74 6.20 55.25 17.70 4.45 55.72 16.64 coo 9.85 -11.05 36.81 10.11 -10.72 36.08 1.32 48.34 7.45 1.06 48.38 8.26 coo 11.50 -5.91 34.73 9.62 -6.14 32.85 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 4 1cqq_c00 TYPE 2 RHINOVIRUS 3C PROTEASE user 2 4 # 2 A 40 HIS B 66 HIS~? 3.43 MN MN B 607s A 71 GLU B 70 GLU~? -2.57 MN MN B 607s A 145 GLY B 23 GLY~? 8.34 S2 BME B 602 A 147 CYH B 21 CYH~? -2.10 S2 BME B 602s coo 5.27 -2.35 33.27 6.82 -3.75 33.56 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 8.33 0.95 29.83 6.39 0.91 30.74 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 9.85 -11.05 36.81 10.11 -10.72 36.08 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 11.50 -5.91 34.73 9.62 -6.14 32.85 -7.07 84.75 5.98 -9.76 85.47 5.91 1cqq_c00 source 1cqq TYPE 2 RHINOVIRUS 3C PROTEASE : 2 hits 1cqq_c00 naa= 4 ULMN 4 1dco_c01 DCOH user 1 4 # 1 B 62 HIS A 66 HIS~? 3.42 MN MN A 604s B 63 HIS A 22 HIS~? -3.40 MN MN A 604s B 80 HIS A 96 HIS~? -3.41 MN MN A 605s B 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 30.13 28.91 18.82 29.78 26.89 19.27 3.21 51.23 16.81 3.87 52.43 15.22 coo 30.80 33.19 23.94 30.03 35.03 23.38 3.18 53.06 10.64 3.66 54.63 11.95 coo 25.47 25.21 25.04 27.09 24.88 26.31 0.59 58.54 20.35 2.20 57.89 19.15 coo 32.70 23.27 17.35 31.06 23.48 18.68 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c01 DCOH user 2 4 # 2 B 62 HIS A 67 HIS~? -4.40 CL CL A 608s B 63 HIS A 136 HIS~? 3.48 MN MN A 605s B 80 HIS A 22 HIS~? -3.40 MN MN A 604s B 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 30.13 28.91 18.82 29.78 26.89 19.27 0.35 54.22 20.29 -1.10 54.30 18.77 coo 30.80 33.19 23.94 30.03 35.03 23.38 -0.57 59.60 14.33 0.78 59.36 15.93 coo 25.47 25.21 25.04 27.09 24.88 26.31 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.70 23.27 17.35 31.06 23.48 18.68 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c01 DCOH user 3 4 # 3 B 62 HIS A 100 HIS~? 8.88 CL CL A 608 B 63 HIS A 67 HIS~? -4.40 CL CL A 608s B 80 HIS A 136 HIS~? 3.48 MN MN A 605s B 89 ASP A 101 ASP~? 14.47 MN MN A 605 coo 30.13 28.91 18.82 29.78 26.89 19.27 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 30.80 33.19 23.94 30.03 35.03 23.38 0.35 54.22 20.29 -1.10 54.30 18.77 coo 25.47 25.21 25.04 27.09 24.88 26.31 -0.57 59.60 14.33 0.78 59.36 15.93 coo 32.70 23.27 17.35 31.06 23.48 18.68 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 4 1dco_c01 DCOH user 4 4 # 4 B 62 HIS B 66 HIS~? 3.43 MN MN B 607s B 63 HIS B 22 HIS~? -3.40 MN MN B 607s B 80 HIS B 96 HIS~? -3.43 MN MN B 606s B 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 30.13 28.91 18.82 29.78 26.89 19.27 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 30.80 33.19 23.94 30.03 35.03 23.38 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 25.47 25.21 25.04 27.09 24.88 26.31 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 32.70 23.27 17.35 31.06 23.48 18.68 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 4 1dco_c01 DCOH user 5 4 # 5 B 62 HIS B 67 HIS~? -4.45 CL CL B 609s B 63 HIS B 136 HIS~? 3.50 MN MN B 606s B 80 HIS B 22 HIS~? -3.40 MN MN B 607s B 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 30.13 28.91 18.82 29.78 26.89 19.27 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 30.80 33.19 23.94 30.03 35.03 23.38 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 25.47 25.21 25.04 27.09 24.88 26.31 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.70 23.27 17.35 31.06 23.48 18.68 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 4 1dco_c01 DCOH user 6 4 # 6 B 62 HIS B 100 HIS~? 8.87 CL CL B 609 B 63 HIS B 67 HIS~? -4.45 CL CL B 609s B 80 HIS B 136 HIS~? 3.50 MN MN B 606s B 89 ASP B 101 ASP~? 14.48 MN MN B 606 coo 30.13 28.91 18.82 29.78 26.89 19.27 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 30.80 33.19 23.94 30.03 35.03 23.38 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 25.47 25.21 25.04 27.09 24.88 26.31 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 32.70 23.27 17.35 31.06 23.48 18.68 -10.99 72.82 22.17 -12.93 72.02 22.11 1dco_c01 source 1dco DCOH : 6 hits 1dco_c01 naa= 4 ULMN 4 1dco_c02 DCOH user 1 4 # 1 C 62 HIS A 66 HIS~? 3.42 MN MN A 604s C 63 HIS A 22 HIS~? -3.40 MN MN A 604s C 80 HIS A 96 HIS~? -3.41 MN MN A 605s C 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.60 51.54 13.33 29.70 53.54 12.79 3.21 51.23 16.81 3.87 52.43 15.22 coo 35.52 48.78 13.63 35.21 46.77 13.20 3.18 53.06 10.64 3.66 54.63 11.95 coo 33.83 55.44 5.53 34.68 55.77 3.67 0.59 58.54 20.35 2.20 57.89 19.15 coo 27.62 57.06 14.62 28.16 56.67 12.64 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c02 DCOH user 2 4 # 2 C 62 HIS B 66 HIS~? 3.43 MN MN B 607s C 63 HIS B 22 HIS~? -3.40 MN MN B 607s C 80 HIS B 96 HIS~? -3.43 MN MN B 606s C 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.60 51.54 13.33 29.70 53.54 12.79 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 35.52 48.78 13.63 35.21 46.77 13.20 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 33.83 55.44 5.53 34.68 55.77 3.67 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 27.62 57.06 14.62 28.16 56.67 12.64 -15.81 81.35 4.53 -16.00 83.45 4.93 1dco_c02 source 1dco DCOH : 2 hits 1dco_c02 naa= 4 ULMN 4 1dco_c03 DCOH user 1 4 # 1 D 62 HIS A 66 HIS~? 3.42 MN MN A 604s D 63 HIS A 22 HIS~? -3.40 MN MN A 604s D 80 HIS A 96 HIS~? -3.41 MN MN A 605s D 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 57.14 54.52 28.76 58.02 56.20 27.93 3.21 51.23 16.81 3.87 52.43 15.22 coo 50.55 54.00 30.19 50.52 53.10 32.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 55.23 64.51 29.49 55.46 66.50 28.94 0.59 58.54 20.35 2.20 57.89 19.15 coo 60.71 56.13 24.08 59.92 57.52 25.41 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c03 DCOH user 2 4 # 2 D 62 HIS B 66 HIS~? 3.43 MN MN B 607s D 63 HIS B 22 HIS~? -3.40 MN MN B 607s D 80 HIS B 96 HIS~? -3.43 MN MN B 606s D 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 57.14 54.52 28.76 58.02 56.20 27.93 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 50.55 54.00 30.19 50.52 53.10 32.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 55.23 64.51 29.49 55.46 66.50 28.94 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 60.71 56.13 24.08 59.92 57.52 25.41 -15.81 81.35 4.53 -16.00 83.45 4.93 1dco_c03 source 1dco DCOH : 2 hits 1dco_c03 naa= 4 ULMN 4 1dco_c05 DCOH user 1 4 # 1 F 62 HIS A 66 HIS~? 3.42 MN MN A 604s F 63 HIS A 22 HIS~? -3.40 MN MN A 604s F 80 HIS A 96 HIS~? -3.41 MN MN A 605s F 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 12.05 28.43 70.32 10.75 27.97 68.79 3.21 51.23 16.81 3.87 52.43 15.22 coo 17.14 32.02 68.53 18.69 31.37 69.75 3.18 53.06 10.64 3.66 54.63 11.95 coo 14.97 24.19 61.54 16.03 23.48 59.90 0.59 58.54 20.35 2.20 57.89 19.15 coo 5.92 28.03 68.57 7.27 26.97 67.43 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c05 DCOH user 2 4 # 2 F 62 HIS B 66 HIS~? 3.43 MN MN B 607s F 63 HIS B 22 HIS~? -3.40 MN MN B 607s F 80 HIS B 96 HIS~? -3.43 MN MN B 606s F 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 12.05 28.43 70.32 10.75 27.97 68.79 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 17.14 32.02 68.53 18.69 31.37 69.75 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 14.97 24.19 61.54 16.03 23.48 59.90 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 5.92 28.03 68.57 7.27 26.97 67.43 -15.81 81.35 4.53 -16.00 83.45 4.93 1dco_c05 source 1dco DCOH : 2 hits 1dco_c05 naa= 4 ULMN 4 1dco_c06 DCOH user 1 4 # 1 G 62 HIS A 66 HIS~? 3.42 MN MN A 604s G 63 HIS A 22 HIS~? -3.40 MN MN A 604s G 80 HIS A 96 HIS~? -3.41 MN MN A 605s G 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 27.23 31.17 87.27 28.54 31.18 88.89 3.21 51.23 16.81 3.87 52.43 15.22 coo 22.77 36.07 86.61 21.15 35.09 85.77 3.18 53.06 10.64 3.66 54.63 11.95 coo 24.24 31.95 96.92 23.16 32.10 98.71 0.59 58.54 20.35 2.20 57.89 19.15 coo 33.04 31.03 88.73 31.44 31.21 90.04 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c06 DCOH user 2 4 # 2 G 62 HIS B 66 HIS~? 3.43 MN MN B 607s G 63 HIS B 22 HIS~? -3.40 MN MN B 607s G 80 HIS B 96 HIS~? -3.43 MN MN B 606s G 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 27.23 31.17 87.27 28.54 31.18 88.89 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 22.77 36.07 86.61 21.15 35.09 85.77 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 24.24 31.95 96.92 23.16 32.10 98.71 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 33.04 31.03 88.73 31.44 31.21 90.04 -15.81 81.35 4.53 -16.00 83.45 4.93 1dco_c06 source 1dco DCOH : 2 hits 1dco_c06 naa= 4 ULMN 4 1dco_c07 DCOH user 1 4 # 1 H 62 HIS A 66 HIS~? 3.42 MN MN A 604s H 63 HIS A 22 HIS~? -3.40 MN MN A 604s H 80 HIS A 96 HIS~? -3.41 MN MN A 605s H 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 25.41 62.31 81.97 26.41 62.87 83.70 3.21 51.23 16.81 3.87 52.43 15.22 coo 27.91 57.00 79.64 28.08 57.36 77.58 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.94 62.32 86.32 31.68 60.75 86.87 0.59 58.54 20.35 2.20 57.89 19.15 coo 22.93 64.49 87.27 24.97 64.23 86.95 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c07 DCOH user 2 4 # 2 H 62 HIS A 67 HIS~? -4.40 CL CL A 608s H 63 HIS A 96 HIS~? -3.41 MN MN A 605s H 80 HIS A 22 HIS~? -3.40 MN MN A 604s H 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 25.41 62.31 81.97 26.41 62.87 83.70 0.35 54.22 20.29 -1.10 54.30 18.77 coo 27.91 57.00 79.64 28.08 57.36 77.58 0.59 58.54 20.35 2.20 57.89 19.15 coo 32.94 62.32 86.32 31.68 60.75 86.87 3.18 53.06 10.64 3.66 54.63 11.95 coo 22.93 64.49 87.27 24.97 64.23 86.95 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c07 DCOH user 3 4 # 3 H 62 HIS A 67 HIS~? -4.40 CL CL A 608s H 63 HIS A 136 HIS~? 3.48 MN MN A 605s H 80 HIS A 22 HIS~? -3.40 MN MN A 604s H 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 25.41 62.31 81.97 26.41 62.87 83.70 0.35 54.22 20.29 -1.10 54.30 18.77 coo 27.91 57.00 79.64 28.08 57.36 77.58 -0.57 59.60 14.33 0.78 59.36 15.93 coo 32.94 62.32 86.32 31.68 60.75 86.87 3.18 53.06 10.64 3.66 54.63 11.95 coo 22.93 64.49 87.27 24.97 64.23 86.95 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1dco_c07 DCOH user 4 4 # 4 H 62 HIS B 66 HIS~? 3.43 MN MN B 607s H 63 HIS B 22 HIS~? -3.40 MN MN B 607s H 80 HIS B 96 HIS~? -3.43 MN MN B 606s H 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 25.41 62.31 81.97 26.41 62.87 83.70 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.91 57.00 79.64 28.08 57.36 77.58 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.94 62.32 86.32 31.68 60.75 86.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 22.93 64.49 87.27 24.97 64.23 86.95 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 4 1dco_c07 DCOH user 5 4 # 5 H 62 HIS B 67 HIS~? -4.45 CL CL B 609s H 63 HIS B 136 HIS~? 3.50 MN MN B 606s H 80 HIS B 22 HIS~? -3.40 MN MN B 607s H 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 25.41 62.31 81.97 26.41 62.87 83.70 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 27.91 57.00 79.64 28.08 57.36 77.58 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 32.94 62.32 86.32 31.68 60.75 86.87 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 22.93 64.49 87.27 24.97 64.23 86.95 -15.81 81.35 4.53 -16.00 83.45 4.93 1dco_c07 source 1dco DCOH : 5 hits 1dco_c07 naa= 4 ULMN 4 1dnk_c00 DNA (5'-D(*GP*GP*TP*AP*TP*AP*C)-3') user 1 4 # 1 A 78 GLU A 141 GLU~? 7.70 MN MN A 604 A 134 HIS A 22 HIS~? -3.40 MN MN A 604s A 212 ASP A 69 ASP~? 7.42 O1 BME A 601 A 252 HIS A 66 HIS~? 3.42 MN MN A 604s coo -14.14 41.26 -17.08 -15.94 40.74 -16.28 4.84 56.74 8.27 3.91 55.44 6.87 coo -19.39 38.52 -15.93 -19.35 39.89 -14.38 3.18 53.06 10.64 3.66 54.63 11.95 coo -23.92 32.04 -10.64 -22.67 33.68 -10.21 7.88 51.22 19.98 7.64 49.14 20.25 coo -20.50 36.14 -8.06 -21.57 37.72 -8.96 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1dnk_c00 DNA (5'-D(*GP*GP*TP*AP*TP*AP*C)-3') user 2 4 # 2 A 78 GLU B 141 GLU~? 7.71 MN MN B 607 A 134 HIS B 22 HIS~? -3.40 MN MN B 607s A 212 ASP B 69 ASP~? 7.66 S2 BME B 602 A 252 HIS B 66 HIS~? 3.43 MN MN B 607s coo -14.14 41.26 -17.08 -15.94 40.74 -16.28 -3.60 76.13 2.85 -2.01 77.43 3.31 coo -19.39 38.52 -15.93 -19.35 39.89 -14.38 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -23.92 32.04 -10.64 -22.67 33.68 -10.21 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -20.50 36.14 -8.06 -21.57 37.72 -8.96 -11.11 81.39 7.66 -9.84 80.27 6.41 1dnk_c00 source 1dnk DNA (5'-D(*GP*GP*TP*AP*TP*AP*C)-3') : 2 hits 1dnk_c00 naa= 4 ULMN 4 1e7l_c00 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS A 96 HIS~? -3.41 MN MN A 605s A 43 HIS A 136 HIS~? 3.48 MN MN A 605s A 65 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 105 HIS A 67 HIS~? -4.40 CL CL A 608s coo -8.56 17.41 8.71 -9.21 15.58 9.51 0.59 58.54 20.35 2.20 57.89 19.15 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -0.57 59.60 14.33 0.78 59.36 15.93 coo 0.61 18.90 14.14 -0.63 19.28 12.44 0.70 67.61 16.19 -1.02 68.27 17.25 coo -9.53 15.99 5.74 -8.28 14.32 5.53 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 4 1e7l_c00 RECOMBINATION ENDONUCLEASE VII user 2 4 # 2 A 41 HIS B 67 HIS~? -4.45 CL CL B 609s A 43 HIS B 96 HIS~? -3.43 MN MN B 606s A 65 GLU B 72 GLU~? 13.02 MN MN B 606 B 105 HIS B 66 HIS~? 3.43 MN MN B 607s coo -8.56 17.41 8.71 -9.21 15.58 9.51 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -22.12 78.07 6.79 -23.41 76.46 7.29 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1e7l_c00 RECOMBINATION ENDONUCLEASE VII user 3 4 # 3 A 41 HIS B 96 HIS~? -3.43 MN MN B 606s A 43 HIS B 136 HIS~? 3.50 MN MN B 606s A 65 GLU B 91 GLU~? 11.42 MN MN B 606 B 105 HIS B 67 HIS~? -4.45 CL CL B 609s coo -8.56 17.41 8.71 -9.21 15.58 9.51 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -13.16 78.27 11.53 -11.33 78.28 12.55 1e7l_c00 source 1e7l RECOMBINATION ENDONUCLEASE VII : 3 hits 1e7l_c00 naa= 4 ULMN 4 1e7l_c02 RECOMBINATION ENDONUCLEASE VII user 1 4 # 1 A 41 HIS A 96 HIS~? -3.41 MN MN A 605s A 43 HIS A 136 HIS~? 3.48 MN MN A 605s A 65 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 105 HIS A 67 HIS~? -4.40 CL CL A 608s coo -8.56 17.41 8.71 -9.21 15.58 9.51 0.59 58.54 20.35 2.20 57.89 19.15 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -0.57 59.60 14.33 0.78 59.36 15.93 coo 0.61 18.90 14.14 -0.63 19.28 12.44 0.70 67.61 16.19 -1.02 68.27 17.25 coo -9.53 15.99 5.74 -8.28 14.32 5.53 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 4 1e7l_c02 RECOMBINATION ENDONUCLEASE VII user 2 4 # 2 A 41 HIS B 67 HIS~? -4.45 CL CL B 609s A 43 HIS B 96 HIS~? -3.43 MN MN B 606s A 65 GLU B 72 GLU~? 13.02 MN MN B 606 B 105 HIS B 66 HIS~? 3.43 MN MN B 607s coo -8.56 17.41 8.71 -9.21 15.58 9.51 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -22.12 78.07 6.79 -23.41 76.46 7.29 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 4 1e7l_c02 RECOMBINATION ENDONUCLEASE VII user 3 4 # 3 A 41 HIS B 96 HIS~? -3.43 MN MN B 606s A 43 HIS B 136 HIS~? 3.50 MN MN B 606s A 65 GLU B 91 GLU~? 11.42 MN MN B 606 B 105 HIS B 67 HIS~? -4.45 CL CL B 609s coo -8.56 17.41 8.71 -9.21 15.58 9.51 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -7.86 15.79 13.55 -6.41 15.13 12.19 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 0.61 18.90 14.14 -0.63 19.28 12.44 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -9.53 15.99 5.74 -8.28 14.32 5.53 -13.16 78.27 11.53 -11.33 78.28 12.55 1e7l_c02 source 1e7l RECOMBINATION ENDONUCLEASE VII : 3 hits 1e7l_c02 naa= 4 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 1 4 # 1 9 GLU A 91 GLU~? 5.92 C1 GOL B 603 111 ASP B 134 ASP~? -3.66 O1 GOL B 603s 319 TYR B 133 TYR~? 5.56 CL CL B 609 365 HIS B 22 HIS~? -3.40 MN MN B 607s coo 40.90 33.12 50.07 39.32 31.72 50.03 0.70 67.61 16.19 -1.02 68.27 17.25 coo 38.20 29.86 46.47 38.01 31.94 46.26 1.27 73.42 12.01 2.60 75.02 12.38 coo 35.52 29.82 41.60 37.98 29.12 42.65 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 32.44 22.36 39.83 33.57 21.39 41.30 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 4 1ecl_c00 MOLECULE: ESCHERICHIA COLI TOPOISOMEuser 2 4 # 2 9 GLU B 91 GLU~? 11.42 MN MN B 606 111 ASP A 134 ASP~? 12.23 CL CL A 608 319 TYR A 133 TYR~? 5.56 CL CL A 608 365 HIS A 22 HIS~? -3.40 MN MN A 604s coo 40.90 33.12 50.07 39.32 31.72 50.03 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 38.20 29.86 46.47 38.01 31.94 46.26 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 35.52 29.82 41.60 37.98 29.12 42.65 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 32.44 22.36 39.83 33.57 21.39 41.30 3.18 53.06 10.64 3.66 54.63 11.95 1ecl_c00 source 1ecl MOLECULE: ESCHERICHIA COLI TOPOISOMERASE I : 2 hits 1ecl_c00 naa= 4 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 4 # 1 168 GLU A 70 GLU~? -2.54 MN MN A 604s 211 GLU A 140 GLU~? -2.42 MN MN A 605s 345 LYS A 24 LYS~? 4.08 C2 BME A 601 373 HIS A 22 HIS~? -3.40 MN MN A 604s coo 93.43 51.01 30.24 95.07 49.77 29.67 6.20 55.25 17.70 4.45 55.72 16.64 coo 91.65 44.62 30.04 93.01 45.95 29.66 5.06 58.75 13.41 3.74 57.63 14.59 coo 103.59 43.46 23.85 98.61 47.18 23.58 -0.91 46.54 9.97 2.66 42.32 12.44 coo 97.00 42.72 29.81 95.87 44.35 30.62 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 2 4 # 2 168 GLU A 140 GLU~? -2.42 MN MN A 605s 211 GLU A 70 GLU~? -2.54 MN MN A 604s 345 LYS A 24 LYS~? 4.08 C2 BME A 601 373 HIS A 66 HIS~? 3.42 MN MN A 604s coo 93.43 51.01 30.24 95.07 49.77 29.67 5.06 58.75 13.41 3.74 57.63 14.59 coo 91.65 44.62 30.04 93.01 45.95 29.66 6.20 55.25 17.70 4.45 55.72 16.64 coo 103.59 43.46 23.85 98.61 47.18 23.58 -0.91 46.54 9.97 2.66 42.32 12.44 coo 97.00 42.72 29.81 95.87 44.35 30.62 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 3 4 # 3 168 GLU B 70 GLU~? -2.57 MN MN B 607s 211 GLU B 140 GLU~? -2.41 MN MN B 606s 345 LYS B 24 LYS~? -3.00 C2 BME B 602s 373 HIS B 22 HIS~? -3.40 MN MN B 607s coo 93.43 51.01 30.24 95.07 49.77 29.67 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 91.65 44.62 30.04 93.01 45.95 29.66 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 103.59 43.46 23.85 98.61 47.18 23.58 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 97.00 42.72 29.81 95.87 44.35 30.62 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 4 4 # 4 168 GLU B 140 GLU~? -2.41 MN MN B 606s 211 GLU B 70 GLU~? -2.57 MN MN B 607s 345 LYS B 24 LYS~? -3.00 C2 BME B 602s 373 HIS B 66 HIS~? 3.43 MN MN B 607s coo 93.43 51.01 30.24 95.07 49.77 29.67 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 91.65 44.62 30.04 93.01 45.95 29.66 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 103.59 43.46 23.85 98.61 47.18 23.58 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 97.00 42.72 29.81 95.87 44.35 30.62 -11.11 81.39 7.66 -9.84 80.27 6.41 1els_c01 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 4 hits 1els_c01 naa= 4 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 4 # 1 B 95 ASP A 69 ASP~? 7.42 O1 BME A 601 B 117 GLU A 68 GLU~? 10.93 O1 BME A 601 B 131 GLU A 70 GLU~? -2.54 MN MN A 604s B 213 HIS A 22 HIS~? -3.40 MN MN A 604s coo 39.14 56.64 24.68 38.62 56.32 26.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 40.54 62.45 29.38 39.23 60.98 30.16 5.73 51.66 25.85 5.32 49.97 27.08 coo 38.13 52.78 25.48 37.33 50.83 25.51 6.20 55.25 17.70 4.45 55.72 16.64 coo 35.79 48.48 32.46 36.87 50.29 32.45 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 4 # 2 B 95 ASP A 69 ASP~? 7.42 O1 BME A 601 B 117 GLU A 68 GLU~? 10.93 O1 BME A 601 B 131 GLU A 70 GLU~? -2.54 MN MN A 604s B 213 HIS A 136 HIS~? 3.48 MN MN A 605s coo 39.14 56.64 24.68 38.62 56.32 26.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 40.54 62.45 29.38 39.23 60.98 30.16 5.73 51.66 25.85 5.32 49.97 27.08 coo 38.13 52.78 25.48 37.33 50.83 25.51 6.20 55.25 17.70 4.45 55.72 16.64 coo 35.79 48.48 32.46 36.87 50.29 32.45 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 4 # 3 B 95 ASP A 69 ASP~? 7.42 O1 BME A 601 B 117 GLU A 72 GLU~? 12.86 MN MN A 605 B 131 GLU A 70 GLU~? -2.54 MN MN A 604s B 213 HIS A 22 HIS~? -3.40 MN MN A 604s coo 39.14 56.64 24.68 38.62 56.32 26.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 40.54 62.45 29.38 39.23 60.98 30.16 8.16 54.29 26.80 8.10 55.96 28.07 coo 38.13 52.78 25.48 37.33 50.83 25.51 6.20 55.25 17.70 4.45 55.72 16.64 coo 35.79 48.48 32.46 36.87 50.29 32.45 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 4 # 4 B 95 ASP A 69 ASP~? 7.42 O1 BME A 601 B 117 GLU A 72 GLU~? 12.86 MN MN A 605 B 131 GLU A 70 GLU~? -2.54 MN MN A 604s B 213 HIS A 136 HIS~? 3.48 MN MN A 605s coo 39.14 56.64 24.68 38.62 56.32 26.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 40.54 62.45 29.38 39.23 60.98 30.16 8.16 54.29 26.80 8.10 55.96 28.07 coo 38.13 52.78 25.48 37.33 50.83 25.51 6.20 55.25 17.70 4.45 55.72 16.64 coo 35.79 48.48 32.46 36.87 50.29 32.45 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 4 # 5 B 95 ASP B 69 ASP~? 7.66 S2 BME B 602 B 117 GLU B 68 GLU~? 12.41 MN MN B 606 B 131 GLU B 70 GLU~? -2.57 MN MN B 607s B 213 HIS B 22 HIS~? -3.40 MN MN B 607s coo 39.14 56.64 24.68 38.62 56.32 26.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 38.13 52.78 25.48 37.33 50.83 25.51 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 35.79 48.48 32.46 36.87 50.29 32.45 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 4 # 6 B 95 ASP B 69 ASP~? 7.66 S2 BME B 602 B 117 GLU B 68 GLU~? 12.41 MN MN B 606 B 131 GLU B 70 GLU~? -2.57 MN MN B 607s B 213 HIS B 136 HIS~? 3.50 MN MN B 606s coo 39.14 56.64 24.68 38.62 56.32 26.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 38.13 52.78 25.48 37.33 50.83 25.51 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 35.79 48.48 32.46 36.87 50.29 32.45 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 7 4 # 7 B 95 ASP B 69 ASP~? 7.66 S2 BME B 602 B 117 GLU B 72 GLU~? 13.02 MN MN B 606 B 131 GLU B 70 GLU~? -2.57 MN MN B 607s B 213 HIS B 22 HIS~? -3.40 MN MN B 607s coo 39.14 56.64 24.68 38.62 56.32 26.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 38.13 52.78 25.48 37.33 50.83 25.51 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 35.79 48.48 32.46 36.87 50.29 32.45 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 4 1f6d_c01 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 8 4 # 8 B 95 ASP B 69 ASP~? 7.66 S2 BME B 602 B 117 GLU B 72 GLU~? 13.02 MN MN B 606 B 131 GLU B 70 GLU~? -2.57 MN MN B 607s B 213 HIS B 136 HIS~? 3.50 MN MN B 606s coo 39.14 56.64 24.68 38.62 56.32 26.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 40.54 62.45 29.38 39.23 60.98 30.16 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 38.13 52.78 25.48 37.33 50.83 25.51 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 35.79 48.48 32.46 36.87 50.29 32.45 -7.23 73.04 10.16 -9.24 73.26 9.58 1f6d_c01 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 8 hits 1f6d_c01 naa= 4 ULMN 4 1fr2_c01 COLICIN E9 user 1 4 # 1 B 5 ARG A 167 ARG~? -4.94 O1 BME A 601s B 100 GLU A 72 GLU~? 12.86 MN MN A 605 B 102 HIS A 67 HIS~? -4.40 CL CL A 608s B 103 HIS A 66 HIS~? 3.42 MN MN A 604s coo 7.07 18.80 36.78 9.58 17.30 35.86 6.75 43.81 21.29 6.50 46.65 20.31 coo 8.48 7.22 38.94 10.30 7.64 39.97 8.16 54.29 26.80 8.10 55.96 28.07 coo 12.42 9.76 31.50 14.31 10.36 30.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 9.40 15.10 30.15 7.50 15.55 30.93 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 1fr2_c01 COLICIN E9 user 2 4 # 2 B 5 ARG B 167 ARG~? 6.18 S2 BME B 602 B 100 GLU B 72 GLU~? 13.02 MN MN B 606 B 102 HIS B 67 HIS~? -4.45 CL CL B 609s B 103 HIS B 66 HIS~? 3.43 MN MN B 607s coo 7.07 18.80 36.78 9.58 17.30 35.86 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 8.48 7.22 38.94 10.30 7.64 39.97 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 12.42 9.76 31.50 14.31 10.36 30.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 9.40 15.10 30.15 7.50 15.55 30.93 -11.11 81.39 7.66 -9.84 80.27 6.41 1fr2_c01 source 1fr2 COLICIN E9 : 2 hits 1fr2_c01 naa= 4 ULMN 4 1g0d_c00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 1 4 # 1 A 272 CYH A 21 CYH~? -2.28 S2 BME A 601s A 332 HIS A 66 HIS~? 3.42 MN MN A 604s A 355 ASP A 69 ASP~? 7.42 O1 BME A 601 A 515 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 46.10 15.37 7.21 48.39 16.33 5.98 3.34 47.98 12.34 4.26 47.15 14.87 coo 52.08 14.39 6.78 50.88 13.04 7.85 3.21 51.23 16.81 3.87 52.43 15.22 coo 51.01 10.60 12.62 50.82 11.50 10.72 7.88 51.22 19.98 7.64 49.14 20.25 coo 48.55 18.50 0.51 47.48 16.93 2.61 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 4 1g0d_c00 PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANuser 2 4 # 2 A 272 CYH B 21 CYH~? -2.10 S2 BME B 602s A 332 HIS B 66 HIS~? 3.43 MN MN B 607s A 355 ASP B 69 ASP~? 7.66 S2 BME B 602 A 515 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 46.10 15.37 7.21 48.39 16.33 5.98 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 52.08 14.39 6.78 50.88 13.04 7.85 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 51.01 10.60 12.62 50.82 11.50 10.72 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 48.55 18.50 0.51 47.48 16.93 2.61 -7.48 86.83 13.23 -7.97 85.45 10.86 1g0d_c00 source 1g0d PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE : 2 hits 1g0d_c00 naa= 4 ULMN 4 1i7q_c00 TRPG user 1 4 # 1 A 398 HIS A 96 HIS~? -3.41 MN MN A 605s B 85 CYH B 21 CYH~? -2.10 S2 BME B 602s B 172 HIS B 22 HIS~? -3.40 MN MN B 607s B 174 GLU B 140 GLU~? -2.41 MN MN B 606s coo 20.89 -4.66 25.45 18.80 -4.64 25.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 4 1i7q_c00 TRPG user 2 4 # 2 A 398 HIS A 96 HIS~? -3.41 MN MN A 605s B 85 CYH B 21 CYH~? -2.10 S2 BME B 602s B 172 HIS B 22 HIS~? -3.40 MN MN B 607s B 174 GLU B 141 GLU~? 7.71 MN MN B 607 coo 20.89 -4.66 25.45 18.80 -4.64 25.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 4 1i7q_c00 TRPG user 3 4 # 3 A 398 HIS B 96 HIS~? -3.43 MN MN B 606s B 85 CYH A 21 CYH~? -2.28 S2 BME A 601s B 172 HIS A 22 HIS~? -3.40 MN MN A 604s B 174 GLU A 140 GLU~? -2.42 MN MN A 605s coo 20.89 -4.66 25.45 18.80 -4.64 25.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 3.34 47.98 12.34 4.26 47.15 14.87 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 4 1i7q_c00 TRPG user 4 4 # 4 A 398 HIS B 96 HIS~? -3.43 MN MN B 606s B 85 CYH A 21 CYH~? -2.28 S2 BME A 601s B 172 HIS A 22 HIS~? -3.40 MN MN A 604s B 174 GLU A 141 GLU~? 7.70 MN MN A 604 coo 20.89 -4.66 25.45 18.80 -4.64 25.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 3.34 47.98 12.34 4.26 47.15 14.87 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 4.84 56.74 8.27 3.91 55.44 6.87 1i7q_c00 source 1i7q TRPG : 4 hits 1i7q_c00 naa= 4 ULMN 4 1i7q_c02 TRPG user 1 4 # 1 A 398 HIS A 96 HIS~? -3.41 MN MN A 605s B 85 CYH B 21 CYH~? -2.10 S2 BME B 602s B 172 HIS B 22 HIS~? -3.40 MN MN B 607s B 174 GLU B 140 GLU~? -2.41 MN MN B 606s coo 20.89 -4.66 25.45 18.80 -4.64 25.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 4 1i7q_c02 TRPG user 2 4 # 2 A 398 HIS A 96 HIS~? -3.41 MN MN A 605s B 85 CYH B 21 CYH~? -2.10 S2 BME B 602s B 172 HIS B 22 HIS~? -3.40 MN MN B 607s B 174 GLU B 141 GLU~? 7.71 MN MN B 607 coo 20.89 -4.66 25.45 18.80 -4.64 25.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 4 1i7q_c02 TRPG user 3 4 # 3 A 398 HIS B 96 HIS~? -3.43 MN MN B 606s B 85 CYH A 21 CYH~? -2.28 S2 BME A 601s B 172 HIS A 22 HIS~? -3.40 MN MN A 604s B 174 GLU A 140 GLU~? -2.42 MN MN A 605s coo 20.89 -4.66 25.45 18.80 -4.64 25.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 3.34 47.98 12.34 4.26 47.15 14.87 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 4 1i7q_c02 TRPG user 4 4 # 4 A 398 HIS B 96 HIS~? -3.43 MN MN B 606s B 85 CYH A 21 CYH~? -2.28 S2 BME A 601s B 172 HIS A 22 HIS~? -3.40 MN MN A 604s B 174 GLU A 141 GLU~? 7.70 MN MN A 604 coo 20.89 -4.66 25.45 18.80 -4.64 25.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 28.83 -16.77 -1.56 27.26 -17.06 0.72 3.34 47.98 12.34 4.26 47.15 14.87 coo 30.36 -13.76 3.56 28.40 -14.17 2.96 3.18 53.06 10.64 3.66 54.63 11.95 coo 32.23 -8.53 2.85 31.71 -10.57 2.38 4.84 56.74 8.27 3.91 55.44 6.87 1i7q_c02 source 1i7q TRPG : 4 hits 1i7q_c02 naa= 4 ULMN 4 1ohh_c03 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 4 # 1 A 373 ARG B 167 ARG~? 6.18 S2 BME B 602 E 162 LYS B 24 LYS~? -3.00 C2 BME B 602s E 188 GLU B 70 GLU~? -2.57 MN MN B 607s E 189 ARG B 166 ARG~? 12.22 S2 BME B 602 coo 101.13 34.06 -17.55 103.52 32.17 -17.47 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 99.70 45.17 -13.94 103.86 40.77 -11.97 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 111.54 40.04 -16.26 109.58 40.74 -16.69 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 107.06 33.49 -18.08 106.01 34.28 -15.30 -19.40 84.27 7.18 -20.75 82.43 4.97 1ohh_c03 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c03 naa= 4 ULMN 4 1pjb_c00 L-ALANINE DEHYDROGENASE user 1 4 # 1 A 74 LYS A 24 LYS~? 4.08 C2 BME A 601 A 95 HIS A 22 HIS~? -3.40 MN MN A 604s A 117 GLU A 141 GLU~? 7.70 MN MN A 604 A 269 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 8.15 32.64 23.74 10.45 29.09 22.22 -0.91 46.54 9.97 2.66 42.32 12.44 coo 13.22 26.82 27.06 12.30 25.69 25.54 3.18 53.06 10.64 3.66 54.63 11.95 coo 9.91 23.87 29.04 9.51 25.99 29.30 4.84 56.74 8.27 3.91 55.44 6.87 coo 19.03 25.15 20.47 17.35 23.93 20.93 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 4 1pjb_c00 L-ALANINE DEHYDROGENASE user 2 4 # 2 A 74 LYS B 24 LYS~? -3.00 C2 BME B 602s A 95 HIS B 22 HIS~? -3.40 MN MN B 607s A 117 GLU B 141 GLU~? 7.71 MN MN B 607 A 269 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 8.15 32.64 23.74 10.45 29.09 22.22 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 13.22 26.82 27.06 12.30 25.69 25.54 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 9.91 23.87 29.04 9.51 25.99 29.30 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 19.03 25.15 20.47 17.35 23.93 20.93 -15.81 81.35 4.53 -16.00 83.45 4.93 1pjb_c00 source 1pjb L-ALANINE DEHYDROGENASE : 2 hits 1pjb_c00 naa= 4 ULMN 4 1qdl_c00 ANTHRANILATE SYNTHASE (TRPG-SUBUNIT)user 1 4 # 1 A 306 HIS A 96 HIS~? -3.41 MN MN A 605s B 84 CYH B 21 CYH~? -2.10 S2 BME B 602s B 175 HIS B 22 HIS~? -3.40 MN MN B 607s B 177 GLU B 141 GLU~? 7.71 MN MN B 607 coo 55.83 56.91 94.46 55.42 58.69 95.48 0.59 58.54 20.35 2.20 57.89 19.15 coo 43.27 49.68 68.58 42.94 51.51 70.81 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 48.16 48.72 72.45 46.70 50.20 72.14 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 52.64 49.71 69.47 51.08 49.88 70.90 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 4 1qdl_c00 ANTHRANILATE SYNTHASE (TRPG-SUBUNIT)user 2 4 # 2 A 306 HIS B 96 HIS~? -3.43 MN MN B 606s B 84 CYH A 21 CYH~? -2.28 S2 BME A 601s B 175 HIS A 22 HIS~? -3.40 MN MN A 604s B 177 GLU A 141 GLU~? 7.70 MN MN A 604 coo 55.83 56.91 94.46 55.42 58.69 95.48 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 43.27 49.68 68.58 42.94 51.51 70.81 3.34 47.98 12.34 4.26 47.15 14.87 coo 48.16 48.72 72.45 46.70 50.20 72.14 3.18 53.06 10.64 3.66 54.63 11.95 coo 52.64 49.71 69.47 51.08 49.88 70.90 4.84 56.74 8.27 3.91 55.44 6.87 1qdl_c00 source 1qdl ANTHRANILATE SYNTHASE (TRPG-SUBUNIT) : 2 hits 1qdl_c00 naa= 4 ULMN 4 1qdl_c01 ANTHRANILATE SYNTHASE (TRPG-SUBUNIT)user 1 4 # 1 A 306 HIS A 96 HIS~? -3.41 MN MN A 605s B 84 CYH B 21 CYH~? -2.10 S2 BME B 602s B 175 HIS B 22 HIS~? -3.40 MN MN B 607s B 177 GLU B 141 GLU~? 7.71 MN MN B 607 coo 55.83 56.91 94.46 55.42 58.69 95.48 0.59 58.54 20.35 2.20 57.89 19.15 coo 43.27 49.68 68.58 42.94 51.51 70.81 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 48.16 48.72 72.45 46.70 50.20 72.14 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 52.64 49.71 69.47 51.08 49.88 70.90 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 4 1qdl_c01 ANTHRANILATE SYNTHASE (TRPG-SUBUNIT)user 2 4 # 2 A 306 HIS B 96 HIS~? -3.43 MN MN B 606s B 84 CYH A 21 CYH~? -2.28 S2 BME A 601s B 175 HIS A 22 HIS~? -3.40 MN MN A 604s B 177 GLU A 141 GLU~? 7.70 MN MN A 604 coo 55.83 56.91 94.46 55.42 58.69 95.48 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 43.27 49.68 68.58 42.94 51.51 70.81 3.34 47.98 12.34 4.26 47.15 14.87 coo 48.16 48.72 72.45 46.70 50.20 72.14 3.18 53.06 10.64 3.66 54.63 11.95 coo 52.64 49.71 69.47 51.08 49.88 70.90 4.84 56.74 8.27 3.91 55.44 6.87 1qdl_c01 source 1qdl ANTHRANILATE SYNTHASE (TRPG-SUBUNIT) : 2 hits 1qdl_c01 naa= 4 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 4 # 1 168 GLU A 70 GLU~? -2.54 MN MN A 604s 211 GLU A 140 GLU~? -2.42 MN MN A 605s 345 LYS A 24 LYS~? 4.08 C2 BME A 601 373 HIS A 22 HIS~? -3.40 MN MN A 604s coo 93.06 51.30 30.12 94.58 49.94 29.58 6.20 55.25 17.70 4.45 55.72 16.64 coo 91.99 44.43 29.92 93.23 45.97 29.33 5.06 58.75 13.41 3.74 57.63 14.59 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.91 46.54 9.97 2.66 42.32 12.44 coo 97.15 42.73 29.83 95.81 44.24 30.44 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 4 # 2 168 GLU A 140 GLU~? -2.42 MN MN A 605s 211 GLU A 70 GLU~? -2.54 MN MN A 604s 345 LYS A 24 LYS~? 4.08 C2 BME A 601 373 HIS A 66 HIS~? 3.42 MN MN A 604s coo 93.06 51.30 30.12 94.58 49.94 29.58 5.06 58.75 13.41 3.74 57.63 14.59 coo 91.99 44.43 29.92 93.23 45.97 29.33 6.20 55.25 17.70 4.45 55.72 16.64 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.91 46.54 9.97 2.66 42.32 12.44 coo 97.15 42.73 29.83 95.81 44.24 30.44 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 4 # 3 168 GLU B 70 GLU~? -2.57 MN MN B 607s 211 GLU B 140 GLU~? -2.41 MN MN B 606s 345 LYS B 24 LYS~? -3.00 C2 BME B 602s 373 HIS B 22 HIS~? -3.40 MN MN B 607s coo 93.06 51.30 30.12 94.58 49.94 29.58 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 91.99 44.43 29.92 93.23 45.97 29.33 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 103.66 43.57 23.68 98.86 47.65 23.32 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 97.15 42.73 29.83 95.81 44.24 30.44 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 4 5enl_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 4 # 4 168 GLU B 140 GLU~? -2.41 MN MN B 606s 211 GLU B 70 GLU~? -2.57 MN MN B 607s 345 LYS B 24 LYS~? -3.00 C2 BME B 602s 373 HIS B 66 HIS~? 3.43 MN MN B 607s coo 93.06 51.30 30.12 94.58 49.94 29.58 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 91.99 44.43 29.92 93.23 45.97 29.33 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 103.66 43.57 23.68 98.86 47.65 23.32 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 97.15 42.73 29.83 95.81 44.24 30.44 -11.11 81.39 7.66 -9.84 80.27 6.41 5enl_c01 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 4 hits 5enl_c01 naa= 4 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 1 3 # 1 A 46 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 100 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 116 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 5.32 68.36 21.17 7.09 68.49 22.34 coo 26.40 25.34 6.28 26.15 22.33 7.25 -0.58 68.78 21.39 1.97 70.41 20.81 coo 26.74 21.94 13.78 27.57 20.97 12.08 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 2 3 # 2 A 46 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 100 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 116 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 32.24 20.09 5.34 30.38 19.04 5.27 5.32 68.36 21.17 7.09 68.49 22.34 coo 26.40 25.34 6.28 26.15 22.33 7.25 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 26.74 21.94 13.78 27.57 20.97 12.08 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 12as_c00 ASPARAGINE SYNTHETASE user 3 3 # 3 A 46 ASP B 90 ASP~? 13.30 MN MN B 606 A 100 ARG A 128 ARG~? 18.10 CL CL A 608 A 116 GLN B 95 GLN~? 8.04 MN MN B 606 coo 32.24 20.09 5.34 30.38 19.04 5.27 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 26.40 25.34 6.28 26.15 22.33 7.25 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 26.74 21.94 13.78 27.57 20.97 12.08 -8.78 68.50 12.35 -7.20 68.45 10.97 12as_c00 source 12as ASPARAGINE SYNTHETASE : 3 hits 12as_c00 naa= 3 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 1 3 # 1 B 46 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 100 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 116 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 32.18 48.37 12.48 33.96 49.46 12.97 5.32 68.36 21.17 7.09 68.49 22.34 coo 39.04 43.25 11.37 38.30 45.35 13.56 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 37.43 42.63 19.41 36.76 44.08 17.97 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 2 3 # 2 B 46 ASP A 134 ASP~? 12.23 CL CL A 608 B 100 ARG B 94 ARG~? 13.57 MN MN B 606 B 116 GLN B 95 GLN~? 8.04 MN MN B 606 coo 32.18 48.37 12.48 33.96 49.46 12.97 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 39.04 43.25 11.37 38.30 45.35 13.56 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 37.43 42.63 19.41 36.76 44.08 17.97 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 12as_c01 ASPARAGINE SYNTHETASE user 3 3 # 3 B 46 ASP B 90 ASP~? 13.30 MN MN B 606 B 100 ARG A 128 ARG~? 18.10 CL CL A 608 B 116 GLN B 95 GLN~? 8.04 MN MN B 606 coo 32.18 48.37 12.48 33.96 49.46 12.97 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 39.04 43.25 11.37 38.30 45.35 13.56 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 37.43 42.63 19.41 36.76 44.08 17.97 -8.78 68.50 12.35 -7.20 68.45 10.97 12as_c01 source 12as ASPARAGINE SYNTHETASE : 3 hits 12as_c01 naa= 3 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 66 HIS~? 3.42 MN MN A 604s A 102 ASP A 69 ASP~? 7.42 O1 BME A 601 A 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 25.57 41.22 61.68 24.18 39.98 62.50 3.21 51.23 16.81 3.87 52.43 15.22 coo 22.33 45.48 59.73 23.35 43.67 60.06 7.88 51.22 19.98 7.64 49.14 20.25 coo 22.57 32.23 64.13 21.98 32.82 64.22 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1a0j_c12 TRYPSIN user 2 3 # 2 A 57 HIS B 66 HIS~? 3.43 MN MN B 607s A 102 ASP B 69 ASP~? 7.66 S2 BME B 602 A 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 22.33 45.48 59.73 23.35 43.67 60.06 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 22.57 32.23 64.13 21.98 32.82 64.22 -1.78 84.52 5.86 -2.42 84.42 6.43 1a0j_c12 source 1a0j TRYPSIN : 2 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 66 HIS~? 3.42 MN MN A 604s B 102 ASP A 69 ASP~? 7.42 O1 BME A 601 B 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 44.08 45.58 52.81 45.86 46.55 52.85 3.21 51.23 16.81 3.87 52.43 15.22 coo 43.04 44.75 47.18 43.31 45.51 49.13 7.88 51.22 19.98 7.64 49.14 20.25 coo 50.46 51.91 56.90 50.65 51.62 56.14 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1a0j_c13 TRYPSIN user 2 3 # 2 B 57 HIS B 66 HIS~? 3.43 MN MN B 607s B 102 ASP B 69 ASP~? 7.66 S2 BME B 602 B 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 43.04 44.75 47.18 43.31 45.51 49.13 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 50.46 51.91 56.90 50.65 51.62 56.14 -1.78 84.52 5.86 -2.42 84.42 6.43 1a0j_c13 source 1a0j TRYPSIN : 2 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 66 HIS~? 3.42 MN MN A 604s C 102 ASP A 69 ASP~? 7.42 O1 BME A 601 C 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 34.37 41.18 73.21 34.04 43.09 73.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 34.89 38.34 78.12 35.11 39.59 76.42 7.88 51.22 19.98 7.64 49.14 20.25 coo 35.43 51.03 72.12 35.20 50.72 72.87 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1a0j_c14 TRYPSIN user 2 3 # 2 C 57 HIS B 66 HIS~? 3.43 MN MN B 607s C 102 ASP B 69 ASP~? 7.66 S2 BME B 602 C 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 34.89 38.34 78.12 35.11 39.59 76.42 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 35.43 51.03 72.12 35.20 50.72 72.87 -1.78 84.52 5.86 -2.42 84.42 6.43 1a0j_c14 source 1a0j TRYPSIN : 2 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 66 HIS~? 3.42 MN MN A 604s D 102 ASP A 69 ASP~? 7.42 O1 BME A 601 D 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 8.19 15.01 95.72 7.78 16.53 97.01 3.21 51.23 16.81 3.87 52.43 15.22 coo 13.53 16.28 93.98 11.45 16.21 94.40 7.88 51.22 19.98 7.64 49.14 20.25 coo 1.80 21.25 100.04 2.61 21.42 100.18 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1a0j_c15 TRYPSIN user 2 3 # 2 D 57 HIS B 66 HIS~? 3.43 MN MN B 607s D 102 ASP B 69 ASP~? 7.66 S2 BME B 602 D 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 13.53 16.28 93.98 11.45 16.21 94.40 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 1.80 21.25 100.04 2.61 21.42 100.18 -1.78 84.52 5.86 -2.42 84.42 6.43 1a0j_c15 source 1a0j TRYPSIN : 2 hits 1a0j_c15 naa= 3 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 1 3 # 1 B 13 HIS A 67 HIS~? -4.40 CL CL A 608s B 40 LYS A 24 LYS~? 4.08 C2 BME A 601 B 114 HIS A 136 HIS~? 3.48 MN MN A 605s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 0.35 54.22 20.29 -1.10 54.30 18.77 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -0.91 46.54 9.97 2.66 42.32 12.44 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1a4y_c00 RIBONUCLEASE INHIBITOR user 2 3 # 2 B 13 HIS B 67 HIS~? -4.45 CL CL B 609s B 40 LYS B 24 LYS~? -3.00 C2 BME B 602s B 114 HIS B 136 HIS~? 3.50 MN MN B 606s coo 1.80 -13.66 41.28 2.01 -11.61 41.71 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 8.72 -5.06 38.24 5.16 -8.30 41.14 -3.23 86.22 8.94 -7.29 90.78 7.55 coo -3.17 -9.07 46.16 -1.65 -8.08 47.22 -7.23 73.04 10.16 -9.24 73.26 9.58 1a4y_c00 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c00 naa= 3 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 1 3 # 1 E 13 HIS A 67 HIS~? -4.40 CL CL A 608s E 40 LYS A 24 LYS~? 4.08 C2 BME A 601 E 114 HIS A 136 HIS~? 3.48 MN MN A 605s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 0.35 54.22 20.29 -1.10 54.30 18.77 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -0.91 46.54 9.97 2.66 42.32 12.44 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1a4y_c01 RIBONUCLEASE INHIBITOR user 2 3 # 2 E 13 HIS B 67 HIS~? -4.45 CL CL B 609s E 40 LYS B 24 LYS~? -3.00 C2 BME B 602s E 114 HIS B 136 HIS~? 3.50 MN MN B 606s coo 22.66 18.80 -11.81 23.81 19.26 -10.13 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 21.57 20.13 -0.45 23.62 20.29 -5.74 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 30.88 19.38 -11.95 31.04 21.06 -10.71 -7.23 73.04 10.16 -9.24 73.26 9.58 1a4y_c01 source 1a4y RIBONUCLEASE INHIBITOR : 2 hits 1a4y_c01 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 16 GLU~? 14.76 S2 BME A 601 A 60 ASP A 69 ASP~? 7.42 O1 BME A 601 A 175 TYR A 19 TYR~? 9.00 MN MN A 604 coo 46.10 28.27 19.27 45.48 26.99 20.84 13.57 48.33 8.05 14.78 46.83 7.14 coo 56.42 28.06 12.93 55.01 27.92 14.50 7.88 51.22 19.98 7.64 49.14 20.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU A 140 GLU~? -2.42 MN MN A 605s A 60 ASP A 69 ASP~? 7.42 O1 BME A 601 A 175 TYR A 19 TYR~? 9.00 MN MN A 604 coo 46.10 28.27 19.27 45.48 26.99 20.84 5.06 58.75 13.41 3.74 57.63 14.59 coo 56.42 28.06 12.93 55.01 27.92 14.50 7.88 51.22 19.98 7.64 49.14 20.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 3 3 # 3 A 49 GLU A 141 GLU~? 7.70 MN MN A 604 A 60 ASP A 69 ASP~? 7.42 O1 BME A 601 A 175 TYR A 19 TYR~? 9.00 MN MN A 604 coo 46.10 28.27 19.27 45.48 26.99 20.84 4.84 56.74 8.27 3.91 55.44 6.87 coo 56.42 28.06 12.93 55.01 27.92 14.50 7.88 51.22 19.98 7.64 49.14 20.25 coo 45.02 22.04 15.38 46.16 24.00 13.76 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 4 3 # 4 A 49 GLU B 16 GLU~? 10.04 C2 BME B 602 A 60 ASP B 69 ASP~? 7.66 S2 BME B 602 A 175 TYR B 19 TYR~? 9.04 MN MN B 607 coo 46.10 28.27 19.27 45.48 26.99 20.84 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo 56.42 28.06 12.93 55.01 27.92 14.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 45.02 22.04 15.38 46.16 24.00 13.76 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 5 3 # 5 A 49 GLU B 140 GLU~? -2.41 MN MN B 606s A 60 ASP B 69 ASP~? 7.66 S2 BME B 602 A 175 TYR B 19 TYR~? 9.04 MN MN B 607 coo 46.10 28.27 19.27 45.48 26.99 20.84 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 56.42 28.06 12.93 55.01 27.92 14.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 45.02 22.04 15.38 46.16 24.00 13.76 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 6 3 # 6 A 49 GLU B 141 GLU~? 7.71 MN MN B 607 A 60 ASP B 69 ASP~? 7.66 S2 BME B 602 A 175 TYR B 19 TYR~? 9.04 MN MN B 607 coo 46.10 28.27 19.27 45.48 26.99 20.84 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 56.42 28.06 12.93 55.01 27.92 14.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 45.02 22.04 15.38 46.16 24.00 13.76 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 6 hits 1a50_c03 naa= 3 ULMN 3 1a65_c00 LACCASE user 1 3 # 1 A 451 HIS A 22 HIS~? -3.40 MN MN A 604s A 452 CYH A 21 CYH~? -2.28 S2 BME A 601s A 453 HIS A 66 HIS~? 3.42 MN MN A 604s coo 3.92 41.70 29.28 5.16 41.54 27.59 3.18 53.06 10.64 3.66 54.63 11.95 coo 2.17 37.54 30.39 0.70 35.33 29.69 3.34 47.98 12.34 4.26 47.15 14.87 coo 6.12 36.86 25.94 7.22 37.67 24.36 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1a65_c00 LACCASE user 2 3 # 2 A 451 HIS A 66 HIS~? 3.42 MN MN A 604s A 452 CYH A 21 CYH~? -2.28 S2 BME A 601s A 453 HIS A 22 HIS~? -3.40 MN MN A 604s coo 3.92 41.70 29.28 5.16 41.54 27.59 3.21 51.23 16.81 3.87 52.43 15.22 coo 2.17 37.54 30.39 0.70 35.33 29.69 3.34 47.98 12.34 4.26 47.15 14.87 coo 6.12 36.86 25.94 7.22 37.67 24.36 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1a65_c00 LACCASE user 3 3 # 3 A 451 HIS B 22 HIS~? -3.40 MN MN B 607s A 452 CYH B 21 CYH~? -2.10 S2 BME B 602s A 453 HIS B 66 HIS~? 3.43 MN MN B 607s coo 3.92 41.70 29.28 5.16 41.54 27.59 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 2.17 37.54 30.39 0.70 35.33 29.69 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 6.12 36.86 25.94 7.22 37.67 24.36 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1a65_c00 LACCASE user 4 3 # 4 A 451 HIS B 66 HIS~? 3.43 MN MN B 607s A 452 CYH B 21 CYH~? -2.10 S2 BME B 602s A 453 HIS B 22 HIS~? -3.40 MN MN B 607s coo 3.92 41.70 29.28 5.16 41.54 27.59 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 2.17 37.54 30.39 0.70 35.33 29.69 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 6.12 36.86 25.94 7.22 37.67 24.36 -5.34 79.70 5.35 -6.67 78.07 5.35 1a65_c00 source 1a65 LACCASE : 4 hits 1a65_c00 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 133 TYR~? 5.56 CL CL A 608 A 125 HIS A 22 HIS~? -3.40 MN MN A 604s A 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 3.18 53.06 10.64 3.66 54.63 11.95 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 2 3 # 2 A 115 TYR A 133 TYR~? 5.56 CL CL A 608 A 125 HIS A 66 HIS~? 3.42 MN MN A 604s A 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 3.21 51.23 16.81 3.87 52.43 15.22 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 3 3 # 3 A 115 TYR B 133 TYR~? 5.56 CL CL B 609 A 125 HIS B 22 HIS~? -3.40 MN MN B 607s A 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 4 3 # 4 A 115 TYR B 133 TYR~? 5.56 CL CL B 609 A 125 HIS B 66 HIS~? 3.43 MN MN B 607s A 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -3.23 86.22 8.94 -7.29 90.78 7.55 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 133 TYR~? 5.56 CL CL A 608 B 125 HIS A 66 HIS~? 3.42 MN MN A 604s B 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 3.21 51.23 16.81 3.87 52.43 15.22 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 2 3 # 2 B 115 TYR B 133 TYR~? 5.56 CL CL B 609 B 125 HIS B 66 HIS~? 3.43 MN MN B 607s B 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -3.23 86.22 8.94 -7.29 90.78 7.55 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 2 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 19 TYR~? 9.00 MN MN A 604 C 125 HIS A 66 HIS~? 3.42 MN MN A 604s C 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 8.27 52.26 7.85 9.08 54.84 7.01 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 3.21 51.23 16.81 3.87 52.43 15.22 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 2 3 # 2 C 115 TYR A 133 TYR~? 5.56 CL CL A 608 C 125 HIS A 22 HIS~? -3.40 MN MN A 604s C 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 3.18 53.06 10.64 3.66 54.63 11.95 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 3 3 # 3 C 115 TYR A 133 TYR~? 5.56 CL CL A 608 C 125 HIS A 66 HIS~? 3.42 MN MN A 604s C 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 3.21 51.23 16.81 3.87 52.43 15.22 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 4 3 # 4 C 115 TYR B 19 TYR~? 9.04 MN MN B 607 C 125 HIS B 66 HIS~? 3.43 MN MN B 607s C 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 5 3 # 5 C 115 TYR B 133 TYR~? 5.56 CL CL B 609 C 125 HIS B 22 HIS~? -3.40 MN MN B 607s C 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 6 3 # 6 C 115 TYR B 133 TYR~? 5.56 CL CL B 609 C 125 HIS B 66 HIS~? 3.43 MN MN B 607s C 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -3.23 86.22 8.94 -7.29 90.78 7.55 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 6 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 133 TYR~? 5.56 CL CL A 608 D 125 HIS A 22 HIS~? -3.40 MN MN A 604s D 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 54.10 1.42 85.16 54.14 4.17 85.62 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 3.18 53.06 10.64 3.66 54.63 11.95 coo 60.28 4.62 76.00 58.35 6.41 80.65 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 2 3 # 2 D 115 TYR A 133 TYR~? 5.56 CL CL A 608 D 125 HIS A 66 HIS~? 3.42 MN MN A 604s D 156 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 54.10 1.42 85.16 54.14 4.17 85.62 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 61.27 5.43 85.32 62.73 6.38 86.49 3.21 51.23 16.81 3.87 52.43 15.22 coo 60.28 4.62 76.00 58.35 6.41 80.65 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 3 3 # 3 D 115 TYR B 133 TYR~? 5.56 CL CL B 609 D 125 HIS B 22 HIS~? -3.40 MN MN B 607s D 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 54.10 1.42 85.16 54.14 4.17 85.62 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 61.27 5.43 85.32 62.73 6.38 86.49 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 60.28 4.62 76.00 58.35 6.41 80.65 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 4 3 # 4 D 115 TYR B 133 TYR~? 5.56 CL CL B 609 D 125 HIS B 66 HIS~? 3.43 MN MN B 607s D 156 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 54.10 1.42 85.16 54.14 4.17 85.62 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 61.27 5.43 85.32 62.73 6.38 86.49 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 60.28 4.62 76.00 58.35 6.41 80.65 -3.23 86.22 8.94 -7.29 90.78 7.55 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 4 hits 1a79_c03 naa= 3 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 1 3 # 1 16 ALA A 20 ALA~? 6.78 S2 BME A 601 19 HIS A 22 HIS~? -3.40 MN MN A 604s 22 HIS A 66 HIS~? 3.42 MN MN A 604s coo 53.27 36.51 45.29 51.98 36.45 44.47 5.75 47.12 9.54 6.62 45.86 9.91 coo 46.88 33.59 48.26 46.24 34.32 46.40 3.18 53.06 10.64 3.66 54.63 11.95 coo 48.05 31.12 44.60 48.20 33.05 43.77 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 2 3 # 2 16 ALA A 20 ALA~? 6.78 S2 BME A 601 19 HIS A 66 HIS~? 3.42 MN MN A 604s 22 HIS A 22 HIS~? -3.40 MN MN A 604s coo 53.27 36.51 45.29 51.98 36.45 44.47 5.75 47.12 9.54 6.62 45.86 9.91 coo 46.88 33.59 48.26 46.24 34.32 46.40 3.21 51.23 16.81 3.87 52.43 15.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 3 3 # 3 16 ALA A 62 ALA~? -3.33 C1 BME A 601s 19 HIS A 66 HIS~? 3.42 MN MN A 604s 22 HIS A 67 HIS~? -4.40 CL CL A 608s coo 53.27 36.51 45.29 51.98 36.45 44.47 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 3.21 51.23 16.81 3.87 52.43 15.22 coo 48.05 31.12 44.60 48.20 33.05 43.77 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 4 3 # 4 16 ALA A 62 ALA~? -3.33 C1 BME A 601s 19 HIS A 67 HIS~? -4.40 CL CL A 608s 22 HIS A 66 HIS~? 3.42 MN MN A 604s coo 53.27 36.51 45.29 51.98 36.45 44.47 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 46.88 33.59 48.26 46.24 34.32 46.40 0.35 54.22 20.29 -1.10 54.30 18.77 coo 48.05 31.12 44.60 48.20 33.05 43.77 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 5 3 # 5 16 ALA A 63 ALA~? 7.13 CL CL A 608 19 HIS A 96 HIS~? -3.41 MN MN A 605s 22 HIS A 100 HIS~? 8.88 CL CL A 608 coo 53.27 36.51 45.29 51.98 36.45 44.47 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 46.88 33.59 48.26 46.24 34.32 46.40 0.59 58.54 20.35 2.20 57.89 19.15 coo 48.05 31.12 44.60 48.20 33.05 43.77 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 6 3 # 6 16 ALA B 20 ALA~? 6.16 C2 BME B 602 19 HIS B 22 HIS~? -3.40 MN MN B 607s 22 HIS B 66 HIS~? 3.43 MN MN B 607s coo 53.27 36.51 45.29 51.98 36.45 44.47 -5.51 85.82 2.70 -6.35 87.03 2.21 coo 46.88 33.59 48.26 46.24 34.32 46.40 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 48.05 31.12 44.60 48.20 33.05 43.77 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 7 3 # 7 16 ALA B 20 ALA~? 6.16 C2 BME B 602 19 HIS B 66 HIS~? 3.43 MN MN B 607s 22 HIS B 22 HIS~? -3.40 MN MN B 607s coo 53.27 36.51 45.29 51.98 36.45 44.47 -5.51 85.82 2.70 -6.35 87.03 2.21 coo 46.88 33.59 48.26 46.24 34.32 46.40 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 48.05 31.12 44.60 48.20 33.05 43.77 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 8 3 # 8 16 ALA B 62 ALA~? 4.29 C1 BME B 602 19 HIS B 66 HIS~? 3.43 MN MN B 607s 22 HIS B 67 HIS~? -4.45 CL CL B 609s coo 53.27 36.51 45.29 51.98 36.45 44.47 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 46.88 33.59 48.26 46.24 34.32 46.40 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 48.05 31.12 44.60 48.20 33.05 43.77 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 9 3 # 9 16 ALA B 62 ALA~? 4.29 C1 BME B 602 19 HIS B 67 HIS~? -4.45 CL CL B 609s 22 HIS B 66 HIS~? 3.43 MN MN B 607s coo 53.27 36.51 45.29 51.98 36.45 44.47 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 46.88 33.59 48.26 46.24 34.32 46.40 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 48.05 31.12 44.60 48.20 33.05 43.77 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 10 3 # 10 16 ALA B 63 ALA~? 7.11 CL CL B 609 19 HIS B 96 HIS~? -3.43 MN MN B 606s 22 HIS B 100 HIS~? 8.87 CL CL B 609 coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 46.88 33.59 48.26 46.24 34.32 46.40 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 48.05 31.12 44.60 48.20 33.05 43.77 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1a8h_c02 METHIONYL-TRNA SYNTHETASE user 11 3 # 11 16 ALA B 63 ALA~? 7.11 CL CL B 609 19 HIS B 100 HIS~? 8.87 CL CL B 609 22 HIS B 96 HIS~? -3.43 MN MN B 606s coo 53.27 36.51 45.29 51.98 36.45 44.47 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 46.88 33.59 48.26 46.24 34.32 46.40 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 48.05 31.12 44.60 48.20 33.05 43.77 -13.24 74.01 11.32 -12.76 74.71 9.40 1a8h_c02 source 1a8h METHIONYL-TRNA SYNTHETASE : 11 hits 1a8h_c02 naa= 3 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 1 3 # 1 142 TRP A 103 TRP~? 13.04 CL CL A 608 223 ASP A 101 ASP~? 14.47 MN MN A 605 258 LYS A 127 LYS~? 18.61 MN MN B 606 coo 127.19 33.46 26.14 126.78 36.79 28.15 -8.87 50.94 21.19 -10.72 48.76 18.46 coo 126.95 41.66 23.38 128.48 40.72 24.51 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 138.83 37.95 25.17 133.50 36.37 26.52 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1aam_c01 ASPARTATE AMINOTRANSFERASE user 2 3 # 2 142 TRP B 103 TRP~? 12.92 CL CL B 609 223 ASP B 101 ASP~? 14.48 MN MN B 606 258 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 127.19 33.46 26.14 126.78 36.79 28.15 -10.49 81.55 20.44 -7.30 83.78 21.03 coo 126.95 41.66 23.38 128.48 40.72 24.51 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 138.83 37.95 25.17 133.50 36.37 26.52 2.32 75.24 21.44 7.34 73.34 24.59 1aam_c01 source 1aam ASPARTATE AMINOTRANSFERASE : 2 hits 1aam_c01 naa= 3 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 1 3 # 1 A 223 HIS A 22 HIS~? -3.40 MN MN A 604s A 262 HIS A 67 HIS~? -4.40 CL CL A 608s A 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.33 36.13 69.70 30.07 34.20 70.11 3.18 53.06 10.64 3.66 54.63 11.95 coo 38.54 36.60 66.38 37.88 34.77 67.15 0.35 54.22 20.29 -1.10 54.30 18.77 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 2 3 # 2 A 223 HIS A 22 HIS~? -3.40 MN MN A 604s A 262 HIS A 96 HIS~? -3.41 MN MN A 605s A 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.33 36.13 69.70 30.07 34.20 70.11 3.18 53.06 10.64 3.66 54.63 11.95 coo 38.54 36.60 66.38 37.88 34.77 67.15 0.59 58.54 20.35 2.20 57.89 19.15 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 3 3 # 3 A 223 HIS A 67 HIS~? -4.40 CL CL A 608s A 262 HIS A 22 HIS~? -3.40 MN MN A 604s A 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.33 36.13 69.70 30.07 34.20 70.11 0.35 54.22 20.29 -1.10 54.30 18.77 coo 38.54 36.60 66.38 37.88 34.77 67.15 3.18 53.06 10.64 3.66 54.63 11.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 4 3 # 4 A 223 HIS A 96 HIS~? -3.41 MN MN A 605s A 262 HIS A 22 HIS~? -3.40 MN MN A 604s A 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.33 36.13 69.70 30.07 34.20 70.11 0.59 58.54 20.35 2.20 57.89 19.15 coo 38.54 36.60 66.38 37.88 34.77 67.15 3.18 53.06 10.64 3.66 54.63 11.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 5 3 # 5 A 223 HIS A 136 HIS~? 3.48 MN MN A 605s A 262 HIS A 22 HIS~? -3.40 MN MN A 604s A 312 ASP A 134 ASP~? 12.23 CL CL A 608 coo 29.33 36.13 69.70 30.07 34.20 70.11 -0.57 59.60 14.33 0.78 59.36 15.93 coo 38.54 36.60 66.38 37.88 34.77 67.15 3.18 53.06 10.64 3.66 54.63 11.95 coo 30.62 37.23 61.07 30.08 35.73 62.49 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 6 3 # 6 A 223 HIS B 22 HIS~? -3.40 MN MN B 607s A 262 HIS B 67 HIS~? -4.45 CL CL B 609s A 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.33 36.13 69.70 30.07 34.20 70.11 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 38.54 36.60 66.38 37.88 34.77 67.15 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 30.62 37.23 61.07 30.08 35.73 62.49 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 7 3 # 7 A 223 HIS B 22 HIS~? -3.40 MN MN B 607s A 262 HIS B 96 HIS~? -3.43 MN MN B 606s A 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.33 36.13 69.70 30.07 34.20 70.11 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 38.54 36.60 66.38 37.88 34.77 67.15 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 30.62 37.23 61.07 30.08 35.73 62.49 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 8 3 # 8 A 223 HIS B 67 HIS~? -4.45 CL CL B 609s A 262 HIS B 22 HIS~? -3.40 MN MN B 607s A 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.33 36.13 69.70 30.07 34.20 70.11 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 38.54 36.60 66.38 37.88 34.77 67.15 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 30.62 37.23 61.07 30.08 35.73 62.49 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 9 3 # 9 A 223 HIS B 96 HIS~? -3.43 MN MN B 606s A 262 HIS B 22 HIS~? -3.40 MN MN B 607s A 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.33 36.13 69.70 30.07 34.20 70.11 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 38.54 36.60 66.38 37.88 34.77 67.15 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 30.62 37.23 61.07 30.08 35.73 62.49 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c00 CITRATE SYNTHASE user 10 3 # 10 A 223 HIS B 136 HIS~? 3.50 MN MN B 606s A 262 HIS B 22 HIS~? -3.40 MN MN B 607s A 312 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 29.33 36.13 69.70 30.07 34.20 70.11 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 38.54 36.60 66.38 37.88 34.77 67.15 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 30.62 37.23 61.07 30.08 35.73 62.49 1.27 73.42 12.01 2.60 75.02 12.38 1aj8_c00 source 1aj8 CITRATE SYNTHASE : 10 hits 1aj8_c00 naa= 3 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 1 3 # 1 B 223 HIS A 22 HIS~? -3.40 MN MN A 604s B 262 HIS A 67 HIS~? -4.40 CL CL A 608s B 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 23.86 29.50 91.20 24.12 31.58 91.00 3.18 53.06 10.64 3.66 54.63 11.95 coo 29.35 31.42 99.15 28.72 33.09 98.04 0.35 54.22 20.29 -1.10 54.30 18.77 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 2 3 # 2 B 223 HIS A 22 HIS~? -3.40 MN MN A 604s B 262 HIS A 96 HIS~? -3.41 MN MN A 605s B 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 23.86 29.50 91.20 24.12 31.58 91.00 3.18 53.06 10.64 3.66 54.63 11.95 coo 29.35 31.42 99.15 28.72 33.09 98.04 0.59 58.54 20.35 2.20 57.89 19.15 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 3 3 # 3 B 223 HIS A 67 HIS~? -4.40 CL CL A 608s B 262 HIS A 22 HIS~? -3.40 MN MN A 604s B 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 23.86 29.50 91.20 24.12 31.58 91.00 0.35 54.22 20.29 -1.10 54.30 18.77 coo 29.35 31.42 99.15 28.72 33.09 98.04 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 4 3 # 4 B 223 HIS A 96 HIS~? -3.41 MN MN A 605s B 262 HIS A 22 HIS~? -3.40 MN MN A 604s B 312 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 23.86 29.50 91.20 24.12 31.58 91.00 0.59 58.54 20.35 2.20 57.89 19.15 coo 29.35 31.42 99.15 28.72 33.09 98.04 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 5 3 # 5 B 223 HIS A 136 HIS~? 3.48 MN MN A 605s B 262 HIS A 22 HIS~? -3.40 MN MN A 604s B 312 ASP A 134 ASP~? 12.23 CL CL A 608 coo 23.86 29.50 91.20 24.12 31.58 91.00 -0.57 59.60 14.33 0.78 59.36 15.93 coo 29.35 31.42 99.15 28.72 33.09 98.04 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.42 28.25 99.26 20.25 29.62 97.63 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 6 3 # 6 B 223 HIS B 22 HIS~? -3.40 MN MN B 607s B 262 HIS B 67 HIS~? -4.45 CL CL B 609s B 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 23.86 29.50 91.20 24.12 31.58 91.00 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 29.35 31.42 99.15 28.72 33.09 98.04 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 20.42 28.25 99.26 20.25 29.62 97.63 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 7 3 # 7 B 223 HIS B 22 HIS~? -3.40 MN MN B 607s B 262 HIS B 96 HIS~? -3.43 MN MN B 606s B 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 23.86 29.50 91.20 24.12 31.58 91.00 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 29.35 31.42 99.15 28.72 33.09 98.04 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 20.42 28.25 99.26 20.25 29.62 97.63 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 8 3 # 8 B 223 HIS B 67 HIS~? -4.45 CL CL B 609s B 262 HIS B 22 HIS~? -3.40 MN MN B 607s B 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 23.86 29.50 91.20 24.12 31.58 91.00 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 29.35 31.42 99.15 28.72 33.09 98.04 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.42 28.25 99.26 20.25 29.62 97.63 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 9 3 # 9 B 223 HIS B 96 HIS~? -3.43 MN MN B 606s B 262 HIS B 22 HIS~? -3.40 MN MN B 607s B 312 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 23.86 29.50 91.20 24.12 31.58 91.00 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 29.35 31.42 99.15 28.72 33.09 98.04 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.42 28.25 99.26 20.25 29.62 97.63 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1aj8_c01 CITRATE SYNTHASE user 10 3 # 10 B 223 HIS B 136 HIS~? 3.50 MN MN B 606s B 262 HIS B 22 HIS~? -3.40 MN MN B 607s B 312 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 23.86 29.50 91.20 24.12 31.58 91.00 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 29.35 31.42 99.15 28.72 33.09 98.04 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.42 28.25 99.26 20.25 29.62 97.63 1.27 73.42 12.01 2.60 75.02 12.38 1aj8_c01 source 1aj8 CITRATE SYNTHASE : 10 hits 1aj8_c01 naa= 3 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 1 3 # 1 252 THR A 51 THR~? 17.46 S2 BME A 601 350 PHE A 28 PHE~? 9.03 S2 BME A 601 357 CYH A 29 CYH~? 9.71 CL CL A 608 coo 17.85 20.47 14.62 16.85 19.84 12.80 -13.11 40.84 11.29 -13.34 41.71 9.31 coo 7.92 21.96 13.27 8.57 20.30 15.42 -6.17 45.72 11.50 -5.16 43.17 12.10 coo 8.82 20.77 7.90 10.59 19.75 9.80 -8.10 50.91 9.05 -6.68 52.72 10.63 ULMN 3 1akd_c01 CYTOCHROME P450CAM user 2 3 # 2 252 THR B 51 THR~? 17.05 C2 BME B 602 350 PHE B 28 PHE~? 9.03 C2 BME B 602 357 CYH B 29 CYH~? 9.17 O1 GOL B 603 coo 17.85 20.47 14.62 16.85 19.84 12.80 0.21 91.77 20.35 2.10 90.94 19.87 coo 7.92 21.96 13.27 8.57 20.30 15.42 -2.63 86.84 14.28 -3.66 89.36 13.73 coo 8.82 20.77 7.90 10.59 19.75 9.80 0.50 81.71 15.06 -1.49 79.86 14.33 1akd_c01 source 1akd CYTOCHROME P450CAM : 2 hits 1akd_c01 naa= 3 ULMN 3 1al6_c00 CITRATE SYNTHASE user 1 3 # 1 274 HIS A 22 HIS~? -3.40 MN MN A 604s 320 HIS A 67 HIS~? -4.40 CL CL A 608s 375 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 3.18 53.06 10.64 3.66 54.63 11.95 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 0.35 54.22 20.29 -1.10 54.30 18.77 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1al6_c00 CITRATE SYNTHASE user 2 3 # 2 274 HIS A 22 HIS~? -3.40 MN MN A 604s 320 HIS A 96 HIS~? -3.41 MN MN A 605s 375 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 3.18 53.06 10.64 3.66 54.63 11.95 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 0.59 58.54 20.35 2.20 57.89 19.15 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1al6_c00 CITRATE SYNTHASE user 3 3 # 3 274 HIS A 67 HIS~? -4.40 CL CL A 608s 320 HIS A 22 HIS~? -3.40 MN MN A 604s 375 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 0.35 54.22 20.29 -1.10 54.30 18.77 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1al6_c00 CITRATE SYNTHASE user 4 3 # 4 274 HIS A 96 HIS~? -3.41 MN MN A 605s 320 HIS A 22 HIS~? -3.40 MN MN A 604s 375 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 0.59 58.54 20.35 2.20 57.89 19.15 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1al6_c00 CITRATE SYNTHASE user 5 3 # 5 274 HIS A 136 HIS~? 3.48 MN MN A 605s 320 HIS A 22 HIS~? -3.40 MN MN A 604s 375 ASP A 134 ASP~? 12.23 CL CL A 608 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -0.57 59.60 14.33 0.78 59.36 15.93 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 3.18 53.06 10.64 3.66 54.63 11.95 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1al6_c00 CITRATE SYNTHASE user 6 3 # 6 274 HIS B 22 HIS~? -3.40 MN MN B 607s 320 HIS B 67 HIS~? -4.45 CL CL B 609s 375 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 7 3 # 7 274 HIS B 22 HIS~? -3.40 MN MN B 607s 320 HIS B 96 HIS~? -3.43 MN MN B 606s 375 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 8 3 # 8 274 HIS B 67 HIS~? -4.45 CL CL B 609s 320 HIS B 22 HIS~? -3.40 MN MN B 607s 375 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 9 3 # 9 274 HIS B 96 HIS~? -3.43 MN MN B 606s 320 HIS B 22 HIS~? -3.40 MN MN B 607s 375 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1al6_c00 CITRATE SYNTHASE user 10 3 # 10 274 HIS B 136 HIS~? 3.50 MN MN B 606s 320 HIS B 22 HIS~? -3.40 MN MN B 607s 375 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 11.08 -2.90 2.00 11.09 -3.48 -0.01 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 17.22 -10.90 1.81 16.10 -10.23 0.18 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 20.14 -1.52 3.09 18.48 -1.53 1.77 1.27 73.42 12.01 2.60 75.02 12.38 1al6_c00 source 1al6 CITRATE SYNTHASE : 10 hits 1al6_c00 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 37 ASP~? 25.83 CL CL A 608 187 GLU B 87 GLU~? 16.36 MN MN B 606 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -20.38 49.92 2.66 -20.55 51.94 2.14 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -13.10 59.94 3.57 -14.71 59.81 4.92 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 101 ASP~? 14.47 MN MN A 605 187 GLU A 124 GLU~? 15.58 MN MN B 606 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -45.08 48.37 46.81 -46.53 49.74 45.96 -18.72 60.92 13.26 -17.30 61.76 11.93 coo -47.40 44.36 48.48 -50.80 49.18 46.20 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP B 37 ASP~? 15.37 O1 GOL B 603 187 GLU A 87 GLU~? 6.78 O1 GOL B 603 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 11.04 82.75 24.13 11.46 80.73 24.12 coo -45.08 48.37 46.81 -46.53 49.74 45.96 7.70 72.78 18.03 7.03 72.92 20.00 coo -47.40 44.36 48.48 -50.80 49.18 46.20 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP B 101 ASP~? 14.48 MN MN B 606 187 GLU B 124 GLU~? 10.55 C1 GOL B 603 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo -52.57 56.60 47.75 -51.52 54.87 46.95 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -45.08 48.37 46.81 -46.53 49.74 45.96 0.65 71.77 26.43 1.32 70.82 24.72 coo -47.40 44.36 48.48 -50.80 49.18 46.20 2.32 75.24 21.44 7.34 73.34 24.59 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 4 hits 1ald_c00 naa= 3 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 90 ASP~? 8.93 C1 GOL B 603 204 GLU A 87 GLU~? 6.78 O1 GOL B 603 289 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -0.62 65.95 29.97 0.31 67.47 31.05 5.32 68.36 21.17 7.09 68.49 22.34 coo 4.34 62.44 32.05 4.22 64.48 32.53 7.70 72.78 18.03 7.03 72.92 20.00 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 90 ASP~? 8.93 C1 GOL B 603 204 GLU A 91 GLU~? 5.92 C1 GOL B 603 289 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -0.62 65.95 29.97 0.31 67.47 31.05 5.32 68.36 21.17 7.09 68.49 22.34 coo 4.34 62.44 32.05 4.22 64.48 32.53 0.70 67.61 16.19 -1.02 68.27 17.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 134 ASP~? 12.23 CL CL A 608 204 GLU B 91 GLU~? 11.42 MN MN B 606 289 ASP B 90 ASP~? 13.30 MN MN B 606 coo -0.62 65.95 29.97 0.31 67.47 31.05 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 4.34 62.44 32.05 4.22 64.48 32.53 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 90 ASP~? 13.30 MN MN B 606 204 GLU B 87 GLU~? 16.36 MN MN B 606 289 ASP A 134 ASP~? 12.23 CL CL A 608 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 4.34 62.44 32.05 4.22 64.48 32.53 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 90 ASP~? 13.30 MN MN B 606 204 GLU B 91 GLU~? 11.42 MN MN B 606 289 ASP A 134 ASP~? 12.23 CL CL A 608 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 4.34 62.44 32.05 4.22 64.48 32.53 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1amy_c05 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s 204 GLU A 91 GLU~? 5.92 C1 GOL B 603 289 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.27 73.42 12.01 2.60 75.02 12.38 coo 4.34 62.44 32.05 4.22 64.48 32.53 0.70 67.61 16.19 -1.02 68.27 17.25 coo 9.42 68.07 30.27 7.35 68.27 30.10 5.32 68.36 21.17 7.09 68.49 22.34 1amy_c05 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c05 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 90 ASP~? 8.93 C1 GOL B 603 227 GLU A 141 GLU~? 7.70 MN MN A 604 289 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -0.62 65.95 29.97 0.31 67.47 31.05 5.32 68.36 21.17 7.09 68.49 22.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 4.84 56.74 8.27 3.91 55.44 6.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 90 ASP~? 8.93 C1 GOL B 603 227 GLU B 109 GLU~? 18.95 O1 GOL B 603 289 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -0.62 65.95 29.97 0.31 67.47 31.05 5.32 68.36 21.17 7.09 68.49 22.34 coo 3.96 55.76 41.24 4.83 57.69 41.17 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 9.42 68.07 30.27 7.35 68.27 30.10 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 134 ASP~? 12.23 CL CL A 608 227 GLU B 141 GLU~? 7.71 MN MN B 607 289 ASP B 90 ASP~? 13.30 MN MN B 606 coo -0.62 65.95 29.97 0.31 67.47 31.05 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 3.96 55.76 41.24 4.83 57.69 41.17 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP B 90 ASP~? 13.30 MN MN B 606 227 GLU A 109 GLU~? 22.92 CL CL A 608 289 ASP A 134 ASP~? 12.23 CL CL A 608 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP B 90 ASP~? 13.30 MN MN B 606 227 GLU B 141 GLU~? 7.71 MN MN B 607 289 ASP A 134 ASP~? 12.23 CL CL A 608 coo -0.62 65.95 29.97 0.31 67.47 31.05 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 9.42 68.07 30.27 7.35 68.27 30.10 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s 227 GLU A 141 GLU~? 7.70 MN MN A 604 289 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo -0.62 65.95 29.97 0.31 67.47 31.05 1.27 73.42 12.01 2.60 75.02 12.38 coo 3.96 55.76 41.24 4.83 57.69 41.17 4.84 56.74 8.27 3.91 55.44 6.87 coo 9.42 68.07 30.27 7.35 68.27 30.10 5.32 68.36 21.17 7.09 68.49 22.34 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 6 hits 1amy_c06 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS B 22 HIS~? -3.40 MN MN B 607s 254 LYS B 24 LYS~? -3.00 C2 BME B 602s 333 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 28.11 -1.15 8.51 29.21 0.63 8.34 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 26.09 4.87 14.60 27.89 3.33 10.26 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 37.35 7.47 11.84 34.90 6.11 10.60 -16.44 88.73 6.31 -15.58 85.88 6.16 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 1 hits 1aq2_c00 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 75 PHE~? 5.80 MN MN A 605 A 223 ASP A 69 ASP~? 7.42 O1 BME A 601 A 265 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 8.51 60.03 19.19 6.27 59.59 17.55 coo 30.70 47.50 67.53 29.83 49.47 67.39 7.88 51.22 19.98 7.64 49.14 20.25 coo 19.99 54.53 64.11 20.55 58.78 68.33 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 75 PHE~? 5.80 MN MN A 605 A 223 ASP A 69 ASP~? 7.42 O1 BME A 601 A 265 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 39.74 52.86 65.74 41.15 55.14 66.52 8.51 60.03 19.19 6.27 59.59 17.55 coo 30.70 47.50 67.53 29.83 49.47 67.39 7.88 51.22 19.98 7.64 49.14 20.25 coo 19.99 54.53 64.11 20.55 58.78 68.33 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE B 75 PHE~? 5.83 MN MN B 606 A 223 ASP B 69 ASP~? 7.66 S2 BME B 602 A 265 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 39.74 52.86 65.74 41.15 55.14 66.52 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 30.70 47.50 67.53 29.83 49.47 67.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE B 75 PHE~? 5.83 MN MN B 606 A 223 ASP B 69 ASP~? 7.66 S2 BME B 602 A 265 LYS B 169 LYS.? 16.77 C1 BME B 602 coo 39.74 52.86 65.74 41.15 55.14 66.52 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 30.70 47.50 67.53 29.83 49.47 67.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 19.99 54.53 64.11 20.55 58.78 68.33 -23.52 91.35 9.46 -25.45 91.49 15.04 1ax4_c04 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 75 PHE~? 5.80 MN MN A 605 B 223 ASP A 69 ASP~? 7.42 O1 BME A 601 B 265 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 8.51 60.03 19.19 6.27 59.59 17.55 coo 10.43 61.66 91.81 9.80 60.04 90.61 7.88 51.22 19.98 7.64 49.14 20.25 coo 5.43 58.06 80.08 8.57 53.00 79.37 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 75 PHE~? 5.80 MN MN A 605 B 223 ASP A 69 ASP~? 7.42 O1 BME A 601 B 265 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 7.48 54.94 99.62 7.67 52.27 100.42 8.51 60.03 19.19 6.27 59.59 17.55 coo 10.43 61.66 91.81 9.80 60.04 90.61 7.88 51.22 19.98 7.64 49.14 20.25 coo 5.43 58.06 80.08 8.57 53.00 79.37 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE B 75 PHE~? 5.83 MN MN B 606 B 223 ASP B 69 ASP~? 7.66 S2 BME B 602 B 265 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 7.48 54.94 99.62 7.67 52.27 100.42 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 10.43 61.66 91.81 9.80 60.04 90.61 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE B 75 PHE~? 5.83 MN MN B 606 B 223 ASP B 69 ASP~? 7.66 S2 BME B 602 B 265 LYS B 169 LYS.? 16.77 C1 BME B 602 coo 7.48 54.94 99.62 7.67 52.27 100.42 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 10.43 61.66 91.81 9.80 60.04 90.61 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 5.43 58.06 80.08 8.57 53.00 79.37 -23.52 91.35 9.46 -25.45 91.49 15.04 1ax4_c05 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 75 PHE~? 5.80 MN MN A 605 C 223 ASP A 69 ASP~? 7.42 O1 BME A 601 C 265 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 8.51 60.03 19.19 6.27 59.59 17.55 coo -9.52 75.74 33.62 -8.85 73.74 33.93 7.88 51.22 19.98 7.64 49.14 20.25 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 75 PHE~? 5.80 MN MN A 605 C 223 ASP A 69 ASP~? 7.42 O1 BME A 601 C 265 LYS A 169 LYS.? 14.89 O1 BME A 601 coo -6.55 73.45 23.60 -6.77 71.48 21.66 8.51 60.03 19.19 6.27 59.59 17.55 coo -9.52 75.74 33.62 -8.85 73.74 33.93 7.88 51.22 19.98 7.64 49.14 20.25 coo -4.44 67.20 42.32 -7.50 62.41 40.49 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE B 75 PHE~? 5.83 MN MN B 606 C 223 ASP B 69 ASP~? 7.66 S2 BME B 602 C 265 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -6.55 73.45 23.60 -6.77 71.48 21.66 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE B 75 PHE~? 5.83 MN MN B 606 C 223 ASP B 69 ASP~? 7.66 S2 BME B 602 C 265 LYS B 169 LYS.? 16.77 C1 BME B 602 coo -6.55 73.45 23.60 -6.77 71.48 21.66 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -9.52 75.74 33.62 -8.85 73.74 33.93 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -4.44 67.20 42.32 -7.50 62.41 40.49 -23.52 91.35 9.46 -25.45 91.49 15.04 1ax4_c06 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 75 PHE~? 5.80 MN MN A 605 D 223 ASP A 69 ASP~? 7.42 O1 BME A 601 D 265 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 8.51 60.03 19.19 6.27 59.59 17.55 coo -29.46 51.67 48.51 -28.63 53.31 49.56 7.88 51.22 19.98 7.64 49.14 20.25 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 75 PHE~? 5.80 MN MN A 605 D 223 ASP A 69 ASP~? 7.42 O1 BME A 601 D 265 LYS A 169 LYS.? 14.89 O1 BME A 601 coo -38.60 55.38 52.70 -40.06 57.72 53.04 8.51 60.03 19.19 6.27 59.59 17.55 coo -29.46 51.67 48.51 -28.63 53.31 49.56 7.88 51.22 19.98 7.64 49.14 20.25 coo -18.87 56.53 54.79 -19.47 62.22 53.03 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE B 75 PHE~? 5.83 MN MN B 606 D 223 ASP B 69 ASP~? 7.66 S2 BME B 602 D 265 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -38.60 55.38 52.70 -40.06 57.72 53.04 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE B 75 PHE~? 5.83 MN MN B 606 D 223 ASP B 69 ASP~? 7.66 S2 BME B 602 D 265 LYS B 169 LYS.? 16.77 C1 BME B 602 coo -38.60 55.38 52.70 -40.06 57.72 53.04 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -29.46 51.67 48.51 -28.63 53.31 49.56 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -18.87 56.53 54.79 -19.47 62.22 53.03 -23.52 91.35 9.46 -25.45 91.49 15.04 1ax4_c07 source 1ax4 TRYPTOPHANASE : 4 hits 1ax4_c07 naa= 3 ULMN 3 1azy_c00 THYMIDINE PHOSPHORYLASE user 1 3 # 1 A 85 HIS A 22 HIS~? -3.40 MN MN A 604s A 171 ARG A 166 ARG~? 11.02 O1 BME A 601 A 190 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 22.59 2.26 43.22 21.17 3.47 42.27 3.18 53.06 10.64 3.66 54.63 11.95 coo 13.63 3.81 28.83 14.49 2.91 31.59 6.93 48.25 24.41 9.45 50.10 24.73 coo 24.97 7.47 37.69 21.24 10.69 35.89 -0.91 46.54 9.97 2.66 42.32 12.44 1azy_c00 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c00 naa= 3 ULMN 3 1azy_c01 THYMIDINE PHOSPHORYLASE user 1 3 # 1 B 85 HIS A 22 HIS~? -3.40 MN MN A 604s B 171 ARG A 166 ARG~? 11.02 O1 BME A 601 B 190 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -6.44 4.86 -3.45 -5.03 5.97 -2.36 3.18 53.06 10.64 3.66 54.63 11.95 coo 2.83 4.83 10.84 1.96 4.32 7.97 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.96 9.04 2.88 -5.39 12.11 5.08 -0.91 46.54 9.97 2.66 42.32 12.44 1azy_c01 source 1azy THYMIDINE PHOSPHORYLASE : 1 hits 1azy_c01 naa= 3 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 A 40 HIS A 22 HIS~? -3.40 MN MN A 604s A 58 GLU A 140 GLU~? -2.42 MN MN A 605s A 92 HIS A 96 HIS~? -3.41 MN MN A 605s coo 12.70 27.74 1.76 10.77 27.11 1.24 3.18 53.06 10.64 3.66 54.63 11.95 coo 11.38 23.30 3.20 9.27 23.34 3.13 5.06 58.75 13.41 3.74 57.63 14.59 coo 2.67 19.36 1.56 3.51 21.24 1.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1b2m_c00 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 A 40 HIS B 22 HIS~? -3.40 MN MN B 607s A 58 GLU B 140 GLU~? -2.41 MN MN B 606s A 92 HIS B 96 HIS~? -3.43 MN MN B 606s coo 12.70 27.74 1.76 10.77 27.11 1.24 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 11.38 23.30 3.20 9.27 23.34 3.13 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 2.67 19.36 1.56 3.51 21.24 1.94 -13.24 74.01 11.32 -12.76 74.71 9.40 1b2m_c00 source 1b2m 5'-R(*GP*(CH2)U)-3' : 2 hits 1b2m_c00 naa= 3 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 1 3 # 1 B 40 HIS A 22 HIS~? -3.40 MN MN A 604s B 58 GLU A 140 GLU~? -2.42 MN MN A 605s B 92 HIS A 96 HIS~? -3.41 MN MN A 605s coo 10.74 36.24 16.20 9.81 34.52 16.97 3.18 53.06 10.64 3.66 54.63 11.95 coo 5.02 36.40 17.74 5.55 34.41 17.37 5.06 58.75 13.41 3.74 57.63 14.59 coo 0.68 29.04 20.43 2.46 29.56 19.46 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 2 3 # 2 B 40 HIS A 96 HIS~? -3.41 MN MN A 605s B 58 GLU A 70 GLU~? -2.54 MN MN A 604s B 92 HIS A 22 HIS~? -3.40 MN MN A 604s coo 10.74 36.24 16.20 9.81 34.52 16.97 0.59 58.54 20.35 2.20 57.89 19.15 coo 5.02 36.40 17.74 5.55 34.41 17.37 6.20 55.25 17.70 4.45 55.72 16.64 coo 0.68 29.04 20.43 2.46 29.56 19.46 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 3 3 # 3 B 40 HIS B 22 HIS~? -3.40 MN MN B 607s B 58 GLU B 140 GLU~? -2.41 MN MN B 606s B 92 HIS B 96 HIS~? -3.43 MN MN B 606s coo 10.74 36.24 16.20 9.81 34.52 16.97 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 5.02 36.40 17.74 5.55 34.41 17.37 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 0.68 29.04 20.43 2.46 29.56 19.46 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1b2m_c01 5'-R(*GP*(CH2)U)-3' user 4 3 # 4 B 40 HIS B 96 HIS~? -3.43 MN MN B 606s B 58 GLU B 70 GLU~? -2.57 MN MN B 607s B 92 HIS B 22 HIS~? -3.40 MN MN B 607s coo 10.74 36.24 16.20 9.81 34.52 16.97 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 5.02 36.40 17.74 5.55 34.41 17.37 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 0.68 29.04 20.43 2.46 29.56 19.46 -5.34 79.70 5.35 -6.67 78.07 5.35 1b2m_c01 source 1b2m 5'-R(*GP*(CH2)U)-3' : 4 hits 1b2m_c01 naa= 3 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 A 109 ASP A 69 ASP~? 7.42 O1 BME A 601 A 182 GLU A 140 GLU~? -2.42 MN MN A 605s A 286 ASN A 73 ASN~? 13.47 MN MN A 605 coo 26.03 44.66 108.90 25.67 42.61 108.82 7.88 51.22 19.98 7.64 49.14 20.25 coo 18.06 44.02 105.38 18.08 45.37 107.03 5.06 58.75 13.41 3.74 57.63 14.59 coo 25.47 38.28 112.06 27.26 39.30 111.54 12.56 53.31 22.50 12.18 52.20 24.34 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 A 109 ASP A 145 ASP~? 14.76 MN MN A 604 A 182 GLU A 140 GLU~? -2.42 MN MN A 605s A 286 ASN A 148 ASN~? 13.72 MN MN A 604 coo 26.03 44.66 108.90 25.67 42.61 108.82 12.32 59.45 6.26 13.32 58.94 4.48 coo 18.06 44.02 105.38 18.08 45.37 107.03 5.06 58.75 13.41 3.74 57.63 14.59 coo 25.47 38.28 112.06 27.26 39.30 111.54 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 A 109 ASP A 145 ASP~? 14.76 MN MN A 604 A 182 GLU A 141 GLU~? 7.70 MN MN A 604 A 286 ASN A 148 ASN~? 13.72 MN MN A 604 coo 26.03 44.66 108.90 25.67 42.61 108.82 12.32 59.45 6.26 13.32 58.94 4.48 coo 18.06 44.02 105.38 18.08 45.37 107.03 4.84 56.74 8.27 3.91 55.44 6.87 coo 25.47 38.28 112.06 27.26 39.30 111.54 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 A 109 ASP B 69 ASP~? 7.66 S2 BME B 602 A 182 GLU B 68 GLU~? 12.41 MN MN B 606 A 286 ASN B 73 ASN~? 13.50 MN MN B 606 coo 26.03 44.66 108.90 25.67 42.61 108.82 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 18.06 44.02 105.38 18.08 45.37 107.03 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 25.47 38.28 112.06 27.26 39.30 111.54 -19.90 79.31 1.05 -21.42 80.32 2.14 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 A 109 ASP B 69 ASP~? 7.66 S2 BME B 602 A 182 GLU B 140 GLU~? -2.41 MN MN B 606s A 286 ASN B 73 ASN~? 13.50 MN MN B 606 coo 26.03 44.66 108.90 25.67 42.61 108.82 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 18.06 44.02 105.38 18.08 45.37 107.03 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 25.47 38.28 112.06 27.26 39.30 111.54 -19.90 79.31 1.05 -21.42 80.32 2.14 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 A 109 ASP B 145 ASP~? 15.01 MN MN B 607 A 182 GLU B 140 GLU~? -2.41 MN MN B 606s A 286 ASN B 148 ASN~? 13.72 MN MN B 607 coo 26.03 44.66 108.90 25.67 42.61 108.82 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 18.06 44.02 105.38 18.08 45.37 107.03 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 25.47 38.28 112.06 27.26 39.30 111.54 -7.72 77.03 -8.08 -7.79 78.86 -6.95 ULMN 3 1b57_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 7 3 # 7 A 109 ASP B 145 ASP~? 15.01 MN MN B 607 A 182 GLU B 141 GLU~? 7.71 MN MN B 607 A 286 ASN B 148 ASN~? 13.72 MN MN B 607 coo 26.03 44.66 108.90 25.67 42.61 108.82 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 18.06 44.02 105.38 18.08 45.37 107.03 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 25.47 38.28 112.06 27.26 39.30 111.54 -7.72 77.03 -8.08 -7.79 78.86 -6.95 1b57_c00 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 7 hits 1b57_c00 naa= 3 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 1 3 # 1 B 109 ASP A 69 ASP~? 7.42 O1 BME A 601 B 182 GLU A 140 GLU~? -2.42 MN MN A 605s B 286 ASN A 73 ASN~? 13.47 MN MN A 605 coo 13.82 69.26 132.27 11.87 70.14 132.51 7.88 51.22 19.98 7.64 49.14 20.25 coo 8.74 63.05 136.42 9.87 62.19 134.79 5.06 58.75 13.41 3.74 57.63 14.59 coo 8.26 72.60 129.22 10.14 73.45 129.80 12.56 53.31 22.50 12.18 52.20 24.34 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 2 3 # 2 B 109 ASP A 145 ASP~? 14.76 MN MN A 604 B 182 GLU A 140 GLU~? -2.42 MN MN A 605s B 286 ASN A 148 ASN~? 13.72 MN MN A 604 coo 13.82 69.26 132.27 11.87 70.14 132.51 12.32 59.45 6.26 13.32 58.94 4.48 coo 8.74 63.05 136.42 9.87 62.19 134.79 5.06 58.75 13.41 3.74 57.63 14.59 coo 8.26 72.60 129.22 10.14 73.45 129.80 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 3 3 # 3 B 109 ASP A 145 ASP~? 14.76 MN MN A 604 B 182 GLU A 141 GLU~? 7.70 MN MN A 604 B 286 ASN A 148 ASN~? 13.72 MN MN A 604 coo 13.82 69.26 132.27 11.87 70.14 132.51 12.32 59.45 6.26 13.32 58.94 4.48 coo 8.74 63.05 136.42 9.87 62.19 134.79 4.84 56.74 8.27 3.91 55.44 6.87 coo 8.26 72.60 129.22 10.14 73.45 129.80 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 4 3 # 4 B 109 ASP B 69 ASP~? 7.66 S2 BME B 602 B 182 GLU B 140 GLU~? -2.41 MN MN B 606s B 286 ASN B 73 ASN~? 13.50 MN MN B 606 coo 13.82 69.26 132.27 11.87 70.14 132.51 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 8.74 63.05 136.42 9.87 62.19 134.79 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 8.26 72.60 129.22 10.14 73.45 129.80 -19.90 79.31 1.05 -21.42 80.32 2.14 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 5 3 # 5 B 109 ASP B 145 ASP~? 15.01 MN MN B 607 B 182 GLU B 140 GLU~? -2.41 MN MN B 606s B 286 ASN B 148 ASN~? 13.72 MN MN B 607 coo 13.82 69.26 132.27 11.87 70.14 132.51 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 8.74 63.05 136.42 9.87 62.19 134.79 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 8.26 72.60 129.22 10.14 73.45 129.80 -7.72 77.03 -8.08 -7.79 78.86 -6.95 ULMN 3 1b57_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE II user 6 3 # 6 B 109 ASP B 145 ASP~? 15.01 MN MN B 607 B 182 GLU B 141 GLU~? 7.71 MN MN B 607 B 286 ASN B 148 ASN~? 13.72 MN MN B 607 coo 13.82 69.26 132.27 11.87 70.14 132.51 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 8.74 63.05 136.42 9.87 62.19 134.79 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 8.26 72.60 129.22 10.14 73.45 129.80 -7.72 77.03 -8.08 -7.79 78.86 -6.95 1b57_c01 source 1b57 FRUCTOSE-BISPHOSPHATE ALDOLASE II : 6 hits 1b57_c01 naa= 3 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 A 60 GLU A 71 GLU~? 7.91 MN MN A 605 A 148 CYH A 21 CYH~? -2.28 S2 BME A 601s A 179 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 20.47 15.77 27.32 19.04 14.27 26.94 4.56 57.67 23.22 2.91 58.15 24.47 coo 21.87 3.71 21.27 20.32 3.55 23.64 3.34 47.98 12.34 4.26 47.15 14.87 coo 17.09 11.24 20.19 17.85 10.05 21.76 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 A 60 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 A 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 20.47 15.77 27.32 19.04 14.27 26.94 7.70 72.78 18.03 7.03 72.92 20.00 coo 21.87 3.71 21.27 20.32 3.55 23.64 0.50 81.71 15.06 -1.49 79.86 14.33 coo 17.09 11.24 20.19 17.85 10.05 21.76 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 A 60 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 A 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 20.47 15.77 27.32 19.04 14.27 26.94 0.70 67.61 16.19 -1.02 68.27 17.25 coo 21.87 3.71 21.27 20.32 3.55 23.64 0.50 81.71 15.06 -1.49 79.86 14.33 coo 17.09 11.24 20.19 17.85 10.05 21.76 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 A 60 GLU A 141 GLU~? 7.70 MN MN A 604 A 148 CYH A 29 CYH~? 9.71 CL CL A 608 A 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 20.47 15.77 27.32 19.04 14.27 26.94 4.84 56.74 8.27 3.91 55.44 6.87 coo 21.87 3.71 21.27 20.32 3.55 23.64 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 17.09 11.24 20.19 17.85 10.05 21.76 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 A 60 GLU B 71 GLU~? 7.93 MN MN B 606 A 148 CYH B 21 CYH~? -2.10 S2 BME B 602s A 179 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 20.47 15.77 27.32 19.04 14.27 26.94 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 21.87 3.71 21.27 20.32 3.55 23.64 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 17.09 11.24 20.19 17.85 10.05 21.76 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 A 60 GLU B 87 GLU~? 16.36 MN MN B 606 A 148 CYH A 29 CYH~? 9.71 CL CL A 608 A 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 20.47 15.77 27.32 19.04 14.27 26.94 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 21.87 3.71 21.27 20.32 3.55 23.64 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 17.09 11.24 20.19 17.85 10.05 21.76 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 A 60 GLU B 91 GLU~? 11.42 MN MN B 606 A 148 CYH A 29 CYH~? 9.71 CL CL A 608 A 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 20.47 15.77 27.32 19.04 14.27 26.94 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 21.87 3.71 21.27 20.32 3.55 23.64 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 17.09 11.24 20.19 17.85 10.05 21.76 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c04 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 A 60 GLU B 141 GLU~? 7.71 MN MN B 607 A 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 A 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 20.47 15.77 27.32 19.04 14.27 26.94 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 21.87 3.71 21.27 20.32 3.55 23.64 0.50 81.71 15.06 -1.49 79.86 14.33 coo 17.09 11.24 20.19 17.85 10.05 21.76 1.27 73.42 12.01 2.60 75.02 12.38 1b5d_c04 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 8 hits 1b5d_c04 naa= 3 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 1 3 # 1 B 60 GLU A 71 GLU~? 7.91 MN MN A 605 B 148 CYH A 21 CYH~? -2.28 S2 BME A 601s B 179 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 4.56 57.67 23.22 2.91 58.15 24.47 coo 30.30 0.93 3.58 31.01 1.18 0.88 3.34 47.98 12.34 4.26 47.15 14.87 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 2 3 # 2 B 60 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 B 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 7.70 72.78 18.03 7.03 72.92 20.00 coo 30.30 0.93 3.58 31.01 1.18 0.88 0.50 81.71 15.06 -1.49 79.86 14.33 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 3 3 # 3 B 60 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 B 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 0.70 67.61 16.19 -1.02 68.27 17.25 coo 30.30 0.93 3.58 31.01 1.18 0.88 0.50 81.71 15.06 -1.49 79.86 14.33 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 4 3 # 4 B 60 GLU A 141 GLU~? 7.70 MN MN A 604 B 148 CYH A 29 CYH~? 9.71 CL CL A 608 B 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 4.84 56.74 8.27 3.91 55.44 6.87 coo 30.30 0.93 3.58 31.01 1.18 0.88 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 5 3 # 5 B 60 GLU B 71 GLU~? 7.93 MN MN B 606 B 148 CYH B 21 CYH~? -2.10 S2 BME B 602s B 179 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 30.30 0.93 3.58 31.01 1.18 0.88 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 6 3 # 6 B 60 GLU B 87 GLU~? 16.36 MN MN B 606 B 148 CYH A 29 CYH~? 9.71 CL CL A 608 B 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 30.30 0.93 3.58 31.01 1.18 0.88 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 7 3 # 7 B 60 GLU B 91 GLU~? 11.42 MN MN B 606 B 148 CYH A 29 CYH~? 9.71 CL CL A 608 B 179 ASP A 134 ASP~? 12.23 CL CL A 608 coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 30.30 0.93 3.58 31.01 1.18 0.88 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1b5d_c05 DEOXYCYTIDYLATE HYDROXYMETHYLASE user 8 3 # 8 B 60 GLU B 141 GLU~? 7.71 MN MN B 607 B 148 CYH B 29 CYH~? 9.17 O1 GOL B 603 B 179 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 34.11 -11.05 -1.22 32.89 -9.54 -2.05 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 30.30 0.93 3.58 31.01 1.18 0.88 0.50 81.71 15.06 -1.49 79.86 14.33 coo 26.42 -6.51 0.59 28.13 -5.32 0.24 1.27 73.42 12.01 2.60 75.02 12.38 1b5d_c05 source 1b5d DEOXYCYTIDYLATE HYDROXYMETHYLASE : 8 hits 1b5d_c05 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 133 TYR~? 5.56 CL CL A 608 A 230 ASP A 134 ASP~? 12.23 CL CL A 608 A 273 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 9.23 21.44 106.88 10.18 19.34 105.31 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 1.45 22.80 104.16 2.58 21.02 104.01 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 2.97 11.64 107.87 6.59 15.13 107.03 -0.91 46.54 9.97 2.66 42.32 12.44 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 133 TYR~? 5.56 CL CL A 608 B 230 ASP A 134 ASP~? 12.23 CL CL A 608 B 273 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 11.81 13.41 73.03 10.00 13.03 75.12 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 19.17 11.01 76.14 17.26 10.42 76.77 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 11.10 2.31 76.60 10.24 7.24 75.62 -0.91 46.54 9.97 2.66 42.32 12.44 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 1 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 11 PHE.? 7.28 O1 BME A 601 A 159 ASP A 69 ASP~? 7.42 O1 BME A 601 A 188 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 11.74 44.01 17.67 8.98 44.14 18.15 coo 20.97 28.40 16.26 20.19 30.15 15.34 7.88 51.22 19.98 7.64 49.14 20.25 coo 22.55 41.65 15.60 18.92 37.20 14.63 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE A 74 PHE~? 8.88 MN MN A 604 A 159 ASP A 145 ASP~? 14.76 MN MN A 604 A 188 LYS A 153 LYS~? 20.22 C2 BME A 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 11.59 56.31 16.73 12.14 57.65 14.39 coo 20.97 28.40 16.26 20.19 30.15 15.34 12.32 59.45 6.26 13.32 58.94 4.48 coo 22.55 41.65 15.60 18.92 37.20 14.63 23.06 52.60 13.46 22.53 47.10 11.88 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 3 3 # 3 A 88 PHE A 129 PHE~? 10.87 CL CL A 608 A 159 ASP A 134 ASP~? 12.23 CL CL A 608 A 188 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 -10.38 54.19 14.28 -8.39 52.30 14.83 coo 20.97 28.40 16.26 20.19 30.15 15.34 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 22.55 41.65 15.60 18.92 37.20 14.63 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 4 3 # 4 A 88 PHE A 150 PHE~? 16.24 O2 GOL B 603 A 159 ASP A 145 ASP~? 14.76 MN MN A 604 A 188 LYS A 153 LYS~? 20.22 C2 BME A 601 coo 13.91 34.58 14.67 12.95 36.00 12.47 19.27 63.28 11.08 18.70 65.33 9.26 coo 20.97 28.40 16.26 20.19 30.15 15.34 12.32 59.45 6.26 13.32 58.94 4.48 coo 22.55 41.65 15.60 18.92 37.20 14.63 23.06 52.60 13.46 22.53 47.10 11.88 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 5 3 # 5 A 88 PHE B 74 PHE~? 8.86 MN MN B 607 A 159 ASP B 145 ASP~? 15.01 MN MN B 607 A 188 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 13.91 34.58 14.67 12.95 36.00 12.47 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 22.55 41.65 15.60 18.92 37.20 14.63 -15.29 80.48 -11.91 -17.46 85.09 -12.54 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 6 3 # 6 A 88 PHE B 129 PHE~? 10.86 CL CL B 609 A 159 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 188 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 13.91 34.58 14.67 12.95 36.00 12.47 -3.48 78.42 19.16 -4.63 80.39 17.56 coo 20.97 28.40 16.26 20.19 30.15 15.34 1.27 73.42 12.01 2.60 75.02 12.38 coo 22.55 41.65 15.60 18.92 37.20 14.63 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 7 3 # 7 A 88 PHE B 150 PHE~? 19.25 MN MN B 607 A 159 ASP B 145 ASP~? 15.01 MN MN B 607 A 188 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 13.91 34.58 14.67 12.95 36.00 12.47 -11.34 69.63 -9.95 -9.41 67.65 -10.43 coo 20.97 28.40 16.26 20.19 30.15 15.34 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 22.55 41.65 15.60 18.92 37.20 14.63 -15.29 80.48 -11.91 -17.46 85.09 -12.54 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 7 hits 1b9h_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG B 27 ARG~? 11.60 C2 BME B 602 B 141 THR B 51 THR~? 17.05 C2 BME B 602 B 235 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 8.13 67.41 100.27 7.18 68.35 97.45 1.97 89.27 10.36 0.81 91.17 12.49 coo 8.28 67.78 108.81 6.22 67.65 109.43 0.21 91.77 20.35 2.10 90.94 19.87 coo 14.55 73.52 89.47 12.81 73.95 90.56 1.27 73.42 12.01 2.60 75.02 12.38 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 1 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 101 ASP~? 14.47 MN MN A 605 16 HIS A 100 HIS~? 8.88 CL CL A 608 67 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP B 101 ASP~? 14.48 MN MN B 606 16 HIS B 100 HIS~? 8.87 CL CL B 609 67 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -1.78 84.52 5.86 -2.42 84.42 6.43 1be1_c02 source 1be1 GLUTAMATE MUTASE : 2 hits 1be1_c02 naa= 3 ULMN 3 1bf2_c00 ISOAMYLASE user 1 3 # 1 375 ASP A 90 ASP~? 8.93 C1 GOL B 603 435 GLU A 87 GLU~? 6.78 O1 GOL B 603 510 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 88.62 69.90 41.16 89.05 70.67 43.04 5.32 68.36 21.17 7.09 68.49 22.34 coo 89.52 76.11 40.17 89.01 75.16 41.97 7.70 72.78 18.03 7.03 72.92 20.00 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1bf2_c00 ISOAMYLASE user 2 3 # 2 375 ASP A 90 ASP~? 8.93 C1 GOL B 603 435 GLU A 91 GLU~? 5.92 C1 GOL B 603 510 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 88.62 69.90 41.16 89.05 70.67 43.04 5.32 68.36 21.17 7.09 68.49 22.34 coo 89.52 76.11 40.17 89.01 75.16 41.97 0.70 67.61 16.19 -1.02 68.27 17.25 coo 84.89 77.60 46.67 85.63 75.79 46.03 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1bf2_c00 ISOAMYLASE user 3 3 # 3 375 ASP A 134 ASP~? 12.23 CL CL A 608 435 GLU B 91 GLU~? 11.42 MN MN B 606 510 ASP B 90 ASP~? 13.30 MN MN B 606 coo 88.62 69.90 41.16 89.05 70.67 43.04 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 89.52 76.11 40.17 89.01 75.16 41.97 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 84.89 77.60 46.67 85.63 75.79 46.03 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1bf2_c00 ISOAMYLASE user 4 3 # 4 375 ASP B 90 ASP~? 13.30 MN MN B 606 435 GLU B 87 GLU~? 16.36 MN MN B 606 510 ASP A 134 ASP~? 12.23 CL CL A 608 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 84.89 77.60 46.67 85.63 75.79 46.03 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1bf2_c00 ISOAMYLASE user 5 3 # 5 375 ASP B 90 ASP~? 13.30 MN MN B 606 435 GLU B 91 GLU~? 11.42 MN MN B 606 510 ASP A 134 ASP~? 12.23 CL CL A 608 coo 88.62 69.90 41.16 89.05 70.67 43.04 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 89.52 76.11 40.17 89.01 75.16 41.97 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 84.89 77.60 46.67 85.63 75.79 46.03 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1bf2_c00 ISOAMYLASE user 6 3 # 6 375 ASP B 134 ASP~? -3.66 O1 GOL B 603s 435 GLU A 91 GLU~? 5.92 C1 GOL B 603 510 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 88.62 69.90 41.16 89.05 70.67 43.04 1.27 73.42 12.01 2.60 75.02 12.38 coo 89.52 76.11 40.17 89.01 75.16 41.97 0.70 67.61 16.19 -1.02 68.27 17.25 coo 84.89 77.60 46.67 85.63 75.79 46.03 5.32 68.36 21.17 7.09 68.49 22.34 1bf2_c00 source 1bf2 ISOAMYLASE : 6 hits 1bf2_c00 naa= 3 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 1 3 # 1 A 461 GLU A 70 GLU~? -2.54 MN MN A 604s A 503 TYR A 19 TYR~? 9.00 MN MN A 604 A 537 GLU A 141 GLU~? 7.70 MN MN A 604 coo 24.06 146.21 11.09 22.89 146.18 9.36 6.20 55.25 17.70 4.45 55.72 16.64 coo 15.91 140.69 8.32 15.71 143.39 9.13 8.27 52.26 7.85 9.08 54.84 7.01 coo 16.65 144.44 13.24 18.34 145.22 12.33 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bgl_c08 BETA-GALACTOSIDASE user 2 3 # 2 A 461 GLU B 70 GLU~? -2.57 MN MN B 607s A 503 TYR B 19 TYR~? 9.04 MN MN B 607 A 537 GLU B 141 GLU~? 7.71 MN MN B 607 coo 24.06 146.21 11.09 22.89 146.18 9.36 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 15.91 140.69 8.32 15.71 143.39 9.13 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 16.65 144.44 13.24 18.34 145.22 12.33 -3.60 76.13 2.85 -2.01 77.43 3.31 1bgl_c08 source 1bgl BETA-GALACTOSIDASE : 2 hits 1bgl_c08 naa= 3 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 1 3 # 1 A 451 GLU A 140 GLU~? -2.42 MN MN A 605s A 504 TYR A 19 TYR~? 9.00 MN MN A 604 A 540 GLU A 141 GLU~? 7.70 MN MN A 604 coo 81.34 87.29 87.22 82.36 86.09 88.61 5.06 58.75 13.41 3.74 57.63 14.59 coo 80.85 81.34 94.77 81.70 80.16 92.41 8.27 52.26 7.85 9.08 54.84 7.01 coo 79.94 80.46 88.84 81.11 81.36 87.27 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bhg_c02 BETA-GLUCURONIDASE user 2 3 # 2 A 451 GLU B 140 GLU~? -2.41 MN MN B 606s A 504 TYR B 19 TYR~? 9.04 MN MN B 607 A 540 GLU B 141 GLU~? 7.71 MN MN B 607 coo 81.34 87.29 87.22 82.36 86.09 88.61 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 80.85 81.34 94.77 81.70 80.16 92.41 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 79.94 80.46 88.84 81.11 81.36 87.27 -3.60 76.13 2.85 -2.01 77.43 3.31 1bhg_c02 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c02 naa= 3 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 1 3 # 1 B 451 GLU A 70 GLU~? -2.54 MN MN A 604s B 504 TYR A 19 TYR~? 9.00 MN MN A 604 B 540 GLU A 140 GLU~? -2.42 MN MN A 605s coo 86.52 35.28 112.74 87.08 36.38 110.99 6.20 55.25 17.70 4.45 55.72 16.64 coo 84.93 40.21 105.31 85.72 41.45 107.72 8.27 52.26 7.85 9.08 54.84 7.01 coo 83.38 41.19 112.55 85.47 40.59 112.72 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 2 3 # 2 B 451 GLU A 140 GLU~? -2.42 MN MN A 605s B 504 TYR A 19 TYR~? 9.00 MN MN A 604 B 540 GLU A 141 GLU~? 7.70 MN MN A 604 coo 86.52 35.28 112.74 87.08 36.38 110.99 5.06 58.75 13.41 3.74 57.63 14.59 coo 84.93 40.21 105.31 85.72 41.45 107.72 8.27 52.26 7.85 9.08 54.84 7.01 coo 83.38 41.19 112.55 85.47 40.59 112.72 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 3 3 # 3 B 451 GLU B 70 GLU~? -2.57 MN MN B 607s B 504 TYR B 19 TYR~? 9.04 MN MN B 607 B 540 GLU B 140 GLU~? -2.41 MN MN B 606s coo 86.52 35.28 112.74 87.08 36.38 110.99 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 84.93 40.21 105.31 85.72 41.45 107.72 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 83.38 41.19 112.55 85.47 40.59 112.72 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bhg_c03 BETA-GLUCURONIDASE user 4 3 # 4 B 451 GLU B 140 GLU~? -2.41 MN MN B 606s B 504 TYR B 19 TYR~? 9.04 MN MN B 607 B 540 GLU B 141 GLU~? 7.71 MN MN B 607 coo 86.52 35.28 112.74 87.08 36.38 110.99 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 84.93 40.21 105.31 85.72 41.45 107.72 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 83.38 41.19 112.55 85.47 40.59 112.72 -3.60 76.13 2.85 -2.01 77.43 3.31 1bhg_c03 source 1bhg BETA-GLUCURONIDASE : 4 hits 1bhg_c03 naa= 3 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 1 3 # 1 A 382 ARG A 26 ARG~? 9.60 MN MN A 604 A 451 GLU A 140 GLU~? -2.42 MN MN A 605s A 540 GLU A 141 GLU~? 7.70 MN MN A 604 coo 79.04 80.20 80.81 79.58 81.40 83.63 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 81.34 87.29 87.22 82.36 86.09 88.61 5.06 58.75 13.41 3.74 57.63 14.59 coo 79.94 80.46 88.84 81.11 81.36 87.27 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 2 3 # 2 A 382 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 451 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 540 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 79.04 80.20 80.81 79.58 81.40 83.63 -0.58 68.78 21.39 1.97 70.41 20.81 coo 81.34 87.29 87.22 82.36 86.09 88.61 5.68 77.05 25.89 7.75 77.09 25.94 coo 79.94 80.46 88.84 81.11 81.36 87.27 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 3 3 # 3 A 382 ARG A 166 ARG~? 11.02 O1 BME A 601 A 451 GLU A 70 GLU~? -2.54 MN MN A 604s A 540 GLU A 71 GLU~? 7.91 MN MN A 605 coo 79.04 80.20 80.81 79.58 81.40 83.63 6.93 48.25 24.41 9.45 50.10 24.73 coo 81.34 87.29 87.22 82.36 86.09 88.61 6.20 55.25 17.70 4.45 55.72 16.64 coo 79.94 80.46 88.84 81.11 81.36 87.27 4.56 57.67 23.22 2.91 58.15 24.47 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 4 3 # 4 A 382 ARG A 166 ARG~? 11.02 O1 BME A 601 A 451 GLU A 71 GLU~? 7.91 MN MN A 605 A 540 GLU A 70 GLU~? -2.54 MN MN A 604s coo 79.04 80.20 80.81 79.58 81.40 83.63 6.93 48.25 24.41 9.45 50.10 24.73 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.56 57.67 23.22 2.91 58.15 24.47 coo 79.94 80.46 88.84 81.11 81.36 87.27 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 5 3 # 5 A 382 ARG A 166 ARG~? 11.02 O1 BME A 601 A 451 GLU A 71 GLU~? 7.91 MN MN A 605 A 540 GLU A 72 GLU~? 12.86 MN MN A 605 coo 79.04 80.20 80.81 79.58 81.40 83.63 6.93 48.25 24.41 9.45 50.10 24.73 coo 81.34 87.29 87.22 82.36 86.09 88.61 4.56 57.67 23.22 2.91 58.15 24.47 coo 79.94 80.46 88.84 81.11 81.36 87.27 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 6 3 # 6 A 382 ARG B 26 ARG~? 8.42 O2 GOL B 603 A 451 GLU B 140 GLU~? -2.41 MN MN B 606s A 540 GLU B 141 GLU~? 7.71 MN MN B 607 coo 79.04 80.20 80.81 79.58 81.40 83.63 1.24 79.80 7.27 0.69 76.71 7.21 coo 81.34 87.29 87.22 82.36 86.09 88.61 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 79.94 80.46 88.84 81.11 81.36 87.27 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 7 3 # 7 A 382 ARG B 166 ARG~? 12.22 S2 BME B 602 A 451 GLU B 70 GLU~? -2.57 MN MN B 607s A 540 GLU B 71 GLU~? 7.93 MN MN B 606 coo 79.04 80.20 80.81 79.58 81.40 83.63 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 81.34 87.29 87.22 82.36 86.09 88.61 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 79.94 80.46 88.84 81.11 81.36 87.27 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 8 3 # 8 A 382 ARG B 166 ARG~? 12.22 S2 BME B 602 A 451 GLU B 71 GLU~? 7.93 MN MN B 606 A 540 GLU B 70 GLU~? -2.57 MN MN B 607s coo 79.04 80.20 80.81 79.58 81.40 83.63 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 81.34 87.29 87.22 82.36 86.09 88.61 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 79.94 80.46 88.84 81.11 81.36 87.27 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1bhg_c04 BETA-GLUCURONIDASE user 9 3 # 9 A 382 ARG B 166 ARG~? 12.22 S2 BME B 602 A 451 GLU B 71 GLU~? 7.93 MN MN B 606 A 540 GLU B 72 GLU~? 13.02 MN MN B 606 coo 79.04 80.20 80.81 79.58 81.40 83.63 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 81.34 87.29 87.22 82.36 86.09 88.61 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 79.94 80.46 88.84 81.11 81.36 87.27 -22.12 78.07 6.79 -23.41 76.46 7.29 1bhg_c04 source 1bhg BETA-GLUCURONIDASE : 9 hits 1bhg_c04 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 94 ARG~? 6.60 C1 GOL B 603 B 451 GLU B 123 GLU~? 13.36 O1 GOL B 603 B 540 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 82.21 41.07 119.14 83.95 40.66 116.59 -0.58 68.78 21.39 1.97 70.41 20.81 coo 86.52 35.28 112.74 87.08 36.38 110.99 5.68 77.05 25.89 7.75 77.09 25.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG A 128 ARG~? 18.10 CL CL A 608 B 451 GLU A 123 GLU~? 22.37 MN MN B 606 B 540 GLU A 124 GLU~? 15.58 MN MN B 606 coo 82.21 41.07 119.14 83.95 40.66 116.59 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 86.52 35.28 112.74 87.08 36.38 110.99 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 3 3 # 3 B 382 ARG A 166 ARG~? 11.02 O1 BME A 601 B 451 GLU A 71 GLU~? 7.91 MN MN A 605 B 540 GLU A 72 GLU~? 12.86 MN MN A 605 coo 82.21 41.07 119.14 83.95 40.66 116.59 6.93 48.25 24.41 9.45 50.10 24.73 coo 86.52 35.28 112.74 87.08 36.38 110.99 4.56 57.67 23.22 2.91 58.15 24.47 coo 83.38 41.19 112.55 85.47 40.59 112.72 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 4 3 # 4 B 382 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 451 GLU B 140 GLU~? -2.41 MN MN B 606s B 540 GLU B 141 GLU~? 7.71 MN MN B 607 coo 82.21 41.07 119.14 83.95 40.66 116.59 1.24 79.80 7.27 0.69 76.71 7.21 coo 86.52 35.28 112.74 87.08 36.38 110.99 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 83.38 41.19 112.55 85.47 40.59 112.72 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 5 3 # 5 B 382 ARG B 94 ARG~? 13.57 MN MN B 606 B 451 GLU A 123 GLU~? 22.37 MN MN B 606 B 540 GLU A 124 GLU~? 15.58 MN MN B 606 coo 82.21 41.07 119.14 83.95 40.66 116.59 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 86.52 35.28 112.74 87.08 36.38 110.99 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 83.38 41.19 112.55 85.47 40.59 112.72 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 6 3 # 6 B 382 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 451 GLU B 123 GLU~? 13.36 O1 GOL B 603 B 540 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 82.21 41.07 119.14 83.95 40.66 116.59 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 86.52 35.28 112.74 87.08 36.38 110.99 5.68 77.05 25.89 7.75 77.09 25.94 coo 83.38 41.19 112.55 85.47 40.59 112.72 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 7 3 # 7 B 382 ARG B 166 ARG~? 12.22 S2 BME B 602 B 451 GLU B 71 GLU~? 7.93 MN MN B 606 B 540 GLU B 68 GLU~? 12.41 MN MN B 606 coo 82.21 41.07 119.14 83.95 40.66 116.59 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 86.52 35.28 112.74 87.08 36.38 110.99 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 8 3 # 8 B 382 ARG B 166 ARG~? 12.22 S2 BME B 602 B 451 GLU B 71 GLU~? 7.93 MN MN B 606 B 540 GLU B 72 GLU~? 13.02 MN MN B 606 coo 82.21 41.07 119.14 83.95 40.66 116.59 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 86.52 35.28 112.74 87.08 36.38 110.99 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 83.38 41.19 112.55 85.47 40.59 112.72 -22.12 78.07 6.79 -23.41 76.46 7.29 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 8 hits 1bhg_c05 naa= 3 ULMN 3 1bib_c00 BIRA BIFUNCTIONAL PROTEIN (ACTS AS Buser 1 3 # 1 118 ARG A 167 ARG~? -4.94 O1 BME A 601s 183 LYS A 24 LYS~? 4.08 C2 BME A 601 317 ARG A 53 ARG~? 18.39 C1 BME A 601 coo 76.57 109.19 73.41 73.86 110.26 72.16 6.75 43.81 21.29 6.50 46.65 20.31 coo 82.09 117.51 66.37 80.60 114.32 71.44 -0.91 46.54 9.97 2.66 42.32 12.44 coo 65.21 120.62 58.76 63.62 123.14 59.66 -12.36 37.09 18.31 -14.35 36.55 20.61 1bib_c00 source 1bib BIRA BIFUNCTIONAL PROTEIN (ACTS AS BIOTIN OPER: 1 hits 1bib_c00 naa= 3 ULMN 3 1bol_c00 RIBONUCLEASE RH user 1 3 # 1 A 46 HIS A 22 HIS~? -3.40 MN MN A 604s A 105 GLU A 70 GLU~? -2.54 MN MN A 604s A 109 HIS A 67 HIS~? -4.40 CL CL A 608s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 3.18 53.06 10.64 3.66 54.63 11.95 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.20 55.25 17.70 4.45 55.72 16.64 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1bol_c00 RIBONUCLEASE RH user 2 3 # 2 A 46 HIS A 22 HIS~? -3.40 MN MN A 604s A 105 GLU A 140 GLU~? -2.42 MN MN A 605s A 109 HIS A 136 HIS~? 3.48 MN MN A 605s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 3.18 53.06 10.64 3.66 54.63 11.95 coo 43.60 31.12 0.44 42.42 31.86 -1.18 5.06 58.75 13.41 3.74 57.63 14.59 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1bol_c00 RIBONUCLEASE RH user 3 3 # 3 A 46 HIS A 66 HIS~? 3.42 MN MN A 604s A 105 GLU A 70 GLU~? -2.54 MN MN A 604s A 109 HIS A 96 HIS~? -3.41 MN MN A 605s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 3.21 51.23 16.81 3.87 52.43 15.22 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.20 55.25 17.70 4.45 55.72 16.64 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1bol_c00 RIBONUCLEASE RH user 4 3 # 4 A 46 HIS A 67 HIS~? -4.40 CL CL A 608s A 105 GLU A 70 GLU~? -2.54 MN MN A 604s A 109 HIS A 22 HIS~? -3.40 MN MN A 604s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 0.35 54.22 20.29 -1.10 54.30 18.77 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.20 55.25 17.70 4.45 55.72 16.64 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1bol_c00 RIBONUCLEASE RH user 5 3 # 5 A 46 HIS A 96 HIS~? -3.41 MN MN A 605s A 105 GLU A 70 GLU~? -2.54 MN MN A 604s A 109 HIS A 66 HIS~? 3.42 MN MN A 604s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 0.59 58.54 20.35 2.20 57.89 19.15 coo 43.60 31.12 0.44 42.42 31.86 -1.18 6.20 55.25 17.70 4.45 55.72 16.64 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1bol_c00 RIBONUCLEASE RH user 6 3 # 6 A 46 HIS A 136 HIS~? 3.48 MN MN A 605s A 105 GLU A 140 GLU~? -2.42 MN MN A 605s A 109 HIS A 22 HIS~? -3.40 MN MN A 604s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -0.57 59.60 14.33 0.78 59.36 15.93 coo 43.60 31.12 0.44 42.42 31.86 -1.18 5.06 58.75 13.41 3.74 57.63 14.59 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1bol_c00 RIBONUCLEASE RH user 7 3 # 7 A 46 HIS B 22 HIS~? -3.40 MN MN B 607s A 105 GLU B 70 GLU~? -2.57 MN MN B 607s A 109 HIS B 67 HIS~? -4.45 CL CL B 609s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1bol_c00 RIBONUCLEASE RH user 8 3 # 8 A 46 HIS B 22 HIS~? -3.40 MN MN B 607s A 105 GLU B 140 GLU~? -2.41 MN MN B 606s A 109 HIS B 136 HIS~? 3.50 MN MN B 606s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1bol_c00 RIBONUCLEASE RH user 9 3 # 9 A 46 HIS B 66 HIS~? 3.43 MN MN B 607s A 105 GLU B 70 GLU~? -2.57 MN MN B 607s A 109 HIS B 96 HIS~? -3.43 MN MN B 606s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1bol_c00 RIBONUCLEASE RH user 10 3 # 10 A 46 HIS B 67 HIS~? -4.45 CL CL B 609s A 105 GLU B 70 GLU~? -2.57 MN MN B 607s A 109 HIS B 22 HIS~? -3.40 MN MN B 607s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1bol_c00 RIBONUCLEASE RH user 11 3 # 11 A 46 HIS B 96 HIS~? -3.43 MN MN B 606s A 105 GLU B 70 GLU~? -2.57 MN MN B 607s A 109 HIS B 66 HIS~? 3.43 MN MN B 607s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1bol_c00 RIBONUCLEASE RH user 12 3 # 12 A 46 HIS B 136 HIS~? 3.50 MN MN B 606s A 105 GLU B 140 GLU~? -2.41 MN MN B 606s A 109 HIS B 22 HIS~? -3.40 MN MN B 607s coo 40.56 28.26 -3.97 41.87 29.52 -4.90 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 43.60 31.12 0.44 42.42 31.86 -1.18 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 40.53 36.41 -0.12 40.86 36.31 -2.14 -5.34 79.70 5.35 -6.67 78.07 5.35 1bol_c00 source 1bol RIBONUCLEASE RH : 12 hits 1bol_c00 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 23 GLY~? 8.40 S2 BME A 601 48 HIS A 66 HIS~? 3.42 MN MN A 604s 99 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 12.38 5.55 24.25 13.27 5.59 24.39 1.32 48.34 7.45 1.06 48.38 8.26 coo 18.80 12.68 24.53 17.69 13.54 26.08 3.21 51.23 16.81 3.87 52.43 15.22 coo 17.07 18.51 26.62 16.67 17.07 28.09 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 2 3 # 2 30 GLY B 23 GLY~? 8.34 S2 BME B 602 48 HIS B 66 HIS~? 3.43 MN MN B 607s 99 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 12.38 5.55 24.25 13.27 5.59 24.39 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 17.07 18.51 26.62 16.67 17.07 28.09 -15.81 81.35 4.53 -16.00 83.45 4.93 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 2 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 166 ARG~? 11.02 O1 BME A 601 A 128 GLU A 71 GLU~? 7.91 MN MN A 605 A 225 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 38.56 19.11 14.83 37.12 21.00 16.76 6.93 48.25 24.41 9.45 50.10 24.73 coo 36.48 24.43 22.02 36.86 26.34 21.13 4.56 57.67 23.22 2.91 58.15 24.47 coo 40.16 23.71 17.01 38.52 24.96 17.40 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG A 166 ARG~? 11.02 O1 BME A 601 A 128 GLU A 71 GLU~? 7.91 MN MN A 605 A 225 GLU A 72 GLU~? 12.86 MN MN A 605 coo 38.56 19.11 14.83 37.12 21.00 16.76 6.93 48.25 24.41 9.45 50.10 24.73 coo 36.48 24.43 22.02 36.86 26.34 21.13 4.56 57.67 23.22 2.91 58.15 24.47 coo 40.16 23.71 17.01 38.52 24.96 17.40 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1bqc_c01 BETA-MANNANASE user 3 3 # 3 A 50 ARG B 166 ARG~? 12.22 S2 BME B 602 A 128 GLU B 71 GLU~? 7.93 MN MN B 606 A 225 GLU B 68 GLU~? 12.41 MN MN B 606 coo 38.56 19.11 14.83 37.12 21.00 16.76 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 36.48 24.43 22.02 36.86 26.34 21.13 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 40.16 23.71 17.01 38.52 24.96 17.40 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1bqc_c01 BETA-MANNANASE user 4 3 # 4 A 50 ARG B 166 ARG~? 12.22 S2 BME B 602 A 128 GLU B 71 GLU~? 7.93 MN MN B 606 A 225 GLU B 72 GLU~? 13.02 MN MN B 606 coo 38.56 19.11 14.83 37.12 21.00 16.76 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 36.48 24.43 22.02 36.86 26.34 21.13 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 40.16 23.71 17.01 38.52 24.96 17.40 -22.12 78.07 6.79 -23.41 76.46 7.29 1bqc_c01 source 1bqc BETA-MANNANASE : 4 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 A 82 HIS A 22 HIS~? -3.40 MN MN A 604s A 168 ARG A 167 ARG~? -4.94 O1 BME A 601s A 187 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 62.47 12.00 59.65 61.76 10.14 60.31 3.18 53.06 10.64 3.66 54.63 11.95 coo 55.10 8.37 73.00 55.48 9.59 70.20 6.75 43.81 21.29 6.50 46.65 20.31 coo 66.76 10.09 66.23 61.80 8.06 65.82 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1brw_c00 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 A 82 HIS B 22 HIS~? -3.40 MN MN B 607s A 168 ARG B 167 ARG~? 6.18 S2 BME B 602 A 187 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 62.47 12.00 59.65 61.76 10.14 60.31 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 55.10 8.37 73.00 55.48 9.59 70.20 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 66.76 10.09 66.23 61.80 8.06 65.82 -3.23 86.22 8.94 -7.29 90.78 7.55 1brw_c00 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c00 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 22 HIS~? -3.40 MN MN A 604s B1168 ARG A 167 ARG~? -4.94 O1 BME A 601s B1187 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 35.03 5.72 103.61 36.82 5.00 102.79 3.18 53.06 10.64 3.66 54.63 11.95 coo 41.91 5.48 91.85 40.59 6.81 94.28 6.75 43.81 21.29 6.50 46.65 20.31 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS B 22 HIS~? -3.40 MN MN B 607s B1168 ARG B 167 ARG~? 6.18 S2 BME B 602 B1187 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 35.03 5.72 103.61 36.82 5.00 102.79 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 41.91 5.48 91.85 40.59 6.81 94.28 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 32.93 -0.12 99.60 37.71 2.39 99.23 -3.23 86.22 8.94 -7.29 90.78 7.55 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 28 PHE~? 9.03 S2 BME A 601 A 205 ASP A 134 ASP~? 12.23 CL CL A 608 A 236 LYS A 127 LYS~? 18.61 MN MN B 606 coo 4.14 2.10 36.34 6.69 3.08 36.92 -6.17 45.72 11.50 -5.16 43.17 12.10 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 59 PHE~? 9.30 CL CL A 608 A 205 ASP A 122 ASP~? 22.01 MN MN B 606 A 236 LYS A 127 LYS~? 18.61 MN MN B 606 coo 4.14 2.10 36.34 6.69 3.08 36.92 -6.57 49.40 16.71 -5.70 50.05 14.11 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 59 PHE~? 9.30 CL CL A 608 A 205 ASP A 134 ASP~? 12.23 CL CL A 608 A 236 LYS A 127 LYS~? 18.61 MN MN B 606 coo 4.14 2.10 36.34 6.69 3.08 36.92 -6.57 49.40 16.71 -5.70 50.05 14.11 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 110 PHE~? 17.56 S2 BME A 601 A 205 ASP A 37 ASP~? 25.83 CL CL A 608 A 236 LYS A 127 LYS~? 18.61 MN MN B 606 coo 4.14 2.10 36.34 6.69 3.08 36.92 -15.74 46.87 16.94 -14.14 47.51 14.73 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -20.38 49.92 2.66 -20.55 51.94 2.14 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE B 28 PHE~? 9.03 C2 BME B 602 A 205 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 236 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 -2.63 86.84 14.28 -3.66 89.36 13.73 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 1.27 73.42 12.01 2.60 75.02 12.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE B 59 PHE~? 9.18 CL CL B 609 A 205 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 236 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 -7.31 83.22 16.56 -5.26 82.55 14.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE B 59 PHE~? 9.18 CL CL B 609 A 205 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 236 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 -7.31 83.22 16.56 -5.26 82.55 14.74 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 1.27 73.42 12.01 2.60 75.02 12.38 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE B 110 PHE~? 17.53 S2 BME B 602 A 205 ASP B 37 ASP~? 15.37 O1 GOL B 603 A 236 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 4.14 2.10 36.34 6.69 3.08 36.92 -4.01 85.90 25.00 -2.51 85.14 22.70 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 11.04 82.75 24.13 11.46 80.73 24.12 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 2.32 75.24 21.44 7.34 73.34 24.59 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 8 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 91 LEU A 93 LEU~? 8.21 MN MN A 605 A 133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 43.58 43.67 66.73 42.32 42.78 68.15 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 38.58 45.09 70.44 38.28 45.21 72.59 3.29 63.12 22.43 5.19 62.12 22.85 coo 44.05 36.87 70.65 43.15 38.64 69.97 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 91 LEU A 99 LEU~? 6.07 CL CL A 608 A 133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 43.58 43.67 66.73 42.32 42.78 68.15 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 38.58 45.09 70.44 38.28 45.21 72.59 -4.65 57.36 18.32 -3.62 57.88 16.49 coo 44.05 36.87 70.65 43.15 38.64 69.97 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 95 GLN~? 8.04 MN MN B 606 A 91 LEU B 93 LEU~? 8.10 MN MN B 606 A 133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 44.05 36.87 70.65 43.15 38.64 69.97 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 95 GLN~? 8.04 MN MN B 606 A 91 LEU B 99 LEU~? 6.07 CL CL B 609 A 133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 43.58 43.67 66.73 42.32 42.78 68.15 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 38.58 45.09 70.44 38.28 45.21 72.59 -9.33 75.11 15.40 -7.99 74.65 13.76 coo 44.05 36.87 70.65 43.15 38.64 69.97 -8.44 74.11 4.59 -9.08 75.11 6.26 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 95 GLN~? 6.65 C3 GOL B 603 B 591 LEU A 93 LEU~? 8.21 MN MN A 605 B 633 GLU A 140 GLU~? -2.42 MN MN A 605s coo 88.06 44.34 57.19 89.06 45.53 55.74 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 86.70 48.66 52.61 87.15 48.69 50.51 3.29 63.12 22.43 5.19 62.12 22.85 coo 95.42 44.52 54.43 93.46 45.31 54.70 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN A 95 GLN~? 6.65 C3 GOL B 603 B 591 LEU A 99 LEU~? 6.07 CL CL A 608 B 633 GLU A 140 GLU~? -2.42 MN MN A 605s coo 88.06 44.34 57.19 89.06 45.53 55.74 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 86.70 48.66 52.61 87.15 48.69 50.51 -4.65 57.36 18.32 -3.62 57.88 16.49 coo 95.42 44.52 54.43 93.46 45.31 54.70 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 3 3 # 3 B 550 GLN B 95 GLN~? 8.04 MN MN B 606 B 591 LEU B 93 LEU~? 8.10 MN MN B 606 B 633 GLU B 140 GLU~? -2.41 MN MN B 606s coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 95.42 44.52 54.43 93.46 45.31 54.70 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 4 3 # 4 B 550 GLN B 95 GLN~? 8.04 MN MN B 606 B 591 LEU B 99 LEU~? 6.07 CL CL B 609 B 633 GLU B 140 GLU~? -2.41 MN MN B 606s coo 88.06 44.34 57.19 89.06 45.53 55.74 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 86.70 48.66 52.61 87.15 48.69 50.51 -9.33 75.11 15.40 -7.99 74.65 13.76 coo 95.42 44.52 54.43 93.46 45.31 54.70 -8.44 74.11 4.59 -9.08 75.11 6.26 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 95 GLN~? 6.65 C3 GOL B 603 C1091 LEU A 93 LEU~? 8.21 MN MN A 605 C1133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 68.29 34.44 43.03 66.67 34.74 44.37 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 65.83 38.95 47.05 65.46 38.90 49.20 3.29 63.12 22.43 5.19 62.12 22.85 coo 63.14 29.39 46.25 63.84 31.31 45.74 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN A 95 GLN~? 6.65 C3 GOL B 603 C1091 LEU A 99 LEU~? 6.07 CL CL A 608 C1133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 68.29 34.44 43.03 66.67 34.74 44.37 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 65.83 38.95 47.05 65.46 38.90 49.20 -4.65 57.36 18.32 -3.62 57.88 16.49 coo 63.14 29.39 46.25 63.84 31.31 45.74 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 3 3 # 3 C1050 GLN B 95 GLN~? 8.04 MN MN B 606 C1091 LEU B 93 LEU~? 8.10 MN MN B 606 C1133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 63.14 29.39 46.25 63.84 31.31 45.74 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 4 3 # 4 C1050 GLN B 95 GLN~? 8.04 MN MN B 606 C1091 LEU B 99 LEU~? 6.07 CL CL B 609 C1133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 68.29 34.44 43.03 66.67 34.74 44.37 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 65.83 38.95 47.05 65.46 38.90 49.20 -9.33 75.11 15.40 -7.99 74.65 13.76 coo 63.14 29.39 46.25 63.84 31.31 45.74 -8.44 74.11 4.59 -9.08 75.11 6.26 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 4 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 91 LEU A 93 LEU~? 8.21 MN MN A 605 A 133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 38.23 53.34 67.59 38.84 53.87 69.56 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 35.40 53.22 73.30 35.37 54.87 74.74 3.29 63.12 22.43 5.19 62.12 22.85 coo 45.08 56.04 70.60 43.15 55.19 70.77 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 91 LEU A 99 LEU~? 6.07 CL CL A 608 A 133 GLU A 140 GLU~? -2.42 MN MN A 605s coo 38.23 53.34 67.59 38.84 53.87 69.56 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 35.40 53.22 73.30 35.37 54.87 74.74 -4.65 57.36 18.32 -3.62 57.88 16.49 coo 45.08 56.04 70.60 43.15 55.19 70.77 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 3 3 # 3 A 50 GLN B 95 GLN~? 8.04 MN MN B 606 A 91 LEU B 93 LEU~? 8.10 MN MN B 606 A 133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 38.23 53.34 67.59 38.84 53.87 69.56 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 45.08 56.04 70.60 43.15 55.19 70.77 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 4 3 # 4 A 50 GLN B 95 GLN~? 8.04 MN MN B 606 A 91 LEU B 99 LEU~? 6.07 CL CL B 609 A 133 GLU B 140 GLU~? -2.41 MN MN B 606s coo 38.23 53.34 67.59 38.84 53.87 69.56 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 35.40 53.22 73.30 35.37 54.87 74.74 -9.33 75.11 15.40 -7.99 74.65 13.76 coo 45.08 56.04 70.60 43.15 55.19 70.77 -8.44 74.11 4.59 -9.08 75.11 6.26 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 4 hits 1bsj_c00 naa= 3 ULMN 3 1bu7_c02 CYTOCHROME P450 user 1 3 # 1 A 268 THR A 51 THR~? 17.46 S2 BME A 601 A 393 PHE A 28 PHE~? 9.03 S2 BME A 601 A 400 CYH A 29 CYH~? 9.71 CL CL A 608 coo 45.81 71.19 43.26 47.70 70.19 43.25 -13.11 40.84 11.29 -13.34 41.71 9.31 coo 48.54 63.17 48.16 46.74 64.99 49.22 -6.17 45.72 11.50 -5.16 43.17 12.10 coo 53.76 64.39 46.87 52.06 66.55 47.33 -8.10 50.91 9.05 -6.68 52.72 10.63 ULMN 3 1bu7_c02 CYTOCHROME P450 user 2 3 # 2 A 268 THR B 51 THR~? 17.05 C2 BME B 602 A 393 PHE B 28 PHE~? 9.03 C2 BME B 602 A 400 CYH B 29 CYH~? 9.17 O1 GOL B 603 coo 45.81 71.19 43.26 47.70 70.19 43.25 0.21 91.77 20.35 2.10 90.94 19.87 coo 48.54 63.17 48.16 46.74 64.99 49.22 -2.63 86.84 14.28 -3.66 89.36 13.73 coo 53.76 64.39 46.87 52.06 66.55 47.33 0.50 81.71 15.06 -1.49 79.86 14.33 1bu7_c02 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c02 naa= 3 ULMN 3 1bu7_c03 CYTOCHROME P450 user 1 3 # 1 B 268 THR A 51 THR~? 17.46 S2 BME A 601 B 393 PHE A 28 PHE~? 9.03 S2 BME A 601 B 400 CYH A 29 CYH~? 9.71 CL CL A 608 coo 37.20 116.32 52.00 35.18 117.07 52.13 -13.11 40.84 11.29 -13.34 41.71 9.31 coo 33.81 121.65 59.26 35.49 119.55 59.81 -6.17 45.72 11.50 -5.16 43.17 12.10 coo 28.79 121.15 57.00 30.51 118.99 56.70 -8.10 50.91 9.05 -6.68 52.72 10.63 ULMN 3 1bu7_c03 CYTOCHROME P450 user 2 3 # 2 B 268 THR B 51 THR~? 17.05 C2 BME B 602 B 393 PHE B 28 PHE~? 9.03 C2 BME B 602 B 400 CYH B 29 CYH~? 9.17 O1 GOL B 603 coo 37.20 116.32 52.00 35.18 117.07 52.13 0.21 91.77 20.35 2.10 90.94 19.87 coo 33.81 121.65 59.26 35.49 119.55 59.81 -2.63 86.84 14.28 -3.66 89.36 13.73 coo 28.79 121.15 57.00 30.51 118.99 56.70 0.50 81.71 15.06 -1.49 79.86 14.33 1bu7_c03 source 1bu7 CYTOCHROME P450 : 2 hits 1bu7_c03 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 354 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 421 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 31.05 49.37 64.51 31.97 51.11 63.85 5.32 68.36 21.17 7.09 68.49 22.34 coo 29.07 50.42 58.36 29.02 52.18 59.49 7.70 72.78 18.03 7.03 72.92 20.00 coo 30.82 59.76 58.47 31.12 59.02 60.40 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP A 122 ASP~? 22.01 MN MN B 606 A 354 GLU A 123 GLU~? 22.37 MN MN B 606 A 421 ASP A 37 ASP~? 25.83 CL CL A 608 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 29.07 50.42 58.36 29.02 52.18 59.49 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 30.82 59.76 58.47 31.12 59.02 60.40 -20.38 49.92 2.66 -20.55 51.94 2.14 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP A 122 ASP~? 22.01 MN MN B 606 A 354 GLU A 123 GLU~? 22.37 MN MN B 606 A 421 ASP B 90 ASP~? 13.30 MN MN B 606 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 29.07 50.42 58.36 29.02 52.18 59.49 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 4 3 # 4 A 325 ASP A 122 ASP~? 22.01 MN MN B 606 A 354 GLU A 124 GLU~? 15.58 MN MN B 606 A 421 ASP B 90 ASP~? 13.30 MN MN B 606 coo 31.05 49.37 64.51 31.97 51.11 63.85 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 29.07 50.42 58.36 29.02 52.18 59.49 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 30.82 59.76 58.47 31.12 59.02 60.40 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 5 3 # 5 A 325 ASP B 90 ASP~? 13.30 MN MN B 606 A 354 GLU B 87 GLU~? 16.36 MN MN B 606 A 421 ASP A 134 ASP~? 12.23 CL CL A 608 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 29.07 50.42 58.36 29.02 52.18 59.49 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 30.82 59.76 58.47 31.12 59.02 60.40 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 6 3 # 6 A 325 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 354 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 421 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 31.05 49.37 64.51 31.97 51.11 63.85 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 29.07 50.42 58.36 29.02 52.18 59.49 5.68 77.05 25.89 7.75 77.09 25.94 coo 30.82 59.76 58.47 31.12 59.02 60.40 5.32 68.36 21.17 7.09 68.49 22.34 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 7 3 # 7 A 325 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 354 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 421 ASP B 37 ASP~? 15.37 O1 GOL B 603 coo 31.05 49.37 64.51 31.97 51.11 63.85 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 29.07 50.42 58.36 29.02 52.18 59.49 5.68 77.05 25.89 7.75 77.09 25.94 coo 30.82 59.76 58.47 31.12 59.02 60.40 11.04 82.75 24.13 11.46 80.73 24.12 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 8 3 # 8 A 325 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 354 GLU B 124 GLU~? 10.55 C1 GOL B 603 A 421 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 31.05 49.37 64.51 31.97 51.11 63.85 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 29.07 50.42 58.36 29.02 52.18 59.49 0.65 71.77 26.43 1.32 70.82 24.72 coo 30.82 59.76 58.47 31.12 59.02 60.40 5.32 68.36 21.17 7.09 68.49 22.34 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 8 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 354 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 421 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 25.90 8.19 53.87 25.36 6.97 52.29 5.32 68.36 21.17 7.09 68.49 22.34 coo 27.87 10.66 47.95 27.82 8.60 48.27 7.70 72.78 18.03 7.03 72.92 20.00 coo 26.02 1.87 43.38 25.90 1.97 45.49 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 122 ASP~? 22.01 MN MN B 606 B 354 GLU A 123 GLU~? 22.37 MN MN B 606 B 421 ASP B 90 ASP~? 13.30 MN MN B 606 coo 25.90 8.19 53.87 25.36 6.97 52.29 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 27.87 10.66 47.95 27.82 8.60 48.27 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 26.02 1.87 43.38 25.90 1.97 45.49 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 90 ASP~? 13.30 MN MN B 606 B 354 GLU B 87 GLU~? 16.36 MN MN B 606 B 421 ASP A 134 ASP~? 12.23 CL CL A 608 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 27.87 10.66 47.95 27.82 8.60 48.27 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 26.02 1.87 43.38 25.90 1.97 45.49 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 122 ASP~? 15.88 O1 GOL B 603 B 354 GLU B 123 GLU~? 13.36 O1 GOL B 603 B 421 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 25.90 8.19 53.87 25.36 6.97 52.29 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 27.87 10.66 47.95 27.82 8.60 48.27 5.68 77.05 25.89 7.75 77.09 25.94 coo 26.02 1.87 43.38 25.90 1.97 45.49 5.32 68.36 21.17 7.09 68.49 22.34 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 60 ASN~? 13.23 C1 BME A 601 192 ASP A 101 ASP~? 14.47 MN MN A 605 195 HIS A 100 HIS~? 8.88 CL CL A 608 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -7.52 45.83 22.75 -9.56 46.47 22.75 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 60 ASN~? 14.04 C1 BME B 602 192 ASP B 101 ASP~? 14.48 MN MN B 606 195 HIS B 100 HIS~? 8.87 CL CL B 609 coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -12.53 86.72 19.85 -11.70 86.05 21.72 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -13.86 76.47 17.25 -14.56 76.87 15.30 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 2 hits 1bwp_c01 naa= 3 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 1 3 # 1 F 269 CYH A 21 CYH~? -2.28 S2 BME A 601s F 353 HIS A 22 HIS~? -3.40 MN MN A 604s F 355 GLU A 140 GLU~? -2.42 MN MN A 605s coo 18.82 112.01 71.04 17.41 109.69 71.95 3.34 47.98 12.34 4.26 47.15 14.87 coo 19.82 107.03 67.63 19.24 107.06 69.63 3.18 53.06 10.64 3.66 54.63 11.95 coo 25.34 105.41 66.70 23.67 106.48 67.30 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 2 3 # 2 F 269 CYH A 21 CYH~? -2.28 S2 BME A 601s F 353 HIS A 22 HIS~? -3.40 MN MN A 604s F 355 GLU A 141 GLU~? 7.70 MN MN A 604 coo 18.82 112.01 71.04 17.41 109.69 71.95 3.34 47.98 12.34 4.26 47.15 14.87 coo 19.82 107.03 67.63 19.24 107.06 69.63 3.18 53.06 10.64 3.66 54.63 11.95 coo 25.34 105.41 66.70 23.67 106.48 67.30 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 3 3 # 3 F 269 CYH A 21 CYH~? -2.28 S2 BME A 601s F 353 HIS A 66 HIS~? 3.42 MN MN A 604s F 355 GLU A 70 GLU~? -2.54 MN MN A 604s coo 18.82 112.01 71.04 17.41 109.69 71.95 3.34 47.98 12.34 4.26 47.15 14.87 coo 19.82 107.03 67.63 19.24 107.06 69.63 3.21 51.23 16.81 3.87 52.43 15.22 coo 25.34 105.41 66.70 23.67 106.48 67.30 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 4 3 # 4 F 269 CYH B 21 CYH~? -2.10 S2 BME B 602s F 353 HIS B 22 HIS~? -3.40 MN MN B 607s F 355 GLU B 140 GLU~? -2.41 MN MN B 606s coo 18.82 112.01 71.04 17.41 109.69 71.95 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 19.82 107.03 67.63 19.24 107.06 69.63 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 25.34 105.41 66.70 23.67 106.48 67.30 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 5 3 # 5 F 269 CYH B 21 CYH~? -2.10 S2 BME B 602s F 353 HIS B 22 HIS~? -3.40 MN MN B 607s F 355 GLU B 141 GLU~? 7.71 MN MN B 607 coo 18.82 112.01 71.04 17.41 109.69 71.95 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 19.82 107.03 67.63 19.24 107.06 69.63 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 25.34 105.41 66.70 23.67 106.48 67.30 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bxr_c00 CARBAMOYL-PHOSPHATE SYNTHASE user 6 3 # 6 F 269 CYH B 21 CYH~? -2.10 S2 BME B 602s F 353 HIS B 66 HIS~? 3.43 MN MN B 607s F 355 GLU B 70 GLU~? -2.57 MN MN B 607s coo 18.82 112.01 71.04 17.41 109.69 71.95 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 19.82 107.03 67.63 19.24 107.06 69.63 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 25.34 105.41 66.70 23.67 106.48 67.30 -12.98 77.36 5.11 -11.32 76.90 6.35 1bxr_c00 source 1bxr CARBAMOYL-PHOSPHATE SYNTHASE : 6 hits 1bxr_c00 naa= 3 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 1 3 # 1 H 269 CYH A 21 CYH~? -2.28 S2 BME A 601s H 353 HIS A 22 HIS~? -3.40 MN MN A 604s H 355 GLU A 140 GLU~? -2.42 MN MN A 605s coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 3.34 47.98 12.34 4.26 47.15 14.87 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 3.18 53.06 10.64 3.66 54.63 11.95 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 2 3 # 2 H 269 CYH A 21 CYH~? -2.28 S2 BME A 601s H 353 HIS A 22 HIS~? -3.40 MN MN A 604s H 355 GLU A 141 GLU~? 7.70 MN MN A 604 coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 3.34 47.98 12.34 4.26 47.15 14.87 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 3.18 53.06 10.64 3.66 54.63 11.95 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 3 3 # 3 H 269 CYH A 21 CYH~? -2.28 S2 BME A 601s H 353 HIS A 66 HIS~? 3.42 MN MN A 604s H 355 GLU A 70 GLU~? -2.54 MN MN A 604s coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 3.34 47.98 12.34 4.26 47.15 14.87 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 3.21 51.23 16.81 3.87 52.43 15.22 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 4 3 # 4 H 269 CYH B 21 CYH~? -2.10 S2 BME B 602s H 353 HIS B 22 HIS~? -3.40 MN MN B 607s H 355 GLU B 140 GLU~? -2.41 MN MN B 606s coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 5 3 # 5 H 269 CYH B 21 CYH~? -2.10 S2 BME B 602s H 353 HIS B 22 HIS~? -3.40 MN MN B 607s H 355 GLU B 141 GLU~? 7.71 MN MN B 607 coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bxr_c01 CARBAMOYL-PHOSPHATE SYNTHASE user 6 3 # 6 H 269 CYH B 21 CYH~? -2.10 S2 BME B 602s H 353 HIS B 66 HIS~? 3.43 MN MN B 607s H 355 GLU B 70 GLU~? -2.57 MN MN B 607s coo 10.23 -42.92 -46.59 8.57 -40.69 -47.15 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 11.78 -37.81 -43.38 10.78 -37.87 -45.19 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 17.02 -36.36 -43.72 15.28 -37.51 -44.03 -12.98 77.36 5.11 -11.32 76.90 6.35 1bxr_c01 source 1bxr CARBAMOYL-PHOSPHATE SYNTHASE : 6 hits 1bxr_c01 naa= 3 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 1 3 # 1 B 269 CYH A 21 CYH~? -2.28 S2 BME A 601s B 353 HIS A 22 HIS~? -3.40 MN MN A 604s B 355 GLU A 140 GLU~? -2.42 MN MN A 605s coo 22.02 52.06 108.33 23.30 53.71 106.28 3.34 47.98 12.34 4.26 47.15 14.87 coo 20.17 51.43 102.33 20.91 53.22 103.13 3.18 53.06 10.64 3.66 54.63 11.95 coo 14.96 51.49 101.15 16.69 51.40 102.30 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 2 3 # 2 B 269 CYH A 21 CYH~? -2.28 S2 BME A 601s B 353 HIS A 22 HIS~? -3.40 MN MN A 604s B 355 GLU A 141 GLU~? 7.70 MN MN A 604 coo 22.02 52.06 108.33 23.30 53.71 106.28 3.34 47.98 12.34 4.26 47.15 14.87 coo 20.17 51.43 102.33 20.91 53.22 103.13 3.18 53.06 10.64 3.66 54.63 11.95 coo 14.96 51.49 101.15 16.69 51.40 102.30 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 3 3 # 3 B 269 CYH A 21 CYH~? -2.28 S2 BME A 601s B 353 HIS A 66 HIS~? 3.42 MN MN A 604s B 355 GLU A 70 GLU~? -2.54 MN MN A 604s coo 22.02 52.06 108.33 23.30 53.71 106.28 3.34 47.98 12.34 4.26 47.15 14.87 coo 20.17 51.43 102.33 20.91 53.22 103.13 3.21 51.23 16.81 3.87 52.43 15.22 coo 14.96 51.49 101.15 16.69 51.40 102.30 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 4 3 # 4 B 269 CYH B 21 CYH~? -2.10 S2 BME B 602s B 353 HIS B 22 HIS~? -3.40 MN MN B 607s B 355 GLU B 140 GLU~? -2.41 MN MN B 606s coo 22.02 52.06 108.33 23.30 53.71 106.28 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 20.17 51.43 102.33 20.91 53.22 103.13 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 14.96 51.49 101.15 16.69 51.40 102.30 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 5 3 # 5 B 269 CYH B 21 CYH~? -2.10 S2 BME B 602s B 353 HIS B 22 HIS~? -3.40 MN MN B 607s B 355 GLU B 141 GLU~? 7.71 MN MN B 607 coo 22.02 52.06 108.33 23.30 53.71 106.28 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 20.17 51.43 102.33 20.91 53.22 103.13 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 14.96 51.49 101.15 16.69 51.40 102.30 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bxr_c02 CARBAMOYL-PHOSPHATE SYNTHASE user 6 3 # 6 B 269 CYH B 21 CYH~? -2.10 S2 BME B 602s B 353 HIS B 66 HIS~? 3.43 MN MN B 607s B 355 GLU B 70 GLU~? -2.57 MN MN B 607s coo 22.02 52.06 108.33 23.30 53.71 106.28 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 20.17 51.43 102.33 20.91 53.22 103.13 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 14.96 51.49 101.15 16.69 51.40 102.30 -12.98 77.36 5.11 -11.32 76.90 6.35 1bxr_c02 source 1bxr CARBAMOYL-PHOSPHATE SYNTHASE : 6 hits 1bxr_c02 naa= 3 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 1 3 # 1 D 269 CYH A 21 CYH~? -2.28 S2 BME A 601s D 353 HIS A 22 HIS~? -3.40 MN MN A 604s D 355 GLU A 140 GLU~? -2.42 MN MN A 605s coo 6.14 16.68 -83.37 8.12 15.35 -81.77 3.34 47.98 12.34 4.26 47.15 14.87 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 3.18 53.06 10.64 3.66 54.63 11.95 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 2 3 # 2 D 269 CYH A 21 CYH~? -2.28 S2 BME A 601s D 353 HIS A 22 HIS~? -3.40 MN MN A 604s D 355 GLU A 141 GLU~? 7.70 MN MN A 604 coo 6.14 16.68 -83.37 8.12 15.35 -81.77 3.34 47.98 12.34 4.26 47.15 14.87 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 3.18 53.06 10.64 3.66 54.63 11.95 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 3 3 # 3 D 269 CYH A 21 CYH~? -2.28 S2 BME A 601s D 353 HIS A 66 HIS~? 3.42 MN MN A 604s D 355 GLU A 70 GLU~? -2.54 MN MN A 604s coo 6.14 16.68 -83.37 8.12 15.35 -81.77 3.34 47.98 12.34 4.26 47.15 14.87 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 3.21 51.23 16.81 3.87 52.43 15.22 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 4 3 # 4 D 269 CYH B 21 CYH~? -2.10 S2 BME B 602s D 353 HIS B 22 HIS~? -3.40 MN MN B 607s D 355 GLU B 140 GLU~? -2.41 MN MN B 606s coo 6.14 16.68 -83.37 8.12 15.35 -81.77 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 5 3 # 5 D 269 CYH B 21 CYH~? -2.10 S2 BME B 602s D 353 HIS B 22 HIS~? -3.40 MN MN B 607s D 355 GLU B 141 GLU~? 7.71 MN MN B 607 coo 6.14 16.68 -83.37 8.12 15.35 -81.77 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1bxr_c03 CARBAMOYL-PHOSPHATE SYNTHASE user 6 3 # 6 D 269 CYH B 21 CYH~? -2.10 S2 BME B 602s D 353 HIS B 66 HIS~? 3.43 MN MN B 607s D 355 GLU B 70 GLU~? -2.57 MN MN B 607s coo 6.14 16.68 -83.37 8.12 15.35 -81.77 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 5.55 17.41 -77.20 6.45 15.85 -78.23 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 0.63 16.97 -75.01 2.03 17.19 -76.56 -12.98 77.36 5.11 -11.32 76.90 6.35 1bxr_c03 source 1bxr CARBAMOYL-PHOSPHATE SYNTHASE : 6 hits 1bxr_c03 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU A 68 GLU~? 10.93 O1 BME A 601 A 65 ARG A 167 ARG~? -4.94 O1 BME A 601s A 85 HIS A 66 HIS~? 3.42 MN MN A 604s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 5.73 51.66 25.85 5.32 49.97 27.08 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 6.75 43.81 21.29 6.50 46.65 20.31 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1c54_c00 RIBONUCLEASE SA user 2 3 # 2 A 54 GLU A 71 GLU~? 7.91 MN MN A 605 A 65 ARG A 166 ARG~? 11.02 O1 BME A 601 A 85 HIS A 66 HIS~? 3.42 MN MN A 604s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 4.56 57.67 23.22 2.91 58.15 24.47 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 6.93 48.25 24.41 9.45 50.10 24.73 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1c54_c00 RIBONUCLEASE SA user 3 3 # 3 A 54 GLU A 72 GLU~? 12.86 MN MN A 605 A 65 ARG A 167 ARG~? -4.94 O1 BME A 601s A 85 HIS A 66 HIS~? 3.42 MN MN A 604s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 8.16 54.29 26.80 8.10 55.96 28.07 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 6.75 43.81 21.29 6.50 46.65 20.31 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1c54_c00 RIBONUCLEASE SA user 4 3 # 4 A 54 GLU B 71 GLU~? 7.93 MN MN B 606 A 65 ARG B 166 ARG~? 12.22 S2 BME B 602 A 85 HIS B 66 HIS~? 3.43 MN MN B 607s coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 -17.41 74.79 8.70 -17.96 74.30 10.67 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 -11.11 81.39 7.66 -9.84 80.27 6.41 1c54_c00 source 1c54 RIBONUCLEASE SA : 4 hits 1c54_c00 naa= 3 ULMN 3 1c82_c00 HYALURONATE LYASE user 1 3 # 1 A 349 ASN A 102 ASN~? 12.24 CL CL A 608 A 399 HIS A 136 HIS~? 3.48 MN MN A 605s A 408 TYR A 133 TYR~? 5.56 CL CL A 608 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -10.29 57.70 17.47 -10.13 59.75 17.06 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -0.57 59.60 14.33 0.78 59.36 15.93 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1c82_c00 HYALURONATE LYASE user 2 3 # 2 A 349 ASN B 102 ASN~? 10.95 O1 GOL B 603 A 399 HIS B 136 HIS~? 3.50 MN MN B 606s A 408 TYR B 133 TYR~? 5.56 CL CL B 609 coo 11.39 -18.14 26.77 11.56 -16.76 28.37 -6.42 74.86 20.35 -6.05 72.80 20.02 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -4.49 77.34 13.29 -7.09 78.39 13.51 1c82_c00 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c00 naa= 3 ULMN 3 1c82_c01 HYALURONATE LYASE user 1 3 # 1 A 399 HIS A 22 HIS~? -3.40 MN MN A 604s A 408 TYR A 19 TYR~? 9.00 MN MN A 604 A 462 ARG A 26 ARG~? 9.60 MN MN A 604 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 3.18 53.06 10.64 3.66 54.63 11.95 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 8.27 52.26 7.85 9.08 54.84 7.01 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1c82_c01 HYALURONATE LYASE user 2 3 # 2 A 399 HIS B 22 HIS~? -3.40 MN MN B 607s A 408 TYR B 19 TYR~? 9.04 MN MN B 607 A 462 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 13.02 -18.02 35.24 12.75 -16.25 34.15 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 7.81 -17.82 32.55 9.60 -15.69 32.78 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 10.34 -11.56 38.02 10.61 -11.96 35.00 1.24 79.80 7.27 0.69 76.71 7.21 1c82_c01 source 1c82 HYALURONATE LYASE : 2 hits 1c82_c01 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 69 ASP~? 7.42 O1 BME A 601 A 16 HIS A 66 HIS~? 3.42 MN MN A 604s A 67 GLY A 160 GLY~? 13.13 O1 BME A 601 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 7.88 51.22 19.98 7.64 49.14 20.25 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 3.21 51.23 16.81 3.87 52.43 15.22 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 15.62 47.56 18.93 15.86 47.64 19.72 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP B 69 ASP~? 7.66 S2 BME B 602 A 16 HIS B 66 HIS~? 3.43 MN MN B 607s A 67 GLY B 160 GLY~? 13.29 S2 BME B 602 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -17.76 85.15 -2.82 -18.58 85.08 -2.82 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 69 ASP~? 7.42 O1 BME A 601 C 16 HIS A 66 HIS~? 3.42 MN MN A 604s C 67 GLY A 160 GLY~? 13.13 O1 BME A 601 coo 10.04 44.27 88.44 9.47 42.32 89.03 7.88 51.22 19.98 7.64 49.14 20.25 coo 6.38 39.80 88.71 6.88 38.89 86.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 17.63 42.50 89.25 18.11 42.29 88.64 15.62 47.56 18.93 15.86 47.64 19.72 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP B 69 ASP~? 7.66 S2 BME B 602 C 16 HIS B 66 HIS~? 3.43 MN MN B 607s C 67 GLY B 160 GLY~? 13.29 S2 BME B 602 coo 10.04 44.27 88.44 9.47 42.32 89.03 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 17.63 42.50 89.25 18.11 42.29 88.64 -17.76 85.15 -2.82 -18.58 85.08 -2.82 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 2 hits 1cb7_c07 naa= 3 ULMN 3 1cb8_c00 CHONDROITINASE AC user 1 3 # 1 A 175 ASN A 102 ASN~? 12.24 CL CL A 608 A 225 HIS A 136 HIS~? 3.48 MN MN A 605s A 234 TYR A 133 TYR~? 5.56 CL CL A 608 coo 26.32 35.76 46.63 26.28 33.63 46.67 -10.29 57.70 17.47 -10.13 59.75 17.06 coo 27.04 28.61 41.75 26.86 28.65 43.84 -0.57 59.60 14.33 0.78 59.36 15.93 coo 21.80 30.48 43.67 23.70 29.06 45.12 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1cb8_c00 CHONDROITINASE AC user 2 3 # 2 A 175 ASN B 102 ASN~? 10.95 O1 GOL B 603 A 225 HIS B 136 HIS~? 3.50 MN MN B 606s A 234 TYR B 133 TYR~? 5.56 CL CL B 609 coo 26.32 35.76 46.63 26.28 33.63 46.67 -6.42 74.86 20.35 -6.05 72.80 20.02 coo 27.04 28.61 41.75 26.86 28.65 43.84 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 21.80 30.48 43.67 23.70 29.06 45.12 -4.49 77.34 13.29 -7.09 78.39 13.51 1cb8_c00 source 1cb8 CHONDROITINASE AC : 2 hits 1cb8_c00 naa= 3 ULMN 3 1cb8_c01 CHONDROITINASE AC user 1 3 # 1 A 225 HIS A 22 HIS~? -3.40 MN MN A 604s A 234 TYR A 19 TYR~? 9.00 MN MN A 604 A 288 ARG A 26 ARG~? 9.60 MN MN A 604 coo 27.04 28.61 41.75 26.86 28.65 43.84 3.18 53.06 10.64 3.66 54.63 11.95 coo 21.80 30.48 43.67 23.70 29.06 45.12 8.27 52.26 7.85 9.08 54.84 7.01 coo 24.79 22.62 45.60 24.87 25.42 46.81 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1cb8_c01 CHONDROITINASE AC user 2 3 # 2 A 225 HIS B 22 HIS~? -3.40 MN MN B 607s A 234 TYR B 19 TYR~? 9.04 MN MN B 607 A 288 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 27.04 28.61 41.75 26.86 28.65 43.84 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 21.80 30.48 43.67 23.70 29.06 45.12 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 24.79 22.62 45.60 24.87 25.42 46.81 1.24 79.80 7.27 0.69 76.71 7.21 1cb8_c01 source 1cb8 CHONDROITINASE AC : 2 hits 1cb8_c01 naa= 3 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 1 3 # 1 71 ARG A 94 ARG~? 6.60 C1 GOL B 603 127 ARG B 128 ARG~? 13.47 O1 GOL B 603 270 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.58 68.78 21.39 1.97 70.41 20.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 2 3 # 2 71 ARG A 94 ARG~? 6.60 C1 GOL B 603 127 ARG B 128 ARG~? 13.47 O1 GOL B 603 270 GLU B 123 GLU~? 13.36 O1 GOL B 603 coo -0.83 25.63 1.57 0.97 28.05 0.90 -0.58 68.78 21.39 1.97 70.41 20.81 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 5.68 77.05 25.89 7.75 77.09 25.94 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 3 3 # 3 71 ARG A 128 ARG~? 18.10 CL CL A 608 127 ARG B 94 ARG~? 13.57 MN MN B 606 270 GLU A 123 GLU~? 22.37 MN MN B 606 coo -0.83 25.63 1.57 0.97 28.05 0.90 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -19.99 55.60 8.30 -20.84 55.52 6.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 4 3 # 4 71 ARG A 166 ARG~? 11.02 O1 BME A 601 127 ARG A 167 ARG~? -4.94 O1 BME A 601s 270 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -0.83 25.63 1.57 0.97 28.05 0.90 6.93 48.25 24.41 9.45 50.10 24.73 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.75 43.81 21.29 6.50 46.65 20.31 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 5 3 # 5 71 ARG A 167 ARG~? -4.94 O1 BME A 601s 127 ARG A 166 ARG~? 11.02 O1 BME A 601 270 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -0.83 25.63 1.57 0.97 28.05 0.90 6.75 43.81 21.29 6.50 46.65 20.31 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 6.93 48.25 24.41 9.45 50.10 24.73 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 6 3 # 6 71 ARG B 94 ARG~? 13.57 MN MN B 606 127 ARG A 128 ARG~? 18.10 CL CL A 608 270 GLU A 109 GLU~? 22.92 CL CL A 608 coo -0.83 25.63 1.57 0.97 28.05 0.90 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 7 3 # 7 71 ARG B 94 ARG~? 13.57 MN MN B 606 127 ARG A 128 ARG~? 18.10 CL CL A 608 270 GLU A 123 GLU~? 22.37 MN MN B 606 coo -0.83 25.63 1.57 0.97 28.05 0.90 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -19.99 55.60 8.30 -20.84 55.52 6.39 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 8 3 # 8 71 ARG B 128 ARG~? 13.47 O1 GOL B 603 127 ARG A 94 ARG~? 6.60 C1 GOL B 603 270 GLU B 123 GLU~? 13.36 O1 GOL B 603 coo -0.83 25.63 1.57 0.97 28.05 0.90 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -0.58 68.78 21.39 1.97 70.41 20.81 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 5.68 77.05 25.89 7.75 77.09 25.94 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 9 3 # 9 71 ARG B 166 ARG~? 12.22 S2 BME B 602 127 ARG B 167 ARG~? 6.18 S2 BME B 602 270 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -0.83 25.63 1.57 0.97 28.05 0.90 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1cbx_c01 CARBOXYPEPTIDASE A (E.C.3.4.17.1) COuser 10 3 # 10 71 ARG B 167 ARG~? 6.18 S2 BME B 602 127 ARG B 166 ARG~? 12.22 S2 BME B 602 270 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -0.83 25.63 1.57 0.97 28.05 0.90 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 2.68 26.75 -2.61 1.18 28.07 -5.02 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -7.78 30.85 -7.94 -6.11 29.80 -7.25 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1cbx_c01 source 1cbx CARBOXYPEPTIDASE A (E.C.3.4.17.1) COMPLEX WITH: 10 hits 1cbx_c01 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 90 ASP~? 8.93 C1 GOL B 603 264 GLU B 91 GLU~? 11.42 MN MN B 606 328 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 45.62 80.42 43.69 45.65 82.01 45.07 5.32 68.36 21.17 7.09 68.49 22.34 coo 59.69 92.71 39.85 58.53 92.03 41.47 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 134 ASP~? 12.23 CL CL A 608 264 GLU A 109 GLU~? 22.92 CL CL A 608 328 ASP B 90 ASP~? 13.30 MN MN B 606 coo 45.62 80.42 43.69 45.65 82.01 45.07 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 59.69 92.71 39.85 58.53 92.03 41.47 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 134 ASP~? 12.23 CL CL A 608 264 GLU B 70 GLU~? -2.57 MN MN B 607s 328 ASP B 90 ASP~? 13.30 MN MN B 606 coo 45.62 80.42 43.69 45.65 82.01 45.07 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 59.69 92.71 39.85 58.53 92.03 41.47 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 90 ASP~? 13.30 MN MN B 606 264 GLU A 91 GLU~? 5.92 C1 GOL B 603 328 ASP A 134 ASP~? 12.23 CL CL A 608 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 0.70 67.61 16.19 -1.02 68.27 17.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 134 ASP~? -3.66 O1 GOL B 603s 264 GLU A 70 GLU~? -2.54 MN MN A 604s 328 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.27 73.42 12.01 2.60 75.02 12.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 6.20 55.25 17.70 4.45 55.72 16.64 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.32 68.36 21.17 7.09 68.49 22.34 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 134 ASP~? -3.66 O1 GOL B 603s 264 GLU B 109 GLU~? 18.95 O1 GOL B 603 328 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.27 73.42 12.01 2.60 75.02 12.38 coo 59.69 92.71 39.85 58.53 92.03 41.47 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.32 68.36 21.17 7.09 68.49 22.34 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c00 naa= 3 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 90 ASP~? 8.93 C1 GOL B 603 257 GLU A 91 GLU~? 5.92 C1 GOL B 603 328 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 45.62 80.42 43.69 45.65 82.01 45.07 5.32 68.36 21.17 7.09 68.49 22.34 coo 48.97 85.16 40.39 47.18 86.25 40.47 0.70 67.61 16.19 -1.02 68.27 17.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 134 ASP~? 12.23 CL CL A 608 257 GLU B 87 GLU~? 16.36 MN MN B 606 328 ASP B 90 ASP~? 13.30 MN MN B 606 coo 45.62 80.42 43.69 45.65 82.01 45.07 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 48.97 85.16 40.39 47.18 86.25 40.47 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 134 ASP~? 12.23 CL CL A 608 257 GLU B 91 GLU~? 11.42 MN MN B 606 328 ASP B 90 ASP~? 13.30 MN MN B 606 coo 45.62 80.42 43.69 45.65 82.01 45.07 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 45.39 90.72 40.63 45.07 89.14 41.90 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP B 90 ASP~? 13.30 MN MN B 606 257 GLU B 87 GLU~? 16.36 MN MN B 606 328 ASP A 134 ASP~? 12.23 CL CL A 608 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 45.39 90.72 40.63 45.07 89.14 41.90 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 90 ASP~? 13.30 MN MN B 606 257 GLU B 91 GLU~? 11.42 MN MN B 606 328 ASP A 134 ASP~? 12.23 CL CL A 608 coo 45.62 80.42 43.69 45.65 82.01 45.07 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 48.97 85.16 40.39 47.18 86.25 40.47 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 45.39 90.72 40.63 45.07 89.14 41.90 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1cdg_c04 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 134 ASP~? -3.66 O1 GOL B 603s 257 GLU A 91 GLU~? 5.92 C1 GOL B 603 328 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 45.62 80.42 43.69 45.65 82.01 45.07 1.27 73.42 12.01 2.60 75.02 12.38 coo 48.97 85.16 40.39 47.18 86.25 40.47 0.70 67.61 16.19 -1.02 68.27 17.25 coo 45.39 90.72 40.63 45.07 89.14 41.90 5.32 68.36 21.17 7.09 68.49 22.34 1cdg_c04 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 6 hits 1cdg_c04 naa= 3 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 A 232 HIS A 66 HIS~? 3.42 MN MN A 604s A 262 GLU A 68 GLU~? 10.93 O1 BME A 601 A 358 GLU A 71 GLU~? 7.91 MN MN A 605 coo 26.19 60.87 43.98 27.48 59.27 43.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 27.13 54.07 50.45 26.96 54.19 48.35 5.73 51.66 25.85 5.32 49.97 27.08 coo 27.06 50.43 44.36 27.99 52.27 44.74 4.56 57.67 23.22 2.91 58.15 24.47 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 A 232 HIS A 66 HIS~? 3.42 MN MN A 604s A 262 GLU A 71 GLU~? 7.91 MN MN A 605 A 358 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 26.19 60.87 43.98 27.48 59.27 43.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.56 57.67 23.22 2.91 58.15 24.47 coo 27.06 50.43 44.36 27.99 52.27 44.74 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 A 232 HIS A 66 HIS~? 3.42 MN MN A 604s A 262 GLU A 71 GLU~? 7.91 MN MN A 605 A 358 GLU A 72 GLU~? 12.86 MN MN A 605 coo 26.19 60.87 43.98 27.48 59.27 43.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.56 57.67 23.22 2.91 58.15 24.47 coo 27.06 50.43 44.36 27.99 52.27 44.74 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 A 232 HIS A 66 HIS~? 3.42 MN MN A 604s A 262 GLU A 140 GLU~? -2.42 MN MN A 605s A 358 GLU A 141 GLU~? 7.70 MN MN A 604 coo 26.19 60.87 43.98 27.48 59.27 43.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 27.13 54.07 50.45 26.96 54.19 48.35 5.06 58.75 13.41 3.74 57.63 14.59 coo 27.06 50.43 44.36 27.99 52.27 44.74 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 A 232 HIS A 100 HIS~? 8.88 CL CL A 608 A 262 GLU A 71 GLU~? 7.91 MN MN A 605 A 358 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 26.19 60.87 43.98 27.48 59.27 43.30 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.56 57.67 23.22 2.91 58.15 24.47 coo 27.06 50.43 44.36 27.99 52.27 44.74 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 A 232 HIS A 100 HIS~? 8.88 CL CL A 608 A 262 GLU A 71 GLU~? 7.91 MN MN A 605 A 358 GLU A 70 GLU~? -2.54 MN MN A 604s coo 26.19 60.87 43.98 27.48 59.27 43.30 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.56 57.67 23.22 2.91 58.15 24.47 coo 27.06 50.43 44.36 27.99 52.27 44.74 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 A 232 HIS A 136 HIS~? 3.48 MN MN A 605s A 262 GLU A 70 GLU~? -2.54 MN MN A 604s A 358 GLU A 71 GLU~? 7.91 MN MN A 605 coo 26.19 60.87 43.98 27.48 59.27 43.30 -0.57 59.60 14.33 0.78 59.36 15.93 coo 27.13 54.07 50.45 26.96 54.19 48.35 6.20 55.25 17.70 4.45 55.72 16.64 coo 27.06 50.43 44.36 27.99 52.27 44.74 4.56 57.67 23.22 2.91 58.15 24.47 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 A 232 HIS A 136 HIS~? 3.48 MN MN A 605s A 262 GLU A 71 GLU~? 7.91 MN MN A 605 A 358 GLU A 70 GLU~? -2.54 MN MN A 604s coo 26.19 60.87 43.98 27.48 59.27 43.30 -0.57 59.60 14.33 0.78 59.36 15.93 coo 27.13 54.07 50.45 26.96 54.19 48.35 4.56 57.67 23.22 2.91 58.15 24.47 coo 27.06 50.43 44.36 27.99 52.27 44.74 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 A 232 HIS B 66 HIS~? 3.43 MN MN B 607s A 262 GLU B 68 GLU~? 12.41 MN MN B 606 A 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 A 232 HIS B 66 HIS~? 3.43 MN MN B 607s A 262 GLU B 68 GLU~? 12.41 MN MN B 606 A 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 A 232 HIS B 66 HIS~? 3.43 MN MN B 607s A 262 GLU B 71 GLU~? 7.93 MN MN B 606 A 358 GLU B 68 GLU~? 12.41 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 27.06 50.43 44.36 27.99 52.27 44.74 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 A 232 HIS B 66 HIS~? 3.43 MN MN B 607s A 262 GLU B 71 GLU~? 7.93 MN MN B 606 A 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 27.06 50.43 44.36 27.99 52.27 44.74 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 A 232 HIS B 66 HIS~? 3.43 MN MN B 607s A 262 GLU B 140 GLU~? -2.41 MN MN B 606s A 358 GLU B 141 GLU~? 7.71 MN MN B 607 coo 26.19 60.87 43.98 27.48 59.27 43.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 27.13 54.07 50.45 26.96 54.19 48.35 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 27.06 50.43 44.36 27.99 52.27 44.74 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 14 3 # 14 A 232 HIS B 96 HIS~? -3.43 MN MN B 606s A 262 GLU B 68 GLU~? 12.41 MN MN B 606 A 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 15 3 # 15 A 232 HIS B 96 HIS~? -3.43 MN MN B 606s A 262 GLU B 72 GLU~? 13.02 MN MN B 606 A 358 GLU B 68 GLU~? 12.41 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 27.13 54.07 50.45 26.96 54.19 48.35 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 27.06 50.43 44.36 27.99 52.27 44.74 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 16 3 # 16 A 232 HIS B 100 HIS~? 8.87 CL CL B 609 A 262 GLU B 68 GLU~? 12.41 MN MN B 606 A 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 27.13 54.07 50.45 26.96 54.19 48.35 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 17 3 # 17 A 232 HIS B 100 HIS~? 8.87 CL CL B 609 A 262 GLU B 68 GLU~? 12.41 MN MN B 606 A 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 27.13 54.07 50.45 26.96 54.19 48.35 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 27.06 50.43 44.36 27.99 52.27 44.74 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 18 3 # 18 A 232 HIS B 100 HIS~? 8.87 CL CL B 609 A 262 GLU B 71 GLU~? 7.93 MN MN B 606 A 358 GLU B 68 GLU~? 12.41 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 27.13 54.07 50.45 26.96 54.19 48.35 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 27.06 50.43 44.36 27.99 52.27 44.74 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 19 3 # 19 A 232 HIS B 100 HIS~? 8.87 CL CL B 609 A 262 GLU B 71 GLU~? 7.93 MN MN B 606 A 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 26.19 60.87 43.98 27.48 59.27 43.30 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 27.13 54.07 50.45 26.96 54.19 48.35 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 27.06 50.43 44.36 27.99 52.27 44.74 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 20 3 # 20 A 232 HIS B 136 HIS~? 3.50 MN MN B 606s A 262 GLU B 70 GLU~? -2.57 MN MN B 607s A 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 26.19 60.87 43.98 27.48 59.27 43.30 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 27.13 54.07 50.45 26.96 54.19 48.35 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 27.06 50.43 44.36 27.99 52.27 44.74 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c00 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 21 3 # 21 A 232 HIS B 136 HIS~? 3.50 MN MN B 606s A 262 GLU B 71 GLU~? 7.93 MN MN B 606 A 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 26.19 60.87 43.98 27.48 59.27 43.30 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 27.13 54.07 50.45 26.96 54.19 48.35 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 27.06 50.43 44.36 27.99 52.27 44.74 -12.98 77.36 5.11 -11.32 76.90 6.35 1chm_c00 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 21 hits 1chm_c00 naa= 3 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 1 3 # 1 B 232 HIS A 66 HIS~? 3.42 MN MN A 604s B 262 GLU A 68 GLU~? 10.93 O1 BME A 601 B 358 GLU A 71 GLU~? 7.91 MN MN A 605 coo 44.98 77.01 48.39 44.42 78.67 47.18 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.60 83.57 54.16 42.46 83.24 52.25 5.73 51.66 25.85 5.32 49.97 27.08 coo 44.05 87.61 48.73 43.15 85.67 48.52 4.56 57.67 23.22 2.91 58.15 24.47 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 2 3 # 2 B 232 HIS A 66 HIS~? 3.42 MN MN A 604s B 262 GLU A 71 GLU~? 7.91 MN MN A 605 B 358 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 44.98 77.01 48.39 44.42 78.67 47.18 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.56 57.67 23.22 2.91 58.15 24.47 coo 44.05 87.61 48.73 43.15 85.67 48.52 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 3 3 # 3 B 232 HIS A 66 HIS~? 3.42 MN MN A 604s B 262 GLU A 71 GLU~? 7.91 MN MN A 605 B 358 GLU A 72 GLU~? 12.86 MN MN A 605 coo 44.98 77.01 48.39 44.42 78.67 47.18 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.56 57.67 23.22 2.91 58.15 24.47 coo 44.05 87.61 48.73 43.15 85.67 48.52 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 4 3 # 4 B 232 HIS A 66 HIS~? 3.42 MN MN A 604s B 262 GLU A 140 GLU~? -2.42 MN MN A 605s B 358 GLU A 141 GLU~? 7.70 MN MN A 604 coo 44.98 77.01 48.39 44.42 78.67 47.18 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.60 83.57 54.16 42.46 83.24 52.25 5.06 58.75 13.41 3.74 57.63 14.59 coo 44.05 87.61 48.73 43.15 85.67 48.52 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 5 3 # 5 B 232 HIS A 100 HIS~? 8.88 CL CL A 608 B 262 GLU A 71 GLU~? 7.91 MN MN A 605 B 358 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 44.98 77.01 48.39 44.42 78.67 47.18 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.56 57.67 23.22 2.91 58.15 24.47 coo 44.05 87.61 48.73 43.15 85.67 48.52 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 6 3 # 6 B 232 HIS A 100 HIS~? 8.88 CL CL A 608 B 262 GLU A 71 GLU~? 7.91 MN MN A 605 B 358 GLU A 70 GLU~? -2.54 MN MN A 604s coo 44.98 77.01 48.39 44.42 78.67 47.18 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.56 57.67 23.22 2.91 58.15 24.47 coo 44.05 87.61 48.73 43.15 85.67 48.52 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 7 3 # 7 B 232 HIS A 136 HIS~? 3.48 MN MN A 605s B 262 GLU A 70 GLU~? -2.54 MN MN A 604s B 358 GLU A 71 GLU~? 7.91 MN MN A 605 coo 44.98 77.01 48.39 44.42 78.67 47.18 -0.57 59.60 14.33 0.78 59.36 15.93 coo 41.60 83.57 54.16 42.46 83.24 52.25 6.20 55.25 17.70 4.45 55.72 16.64 coo 44.05 87.61 48.73 43.15 85.67 48.52 4.56 57.67 23.22 2.91 58.15 24.47 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 8 3 # 8 B 232 HIS A 136 HIS~? 3.48 MN MN A 605s B 262 GLU A 71 GLU~? 7.91 MN MN A 605 B 358 GLU A 70 GLU~? -2.54 MN MN A 604s coo 44.98 77.01 48.39 44.42 78.67 47.18 -0.57 59.60 14.33 0.78 59.36 15.93 coo 41.60 83.57 54.16 42.46 83.24 52.25 4.56 57.67 23.22 2.91 58.15 24.47 coo 44.05 87.61 48.73 43.15 85.67 48.52 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 9 3 # 9 B 232 HIS B 66 HIS~? 3.43 MN MN B 607s B 262 GLU B 68 GLU~? 12.41 MN MN B 606 B 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 10 3 # 10 B 232 HIS B 66 HIS~? 3.43 MN MN B 607s B 262 GLU B 68 GLU~? 12.41 MN MN B 606 B 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 11 3 # 11 B 232 HIS B 66 HIS~? 3.43 MN MN B 607s B 262 GLU B 71 GLU~? 7.93 MN MN B 606 B 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 44.05 87.61 48.73 43.15 85.67 48.52 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 12 3 # 12 B 232 HIS B 66 HIS~? 3.43 MN MN B 607s B 262 GLU B 140 GLU~? -2.41 MN MN B 606s B 358 GLU B 141 GLU~? 7.71 MN MN B 607 coo 44.98 77.01 48.39 44.42 78.67 47.18 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.60 83.57 54.16 42.46 83.24 52.25 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 44.05 87.61 48.73 43.15 85.67 48.52 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 13 3 # 13 B 232 HIS B 96 HIS~? -3.43 MN MN B 606s B 262 GLU B 68 GLU~? 12.41 MN MN B 606 B 358 GLU B 72 GLU~? 13.02 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 14 3 # 14 B 232 HIS B 96 HIS~? -3.43 MN MN B 606s B 262 GLU B 72 GLU~? 13.02 MN MN B 606 B 358 GLU B 68 GLU~? 12.41 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 41.60 83.57 54.16 42.46 83.24 52.25 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 44.05 87.61 48.73 43.15 85.67 48.52 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 15 3 # 15 B 232 HIS B 100 HIS~? 8.87 CL CL B 609 B 262 GLU B 68 GLU~? 12.41 MN MN B 606 B 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 41.60 83.57 54.16 42.46 83.24 52.25 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 16 3 # 16 B 232 HIS B 100 HIS~? 8.87 CL CL B 609 B 262 GLU B 68 GLU~? 12.41 MN MN B 606 B 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 41.60 83.57 54.16 42.46 83.24 52.25 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 44.05 87.61 48.73 43.15 85.67 48.52 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 17 3 # 17 B 232 HIS B 100 HIS~? 8.87 CL CL B 609 B 262 GLU B 71 GLU~? 7.93 MN MN B 606 B 358 GLU B 68 GLU~? 12.41 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 44.05 87.61 48.73 43.15 85.67 48.52 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 18 3 # 18 B 232 HIS B 100 HIS~? 8.87 CL CL B 609 B 262 GLU B 71 GLU~? 7.93 MN MN B 606 B 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 44.98 77.01 48.39 44.42 78.67 47.18 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 44.05 87.61 48.73 43.15 85.67 48.52 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 19 3 # 19 B 232 HIS B 136 HIS~? 3.50 MN MN B 606s B 262 GLU B 70 GLU~? -2.57 MN MN B 607s B 358 GLU B 71 GLU~? 7.93 MN MN B 606 coo 44.98 77.01 48.39 44.42 78.67 47.18 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 41.60 83.57 54.16 42.46 83.24 52.25 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 44.05 87.61 48.73 43.15 85.67 48.52 -17.41 74.79 8.70 -17.96 74.30 10.67 ULMN 3 1chm_c01 CREATINE AMIDINOHYDROLASE (E.C.3.5.3user 20 3 # 20 B 232 HIS B 136 HIS~? 3.50 MN MN B 606s B 262 GLU B 71 GLU~? 7.93 MN MN B 606 B 358 GLU B 70 GLU~? -2.57 MN MN B 607s coo 44.98 77.01 48.39 44.42 78.67 47.18 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 41.60 83.57 54.16 42.46 83.24 52.25 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 44.05 87.61 48.73 43.15 85.67 48.52 -12.98 77.36 5.11 -11.32 76.90 6.35 1chm_c01 source 1chm CREATINE AMIDINOHYDROLASE (E.C.3.5.3.3) : 20 hits 1chm_c01 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 114 GLU~? 19.73 C1 BME A 601 A 89 GLU A 109 GLU~? 22.92 CL CL A 608 A 120 SER A 107 SER~? 17.07 CL CL A 608 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -19.10 41.71 19.03 -17.20 41.71 19.98 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -19.48 52.51 17.23 -21.47 52.95 17.83 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -14.58 49.59 20.39 -13.79 50.81 22.29 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU A 124 GLU~? 15.58 MN MN B 606 A 89 GLU A 109 GLU~? 22.92 CL CL A 608 A 120 SER A 36 SER~? 22.84 CL CL A 608 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -18.72 60.92 13.26 -17.30 61.76 11.93 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -19.48 52.51 17.23 -21.47 52.95 17.83 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -20.55 50.27 7.47 -20.40 52.14 8.97 ULMN 3 1cns_c00 CHITINASE user 3 3 # 3 A 67 GLU B 114 GLU~? 19.60 C1 BME B 602 A 89 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 120 SER B 107 SER~? 17.45 CL CL B 609 coo -24.35 9.53 67.64 -25.07 11.29 68.60 -4.83 91.16 28.65 -6.46 91.34 27.26 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -2.95 80.34 28.65 -2.60 79.82 30.64 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -7.70 83.12 25.20 -9.96 84.03 25.06 ULMN 3 1cns_c00 CHITINASE user 4 3 # 4 A 67 GLU B 124 GLU~? 10.55 C1 GOL B 603 A 89 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 120 SER B 36 SER~? 14.84 O1 GOL B 603 coo -24.35 9.53 67.64 -25.07 11.29 68.60 0.65 71.77 26.43 1.32 70.82 24.72 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -2.95 80.34 28.65 -2.60 79.82 30.64 coo -34.73 8.57 68.21 -33.63 9.08 70.28 6.57 82.37 26.01 5.17 80.48 26.47 1cns_c00 source 1cns CHITINASE : 4 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 71 GLU~? 7.91 MN MN A 605 B 89 GLU A 140 GLU~? -2.42 MN MN A 605s B 120 SER A 88 SER~? 4.20 C3 GOL B 603 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 4.56 57.67 23.22 2.91 58.15 24.47 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 5.06 58.75 13.41 3.74 57.63 14.59 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 6.33 67.41 15.47 7.25 67.93 13.23 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU B 71 GLU~? 7.93 MN MN B 606 B 89 GLU B 140 GLU~? -2.41 MN MN B 606s B 120 SER B 88 SER~? 11.77 MN MN B 606 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -10.49 65.58 3.90 -8.66 65.20 2.38 1cns_c01 source 1cns CHITINASE : 2 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 19 TYR~? 9.00 MN MN A 604 A 173 ASP A 145 ASP~? 14.76 MN MN A 604 C 48 ARG A 26 ARG~? 9.60 MN MN A 604 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 8.27 52.26 7.85 9.08 54.84 7.01 coo 24.35 4.55 25.11 25.94 3.23 25.53 12.32 59.45 6.26 13.32 58.94 4.48 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 19 TYR~? 9.04 MN MN B 607 A 173 ASP B 145 ASP~? 15.01 MN MN B 607 C 48 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 24.35 4.55 25.11 25.94 3.23 25.53 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 101 TYR B 133 TYR~? 5.56 CL CL B 609 A 173 ASP B 134 ASP~? -3.66 O1 GOL B 603s C 48 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 24.35 4.55 25.11 25.94 3.23 25.53 1.27 73.42 12.01 2.60 75.02 12.38 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -3.66 71.26 23.11 -3.83 72.79 25.78 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 26 ARG~? 9.60 MN MN A 604 C 101 TYR A 19 TYR~? 9.00 MN MN A 604 C 173 ASP A 145 ASP~? 14.76 MN MN A 604 coo 32.27 5.62 48.15 31.93 6.48 51.06 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 29.64 3.64 57.39 31.22 5.14 55.65 8.27 52.26 7.85 9.08 54.84 7.01 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG A 128 ARG~? 18.10 CL CL A 608 C 101 TYR A 133 TYR~? 5.56 CL CL A 608 C 173 ASP A 134 ASP~? 12.23 CL CL A 608 coo 32.27 5.62 48.15 31.93 6.48 51.06 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 48 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 101 TYR B 19 TYR~? 9.04 MN MN B 607 C 173 ASP B 145 ASP~? 15.01 MN MN B 607 coo 32.27 5.62 48.15 31.93 6.48 51.06 1.24 79.80 7.27 0.69 76.71 7.21 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 A 48 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 101 TYR B 133 TYR~? 5.56 CL CL B 609 C 173 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 32.27 5.62 48.15 31.93 6.48 51.06 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 1.27 73.42 12.01 2.60 75.02 12.38 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 26 ARG~? 9.60 MN MN A 604 D 101 TYR A 19 TYR~? 9.00 MN MN A 604 D 173 ASP A 145 ASP~? 14.76 MN MN A 604 coo 69.08 8.58 32.60 69.70 10.81 30.58 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 71.77 11.86 24.26 70.23 12.22 26.56 8.27 52.26 7.85 9.08 54.84 7.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 26 ARG~? 8.42 O2 GOL B 603 D 101 TYR B 19 TYR~? 9.04 MN MN B 607 D 173 ASP B 145 ASP~? 15.01 MN MN B 607 coo 69.08 8.58 32.60 69.70 10.81 30.58 1.24 79.80 7.27 0.69 76.71 7.21 coo 71.77 11.86 24.26 70.23 12.22 26.56 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 71.60 6.14 19.25 70.26 6.87 20.69 -4.45 73.67 -4.82 -3.36 73.65 -6.63 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 19 TYR~? 9.00 MN MN A 604 B 173 ASP A 145 ASP~? 14.76 MN MN A 604 D 48 ARG A 26 ARG~? 9.60 MN MN A 604 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 8.27 52.26 7.85 9.08 54.84 7.01 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 12.32 59.45 6.26 13.32 58.94 4.48 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR A 133 TYR~? 5.56 CL CL A 608 B 173 ASP A 134 ASP~? 12.23 CL CL A 608 D 48 ARG A 128 ARG~? 18.10 CL CL A 608 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 101 TYR B 19 TYR~? 9.04 MN MN B 607 B 173 ASP B 145 ASP~? 15.01 MN MN B 607 D 48 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 4 3 # 4 B 101 TYR B 133 TYR~? 5.56 CL CL B 609 B 173 ASP B 134 ASP~? -3.66 O1 GOL B 603s D 48 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 1.27 73.42 12.01 2.60 75.02 12.38 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -3.66 71.26 23.11 -3.83 72.79 25.78 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 4 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA B 40 ALA~? 20.75 O1 GOL B 603 A 74 ASN B 42 ASN~? 23.97 O1 GOL B 603 A 75 GLY B 43 GLY~? 25.26 O1 GOL B 603 coo -1.80 62.71 122.76 -1.88 63.70 123.92 10.41 85.38 29.86 10.98 84.00 29.54 coo 1.20 66.40 122.20 2.03 64.53 121.46 10.75 91.50 27.13 12.28 91.20 25.69 coo 4.68 65.84 125.52 4.11 65.60 126.05 8.19 90.64 30.80 8.19 90.56 29.96 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 40 ALA~? 29.67 CL CL A 608 B 74 ASN A 42 ASN~? 28.57 S2 BME A 601 B 75 GLY A 43 GLY~? 29.48 S2 BME A 601 coo 39.21 14.97 27.55 40.19 16.01 27.08 -25.59 47.36 5.27 -25.56 48.74 4.67 coo 43.06 12.94 25.74 42.26 11.81 27.44 -23.24 41.26 4.00 -22.40 41.46 2.08 coo 46.38 13.54 29.18 46.14 14.29 29.26 -25.70 42.22 7.68 -24.92 42.27 7.40 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 40 ALA~? 29.67 CL CL A 608 C 74 ASN A 42 ASN~? 28.57 S2 BME A 601 C 75 GLY A 43 GLY~? 29.48 S2 BME A 601 coo 16.14 15.08 36.63 15.28 14.65 37.81 -25.59 47.36 5.27 -25.56 48.74 4.67 coo 11.60 16.13 36.70 12.80 17.74 35.96 -23.24 41.26 4.00 -22.40 41.46 2.08 coo 10.99 19.23 40.32 11.50 18.77 40.74 -25.70 42.22 7.68 -24.92 42.27 7.40 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 1 hits 1ct9_c06 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 69 ASP~? 7.42 O1 BME A 601 315 GLU A 70 GLU~? -2.54 MN MN A 604s 390 TYR A 19 TYR~? 9.00 MN MN A 604 coo 32.46 99.13 19.34 30.94 100.38 20.07 7.88 51.22 19.98 7.64 49.14 20.25 coo 32.04 94.22 18.23 30.57 94.75 16.88 6.20 55.25 17.70 4.45 55.72 16.64 coo 21.10 94.74 18.36 23.09 96.71 18.59 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP B 69 ASP~? 7.66 S2 BME B 602 315 GLU B 70 GLU~? -2.57 MN MN B 607s 390 TYR B 19 TYR~? 9.04 MN MN B 607 coo 32.46 99.13 19.34 30.94 100.38 20.07 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 32.04 94.22 18.23 30.57 94.75 16.88 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 21.10 94.74 18.36 23.09 96.71 18.59 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 2 hits 1ctn_c00 naa= 3 ULMN 3 1cwy_c00 AMYLOMALTASE user 1 3 # 1 A 293 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 340 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 395 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 5.32 68.36 21.17 7.09 68.49 22.34 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 7.70 72.78 18.03 7.03 72.92 20.00 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 2 3 # 2 A 293 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 340 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 395 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 5.32 68.36 21.17 7.09 68.49 22.34 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 0.70 67.61 16.19 -1.02 68.27 17.25 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1cwy_c00 AMYLOMALTASE user 3 3 # 3 A 293 ASP B 90 ASP~? 13.30 MN MN B 606 A 340 GLU B 87 GLU~? 16.36 MN MN B 606 A 395 ASP A 134 ASP~? 12.23 CL CL A 608 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -15.47 64.24 6.89 -17.14 64.04 5.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -13.10 59.94 3.57 -14.71 59.81 4.92 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1cwy_c00 AMYLOMALTASE user 4 3 # 4 A 293 ASP B 90 ASP~? 13.30 MN MN B 606 A 340 GLU B 91 GLU~? 11.42 MN MN B 606 A 395 ASP A 134 ASP~? 12.23 CL CL A 608 coo -48.00 -26.48 6.86 -46.51 -25.94 5.49 -15.47 64.24 6.89 -17.14 64.04 5.63 coo -43.58 -29.03 7.13 -42.45 -27.34 7.75 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -42.28 -26.47 -1.32 -44.06 -25.60 -0.58 -5.53 59.28 7.24 -6.39 57.64 6.27 1cwy_c00 source 1cwy AMYLOMALTASE : 4 hits 1cwy_c00 naa= 3 ULMN 3 1cz0_c00 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 1 3 # 1 A 61 ARG A 166 ARG~? 11.02 O1 BME A 601 A 98 HIS A 66 HIS~? 3.42 MN MN A 604s A 105 CYH A 21 CYH~? -2.28 S2 BME A 601s coo 7.07 33.61 23.71 5.33 32.14 25.75 6.93 48.25 24.41 9.45 50.10 24.73 coo 3.48 23.70 23.03 2.52 25.46 22.40 3.21 51.23 16.81 3.87 52.43 15.22 coo -0.29 24.99 18.39 -1.39 22.52 19.08 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 3 1cz0_c00 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 2 3 # 2 A 61 ARG B 166 ARG~? 12.22 S2 BME B 602 A 98 HIS B 66 HIS~? 3.43 MN MN B 607s A 105 CYH B 21 CYH~? -2.10 S2 BME B 602s coo 7.07 33.61 23.71 5.33 32.14 25.75 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 3.48 23.70 23.03 2.52 25.46 22.40 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -0.29 24.99 18.39 -1.39 22.52 19.08 -7.07 84.75 5.98 -9.76 85.47 5.91 1cz0_c00 source 1cz0 INTRON-ENCODED HOMING ENDONUCLEASE I-PPOI : 2 hits 1cz0_c00 naa= 3 ULMN 3 1cz0_c01 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 1 3 # 1 B 261 ARG A 166 ARG~? 11.02 O1 BME A 601 B 298 HIS A 66 HIS~? 3.42 MN MN A 604s B 305 CYH A 21 CYH~? -2.28 S2 BME A 601s coo 29.33 30.70 34.35 30.40 28.94 32.09 6.93 48.25 24.41 9.45 50.10 24.73 coo 30.19 20.41 34.76 31.59 21.88 35.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 34.39 20.58 39.40 34.78 17.92 38.61 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 3 1cz0_c01 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 2 3 # 2 B 261 ARG A 167 ARG~? -4.94 O1 BME A 601s B 298 HIS A 66 HIS~? 3.42 MN MN A 604s B 305 CYH A 21 CYH~? -2.28 S2 BME A 601s coo 29.33 30.70 34.35 30.40 28.94 32.09 6.75 43.81 21.29 6.50 46.65 20.31 coo 30.19 20.41 34.76 31.59 21.88 35.30 3.21 51.23 16.81 3.87 52.43 15.22 coo 34.39 20.58 39.40 34.78 17.92 38.61 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 3 1cz0_c01 INTRON-ENCODED HOMING ENDONUCLEASE Iuser 3 3 # 3 B 261 ARG B 166 ARG~? 12.22 S2 BME B 602 B 298 HIS B 66 HIS~? 3.43 MN MN B 607s B 305 CYH B 21 CYH~? -2.10 S2 BME B 602s coo 29.33 30.70 34.35 30.40 28.94 32.09 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 30.19 20.41 34.76 31.59 21.88 35.30 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 34.39 20.58 39.40 34.78 17.92 38.61 -7.07 84.75 5.98 -9.76 85.47 5.91 1cz0_c01 source 1cz0 INTRON-ENCODED HOMING ENDONUCLEASE I-PPOI : 3 hits 1cz0_c01 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 69 ASP~? 7.42 O1 BME A 601 A 56 ILE A 15 ILE~? 10.71 MN MN A 604 A 82 TYR A 19 TYR~? 9.00 MN MN A 604 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 7.88 51.22 19.98 7.64 49.14 20.25 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 13.30 52.76 11.49 13.60 54.20 11.36 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 69 ASP~? 7.66 S2 BME B 602 A 56 ILE B 15 ILE~? 10.80 MN MN B 607 A 82 TYR B 19 TYR~? 9.04 MN MN B 607 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -9.96 80.21 -3.74 -9.87 78.81 -4.13 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 69 ASP~? 7.42 O1 BME A 601 B 56 ILE A 15 ILE~? 10.71 MN MN A 604 B 82 TYR A 19 TYR~? 9.00 MN MN A 604 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 7.88 51.22 19.98 7.64 49.14 20.25 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 13.30 52.76 11.49 13.60 54.20 11.36 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 69 ASP~? 7.66 S2 BME B 602 B 56 ILE B 15 ILE~? 10.80 MN MN B 607 B 82 TYR B 19 TYR~? 9.04 MN MN B 607 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -9.96 80.21 -3.74 -9.87 78.81 -4.13 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 19 TYR~? 9.00 MN MN A 604 A 243 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 272 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 2.03 68.31 21.46 0.66 68.36 23.90 8.27 52.26 7.85 9.08 54.84 7.01 coo 16.93 55.67 9.65 17.16 54.23 11.19 1.27 73.42 12.01 2.60 75.02 12.38 coo 14.13 45.79 13.40 14.25 49.41 18.30 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR B 19 TYR~? 9.04 MN MN B 607 A 243 ASP A 134 ASP~? 12.23 CL CL A 608 A 272 LYS A 127 LYS~? 18.61 MN MN B 606 coo 2.03 68.31 21.46 0.66 68.36 23.90 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 16.93 55.67 9.65 17.16 54.23 11.19 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 14.13 45.79 13.40 14.25 49.41 18.30 -14.62 57.47 9.74 -19.33 59.04 5.94 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 2 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS B 153 LYS~? 21.64 S2 BME B 602 A 177 GLU B 13 GLU~? 14.49 C2 BME B 602 A 201 LEU B 156 LEU~? 15.23 MN MN B 607 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -10.54 87.21 -7.31 -10.84 89.32 -6.98 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -15.37 80.75 -7.44 -13.99 79.12 -7.06 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 155 LYS~? 22.59 MN MN B 607 A 177 GLU B 13 GLU~? 14.49 C2 BME B 602 A 201 LEU B 156 LEU~? 15.23 MN MN B 607 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 -10.54 87.21 -7.31 -10.84 89.32 -6.98 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 -15.37 80.75 -7.44 -13.99 79.12 -7.06 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1dco_c00 DCOH user 1 3 # 1 A 62 HIS A 66 HIS~? 3.42 MN MN A 604s A 63 HIS A 22 HIS~? -3.40 MN MN A 604s A 89 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 49.66 36.74 42.37 48.88 35.30 43.64 3.21 51.23 16.81 3.87 52.43 15.22 coo 49.93 35.76 35.94 51.58 36.96 35.47 3.18 53.06 10.64 3.66 54.63 11.95 coo 46.15 35.33 47.12 47.46 33.99 46.29 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1dco_c00 DCOH user 2 3 # 2 A 62 HIS A 100 HIS~? 8.88 CL CL A 608 A 63 HIS A 67 HIS~? -4.40 CL CL A 608s A 89 ASP A 101 ASP~? 14.47 MN MN A 605 coo 49.66 36.74 42.37 48.88 35.30 43.64 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 49.93 35.76 35.94 51.58 36.96 35.47 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1dco_c00 DCOH user 3 3 # 3 A 62 HIS A 100 HIS~? 8.88 CL CL A 608 A 63 HIS A 96 HIS~? -3.41 MN MN A 605s A 89 ASP A 101 ASP~? 14.47 MN MN A 605 coo 49.66 36.74 42.37 48.88 35.30 43.64 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 49.93 35.76 35.94 51.58 36.96 35.47 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1dco_c00 DCOH user 4 3 # 4 A 62 HIS B 66 HIS~? 3.43 MN MN B 607s A 63 HIS B 22 HIS~? -3.40 MN MN B 607s A 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 49.66 36.74 42.37 48.88 35.30 43.64 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 49.93 35.76 35.94 51.58 36.96 35.47 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 46.15 35.33 47.12 47.46 33.99 46.29 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1dco_c00 DCOH user 5 3 # 5 A 62 HIS B 67 HIS~? -4.45 CL CL B 609s A 63 HIS B 100 HIS~? 8.87 CL CL B 609 A 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 49.66 36.74 42.37 48.88 35.30 43.64 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 49.93 35.76 35.94 51.58 36.96 35.47 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 46.15 35.33 47.12 47.46 33.99 46.29 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1dco_c00 DCOH user 6 3 # 6 A 62 HIS B 67 HIS~? -4.45 CL CL B 609s A 63 HIS B 136 HIS~? 3.50 MN MN B 606s A 89 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 49.66 36.74 42.37 48.88 35.30 43.64 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 49.93 35.76 35.94 51.58 36.96 35.47 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.15 35.33 47.12 47.46 33.99 46.29 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1dco_c00 DCOH user 7 3 # 7 A 62 HIS B 100 HIS~? 8.87 CL CL B 609 A 63 HIS B 67 HIS~? -4.45 CL CL B 609s A 89 ASP B 101 ASP~? 14.48 MN MN B 606 coo 49.66 36.74 42.37 48.88 35.30 43.64 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 49.93 35.76 35.94 51.58 36.96 35.47 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.99 72.82 22.17 -12.93 72.02 22.11 ULMN 3 1dco_c00 DCOH user 8 3 # 8 A 62 HIS B 100 HIS~? 8.87 CL CL B 609 A 63 HIS B 96 HIS~? -3.43 MN MN B 606s A 89 ASP B 101 ASP~? 14.48 MN MN B 606 coo 49.66 36.74 42.37 48.88 35.30 43.64 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 49.93 35.76 35.94 51.58 36.96 35.47 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.15 35.33 47.12 47.46 33.99 46.29 -10.99 72.82 22.17 -12.93 72.02 22.11 1dco_c00 source 1dco DCOH : 8 hits 1dco_c00 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 67 HIS~? -4.40 CL CL A 608s A 646 ASP A 69 ASP~? 7.42 O1 BME A 601 A 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 0.35 54.22 20.29 -1.10 54.30 18.77 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 7.88 51.22 19.98 7.64 49.14 20.25 coo 11.37 50.89 2.29 11.05 51.63 2.25 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS B 67 HIS~? -4.45 CL CL B 609s A 646 ASP B 69 ASP~? 7.66 S2 BME B 602 A 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 11.37 50.89 2.29 11.05 51.63 2.25 -1.78 84.52 5.86 -2.42 84.42 6.43 1ddj_c12 source 1ddj PLASMINOGEN : 2 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 67 HIS~? -4.40 CL CL A 608s B 646 ASP A 69 ASP~? 7.42 O1 BME A 601 B 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 0.35 54.22 20.29 -1.10 54.30 18.77 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 7.88 51.22 19.98 7.64 49.14 20.25 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS B 67 HIS~? -4.45 CL CL B 609s B 646 ASP B 69 ASP~? 7.66 S2 BME B 602 B 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -1.78 84.52 5.86 -2.42 84.42 6.43 1ddj_c13 source 1ddj PLASMINOGEN : 2 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 66 HIS~? 3.42 MN MN A 604s C 646 ASP A 69 ASP~? 7.42 O1 BME A 601 C 739 GLY A 147 GLY~? 13.13 MN MN A 604 coo 15.33 59.81 59.60 13.98 60.99 60.69 3.21 51.23 16.81 3.87 52.43 15.22 coo 16.06 55.72 54.73 15.97 56.49 56.70 7.88 51.22 19.98 7.64 49.14 20.25 coo 9.38 49.29 65.28 9.01 50.03 65.31 15.60 58.74 12.01 15.70 58.76 11.21 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 67 HIS~? -4.40 CL CL A 608s C 646 ASP A 69 ASP~? 7.42 O1 BME A 601 C 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 15.33 59.81 59.60 13.98 60.99 60.69 0.35 54.22 20.29 -1.10 54.30 18.77 coo 16.06 55.72 54.73 15.97 56.49 56.70 7.88 51.22 19.98 7.64 49.14 20.25 coo 9.38 49.29 65.28 9.01 50.03 65.31 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS B 66 HIS~? 3.43 MN MN B 607s C 646 ASP B 69 ASP~? 7.66 S2 BME B 602 C 739 GLY B 147 GLY~? 13.16 MN MN B 607 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 16.06 55.72 54.73 15.97 56.49 56.70 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 9.38 49.29 65.28 9.01 50.03 65.31 -11.11 74.27 -5.81 -10.35 74.26 -6.24 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 67 HIS~? -4.45 CL CL B 609s C 646 ASP B 69 ASP~? 7.66 S2 BME B 602 C 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 15.33 59.81 59.60 13.98 60.99 60.69 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 16.06 55.72 54.73 15.97 56.49 56.70 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 9.38 49.29 65.28 9.01 50.03 65.31 -1.78 84.52 5.86 -2.42 84.42 6.43 1ddj_c14 source 1ddj PLASMINOGEN : 4 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 66 HIS~? 3.42 MN MN A 604s D 646 ASP A 69 ASP~? 7.42 O1 BME A 601 D 739 GLY A 147 GLY~? 13.13 MN MN A 604 coo -30.51 33.83 43.05 -30.50 33.12 45.03 3.21 51.23 16.81 3.87 52.43 15.22 coo -25.73 33.05 39.28 -27.50 34.05 39.88 7.88 51.22 19.98 7.64 49.14 20.25 coo -27.66 47.32 40.66 -27.81 47.01 41.41 15.60 58.74 12.01 15.70 58.76 11.21 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS B 66 HIS~? 3.43 MN MN B 607s D 646 ASP B 69 ASP~? 7.66 S2 BME B 602 D 739 GLY B 147 GLY~? 13.16 MN MN B 607 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -11.11 74.27 -5.81 -10.35 74.26 -6.24 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 67 HIS~? -4.45 CL CL B 609s D 646 ASP B 69 ASP~? 7.66 S2 BME B 602 D 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -1.78 84.52 5.86 -2.42 84.42 6.43 1ddj_c15 source 1ddj PLASMINOGEN : 3 hits 1ddj_c15 naa= 3 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 1 3 # 1 A 50 HIS A 22 HIS~? -3.40 MN MN A 604s A 96 GLU A 140 GLU~? -2.42 MN MN A 605s A 137 HIS A 67 HIS~? -4.40 CL CL A 608s coo 1.83 2.95 4.76 1.26 0.98 4.81 3.18 53.06 10.64 3.66 54.63 11.95 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 5.06 58.75 13.41 3.74 57.63 14.59 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 2 3 # 2 A 50 HIS A 22 HIS~? -3.40 MN MN A 604s A 96 GLU A 140 GLU~? -2.42 MN MN A 605s A 137 HIS A 96 HIS~? -3.41 MN MN A 605s coo 1.83 2.95 4.76 1.26 0.98 4.81 3.18 53.06 10.64 3.66 54.63 11.95 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 5.06 58.75 13.41 3.74 57.63 14.59 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 3 3 # 3 A 50 HIS A 67 HIS~? -4.40 CL CL A 608s A 96 GLU A 70 GLU~? -2.54 MN MN A 604s A 137 HIS A 22 HIS~? -3.40 MN MN A 604s coo 1.83 2.95 4.76 1.26 0.98 4.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 6.20 55.25 17.70 4.45 55.72 16.64 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 4 3 # 4 A 50 HIS A 96 HIS~? -3.41 MN MN A 605s A 96 GLU A 70 GLU~? -2.54 MN MN A 604s A 137 HIS A 22 HIS~? -3.40 MN MN A 604s coo 1.83 2.95 4.76 1.26 0.98 4.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 6.20 55.25 17.70 4.45 55.72 16.64 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 5 3 # 5 A 50 HIS B 22 HIS~? -3.40 MN MN B 607s A 96 GLU B 140 GLU~? -2.41 MN MN B 606s A 137 HIS B 67 HIS~? -4.45 CL CL B 609s coo 1.83 2.95 4.76 1.26 0.98 4.81 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 6 3 # 6 A 50 HIS B 22 HIS~? -3.40 MN MN B 607s A 96 GLU B 140 GLU~? -2.41 MN MN B 606s A 137 HIS B 96 HIS~? -3.43 MN MN B 606s coo 1.83 2.95 4.76 1.26 0.98 4.81 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 7 3 # 7 A 50 HIS B 67 HIS~? -4.45 CL CL B 609s A 96 GLU B 70 GLU~? -2.57 MN MN B 607s A 137 HIS B 22 HIS~? -3.40 MN MN B 607s coo 1.83 2.95 4.76 1.26 0.98 4.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1de3_c00 RIBONUCLEASE ALPHA-SARCIN user 8 3 # 8 A 50 HIS B 96 HIS~? -3.43 MN MN B 606s A 96 GLU B 70 GLU~? -2.57 MN MN B 607s A 137 HIS B 22 HIS~? -3.40 MN MN B 607s coo 1.83 2.95 4.76 1.26 0.98 4.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 2.09 -1.43 1.72 1.90 -3.41 2.37 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -3.67 -7.38 4.26 -2.89 -5.51 4.56 -5.34 79.70 5.35 -6.67 78.07 5.35 1de3_c00 source 1de3 RIBONUCLEASE ALPHA-SARCIN : 8 hits 1de3_c00 naa= 3 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 123 HIS A 100 HIS~? 8.88 CL CL A 608 A 200 ASP B 101 ASP~? 14.48 MN MN B 606 A 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 1.13 77.49 40.64 0.62 75.57 39.98 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 0.84 91.24 49.01 2.91 91.61 49.23 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 10.53 97.56 43.71 9.33 93.71 47.17 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1dfo_c12 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 123 HIS B 100 HIS~? 8.87 CL CL B 609 A 200 ASP A 101 ASP~? 14.47 MN MN A 605 A 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo 1.13 77.49 40.64 0.62 75.57 39.98 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 0.84 91.24 49.01 2.91 91.61 49.23 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 10.53 97.56 43.71 9.33 93.71 47.17 -14.62 57.47 9.74 -19.33 59.04 5.94 1dfo_c12 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c12 naa= 3 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 123 HIS A 100 HIS~? 8.88 CL CL A 608 B 200 ASP B 101 ASP~? 14.48 MN MN B 606 B 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 9.24 94.26 88.22 8.02 94.07 89.92 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 17.54 90.31 75.01 17.17 92.01 73.80 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 22.32 101.61 71.64 17.89 98.63 71.55 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1dfo_c13 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 123 HIS B 100 HIS~? 8.87 CL CL B 609 B 200 ASP A 101 ASP~? 14.47 MN MN A 605 B 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo 9.24 94.26 88.22 8.02 94.07 89.92 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 17.54 90.31 75.01 17.17 92.01 73.80 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 22.32 101.61 71.64 17.89 98.63 71.55 -14.62 57.47 9.74 -19.33 59.04 5.94 1dfo_c13 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c13 naa= 3 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 123 HIS A 100 HIS~? 8.88 CL CL A 608 C 200 ASP B 101 ASP~? 14.48 MN MN B 606 C 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 26.77 65.84 83.49 27.06 67.76 84.27 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 19.52 52.01 79.59 20.28 51.65 77.65 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 28.90 45.91 73.55 25.22 49.72 72.97 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1dfo_c14 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 123 HIS B 100 HIS~? 8.87 CL CL B 609 C 200 ASP A 101 ASP~? 14.47 MN MN A 605 C 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo 26.77 65.84 83.49 27.06 67.76 84.27 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 19.52 52.01 79.59 20.28 51.65 77.65 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 28.90 45.91 73.55 25.22 49.72 72.97 -14.62 57.47 9.74 -19.33 59.04 5.94 1dfo_c14 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c14 naa= 3 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 123 HIS A 100 HIS~? 8.88 CL CL A 608 D 200 ASP B 101 ASP~? 14.48 MN MN B 606 D 229 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 4.60 52.95 52.50 5.57 51.29 53.40 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 10.05 41.79 49.80 7.94 44.71 53.76 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1dfo_c15 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 123 HIS B 100 HIS~? 8.87 CL CL B 609 D 200 ASP A 101 ASP~? 14.47 MN MN A 605 D 229 LYS A 127 LYS~? 18.61 MN MN B 606 coo -10.90 48.74 53.41 -12.98 48.90 53.67 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 4.60 52.95 52.50 5.57 51.29 53.40 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 10.05 41.79 49.80 7.94 44.71 53.76 -14.62 57.47 9.74 -19.33 59.04 5.94 1dfo_c15 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c15 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 58 TYR~? -4.88 S2 BME A 601s 150 LYS A 24 LYS~? 4.08 C2 BME A 601 186 ASN A 102 ASN~? 12.24 CL CL A 608 coo 32.88 50.55 24.33 31.89 51.78 26.65 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 27.04 52.42 22.30 26.88 49.99 27.00 -0.91 46.54 9.97 2.66 42.32 12.44 coo 36.98 50.30 37.29 35.85 50.29 35.50 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 119 TYR.? 27.19 CL CL A 608 150 LYS A 112 LYS~? 24.85 CL CL A 608 186 ASN A 42 ASN~? 28.57 S2 BME A 601 coo 32.88 50.55 24.33 31.89 51.78 26.65 -25.91 48.64 16.91 -24.81 51.15 17.51 coo 27.04 52.42 22.30 26.88 49.99 27.00 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 36.98 50.30 37.29 35.85 50.29 35.50 -23.24 41.26 4.00 -22.40 41.46 2.08 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 58 TYR~? -4.91 S2 BME B 602s 150 LYS B 24 LYS~? -3.00 C2 BME B 602s 186 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 27.04 52.42 22.30 26.88 49.99 27.00 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 36.98 50.30 37.29 35.85 50.29 35.50 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 119 TYR.? 22.89 O1 GOL B 603 150 LYS B 112 LYS~? 25.52 O1 GOL B 603 186 ASN B 42 ASN~? 23.97 O1 GOL B 603 coo 32.88 50.55 24.33 31.89 51.78 26.65 -0.36 84.32 34.43 -1.33 81.81 33.61 coo 27.04 52.42 22.30 26.88 49.99 27.00 -4.73 86.07 32.89 -5.14 81.77 36.42 coo 36.98 50.30 37.29 35.85 50.29 35.50 10.75 91.50 27.13 12.28 91.20 25.69 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 4 hits 1dhr_c00 naa= 3 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 1 3 # 1 123 CYH A 21 CYH~? -2.28 S2 BME A 601s 171 ASP A 69 ASP~? 7.42 O1 BME A 601 202 HIS A 66 HIS~? 3.42 MN MN A 604s coo 13.53 50.63 6.92 14.43 49.91 4.38 3.34 47.98 12.34 4.26 47.15 14.87 coo 11.86 58.52 0.90 11.25 56.63 1.71 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.37 53.26 1.34 11.86 52.62 3.19 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1din_c00 DIENELACTONE HYDROLASE user 2 3 # 2 123 CYH B 21 CYH~? -2.10 S2 BME B 602s 171 ASP B 69 ASP~? 7.66 S2 BME B 602 202 HIS B 66 HIS~? 3.43 MN MN B 607s coo 13.53 50.63 6.92 14.43 49.91 4.38 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 11.86 58.52 0.90 11.25 56.63 1.71 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 12.37 53.26 1.34 11.86 52.62 3.19 -11.11 81.39 7.66 -9.84 80.27 6.41 1din_c00 source 1din DIENELACTONE HYDROLASE : 2 hits 1din_c00 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 66 HIS~? 3.42 MN MN A 604s E 102 ASP A 69 ASP~? 7.42 O1 BME A 601 E 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 11.39 26.86 25.95 9.85 26.64 27.36 3.21 51.23 16.81 3.87 52.43 15.22 coo 10.90 32.83 25.96 10.83 30.68 25.98 7.88 51.22 19.98 7.64 49.14 20.25 coo 4.57 20.60 30.29 4.74 21.36 30.66 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 66 HIS~? 3.43 MN MN B 607s E 102 ASP B 69 ASP~? 7.66 S2 BME B 602 E 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 10.90 32.83 25.96 10.83 30.68 25.98 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 4.57 20.60 30.29 4.74 21.36 30.66 -1.78 84.52 5.86 -2.42 84.42 6.43 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 2 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 160 GLY~? 13.13 O1 BME A 601 B 144 GLU A 161 GLU~? 18.40 O1 BME A 601 B 164 GLU A 158 GLU~? 21.27 MN MN A 604 coo 88.87 114.43 152.30 88.45 115.15 152.32 15.62 47.56 18.93 15.86 47.64 19.72 coo 85.20 111.99 152.05 86.60 110.89 150.91 19.17 45.23 21.71 20.94 45.20 22.85 coo 88.14 113.46 145.73 86.79 113.92 147.30 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 160 GLY~? 13.29 S2 BME B 602 B 144 GLU B 161 GLU~? 19.04 O1 BME B 602 B 164 GLU B 158 GLU~? 21.38 MN MN B 607 coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 85.20 111.99 152.05 86.60 110.89 150.91 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 88.14 113.46 145.73 86.79 113.92 147.30 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 160 GLY~? 13.13 O1 BME A 601 C 144 GLU A 161 GLU~? 18.40 O1 BME A 601 C 164 GLU A 158 GLU~? 21.27 MN MN A 604 coo 56.28 104.55 135.84 56.09 105.34 136.05 15.62 47.56 18.93 15.86 47.64 19.72 coo 58.46 103.90 139.48 57.57 102.00 139.16 19.17 45.23 21.71 20.94 45.20 22.85 coo 51.71 102.03 140.09 53.02 103.62 140.54 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 160 GLY~? 13.29 S2 BME B 602 C 144 GLU B 161 GLU~? 19.04 O1 BME B 602 C 164 GLU B 158 GLU~? 21.38 MN MN B 607 coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 58.46 103.90 139.48 57.57 102.00 139.16 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 51.71 102.03 140.09 53.02 103.62 140.54 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 160 GLY~? 13.13 O1 BME A 601 D 144 GLU A 161 GLU~? 18.40 O1 BME A 601 D 164 GLU A 158 GLU~? 21.27 MN MN A 604 coo 86.19 80.64 132.77 86.38 79.85 132.93 15.62 47.56 18.93 15.86 47.64 19.72 coo 84.75 81.24 136.88 85.62 83.14 136.43 19.17 45.23 21.71 20.94 45.20 22.85 coo 91.47 83.05 136.24 90.35 81.38 136.84 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 160 GLY~? 13.29 S2 BME B 602 D 144 GLU B 161 GLU~? 19.04 O1 BME B 602 D 164 GLU B 158 GLU~? 21.38 MN MN B 607 coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 84.75 81.24 136.88 85.62 83.14 136.43 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 91.47 83.05 136.24 90.35 81.38 136.84 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 160 GLY~? 13.13 O1 BME A 601 E 144 GLU A 161 GLU~? 18.40 O1 BME A 601 E 164 GLU A 158 GLU~? 21.27 MN MN A 604 coo 90.07 81.07 170.50 90.23 80.26 170.38 15.62 47.56 18.93 15.86 47.64 19.72 coo 87.05 81.30 167.53 86.38 82.74 168.94 19.17 45.23 21.71 20.94 45.20 22.85 coo 84.40 80.02 173.80 85.08 79.06 172.03 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 160 GLY~? 13.29 S2 BME B 602 E 144 GLU B 161 GLU~? 19.04 O1 BME B 602 E 164 GLU B 158 GLU~? 21.38 MN MN B 607 coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 87.05 81.30 167.53 86.38 82.74 168.94 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 84.40 80.02 173.80 85.08 79.06 172.03 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 160 GLY~? 13.13 O1 BME A 601 F 144 GLU A 161 GLU~? 18.40 O1 BME A 601 F 164 GLU A 158 GLU~? 21.27 MN MN A 604 coo 57.12 70.68 155.10 57.52 69.95 155.02 15.62 47.56 18.93 15.86 47.64 19.72 coo 60.62 73.13 154.21 59.05 74.26 153.35 19.17 45.23 21.71 20.94 45.20 22.85 coo 56.75 71.71 148.46 58.44 71.01 149.54 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 160 GLY~? 13.29 S2 BME B 602 F 144 GLU B 161 GLU~? 19.04 O1 BME B 602 F 164 GLU B 158 GLU~? 21.38 MN MN B 607 coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 60.62 73.13 154.21 59.05 74.26 153.35 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 56.75 71.71 148.46 58.44 71.01 149.54 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 A 69 CYH A 21 CYH~? -2.28 S2 BME A 601s A 107 HIS A 66 HIS~? 3.42 MN MN A 604s A 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 107.06 101.85 70.21 107.82 99.27 70.56 3.34 47.98 12.34 4.26 47.15 14.87 coo 112.02 99.34 69.11 112.26 101.12 70.20 3.21 51.23 16.81 3.87 52.43 15.22 coo 114.37 105.59 70.16 113.40 104.00 71.21 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c00 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 A 69 CYH B 21 CYH~? -2.10 S2 BME B 602s A 107 HIS B 66 HIS~? 3.43 MN MN B 607s A 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 107.06 101.85 70.21 107.82 99.27 70.56 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 112.02 99.34 69.11 112.26 101.12 70.20 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 114.37 105.59 70.16 113.40 104.00 71.21 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c00 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c00 naa= 3 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 B 69 CYH A 21 CYH~? -2.28 S2 BME A 601s B 107 HIS A 66 HIS~? 3.42 MN MN A 604s B 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 71.18 90.15 69.62 72.19 87.91 68.26 3.34 47.98 12.34 4.26 47.15 14.87 coo 68.66 85.12 69.19 67.36 86.67 68.68 3.21 51.23 16.81 3.87 52.43 15.22 coo 63.06 88.82 69.94 64.68 88.56 68.63 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c01 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 B 69 CYH B 21 CYH~? -2.10 S2 BME B 602s B 107 HIS B 66 HIS~? 3.43 MN MN B 607s B 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 71.18 90.15 69.62 72.19 87.91 68.26 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 68.66 85.12 69.19 67.36 86.67 68.68 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 63.06 88.82 69.94 64.68 88.56 68.63 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c01 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c01 naa= 3 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 C 69 CYH A 21 CYH~? -2.28 S2 BME A 601s C 107 HIS A 66 HIS~? 3.42 MN MN A 604s C 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 87.22 70.88 82.51 87.10 73.53 83.33 3.34 47.98 12.34 4.26 47.15 14.87 coo 83.94 73.51 86.28 84.82 71.77 87.03 3.21 51.23 16.81 3.87 52.43 15.22 coo 83.85 67.31 89.02 85.24 68.84 88.61 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c02 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 C 69 CYH B 21 CYH~? -2.10 S2 BME B 602s C 107 HIS B 66 HIS~? 3.43 MN MN B 607s C 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 87.22 70.88 82.51 87.10 73.53 83.33 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 83.94 73.51 86.28 84.82 71.77 87.03 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 83.85 67.31 89.02 85.24 68.84 88.61 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c02 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c02 naa= 3 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 D 69 CYH A 21 CYH~? -2.28 S2 BME A 601s D 107 HIS A 66 HIS~? 3.42 MN MN A 604s D 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 103.83 82.01 50.25 102.30 84.27 50.28 3.34 47.98 12.34 4.26 47.15 14.87 coo 104.67 87.04 47.86 104.93 85.42 46.57 3.21 51.23 16.81 3.87 52.43 15.22 coo 108.03 83.30 43.35 106.06 83.62 44.11 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c03 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 D 69 CYH B 21 CYH~? -2.10 S2 BME B 602s D 107 HIS B 66 HIS~? 3.43 MN MN B 607s D 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 103.83 82.01 50.25 102.30 84.27 50.28 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 104.67 87.04 47.86 104.93 85.42 46.57 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 108.03 83.30 43.35 106.06 83.62 44.11 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c03 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c03 naa= 3 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 E 69 CYH A 21 CYH~? -2.28 S2 BME A 601s E 107 HIS A 66 HIS~? 3.42 MN MN A 604s E 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 26.92 104.93 15.26 26.00 102.32 15.14 3.34 47.98 12.34 4.26 47.15 14.87 coo 21.83 102.75 16.48 21.72 104.53 15.38 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.90 109.15 15.39 20.77 107.51 14.36 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c04 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 E 69 CYH B 21 CYH~? -2.10 S2 BME B 602s E 107 HIS B 66 HIS~? 3.43 MN MN B 607s E 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 26.92 104.93 15.26 26.00 102.32 15.14 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 21.83 102.75 16.48 21.72 104.53 15.38 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 19.90 109.15 15.39 20.77 107.51 14.36 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c04 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c04 naa= 3 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 F 69 CYH A 21 CYH~? -2.28 S2 BME A 601s F 107 HIS A 66 HIS~? 3.42 MN MN A 604s F 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 61.95 90.52 15.40 60.72 88.41 16.77 3.34 47.98 12.34 4.26 47.15 14.87 coo 64.03 85.31 15.74 65.44 86.77 16.21 3.21 51.23 16.81 3.87 52.43 15.22 coo 69.94 88.54 14.99 68.36 88.38 16.36 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c05 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 F 69 CYH B 21 CYH~? -2.10 S2 BME B 602s F 107 HIS B 66 HIS~? 3.43 MN MN B 607s F 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 61.95 90.52 15.40 60.72 88.41 16.77 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 64.03 85.31 15.74 65.44 86.77 16.21 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 69.94 88.54 14.99 68.36 88.38 16.36 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c05 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c05 naa= 3 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 G 69 CYH A 21 CYH~? -2.28 S2 BME A 601s G 107 HIS A 66 HIS~? 3.42 MN MN A 604s G 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 29.36 85.15 35.54 31.07 87.28 35.30 3.34 47.98 12.34 4.26 47.15 14.87 coo 28.98 90.29 37.87 28.74 88.77 39.28 3.21 51.23 16.81 3.87 52.43 15.22 coo 25.53 86.86 42.58 27.46 86.99 41.71 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c06 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 G 69 CYH B 21 CYH~? -2.10 S2 BME B 602s G 107 HIS B 66 HIS~? 3.43 MN MN B 607s G 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.36 85.15 35.54 31.07 87.28 35.30 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 28.98 90.29 37.87 28.74 88.77 39.28 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 25.53 86.86 42.58 27.46 86.99 41.71 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c06 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c06 naa= 3 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 1 3 # 1 H 69 CYH A 21 CYH~? -2.28 S2 BME A 601s H 107 HIS A 66 HIS~? 3.42 MN MN A 604s H 122 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 44.08 72.69 2.52 44.26 75.30 1.64 3.34 47.98 12.34 4.26 47.15 14.87 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 3.21 51.23 16.81 3.87 52.43 15.22 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1e2t_c07 N-HYDROXYARYLAMINE O-ACETYLTRANSFERAuser 2 3 # 2 H 69 CYH B 21 CYH~? -2.10 S2 BME B 602s H 107 HIS B 66 HIS~? 3.43 MN MN B 607s H 122 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 44.08 72.69 2.52 44.26 75.30 1.64 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 47.49 75.16 -1.32 46.47 73.52 -2.11 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 47.09 69.01 -4.12 45.87 70.66 -3.64 -15.81 81.35 4.53 -16.00 83.45 4.93 1e2t_c07 source 1e2t N-HYDROXYARYLAMINE O-ACETYLTRANSFERASE : 2 hits 1e2t_c07 naa= 3 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 1 3 # 1 B 41 HIS A 66 HIS~? 3.42 MN MN A 604s B 43 HIS A 67 HIS~? -4.40 CL CL A 608s B 65 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 20.15 22.08 34.36 20.84 20.10 34.21 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 2 3 # 2 B 41 HIS A 66 HIS~? 3.42 MN MN A 604s B 43 HIS A 67 HIS~? -4.40 CL CL A 608s B 65 GLU A 72 GLU~? 12.86 MN MN A 605 coo 20.15 22.08 34.36 20.84 20.10 34.21 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 3 3 # 3 B 41 HIS A 67 HIS~? -4.40 CL CL A 608s B 43 HIS A 66 HIS~? 3.42 MN MN A 604s B 65 GLU A 140 GLU~? -2.42 MN MN A 605s coo 20.15 22.08 34.36 20.84 20.10 34.21 0.35 54.22 20.29 -1.10 54.30 18.77 coo 19.55 18.91 30.27 18.21 18.65 31.84 3.21 51.23 16.81 3.87 52.43 15.22 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 4 3 # 4 B 41 HIS A 67 HIS~? -4.40 CL CL A 608s B 43 HIS A 96 HIS~? -3.41 MN MN A 605s B 65 GLU A 72 GLU~? 12.86 MN MN A 605 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.35 54.22 20.29 -1.10 54.30 18.77 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.59 58.54 20.35 2.20 57.89 19.15 coo 10.90 21.31 28.81 12.14 22.15 30.31 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 5 3 # 5 B 41 HIS A 67 HIS~? -4.40 CL CL A 608s B 43 HIS A 96 HIS~? -3.41 MN MN A 605s B 65 GLU A 140 GLU~? -2.42 MN MN A 605s coo 20.15 22.08 34.36 20.84 20.10 34.21 0.35 54.22 20.29 -1.10 54.30 18.77 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.59 58.54 20.35 2.20 57.89 19.15 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 6 3 # 6 B 41 HIS A 96 HIS~? -3.41 MN MN A 605s B 43 HIS A 67 HIS~? -4.40 CL CL A 608s B 65 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.59 58.54 20.35 2.20 57.89 19.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 7 3 # 7 B 41 HIS A 96 HIS~? -3.41 MN MN A 605s B 43 HIS A 67 HIS~? -4.40 CL CL A 608s B 65 GLU A 72 GLU~? 12.86 MN MN A 605 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.59 58.54 20.35 2.20 57.89 19.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 8 3 # 8 B 41 HIS A 96 HIS~? -3.41 MN MN A 605s B 43 HIS A 136 HIS~? 3.48 MN MN A 605s B 65 GLU A 91 GLU~? 5.92 C1 GOL B 603 coo 20.15 22.08 34.36 20.84 20.10 34.21 0.59 58.54 20.35 2.20 57.89 19.15 coo 19.55 18.91 30.27 18.21 18.65 31.84 -0.57 59.60 14.33 0.78 59.36 15.93 coo 10.90 21.31 28.81 12.14 22.15 30.31 0.70 67.61 16.19 -1.02 68.27 17.25 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 9 3 # 9 B 41 HIS A 100 HIS~? 8.88 CL CL A 608 B 43 HIS A 67 HIS~? -4.40 CL CL A 608s B 65 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 20.15 22.08 34.36 20.84 20.10 34.21 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 10 3 # 10 B 41 HIS A 100 HIS~? 8.88 CL CL A 608 B 43 HIS A 96 HIS~? -3.41 MN MN A 605s B 65 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 20.15 22.08 34.36 20.84 20.10 34.21 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 19.55 18.91 30.27 18.21 18.65 31.84 0.59 58.54 20.35 2.20 57.89 19.15 coo 10.90 21.31 28.81 12.14 22.15 30.31 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 11 3 # 11 B 41 HIS B 66 HIS~? 3.43 MN MN B 607s B 43 HIS B 67 HIS~? -4.45 CL CL B 609s B 65 GLU B 72 GLU~? 13.02 MN MN B 606 coo 20.15 22.08 34.36 20.84 20.10 34.21 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 19.55 18.91 30.27 18.21 18.65 31.84 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 10.90 21.31 28.81 12.14 22.15 30.31 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 12 3 # 12 B 41 HIS B 67 HIS~? -4.45 CL CL B 609s B 43 HIS B 66 HIS~? 3.43 MN MN B 607s B 65 GLU B 140 GLU~? -2.41 MN MN B 606s coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 19.55 18.91 30.27 18.21 18.65 31.84 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 10.90 21.31 28.81 12.14 22.15 30.31 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 13 3 # 13 B 41 HIS B 67 HIS~? -4.45 CL CL B 609s B 43 HIS B 96 HIS~? -3.43 MN MN B 606s B 65 GLU B 72 GLU~? 13.02 MN MN B 606 coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 19.55 18.91 30.27 18.21 18.65 31.84 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 10.90 21.31 28.81 12.14 22.15 30.31 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 14 3 # 14 B 41 HIS B 67 HIS~? -4.45 CL CL B 609s B 43 HIS B 96 HIS~? -3.43 MN MN B 606s B 65 GLU B 140 GLU~? -2.41 MN MN B 606s coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 19.55 18.91 30.27 18.21 18.65 31.84 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 10.90 21.31 28.81 12.14 22.15 30.31 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 15 3 # 15 B 41 HIS B 96 HIS~? -3.43 MN MN B 606s B 43 HIS B 67 HIS~? -4.45 CL CL B 609s B 65 GLU B 72 GLU~? 13.02 MN MN B 606 coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 19.55 18.91 30.27 18.21 18.65 31.84 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 10.90 21.31 28.81 12.14 22.15 30.31 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 16 3 # 16 B 41 HIS B 96 HIS~? -3.43 MN MN B 606s B 43 HIS B 136 HIS~? 3.50 MN MN B 606s B 65 GLU B 91 GLU~? 11.42 MN MN B 606 coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 19.55 18.91 30.27 18.21 18.65 31.84 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 10.90 21.31 28.81 12.14 22.15 30.31 -9.23 65.09 9.44 -9.52 64.33 11.38 ULMN 3 1e7l_c01 RECOMBINATION ENDONUCLEASE VII user 17 3 # 17 B 41 HIS B 100 HIS~? 8.87 CL CL B 609 B 43 HIS B 96 HIS~? -3.43 MN MN B 606s B 65 GLU B 68 GLU~? 12.41 MN MN B 606 coo 20.15 22.08 34.36 20.84 20.10 34.21 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 19.55 18.91 30.27 18.21 18.65 31.84 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 10.90 21.31 28.81 12.14 22.15 30.31 -19.03 80.53 10.71 -20.46 81.67 11.84 1e7l_c01 source 1e7l RECOMBINATION ENDONUCLEASE VII : 17 hits 1e7l_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA B 108 ALA~? 20.82 CL CL B 609 A 136 TYR B 119 TYR.? 22.89 O1 GOL B 603 A 140 LYS B 112 LYS~? 25.52 O1 GOL B 603 coo 55.90 7.49 23.83 56.71 8.23 22.76 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 59.38 10.02 17.51 59.95 9.89 20.21 -0.36 84.32 34.43 -1.33 81.81 33.61 coo 59.52 3.69 18.67 62.31 6.19 22.58 -4.73 86.07 32.89 -5.14 81.77 36.42 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 118 ALA.? 29.04 O1 GOL B 603 A 136 TYR B 119 TYR.? 22.89 O1 GOL B 603 A 140 LYS B 112 LYS~? 25.52 O1 GOL B 603 coo 55.90 7.49 23.83 56.71 8.23 22.76 3.48 88.84 36.39 3.65 89.07 37.92 coo 59.38 10.02 17.51 59.95 9.89 20.21 -0.36 84.32 34.43 -1.33 81.81 33.61 coo 59.52 3.69 18.67 62.31 6.19 22.58 -4.73 86.07 32.89 -5.14 81.77 36.42 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 2 hits 1e7q_c01 naa= 3 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 1 3 # 1 A 99 HIS A 67 HIS~? -4.40 CL CL A 608s A 177 ASP A 69 ASP~? 7.42 O1 BME A 601 A 203 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 8.74 45.76 47.19 9.33 46.93 45.56 0.35 54.22 20.29 -1.10 54.30 18.77 coo 11.68 42.31 52.96 12.05 43.92 51.65 7.88 51.22 19.98 7.64 49.14 20.25 coo 18.07 52.81 49.62 14.17 49.99 48.07 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 2 3 # 2 A 99 HIS A 136 HIS~? 3.48 MN MN A 605s A 177 ASP A 134 ASP~? 12.23 CL CL A 608 A 203 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 8.74 45.76 47.19 9.33 46.93 45.56 -0.57 59.60 14.33 0.78 59.36 15.93 coo 11.68 42.31 52.96 12.05 43.92 51.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 18.07 52.81 49.62 14.17 49.99 48.07 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 3 3 # 3 A 99 HIS B 67 HIS~? -4.45 CL CL B 609s A 177 ASP B 69 ASP~? 7.66 S2 BME B 602 A 203 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 8.74 45.76 47.19 9.33 46.93 45.56 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 11.68 42.31 52.96 12.05 43.92 51.65 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 18.07 52.81 49.62 14.17 49.99 48.07 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ecx_c02 AMINOTRANSFERASE user 4 3 # 4 A 99 HIS B 136 HIS~? 3.50 MN MN B 606s A 177 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 203 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 8.74 45.76 47.19 9.33 46.93 45.56 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 11.68 42.31 52.96 12.05 43.92 51.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 18.07 52.81 49.62 14.17 49.99 48.07 -3.23 86.22 8.94 -7.29 90.78 7.55 1ecx_c02 source 1ecx AMINOTRANSFERASE : 4 hits 1ecx_c02 naa= 3 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 1 3 # 1 B 99 HIS A 67 HIS~? -4.40 CL CL A 608s B 177 ASP A 69 ASP~? 7.42 O1 BME A 601 B 203 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 14.87 88.04 21.51 13.64 87.90 19.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 15.87 92.46 27.37 14.46 91.76 25.94 7.88 51.22 19.98 7.64 49.14 20.25 coo 3.60 91.42 23.52 8.20 89.55 22.63 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 2 3 # 2 B 99 HIS A 136 HIS~? 3.48 MN MN A 605s B 177 ASP A 134 ASP~? 12.23 CL CL A 608 B 203 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 14.87 88.04 21.51 13.64 87.90 19.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 15.87 92.46 27.37 14.46 91.76 25.94 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 3.60 91.42 23.52 8.20 89.55 22.63 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 3 3 # 3 B 99 HIS B 67 HIS~? -4.45 CL CL B 609s B 177 ASP B 69 ASP~? 7.66 S2 BME B 602 B 203 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 14.87 88.04 21.51 13.64 87.90 19.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 15.87 92.46 27.37 14.46 91.76 25.94 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 3.60 91.42 23.52 8.20 89.55 22.63 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1ecx_c03 AMINOTRANSFERASE user 4 3 # 4 B 99 HIS B 136 HIS~? 3.50 MN MN B 606s B 177 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 203 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 14.87 88.04 21.51 13.64 87.90 19.81 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 15.87 92.46 27.37 14.46 91.76 25.94 1.27 73.42 12.01 2.60 75.02 12.38 coo 3.60 91.42 23.52 8.20 89.55 22.63 -3.23 86.22 8.94 -7.29 90.78 7.55 1ecx_c03 source 1ecx AMINOTRANSFERASE : 4 hits 1ecx_c03 naa= 3 ULMN 3 1ef8_c00 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 A 66 HIS B 22 HIS~? -3.40 MN MN B 607s A 110 GLY B 23 GLY~? 8.34 S2 BME B 602 A 140 TYR B 19 TYR~? 9.04 MN MN B 607 coo 24.53 0.12 1.91 23.47 1.90 2.27 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 22.96 1.26 5.85 23.32 1.32 6.60 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 21.28 7.32 1.28 21.07 5.14 3.02 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1ef8_c00 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 1 hits 1ef8_c00 naa= 3 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 B 66 HIS A 22 HIS~? -3.40 MN MN A 604s B 110 GLY A 23 GLY~? 8.40 S2 BME A 601 B 140 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 15.25 42.02 9.50 15.08 40.17 8.54 3.18 53.06 10.64 3.66 54.63 11.95 coo 16.54 37.86 10.86 17.07 37.78 11.48 1.32 48.34 7.45 1.06 48.38 8.26 coo 8.70 35.97 10.91 11.44 36.02 10.35 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 B 66 HIS A 100 HIS~? 8.88 CL CL A 608 B 110 GLY A 98 GLY~? 10.67 MN MN A 605 B 140 TYR A 133 TYR~? 5.56 CL CL A 608 coo 15.25 42.02 9.50 15.08 40.17 8.54 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 16.54 37.86 10.86 17.07 37.78 11.48 -6.79 61.25 20.29 -6.32 60.57 20.44 coo 8.70 35.97 10.91 11.44 36.02 10.35 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 B 66 HIS B 22 HIS~? -3.40 MN MN B 607s B 110 GLY B 23 GLY~? 8.34 S2 BME B 602 B 140 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 15.25 42.02 9.50 15.08 40.17 8.54 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 16.54 37.86 10.86 17.07 37.78 11.48 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 8.70 35.97 10.91 11.44 36.02 10.35 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1ef8_c01 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 B 66 HIS B 100 HIS~? 8.87 CL CL B 609 B 110 GLY B 98 GLY~? 10.76 MN MN B 606 B 140 TYR B 133 TYR~? 5.56 CL CL B 609 coo 15.25 42.02 9.50 15.08 40.17 8.54 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 16.54 37.86 10.86 17.07 37.78 11.48 -10.36 71.24 18.20 -10.64 71.91 17.78 coo 8.70 35.97 10.91 11.44 36.02 10.35 -4.49 77.34 13.29 -7.09 78.39 13.51 1ef8_c01 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c01 naa= 3 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 1 3 # 1 C 66 HIS A 22 HIS~? -3.40 MN MN A 604s C 110 GLY A 23 GLY~? 8.40 S2 BME A 601 C 140 TYR A 58 TYR~? -4.88 S2 BME A 601s coo -9.82 10.01 28.41 -9.17 11.02 26.71 3.18 53.06 10.64 3.66 54.63 11.95 coo -5.73 12.49 27.77 -5.15 12.61 28.37 1.32 48.34 7.45 1.06 48.38 8.26 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 2 3 # 2 C 66 HIS A 100 HIS~? 8.88 CL CL A 608 C 110 GLY A 98 GLY~? 10.67 MN MN A 605 C 140 TYR A 133 TYR~? 5.56 CL CL A 608 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -6.79 61.25 20.29 -6.32 60.57 20.44 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 3 3 # 3 C 66 HIS B 22 HIS~? -3.40 MN MN B 607s C 110 GLY B 23 GLY~? 8.34 S2 BME B 602 C 140 TYR B 58 TYR~? -4.91 S2 BME B 602s coo -9.82 10.01 28.41 -9.17 11.02 26.71 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -1.78 84.52 5.86 -2.42 84.42 6.43 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1ef8_c02 METHYLMALONYL COA DECARBOXYLASE user 4 3 # 4 C 66 HIS B 100 HIS~? 8.87 CL CL B 609 C 110 GLY B 98 GLY~? 10.76 MN MN B 606 C 140 TYR B 133 TYR~? 5.56 CL CL B 609 coo -9.82 10.01 28.41 -9.17 11.02 26.71 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -5.73 12.49 27.77 -5.15 12.61 28.37 -10.36 71.24 18.20 -10.64 71.91 17.78 coo -4.68 8.05 21.05 -4.91 10.19 22.84 -4.49 77.34 13.29 -7.09 78.39 13.51 1ef8_c02 source 1ef8 METHYLMALONYL COA DECARBOXYLASE : 4 hits 1ef8_c02 naa= 3 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 A 114 HIS A 67 HIS~? -4.40 CL CL A 608s A 197 ASP A 69 ASP~? 7.42 O1 BME A 601 A 223 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 0.35 54.22 20.29 -1.10 54.30 18.77 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 7.88 51.22 19.98 7.64 49.14 20.25 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 A 114 HIS A 136 HIS~? 3.48 MN MN A 605s A 197 ASP A 134 ASP~? 12.23 CL CL A 608 A 223 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -0.57 59.60 14.33 0.78 59.36 15.93 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 A 114 HIS B 67 HIS~? -4.45 CL CL B 609s A 197 ASP B 69 ASP~? 7.66 S2 BME B 602 A 223 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1elq_c02 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 A 114 HIS B 136 HIS~? 3.50 MN MN B 606s A 197 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 223 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -61.07 -8.57 -27.49 -61.31 -7.57 -25.66 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -56.76 -14.14 -29.82 -57.30 -12.99 -28.11 1.27 73.42 12.01 2.60 75.02 12.38 coo -56.15 -13.54 -16.74 -58.44 -10.91 -21.86 -3.23 86.22 8.94 -7.29 90.78 7.55 1elq_c02 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c02 naa= 3 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 1 3 # 1 B 114 HIS A 67 HIS~? -4.40 CL CL A 608s B 197 ASP A 69 ASP~? 7.42 O1 BME A 601 B 223 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 0.35 54.22 20.29 -1.10 54.30 18.77 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 7.88 51.22 19.98 7.64 49.14 20.25 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 2 3 # 2 B 114 HIS A 136 HIS~? 3.48 MN MN A 605s B 197 ASP A 134 ASP~? 12.23 CL CL A 608 B 223 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -0.57 59.60 14.33 0.78 59.36 15.93 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 3 3 # 3 B 114 HIS B 67 HIS~? -4.45 CL CL B 609s B 197 ASP B 69 ASP~? 7.66 S2 BME B 602 B 223 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1elq_c03 L-CYSTEINE/L-CYSTINE C-S LYASE user 4 3 # 4 B 114 HIS B 136 HIS~? 3.50 MN MN B 606s B 197 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 223 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -32.28 6.89 -26.40 -32.14 5.42 -24.92 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -36.60 12.85 -27.61 -36.03 11.43 -26.18 1.27 73.42 12.01 2.60 75.02 12.38 coo -37.05 10.01 -14.84 -34.42 8.53 -20.24 -3.23 86.22 8.94 -7.29 90.78 7.55 1elq_c03 source 1elq L-CYSTEINE/L-CYSTINE C-S LYASE : 4 hits 1elq_c03 naa= 3 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 1 3 # 1 150 ASP A 69 ASP~? 7.42 O1 BME A 601 153 ARG A 166 ARG~? 11.02 O1 BME A 601 177 HIS A 66 HIS~? 3.42 MN MN A 604s coo 6.83 2.75 19.17 7.40 0.75 19.11 7.88 51.22 19.98 7.64 49.14 20.25 coo 1.78 0.50 17.43 2.55 -2.31 16.44 6.93 48.25 24.41 9.45 50.10 24.73 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 2 3 # 2 150 ASP A 69 ASP~? 7.42 O1 BME A 601 153 ARG A 167 ARG~? -4.94 O1 BME A 601s 177 HIS A 66 HIS~? 3.42 MN MN A 604s coo 6.83 2.75 19.17 7.40 0.75 19.11 7.88 51.22 19.98 7.64 49.14 20.25 coo 1.78 0.50 17.43 2.55 -2.31 16.44 6.75 43.81 21.29 6.50 46.65 20.31 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 3 3 # 3 150 ASP B 69 ASP~? 7.66 S2 BME B 602 153 ARG B 166 ARG~? 12.22 S2 BME B 602 177 HIS B 66 HIS~? 3.43 MN MN B 607s coo 6.83 2.75 19.17 7.40 0.75 19.11 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1emd_c01 MALATE DEHYDROGENASE (E.C.1.1.1.37) user 4 3 # 4 150 ASP B 69 ASP~? 7.66 S2 BME B 602 153 ARG B 167 ARG~? 6.18 S2 BME B 602 177 HIS B 66 HIS~? 3.43 MN MN B 607s coo 6.83 2.75 19.17 7.40 0.75 19.11 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 1.78 0.50 17.43 2.55 -2.31 16.44 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 9.81 -2.34 18.22 7.84 -2.69 17.56 -11.11 81.39 7.66 -9.84 80.27 6.41 1emd_c01 source 1emd MALATE DEHYDROGENASE (E.C.1.1.1.37) : 4 hits 1emd_c01 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 62 ALA~? -3.33 C1 BME A 601s A 257 ALA A 63 ALA~? 7.13 CL CL A 608 A 328 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 39.84 24.12 8.44 38.50 24.23 9.11 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 43.22 26.73 5.37 41.81 27.09 5.79 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 38.17 34.10 6.67 37.72 32.06 6.84 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 63 ALA~? 7.13 CL CL A 608 A 257 ALA A 62 ALA~? -3.33 C1 BME A 601s A 328 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 39.84 24.12 8.44 38.50 24.23 9.11 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 43.22 26.73 5.37 41.81 27.09 5.79 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 38.17 34.10 6.67 37.72 32.06 6.84 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 104 ALA~? 15.83 CL CL A 608 A 257 ALA A 105 ALA~? 17.22 CL CL A 608 A 328 ASP A 122 ASP~? 22.01 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.51 53.62 22.46 -12.36 54.50 23.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.38 54.89 20.37 -15.49 56.26 19.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -21.79 55.48 15.36 -21.54 57.57 15.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA A 104 ALA~? 15.83 CL CL A 608 A 257 ALA A 108 ALA~? 20.95 CL CL A 608 A 328 ASP A 122 ASP~? 22.01 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.51 53.62 22.46 -12.36 54.50 23.69 coo 43.22 26.73 5.37 41.81 27.09 5.79 -17.92 50.65 21.89 -18.27 51.97 22.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 -21.79 55.48 15.36 -21.54 57.57 15.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA A 108 ALA~? 20.95 CL CL A 608 A 257 ALA A 105 ALA~? 17.22 CL CL A 608 A 328 ASP A 101 ASP~? 14.47 MN MN A 605 coo 39.84 24.12 8.44 38.50 24.23 9.11 -17.92 50.65 21.89 -18.27 51.97 22.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.38 54.89 20.37 -15.49 56.26 19.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA A 108 ALA~? 20.95 CL CL A 608 A 257 ALA A 105 ALA~? 17.22 CL CL A 608 A 328 ASP A 122 ASP~? 22.01 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -17.92 50.65 21.89 -18.27 51.97 22.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.38 54.89 20.37 -15.49 56.26 19.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -21.79 55.48 15.36 -21.54 57.57 15.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 7 3 # 7 A 229 ALA A 108 ALA~? 20.95 CL CL A 608 A 257 ALA A 111 ALA~? 22.16 C1 BME A 601 A 328 ASP A 116 ASP~? 31.90 C1 BME A 601 coo 39.84 24.12 8.44 38.50 24.23 9.11 -17.92 50.65 21.89 -18.27 51.97 22.49 coo 43.22 26.73 5.37 41.81 27.09 5.79 -19.42 45.71 21.50 -19.08 46.37 22.86 coo 38.17 34.10 6.67 37.72 32.06 6.84 -27.84 44.25 19.33 -29.63 44.62 18.19 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 8 3 # 8 A 229 ALA A 111 ALA~? 22.16 C1 BME A 601 A 257 ALA A 108 ALA~? 20.95 CL CL A 608 A 328 ASP A 122 ASP~? 22.01 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -19.42 45.71 21.50 -19.08 46.37 22.86 coo 43.22 26.73 5.37 41.81 27.09 5.79 -17.92 50.65 21.89 -18.27 51.97 22.49 coo 38.17 34.10 6.67 37.72 32.06 6.84 -21.79 55.48 15.36 -21.54 57.57 15.22 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 9 3 # 9 A 229 ALA A 125 ALA~? 18.76 CL CL A 608 A 257 ALA A 105 ALA~? 17.22 CL CL A 608 A 328 ASP A 101 ASP~? 14.47 MN MN A 605 coo 39.84 24.12 8.44 38.50 24.23 9.11 -16.97 56.66 14.75 -17.54 55.68 15.76 coo 43.22 26.73 5.37 41.81 27.09 5.79 -15.38 54.89 20.37 -15.49 56.26 19.70 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 10 3 # 10 A 229 ALA A 164 ALA~? 10.35 O1 BME A 601 A 257 ALA A 165 ALA~? 12.24 O1 BME A 601 A 328 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 39.84 24.12 8.44 38.50 24.23 9.11 11.84 43.25 21.44 13.14 42.59 21.00 coo 43.22 26.73 5.37 41.81 27.09 5.79 11.59 42.83 25.29 12.62 43.38 26.27 coo 38.17 34.10 6.67 37.72 32.06 6.84 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 11 3 # 11 A 229 ALA A 165 ALA~? 12.24 O1 BME A 601 A 257 ALA A 164 ALA~? 10.35 O1 BME A 601 A 328 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 39.84 24.12 8.44 38.50 24.23 9.11 11.59 42.83 25.29 12.62 43.38 26.27 coo 43.22 26.73 5.37 41.81 27.09 5.79 11.84 43.25 21.44 13.14 42.59 21.00 coo 38.17 34.10 6.67 37.72 32.06 6.84 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 12 3 # 12 A 229 ALA B 62 ALA~? 4.29 C1 BME B 602 A 257 ALA B 63 ALA~? 7.11 CL CL B 609 A 328 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 39.84 24.12 8.44 38.50 24.23 9.11 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 43.22 26.73 5.37 41.81 27.09 5.79 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 13 3 # 13 A 229 ALA B 63 ALA~? 7.11 CL CL B 609 A 257 ALA B 62 ALA~? 4.29 C1 BME B 602 A 328 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 39.84 24.12 8.44 38.50 24.23 9.11 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 43.22 26.73 5.37 41.81 27.09 5.79 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 14 3 # 14 A 229 ALA B 104 ALA~? 15.71 CL CL B 609 A 257 ALA B 105 ALA~? 15.84 O1 GOL B 603 A 328 ASP B 122 ASP~? 15.88 O1 GOL B 603 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.27 78.94 24.18 -11.44 78.04 24.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.22 77.82 26.19 -6.45 76.51 26.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.15 77.17 30.18 -0.01 75.13 29.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 15 3 # 15 A 229 ALA B 104 ALA~? 15.71 CL CL B 609 A 257 ALA B 108 ALA~? 20.82 CL CL B 609 A 328 ASP B 122 ASP~? 15.88 O1 GOL B 603 coo 39.84 24.12 8.44 38.50 24.23 9.11 -10.27 78.94 24.18 -11.44 78.04 24.53 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.15 77.17 30.18 -0.01 75.13 29.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 16 3 # 16 A 229 ALA B 108 ALA~? 20.82 CL CL B 609 A 257 ALA B 105 ALA~? 15.84 O1 GOL B 603 A 328 ASP B 101 ASP~? 14.48 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.22 77.82 26.19 -6.45 76.51 26.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.99 72.82 22.17 -12.93 72.02 22.11 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 17 3 # 17 A 229 ALA B 108 ALA~? 20.82 CL CL B 609 A 257 ALA B 105 ALA~? 15.84 O1 GOL B 603 A 328 ASP B 122 ASP~? 15.88 O1 GOL B 603 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.22 77.82 26.19 -6.45 76.51 26.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.15 77.17 30.18 -0.01 75.13 29.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 18 3 # 18 A 229 ALA B 108 ALA~? 20.82 CL CL B 609 A 257 ALA B 111 ALA~? 22.27 C1 BME B 602 A 328 ASP B 116 ASP~? 29.02 O1 GOL B 603 coo 39.84 24.12 8.44 38.50 24.23 9.11 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 43.22 26.73 5.37 41.81 27.09 5.79 -6.97 87.14 29.96 -8.37 86.55 30.15 coo 38.17 34.10 6.67 37.72 32.06 6.84 -2.03 88.79 36.93 -0.39 88.32 38.14 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 19 3 # 19 A 229 ALA B 111 ALA~? 22.27 C1 BME B 602 A 257 ALA B 108 ALA~? 20.82 CL CL B 609 A 328 ASP B 122 ASP~? 15.88 O1 GOL B 603 coo 39.84 24.12 8.44 38.50 24.23 9.11 -6.97 87.14 29.96 -8.37 86.55 30.15 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.86 82.27 28.90 -8.27 80.95 29.48 coo 38.17 34.10 6.67 37.72 32.06 6.84 -0.15 77.17 30.18 -0.01 75.13 29.61 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 20 3 # 20 A 229 ALA B 125 ALA~? 14.10 O1 GOL B 603 A 257 ALA B 105 ALA~? 15.84 O1 GOL B 603 A 328 ASP B 101 ASP~? 14.48 MN MN B 606 coo 39.84 24.12 8.44 38.50 24.23 9.11 -1.46 75.97 25.50 -2.22 76.93 26.41 coo 43.22 26.73 5.37 41.81 27.09 5.79 -7.22 77.82 26.19 -6.45 76.51 26.05 coo 38.17 34.10 6.67 37.72 32.06 6.84 -10.99 72.82 22.17 -12.93 72.02 22.11 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 21 3 # 21 A 229 ALA B 164 ALA~? 11.00 O1 BME B 602 A 257 ALA B 165 ALA~? 14.02 O1 BME B 602 A 328 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 39.84 24.12 8.44 38.50 24.23 9.11 -18.67 89.30 1.59 -18.68 90.00 0.23 coo 43.22 26.73 5.37 41.81 27.09 5.79 -22.15 89.69 3.17 -23.48 89.22 2.57 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 22 3 # 22 A 229 ALA B 165 ALA~? 14.02 O1 BME B 602 A 257 ALA B 164 ALA~? 11.00 O1 BME B 602 A 328 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 39.84 24.12 8.44 38.50 24.23 9.11 -22.15 89.69 3.17 -23.48 89.22 2.57 coo 43.22 26.73 5.37 41.81 27.09 5.79 -18.67 89.30 1.59 -18.68 90.00 0.23 coo 38.17 34.10 6.67 37.72 32.06 6.84 -15.81 81.35 4.53 -16.00 83.45 4.93 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 22 hits 1eo7_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 149 THR~? 18.02 O3 GOL B 603 A 159 LYS A 153 LYS~? 20.22 C2 BME A 601 A 193 GLU A 13 GLU~? 14.48 C2 BME A 601 coo -2.58 16.31 54.79 -4.02 14.93 55.64 19.17 59.55 8.18 18.83 61.06 6.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 23.06 52.60 13.46 22.53 47.10 11.88 coo -5.33 11.71 69.72 -4.62 11.92 67.73 16.66 45.80 10.16 16.30 43.75 10.43 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 149 THR~? 18.02 O3 GOL B 603 A 159 LYS A 153 LYS~? 20.22 C2 BME A 601 A 193 GLU A 158 GLU~? 21.27 MN MN A 604 coo -2.58 16.31 54.79 -4.02 14.93 55.64 19.17 59.55 8.18 18.83 61.06 6.69 coo 2.10 10.68 61.44 -2.14 13.16 60.61 23.06 52.60 13.46 22.53 47.10 11.88 coo -5.33 11.71 69.72 -4.62 11.92 67.73 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 149 THR~? -18.36 MN MN B 607s A 159 LYS B 153 LYS~? 21.64 S2 BME B 602 A 193 GLU B 13 GLU~? 14.49 C2 BME B 602 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.69 73.30 -10.51 -7.30 71.68 -10.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -10.54 87.21 -7.31 -10.84 89.32 -6.98 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 149 THR~? -18.36 MN MN B 607s A 159 LYS B 153 LYS~? 21.64 S2 BME B 602 A 193 GLU B 16 GLU~? 10.04 C2 BME B 602 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.69 73.30 -10.51 -7.30 71.68 -10.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -8.79 86.61 -3.48 -7.90 88.30 -2.54 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 5 3 # 5 A 38 THR B 149 THR~? -18.36 MN MN B 607s A 159 LYS B 153 LYS~? 21.64 S2 BME B 602 A 193 GLU B 158 GLU~? 21.38 MN MN B 607 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -8.69 73.30 -10.51 -7.30 71.68 -10.56 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -23.65 82.01 -6.24 -24.87 80.63 -7.27 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 5 hits 1et0_c02 naa= 3 ULMN 3 1euu_c00 SIALIDASE user 1 3 # 1 92 ASP A 69 ASP~? 7.42 O1 BME A 601 260 GLU A 140 GLU~? -2.42 MN MN A 605s 370 TYR A 19 TYR~? 9.00 MN MN A 604 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 7.88 51.22 19.98 7.64 49.14 20.25 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 5.06 58.75 13.41 3.74 57.63 14.59 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1euu_c00 SIALIDASE user 2 3 # 2 92 ASP B 69 ASP~? 7.66 S2 BME B 602 260 GLU B 16 GLU~? 10.04 C2 BME B 602 370 TYR B 19 TYR~? 9.04 MN MN B 607 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1euu_c00 SIALIDASE user 3 3 # 3 92 ASP B 69 ASP~? 7.66 S2 BME B 602 260 GLU B 140 GLU~? -2.41 MN MN B 606s 370 TYR B 19 TYR~? 9.04 MN MN B 607 coo 8.60 -17.93 28.38 7.67 -19.04 26.88 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 0.12 -12.06 25.14 1.33 -13.03 23.72 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 4.66 -12.77 19.52 3.70 -14.16 21.71 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1euu_c00 source 1euu SIALIDASE : 3 hits 1euu_c00 naa= 3 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 1 3 # 1 C 95 ASP A 37 ASP~? 25.83 CL CL A 608 C 117 GLU A 123 GLU~? 22.37 MN MN B 606 C 131 GLU A 41 GLU~? 29.61 S2 BME A 601 coo 68.01 56.37 72.57 68.42 56.10 70.51 -20.38 49.92 2.66 -20.55 51.94 2.14 coo 66.59 62.50 67.44 67.57 60.64 67.12 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 69.24 52.27 71.96 69.91 50.26 71.89 -23.83 46.41 0.54 -22.24 46.41 -0.85 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 2 3 # 2 C 95 ASP A 90 ASP~? 8.93 C1 GOL B 603 C 117 GLU B 124 GLU~? 10.55 C1 GOL B 603 C 131 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 68.01 56.37 72.57 68.42 56.10 70.51 5.32 68.36 21.17 7.09 68.49 22.34 coo 66.59 62.50 67.44 67.57 60.64 67.12 0.65 71.77 26.43 1.32 70.82 24.72 coo 69.24 52.27 71.96 69.91 50.26 71.89 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 3 3 # 3 C 95 ASP B 37 ASP~? 15.37 O1 GOL B 603 C 117 GLU B 123 GLU~? 13.36 O1 GOL B 603 C 131 GLU B 41 GLU~? 20.43 O1 GOL B 603 coo 68.01 56.37 72.57 68.42 56.10 70.51 11.04 82.75 24.13 11.46 80.73 24.12 coo 66.59 62.50 67.44 67.57 60.64 67.12 5.68 77.05 25.89 7.75 77.09 25.94 coo 69.24 52.27 71.96 69.91 50.26 71.89 14.65 86.53 26.90 14.45 85.39 25.16 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 4 3 # 4 C 95 ASP B 90 ASP~? 13.30 MN MN B 606 C 117 GLU A 124 GLU~? 15.58 MN MN B 606 C 131 GLU B 87 GLU~? 16.36 MN MN B 606 coo 68.01 56.37 72.57 68.42 56.10 70.51 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 66.59 62.50 67.44 67.57 60.64 67.12 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 69.24 52.27 71.96 69.91 50.26 71.89 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 5 3 # 5 C 95 ASP B 122 ASP~? 15.88 O1 GOL B 603 C 117 GLU B 123 GLU~? 13.36 O1 GOL B 603 C 131 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 68.01 56.37 72.57 68.42 56.10 70.51 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 66.59 62.50 67.44 67.57 60.64 67.12 5.68 77.05 25.89 7.75 77.09 25.94 coo 69.24 52.27 71.96 69.91 50.26 71.89 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1f6d_c02 UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE user 6 3 # 6 C 95 ASP B 122 ASP~? 15.88 O1 GOL B 603 C 117 GLU B 124 GLU~? 10.55 C1 GOL B 603 C 131 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 68.01 56.37 72.57 68.42 56.10 70.51 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 66.59 62.50 67.44 67.57 60.64 67.12 0.65 71.77 26.43 1.32 70.82 24.72 coo 69.24 52.27 71.96 69.91 50.26 71.89 -2.95 80.34 28.65 -2.60 79.82 30.64 1f6d_c02 source 1f6d UDP-N-ACETYLGLUCOSAMINE 2-EPIMERASE : 6 hits 1f6d_c02 naa= 3 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 1 3 # 1 A 156 LYS A 24 LYS~? 4.08 C2 BME A 601 A 159 HIS A 22 HIS~? -3.40 MN MN A 604s A 162 HIS A 66 HIS~? 3.42 MN MN A 604s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -0.91 46.54 9.97 2.66 42.32 12.44 coo 29.80 39.37 7.24 28.18 38.06 7.48 3.18 53.06 10.64 3.66 54.63 11.95 coo 30.26 35.04 5.34 28.61 35.92 4.39 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 2 3 # 2 A 156 LYS A 24 LYS~? 4.08 C2 BME A 601 A 159 HIS A 66 HIS~? 3.42 MN MN A 604s A 162 HIS A 22 HIS~? -3.40 MN MN A 604s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -0.91 46.54 9.97 2.66 42.32 12.44 coo 29.80 39.37 7.24 28.18 38.06 7.48 3.21 51.23 16.81 3.87 52.43 15.22 coo 30.26 35.04 5.34 28.61 35.92 4.39 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 3 3 # 3 A 156 LYS B 24 LYS~? -3.00 C2 BME B 602s A 159 HIS B 22 HIS~? -3.40 MN MN B 607s A 162 HIS B 66 HIS~? 3.43 MN MN B 607s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 29.80 39.37 7.24 28.18 38.06 7.48 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 30.26 35.04 5.34 28.61 35.92 4.39 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1f7u_c00 ARGINYL-TRNA SYNTHETASE user 4 3 # 4 A 156 LYS B 24 LYS~? -3.00 C2 BME B 602s A 159 HIS B 66 HIS~? 3.43 MN MN B 607s A 162 HIS B 22 HIS~? -3.40 MN MN B 607s coo 28.43 39.38 -0.97 23.05 38.55 -2.04 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 29.80 39.37 7.24 28.18 38.06 7.48 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 30.26 35.04 5.34 28.61 35.92 4.39 -5.34 79.70 5.35 -6.67 78.07 5.35 1f7u_c00 source 1f7u ARGINYL-TRNA SYNTHETASE : 4 hits 1f7u_c00 naa= 3 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 1 3 # 1 A 105 HIS A 67 HIS~? -4.40 CL CL A 608s C 62 LYS A 24 LYS~? 4.08 C2 BME A 601 F 35 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 15.40 22.79 16.66 13.93 24.10 15.98 0.35 54.22 20.29 -1.10 54.30 18.77 coo 19.95 18.98 4.81 18.82 20.94 10.49 -0.91 46.54 9.97 2.66 42.32 12.44 coo 16.32 15.30 17.19 17.71 14.73 18.69 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 2 3 # 2 A 105 HIS A 136 HIS~? 3.48 MN MN A 605s C 62 LYS A 24 LYS~? 4.08 C2 BME A 601 F 35 ASP A 134 ASP~? 12.23 CL CL A 608 coo 15.40 22.79 16.66 13.93 24.10 15.98 -0.57 59.60 14.33 0.78 59.36 15.93 coo 19.95 18.98 4.81 18.82 20.94 10.49 -0.91 46.54 9.97 2.66 42.32 12.44 coo 16.32 15.30 17.19 17.71 14.73 18.69 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 3 3 # 3 A 105 HIS B 67 HIS~? -4.45 CL CL B 609s C 62 LYS B 24 LYS~? -3.00 C2 BME B 602s F 35 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 15.40 22.79 16.66 13.93 24.10 15.98 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 16.32 15.30 17.19 17.71 14.73 18.69 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1f80_c03 ACYL CARRIER PROTEIN user 4 3 # 4 A 105 HIS B 136 HIS~? 3.50 MN MN B 606s C 62 LYS B 24 LYS~? -3.00 C2 BME B 602s F 35 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 15.40 22.79 16.66 13.93 24.10 15.98 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 19.95 18.98 4.81 18.82 20.94 10.49 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 16.32 15.30 17.19 17.71 14.73 18.69 1.27 73.42 12.01 2.60 75.02 12.38 1f80_c03 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c03 naa= 3 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 1 3 # 1 B 62 LYS A 24 LYS~? 4.08 C2 BME A 601 C 105 HIS A 67 HIS~? -4.40 CL CL A 608s D 35 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 38.76 28.25 7.87 36.33 26.41 13.58 -0.91 46.54 9.97 2.66 42.32 12.44 coo 34.93 19.72 17.37 34.72 18.17 15.98 0.35 54.22 20.29 -1.10 54.30 18.77 coo 41.01 23.02 20.83 40.65 24.26 22.55 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 2 3 # 2 B 62 LYS A 24 LYS~? 4.08 C2 BME A 601 C 105 HIS A 136 HIS~? 3.48 MN MN A 605s D 35 ASP A 134 ASP~? 12.23 CL CL A 608 coo 38.76 28.25 7.87 36.33 26.41 13.58 -0.91 46.54 9.97 2.66 42.32 12.44 coo 34.93 19.72 17.37 34.72 18.17 15.98 -0.57 59.60 14.33 0.78 59.36 15.93 coo 41.01 23.02 20.83 40.65 24.26 22.55 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 3 3 # 3 B 62 LYS B 24 LYS~? -3.00 C2 BME B 602s C 105 HIS B 67 HIS~? -4.45 CL CL B 609s D 35 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 38.76 28.25 7.87 36.33 26.41 13.58 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 34.93 19.72 17.37 34.72 18.17 15.98 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 41.01 23.02 20.83 40.65 24.26 22.55 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1f80_c04 ACYL CARRIER PROTEIN user 4 3 # 4 B 62 LYS B 24 LYS~? -3.00 C2 BME B 602s C 105 HIS B 136 HIS~? 3.50 MN MN B 606s D 35 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 38.76 28.25 7.87 36.33 26.41 13.58 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 34.93 19.72 17.37 34.72 18.17 15.98 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 41.01 23.02 20.83 40.65 24.26 22.55 1.27 73.42 12.01 2.60 75.02 12.38 1f80_c04 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c04 naa= 3 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 1 3 # 1 A 62 LYS A 24 LYS~? 4.08 C2 BME A 601 B 105 HIS A 67 HIS~? -4.40 CL CL A 608s E 35 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 20.51 39.76 8.83 21.23 37.38 14.18 -0.91 46.54 9.97 2.66 42.32 12.44 coo 27.18 37.56 20.68 29.07 38.28 20.13 0.35 54.22 20.29 -1.10 54.30 18.77 coo 19.97 40.39 22.03 18.53 39.30 23.18 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 2 3 # 2 A 62 LYS A 24 LYS~? 4.08 C2 BME A 601 B 105 HIS A 136 HIS~? 3.48 MN MN A 605s E 35 ASP A 134 ASP~? 12.23 CL CL A 608 coo 20.51 39.76 8.83 21.23 37.38 14.18 -0.91 46.54 9.97 2.66 42.32 12.44 coo 27.18 37.56 20.68 29.07 38.28 20.13 -0.57 59.60 14.33 0.78 59.36 15.93 coo 19.97 40.39 22.03 18.53 39.30 23.18 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 3 3 # 3 A 62 LYS B 24 LYS~? -3.00 C2 BME B 602s B 105 HIS B 67 HIS~? -4.45 CL CL B 609s E 35 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 27.18 37.56 20.68 29.07 38.28 20.13 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 19.97 40.39 22.03 18.53 39.30 23.18 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1f80_c05 ACYL CARRIER PROTEIN user 4 3 # 4 A 62 LYS B 24 LYS~? -3.00 C2 BME B 602s B 105 HIS B 136 HIS~? 3.50 MN MN B 606s E 35 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 20.51 39.76 8.83 21.23 37.38 14.18 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 27.18 37.56 20.68 29.07 38.28 20.13 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 19.97 40.39 22.03 18.53 39.30 23.18 1.27 73.42 12.01 2.60 75.02 12.38 1f80_c05 source 1f80 ACYL CARRIER PROTEIN : 4 hits 1f80_c05 naa= 3 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 1 3 # 1 A 180 HIS A 22 HIS~? -3.40 MN MN A 604s A 191 CYH A 29 CYH~? 9.71 CL CL A 608 A 228 ARG A 26 ARG~? 9.60 MN MN A 604 coo 26.35 46.39 51.64 24.52 45.66 52.39 3.18 53.06 10.64 3.66 54.63 11.95 coo 16.62 40.80 48.93 16.46 38.74 50.82 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 24.60 42.24 47.99 21.60 41.75 48.44 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1f8m_c00 ISOCITRATE LYASE user 2 3 # 2 A 180 HIS B 22 HIS~? -3.40 MN MN B 607s A 191 CYH B 29 CYH~? 9.17 O1 GOL B 603 A 228 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 26.35 46.39 51.64 24.52 45.66 52.39 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 16.62 40.80 48.93 16.46 38.74 50.82 0.50 81.71 15.06 -1.49 79.86 14.33 coo 24.60 42.24 47.99 21.60 41.75 48.44 1.24 79.80 7.27 0.69 76.71 7.21 1f8m_c00 source 1f8m ISOCITRATE LYASE : 2 hits 1f8m_c00 naa= 3 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 1 3 # 1 B 180 HIS A 22 HIS~? -3.40 MN MN A 604s B 191 CYH A 29 CYH~? 9.71 CL CL A 608 B 228 ARG A 26 ARG~? 9.60 MN MN A 604 coo -1.29 58.02 79.43 0.64 57.19 79.31 3.18 53.06 10.64 3.66 54.63 11.95 coo 8.78 59.01 84.54 9.56 56.29 85.16 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 0.68 59.10 84.66 3.77 58.91 84.59 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1f8m_c01 ISOCITRATE LYASE user 2 3 # 2 B 180 HIS B 22 HIS~? -3.40 MN MN B 607s B 191 CYH B 29 CYH~? 9.17 O1 GOL B 603 B 228 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo -1.29 58.02 79.43 0.64 57.19 79.31 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 8.78 59.01 84.54 9.56 56.29 85.16 0.50 81.71 15.06 -1.49 79.86 14.33 coo 0.68 59.10 84.66 3.77 58.91 84.59 1.24 79.80 7.27 0.69 76.71 7.21 1f8m_c01 source 1f8m ISOCITRATE LYASE : 2 hits 1f8m_c01 naa= 3 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 1 3 # 1 C 180 HIS A 22 HIS~? -3.40 MN MN A 604s C 191 CYH A 29 CYH~? 9.71 CL CL A 608 C 228 ARG A 26 ARG~? 9.60 MN MN A 604 coo 2.43 65.34 36.80 3.92 66.76 37.21 3.18 53.06 10.64 3.66 54.63 11.95 coo 13.01 68.26 34.18 13.01 71.04 33.71 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 5.82 65.41 32.29 8.60 66.57 33.01 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1f8m_c02 ISOCITRATE LYASE user 2 3 # 2 C 180 HIS B 22 HIS~? -3.40 MN MN B 607s C 191 CYH B 29 CYH~? 9.17 O1 GOL B 603 C 228 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 2.43 65.34 36.80 3.92 66.76 37.21 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 13.01 68.26 34.18 13.01 71.04 33.71 0.50 81.71 15.06 -1.49 79.86 14.33 coo 5.82 65.41 32.29 8.60 66.57 33.01 1.24 79.80 7.27 0.69 76.71 7.21 1f8m_c02 source 1f8m ISOCITRATE LYASE : 2 hits 1f8m_c02 naa= 3 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 1 3 # 1 D 180 HIS A 22 HIS~? -3.40 MN MN A 604s D 191 CYH A 29 CYH~? 9.71 CL CL A 608 D 228 ARG A 26 ARG~? 9.60 MN MN A 604 coo 17.18 84.74 69.76 15.58 84.83 68.40 3.18 53.06 10.64 3.66 54.63 11.95 coo 5.89 86.47 69.92 5.21 88.39 67.91 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 13.48 87.80 72.67 10.60 87.44 71.57 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1f8m_c03 ISOCITRATE LYASE user 2 3 # 2 D 180 HIS B 22 HIS~? -3.40 MN MN B 607s D 191 CYH B 29 CYH~? 9.17 O1 GOL B 603 D 228 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 17.18 84.74 69.76 15.58 84.83 68.40 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 5.89 86.47 69.92 5.21 88.39 67.91 0.50 81.71 15.06 -1.49 79.86 14.33 coo 13.48 87.80 72.67 10.60 87.44 71.57 1.24 79.80 7.27 0.69 76.71 7.21 1f8m_c03 source 1f8m ISOCITRATE LYASE : 2 hits 1f8m_c03 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 59 PHE~? 9.30 CL CL A 608 A 210 ASP A 101 ASP~? 14.47 MN MN A 605 A 244 LYS A 127 LYS~? 18.61 MN MN B 606 coo 9.23 46.77 25.11 11.48 48.39 24.76 -6.57 49.40 16.71 -5.70 50.05 14.11 coo 10.51 37.86 19.71 9.07 39.38 20.04 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -1.20 42.34 17.67 3.19 45.13 19.06 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 74 PHE~? 8.88 MN MN A 604 A 210 ASP A 145 ASP~? 14.76 MN MN A 604 A 244 LYS A 153 LYS~? 20.22 C2 BME A 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 11.59 56.31 16.73 12.14 57.65 14.39 coo 10.51 37.86 19.71 9.07 39.38 20.04 12.32 59.45 6.26 13.32 58.94 4.48 coo -1.20 42.34 17.67 3.19 45.13 19.06 23.06 52.60 13.46 22.53 47.10 11.88 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 75 PHE~? 5.80 MN MN A 605 A 210 ASP A 69 ASP~? 7.42 O1 BME A 601 A 244 LYS A 155 LYS~? 22.50 MN MN A 604 coo 9.23 46.77 25.11 11.48 48.39 24.76 8.51 60.03 19.19 6.27 59.59 17.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE A 129 PHE~? 10.87 CL CL A 608 A 210 ASP A 134 ASP~? 12.23 CL CL A 608 A 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 -10.38 54.19 14.28 -8.39 52.30 14.83 coo 10.51 37.86 19.71 9.07 39.38 20.04 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE A 144 PHE~? 5.39 MN MN A 604 A 210 ASP A 69 ASP~? 7.42 O1 BME A 601 A 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 9.23 46.77 25.11 11.48 48.39 24.76 8.99 56.15 11.10 6.96 55.33 12.85 coo 10.51 37.86 19.71 9.07 39.38 20.04 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE A 144 PHE~? 5.39 MN MN A 604 A 210 ASP A 69 ASP~? 7.42 O1 BME A 601 A 244 LYS A 155 LYS~? 22.50 MN MN A 604 coo 9.23 46.77 25.11 11.48 48.39 24.76 8.99 56.15 11.10 6.96 55.33 12.85 coo 10.51 37.86 19.71 9.07 39.38 20.04 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.20 42.34 17.67 3.19 45.13 19.06 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 A 112 PHE B 59 PHE~? 9.18 CL CL B 609 A 210 ASP B 101 ASP~? 14.48 MN MN B 606 A 244 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 9.23 46.77 25.11 11.48 48.39 24.76 -7.31 83.22 16.56 -5.26 82.55 14.74 coo 10.51 37.86 19.71 9.07 39.38 20.04 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -1.20 42.34 17.67 3.19 45.13 19.06 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 A 112 PHE B 74 PHE~? 8.86 MN MN B 607 A 210 ASP B 145 ASP~? 15.01 MN MN B 607 A 244 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 9.23 46.77 25.11 11.48 48.39 24.76 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 -15.29 80.48 -11.91 -17.46 85.09 -12.54 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 A 112 PHE B 75 PHE~? 5.83 MN MN B 606 A 210 ASP B 69 ASP~? 7.66 S2 BME B 602 A 244 LYS B 155 LYS~? 22.59 MN MN B 607 coo 9.23 46.77 25.11 11.48 48.39 24.76 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 A 112 PHE B 129 PHE~? 10.86 CL CL B 609 A 210 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 9.23 46.77 25.11 11.48 48.39 24.76 -3.48 78.42 19.16 -4.63 80.39 17.56 coo 10.51 37.86 19.71 9.07 39.38 20.04 1.27 73.42 12.01 2.60 75.02 12.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 11 3 # 11 A 112 PHE B 144 PHE~? 5.38 MN MN B 607 A 210 ASP B 69 ASP~? 7.66 S2 BME B 602 A 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 9.23 46.77 25.11 11.48 48.39 24.76 -7.78 76.84 0.08 -8.68 77.53 2.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 12 3 # 12 A 112 PHE B 144 PHE~? 5.38 MN MN B 607 A 210 ASP B 69 ASP~? 7.66 S2 BME B 602 A 244 LYS B 155 LYS~? 22.59 MN MN B 607 coo 9.23 46.77 25.11 11.48 48.39 24.76 -7.78 76.84 0.08 -8.68 77.53 2.69 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 13 3 # 13 A 112 PHE B 150 PHE~? 19.25 MN MN B 607 A 210 ASP B 145 ASP~? 15.01 MN MN B 607 A 244 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 9.23 46.77 25.11 11.48 48.39 24.76 -11.34 69.63 -9.95 -9.41 67.65 -10.43 coo 10.51 37.86 19.71 9.07 39.38 20.04 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo -1.20 42.34 17.67 3.19 45.13 19.06 -15.29 80.48 -11.91 -17.46 85.09 -12.54 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 13 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 59 PHE~? 9.30 CL CL A 608 B 210 ASP A 101 ASP~? 14.47 MN MN A 605 B 244 LYS A 127 LYS~? 18.61 MN MN B 606 coo 8.76 47.85 34.91 11.08 46.36 35.41 -6.57 49.40 16.71 -5.70 50.05 14.11 coo 9.06 56.85 40.30 7.71 55.27 39.90 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -2.38 51.82 41.62 2.07 49.19 40.42 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 75 PHE~? 5.80 MN MN A 605 B 210 ASP A 69 ASP~? 7.42 O1 BME A 601 B 244 LYS A 155 LYS~? 22.50 MN MN A 604 coo 8.76 47.85 34.91 11.08 46.36 35.41 8.51 60.03 19.19 6.27 59.59 17.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 7.88 51.22 19.98 7.64 49.14 20.25 coo -2.38 51.82 41.62 2.07 49.19 40.42 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 129 PHE~? 10.87 CL CL A 608 B 210 ASP A 134 ASP~? 12.23 CL CL A 608 B 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 -10.38 54.19 14.28 -8.39 52.30 14.83 coo 9.06 56.85 40.30 7.71 55.27 39.90 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE A 144 PHE~? 5.39 MN MN A 604 B 210 ASP A 69 ASP~? 7.42 O1 BME A 601 B 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 8.76 47.85 34.91 11.08 46.36 35.41 8.99 56.15 11.10 6.96 55.33 12.85 coo 9.06 56.85 40.30 7.71 55.27 39.90 7.88 51.22 19.98 7.64 49.14 20.25 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE A 144 PHE~? 5.39 MN MN A 604 B 210 ASP A 69 ASP~? 7.42 O1 BME A 601 B 244 LYS A 155 LYS~? 22.50 MN MN A 604 coo 8.76 47.85 34.91 11.08 46.36 35.41 8.99 56.15 11.10 6.96 55.33 12.85 coo 9.06 56.85 40.30 7.71 55.27 39.90 7.88 51.22 19.98 7.64 49.14 20.25 coo -2.38 51.82 41.62 2.07 49.19 40.42 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 59 PHE~? 9.18 CL CL B 609 B 210 ASP B 101 ASP~? 14.48 MN MN B 606 B 244 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 8.76 47.85 34.91 11.08 46.36 35.41 -7.31 83.22 16.56 -5.26 82.55 14.74 coo 9.06 56.85 40.30 7.71 55.27 39.90 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -2.38 51.82 41.62 2.07 49.19 40.42 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 7 3 # 7 B 112 PHE B 75 PHE~? 5.83 MN MN B 606 B 210 ASP B 69 ASP~? 7.66 S2 BME B 602 B 244 LYS B 155 LYS~? 22.59 MN MN B 607 coo 8.76 47.85 34.91 11.08 46.36 35.41 -15.10 72.64 3.42 -12.79 73.08 4.96 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 8 3 # 8 B 112 PHE B 129 PHE~? 10.86 CL CL B 609 B 210 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 8.76 47.85 34.91 11.08 46.36 35.41 -3.48 78.42 19.16 -4.63 80.39 17.56 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.27 73.42 12.01 2.60 75.02 12.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 9 3 # 9 B 112 PHE B 144 PHE~? 5.38 MN MN B 607 B 210 ASP B 69 ASP~? 7.66 S2 BME B 602 B 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 8.76 47.85 34.91 11.08 46.36 35.41 -7.78 76.84 0.08 -8.68 77.53 2.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 10 3 # 10 B 112 PHE B 144 PHE~? 5.38 MN MN B 607 B 210 ASP B 69 ASP~? 7.66 S2 BME B 602 B 244 LYS B 155 LYS~? 22.59 MN MN B 607 coo 8.76 47.85 34.91 11.08 46.36 35.41 -7.78 76.84 0.08 -8.68 77.53 2.69 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -19.72 79.32 -9.05 -24.26 76.03 -9.81 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 10 hits 1fc4_c03 naa= 3 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 136 HIS A 67 HIS~? -4.40 CL CL A 608s A 210 ASP A 69 ASP~? 7.42 O1 BME A 601 A 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 11.28 44.53 18.60 9.91 46.00 19.20 0.35 54.22 20.29 -1.10 54.30 18.77 coo 10.51 37.86 19.71 9.07 39.38 20.04 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 136 HIS A 136 HIS~? 3.48 MN MN A 605s A 210 ASP A 134 ASP~? 12.23 CL CL A 608 A 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 11.28 44.53 18.60 9.91 46.00 19.20 -0.57 59.60 14.33 0.78 59.36 15.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 136 HIS B 67 HIS~? -4.45 CL CL B 609s A 210 ASP B 69 ASP~? 7.66 S2 BME B 602 A 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 11.28 44.53 18.60 9.91 46.00 19.20 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 10.51 37.86 19.71 9.07 39.38 20.04 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c04 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 136 HIS B 136 HIS~? 3.50 MN MN B 606s A 210 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 11.28 44.53 18.60 9.91 46.00 19.20 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 10.51 37.86 19.71 9.07 39.38 20.04 1.27 73.42 12.01 2.60 75.02 12.38 coo -1.20 42.34 17.67 3.19 45.13 19.06 -3.23 86.22 8.94 -7.29 90.78 7.55 1fc4_c04 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c04 naa= 3 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 136 HIS A 67 HIS~? -4.40 CL CL A 608s B 210 ASP A 69 ASP~? 7.42 O1 BME A 601 B 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 10.08 50.18 41.78 8.91 48.61 41.04 0.35 54.22 20.29 -1.10 54.30 18.77 coo 9.06 56.85 40.30 7.71 55.27 39.90 7.88 51.22 19.98 7.64 49.14 20.25 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 136 HIS A 136 HIS~? 3.48 MN MN A 605s B 210 ASP A 134 ASP~? 12.23 CL CL A 608 B 244 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 10.08 50.18 41.78 8.91 48.61 41.04 -0.57 59.60 14.33 0.78 59.36 15.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 136 HIS B 67 HIS~? -4.45 CL CL B 609s B 210 ASP B 69 ASP~? 7.66 S2 BME B 602 B 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 10.08 50.18 41.78 8.91 48.61 41.04 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 9.06 56.85 40.30 7.71 55.27 39.90 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1fc4_c05 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 136 HIS B 136 HIS~? 3.50 MN MN B 606s B 210 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 244 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 10.08 50.18 41.78 8.91 48.61 41.04 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 9.06 56.85 40.30 7.71 55.27 39.90 1.27 73.42 12.01 2.60 75.02 12.38 coo -2.38 51.82 41.62 2.07 49.19 40.42 -3.23 86.22 8.94 -7.29 90.78 7.55 1fc4_c05 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 4 hits 1fc4_c05 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 58 TYR~? -4.88 S2 BME A 601s A 142 LEU A 65 LEU~? 5.32 O1 BME A 601 A 165 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 3.13 47.13 22.25 2.94 45.61 23.80 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 58 TYR~? -4.91 S2 BME B 602s A 142 LEU B 65 LEU~? 7.79 C1 BME B 602 A 165 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -3.23 86.22 8.94 -7.29 90.78 7.55 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 58 TYR~? -4.88 S2 BME A 601s B 142 LEU A 65 LEU~? 5.32 O1 BME A 601 B 165 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 3.13 47.13 22.25 2.94 45.61 23.80 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 58 TYR~? -4.91 S2 BME B 602s B 142 LEU B 65 LEU~? 7.79 C1 BME B 602 B 165 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -16.24 85.22 9.96 -17.65 86.66 10.74 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -3.23 86.22 8.94 -7.29 90.78 7.55 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 58 TYR~? -4.88 S2 BME A 601s C 142 LEU A 65 LEU~? 5.32 O1 BME A 601 C 165 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 3.13 47.13 22.25 2.94 45.61 23.80 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 58 TYR~? -4.91 S2 BME B 602s C 142 LEU B 65 LEU~? 7.79 C1 BME B 602 C 165 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -3.23 86.22 8.94 -7.29 90.78 7.55 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 58 TYR~? -4.88 S2 BME A 601s D 142 LEU A 65 LEU~? 5.32 O1 BME A 601 D 165 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 3.13 47.13 22.25 2.94 45.61 23.80 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 58 TYR~? -4.91 S2 BME B 602s D 142 LEU B 65 LEU~? 7.79 C1 BME B 602 D 165 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -3.23 86.22 8.94 -7.29 90.78 7.55 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 136 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 246 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 13.48 30.30 107.06 11.75 30.99 109.44 -0.58 68.78 21.39 1.97 70.41 20.81 coo 9.46 32.37 115.82 8.50 34.20 115.47 5.68 77.05 25.89 7.75 77.09 25.94 coo 11.99 34.33 109.92 10.08 34.19 110.77 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 128 ARG~? 18.10 CL CL A 608 A 136 GLU A 123 GLU~? 22.37 MN MN B 606 A 246 GLU A 124 GLU~? 15.58 MN MN B 606 coo 13.48 30.30 107.06 11.75 30.99 109.44 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 9.46 32.37 115.82 8.50 34.20 115.47 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 11.99 34.33 109.92 10.08 34.19 110.77 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 166 ARG~? 11.02 O1 BME A 601 A 136 GLU A 71 GLU~? 7.91 MN MN A 605 A 246 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 13.48 30.30 107.06 11.75 30.99 109.44 6.93 48.25 24.41 9.45 50.10 24.73 coo 9.46 32.37 115.82 8.50 34.20 115.47 4.56 57.67 23.22 2.91 58.15 24.47 coo 11.99 34.33 109.92 10.08 34.19 110.77 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG A 166 ARG~? 11.02 O1 BME A 601 A 136 GLU A 71 GLU~? 7.91 MN MN A 605 A 246 GLU A 72 GLU~? 12.86 MN MN A 605 coo 13.48 30.30 107.06 11.75 30.99 109.44 6.93 48.25 24.41 9.45 50.10 24.73 coo 9.46 32.37 115.82 8.50 34.20 115.47 4.56 57.67 23.22 2.91 58.15 24.47 coo 11.99 34.33 109.92 10.08 34.19 110.77 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 94 ARG~? 13.57 MN MN B 606 A 136 GLU A 123 GLU~? 22.37 MN MN B 606 A 246 GLU A 124 GLU~? 15.58 MN MN B 606 coo 13.48 30.30 107.06 11.75 30.99 109.44 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 9.46 32.37 115.82 8.50 34.20 115.47 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 11.99 34.33 109.92 10.08 34.19 110.77 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 136 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 246 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 13.48 30.30 107.06 11.75 30.99 109.44 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 9.46 32.37 115.82 8.50 34.20 115.47 5.68 77.05 25.89 7.75 77.09 25.94 coo 11.99 34.33 109.92 10.08 34.19 110.77 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG B 166 ARG~? 12.22 S2 BME B 602 A 136 GLU B 71 GLU~? 7.93 MN MN B 606 A 246 GLU B 68 GLU~? 12.41 MN MN B 606 coo 13.48 30.30 107.06 11.75 30.99 109.44 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 9.46 32.37 115.82 8.50 34.20 115.47 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 11.99 34.33 109.92 10.08 34.19 110.77 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG B 166 ARG~? 12.22 S2 BME B 602 A 136 GLU B 71 GLU~? 7.93 MN MN B 606 A 246 GLU B 72 GLU~? 13.02 MN MN B 606 coo 13.48 30.30 107.06 11.75 30.99 109.44 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 9.46 32.37 115.82 8.50 34.20 115.47 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 11.99 34.33 109.92 10.08 34.19 110.77 -22.12 78.07 6.79 -23.41 76.46 7.29 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 8 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 136 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 246 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 13.94 29.84 106.80 11.67 30.40 108.79 -0.58 68.78 21.39 1.97 70.41 20.81 coo 9.52 31.97 115.23 8.45 33.74 114.72 5.68 77.05 25.89 7.75 77.09 25.94 coo 11.92 33.82 109.35 10.10 33.50 110.39 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG A 128 ARG~? 18.10 CL CL A 608 A 136 GLU A 123 GLU~? 22.37 MN MN B 606 A 246 GLU A 124 GLU~? 15.58 MN MN B 606 coo 13.94 29.84 106.80 11.67 30.40 108.79 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 9.52 31.97 115.23 8.45 33.74 114.72 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 11.92 33.82 109.35 10.10 33.50 110.39 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 3 3 # 3 A 45 ARG A 166 ARG~? 11.02 O1 BME A 601 A 136 GLU A 71 GLU~? 7.91 MN MN A 605 A 246 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 13.94 29.84 106.80 11.67 30.40 108.79 6.93 48.25 24.41 9.45 50.10 24.73 coo 9.52 31.97 115.23 8.45 33.74 114.72 4.56 57.67 23.22 2.91 58.15 24.47 coo 11.92 33.82 109.35 10.10 33.50 110.39 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 4 3 # 4 A 45 ARG A 166 ARG~? 11.02 O1 BME A 601 A 136 GLU A 71 GLU~? 7.91 MN MN A 605 A 246 GLU A 72 GLU~? 12.86 MN MN A 605 coo 13.94 29.84 106.80 11.67 30.40 108.79 6.93 48.25 24.41 9.45 50.10 24.73 coo 9.52 31.97 115.23 8.45 33.74 114.72 4.56 57.67 23.22 2.91 58.15 24.47 coo 11.92 33.82 109.35 10.10 33.50 110.39 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 5 3 # 5 A 45 ARG B 94 ARG~? 13.57 MN MN B 606 A 136 GLU A 123 GLU~? 22.37 MN MN B 606 A 246 GLU A 124 GLU~? 15.58 MN MN B 606 coo 13.94 29.84 106.80 11.67 30.40 108.79 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 9.52 31.97 115.23 8.45 33.74 114.72 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 11.92 33.82 109.35 10.10 33.50 110.39 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 6 3 # 6 A 45 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 136 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 246 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 13.94 29.84 106.80 11.67 30.40 108.79 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 9.52 31.97 115.23 8.45 33.74 114.72 5.68 77.05 25.89 7.75 77.09 25.94 coo 11.92 33.82 109.35 10.10 33.50 110.39 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 7 3 # 7 A 45 ARG B 166 ARG~? 12.22 S2 BME B 602 A 136 GLU B 71 GLU~? 7.93 MN MN B 606 A 246 GLU B 68 GLU~? 12.41 MN MN B 606 coo 13.94 29.84 106.80 11.67 30.40 108.79 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 9.52 31.97 115.23 8.45 33.74 114.72 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 11.92 33.82 109.35 10.10 33.50 110.39 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 8 3 # 8 A 45 ARG B 166 ARG~? 12.22 S2 BME B 602 A 136 GLU B 71 GLU~? 7.93 MN MN B 606 A 246 GLU B 72 GLU~? 13.02 MN MN B 606 coo 13.94 29.84 106.80 11.67 30.40 108.79 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 9.52 31.97 115.23 8.45 33.74 114.72 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 11.92 33.82 109.35 10.10 33.50 110.39 -22.12 78.07 6.79 -23.41 76.46 7.29 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 8 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 71 GLU~? 7.91 MN MN A 605 B 319 ASP A 69 ASP~? 7.42 O1 BME A 601 B 359 ARG A 167 ARG~? -4.94 O1 BME A 601s coo 10.77 13.13 40.94 11.03 14.73 39.51 4.56 57.67 23.22 2.91 58.15 24.47 coo 3.77 12.64 38.21 3.35 14.53 37.39 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.16 15.32 35.60 -3.32 13.56 36.98 6.75 43.81 21.29 6.50 46.65 20.31 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 72 GLU~? 12.86 MN MN A 605 B 319 ASP A 69 ASP~? 7.42 O1 BME A 601 B 359 ARG A 167 ARG~? -4.94 O1 BME A 601s coo 10.77 13.13 40.94 11.03 14.73 39.51 8.16 54.29 26.80 8.10 55.96 28.07 coo 3.77 12.64 38.21 3.35 14.53 37.39 7.88 51.22 19.98 7.64 49.14 20.25 coo -1.16 15.32 35.60 -3.32 13.56 36.98 6.75 43.81 21.29 6.50 46.65 20.31 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 319 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 359 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 10.77 13.13 40.94 11.03 14.73 39.51 7.70 72.78 18.03 7.03 72.92 20.00 coo 3.77 12.64 38.21 3.35 14.53 37.39 1.27 73.42 12.01 2.60 75.02 12.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 319 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 359 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 10.77 13.13 40.94 11.03 14.73 39.51 0.70 67.61 16.19 -1.02 68.27 17.25 coo 3.77 12.64 38.21 3.35 14.53 37.39 1.27 73.42 12.01 2.60 75.02 12.38 coo -1.16 15.32 35.60 -3.32 13.56 36.98 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 5 3 # 5 B 317 GLU B 71 GLU~? 7.93 MN MN B 606 B 319 ASP B 69 ASP~? 7.66 S2 BME B 602 B 359 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 10.77 13.13 40.94 11.03 14.73 39.51 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 3.77 12.64 38.21 3.35 14.53 37.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -16.44 88.73 6.31 -15.58 85.88 6.16 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 6 3 # 6 B 317 GLU B 72 GLU~? 13.02 MN MN B 606 B 319 ASP B 69 ASP~? 7.66 S2 BME B 602 B 359 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 10.77 13.13 40.94 11.03 14.73 39.51 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 3.77 12.64 38.21 3.35 14.53 37.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -1.16 15.32 35.60 -3.32 13.56 36.98 -16.44 88.73 6.31 -15.58 85.88 6.16 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 6 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 24 LYS~? 4.08 C2 BME A 601 A 331 GLU A 70 GLU~? -2.54 MN MN A 604s B 188 HIS A 66 HIS~? 3.42 MN MN A 604s coo 130.22 155.23 83.49 125.21 153.71 84.04 -0.91 46.54 9.97 2.66 42.32 12.44 coo 120.90 152.23 75.28 120.94 153.09 77.19 6.20 55.25 17.70 4.45 55.72 16.64 coo 122.04 152.80 81.06 120.71 154.37 81.46 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS A 24 LYS~? 4.08 C2 BME A 601 A 331 GLU A 140 GLU~? -2.42 MN MN A 605s B 188 HIS A 22 HIS~? -3.40 MN MN A 604s coo 130.22 155.23 83.49 125.21 153.71 84.04 -0.91 46.54 9.97 2.66 42.32 12.44 coo 120.90 152.23 75.28 120.94 153.09 77.19 5.06 58.75 13.41 3.74 57.63 14.59 coo 122.04 152.80 81.06 120.71 154.37 81.46 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1fuq_c00 FUMARASE C user 3 3 # 3 A 324 LYS A 24 LYS~? 4.08 C2 BME A 601 A 331 GLU A 141 GLU~? 7.70 MN MN A 604 B 188 HIS A 22 HIS~? -3.40 MN MN A 604s coo 130.22 155.23 83.49 125.21 153.71 84.04 -0.91 46.54 9.97 2.66 42.32 12.44 coo 120.90 152.23 75.28 120.94 153.09 77.19 4.84 56.74 8.27 3.91 55.44 6.87 coo 122.04 152.80 81.06 120.71 154.37 81.46 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1fuq_c00 FUMARASE C user 4 3 # 4 A 324 LYS B 24 LYS~? -3.00 C2 BME B 602s A 331 GLU B 70 GLU~? -2.57 MN MN B 607s B 188 HIS B 66 HIS~? 3.43 MN MN B 607s coo 130.22 155.23 83.49 125.21 153.71 84.04 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 120.90 152.23 75.28 120.94 153.09 77.19 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 122.04 152.80 81.06 120.71 154.37 81.46 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1fuq_c00 FUMARASE C user 5 3 # 5 A 324 LYS B 24 LYS~? -3.00 C2 BME B 602s A 331 GLU B 140 GLU~? -2.41 MN MN B 606s B 188 HIS B 22 HIS~? -3.40 MN MN B 607s coo 130.22 155.23 83.49 125.21 153.71 84.04 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 120.90 152.23 75.28 120.94 153.09 77.19 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 122.04 152.80 81.06 120.71 154.37 81.46 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1fuq_c00 FUMARASE C user 6 3 # 6 A 324 LYS B 24 LYS~? -3.00 C2 BME B 602s A 331 GLU B 141 GLU~? 7.71 MN MN B 607 B 188 HIS B 22 HIS~? -3.40 MN MN B 607s coo 130.22 155.23 83.49 125.21 153.71 84.04 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 120.90 152.23 75.28 120.94 153.09 77.19 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 122.04 152.80 81.06 120.71 154.37 81.46 -5.34 79.70 5.35 -6.67 78.07 5.35 1fuq_c00 source 1fuq FUMARASE C : 6 hits 1fuq_c00 naa= 3 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 1 3 # 1 A 197 ARG A 26 ARG~? 9.60 MN MN A 604 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 66 HIS~? 3.42 MN MN A 604s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.35 54.22 20.29 -1.10 54.30 18.77 coo -15.44 20.23 39.72 -16.43 18.87 38.47 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 2 3 # 2 A 197 ARG A 27 ARG~? 11.42 S2 BME A 601 A 201 HIS A 66 HIS~? 3.42 MN MN A 604s A 204 HIS A 22 HIS~? -3.40 MN MN A 604s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -15.08 14.90 41.58 -16.70 13.64 42.02 3.21 51.23 16.81 3.87 52.43 15.22 coo -15.44 20.23 39.72 -16.43 18.87 38.47 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 3 3 # 3 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -0.58 68.78 21.39 1.97 70.41 20.81 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.35 54.22 20.29 -1.10 54.30 18.77 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 4 3 # 4 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -0.58 68.78 21.39 1.97 70.41 20.81 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.35 54.22 20.29 -1.10 54.30 18.77 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 5 3 # 5 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -0.58 68.78 21.39 1.97 70.41 20.81 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 6 3 # 6 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.59 58.54 20.35 2.20 57.89 19.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 7 3 # 7 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 136 HIS~? 3.48 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.59 58.54 20.35 2.20 57.89 19.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 8 3 # 8 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 9 3 # 9 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS B 136 HIS~? 3.50 MN MN B 606s A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 10 3 # 10 A 197 ARG A 166 ARG~? 11.02 O1 BME A 601 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -27.47 20.45 37.96 -26.70 17.86 36.51 6.93 48.25 24.41 9.45 50.10 24.73 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.59 58.54 20.35 2.20 57.89 19.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 11 3 # 11 A 197 ARG A 166 ARG~? 11.02 O1 BME A 601 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 6.93 48.25 24.41 9.45 50.10 24.73 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 12 3 # 12 A 197 ARG A 167 ARG~? -4.94 O1 BME A 601s A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 67 HIS~? -4.40 CL CL A 608s coo -27.47 20.45 37.96 -26.70 17.86 36.51 6.75 43.81 21.29 6.50 46.65 20.31 coo -15.08 14.90 41.58 -16.70 13.64 42.02 0.59 58.54 20.35 2.20 57.89 19.15 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 13 3 # 13 A 197 ARG B 26 ARG~? 8.42 O2 GOL B 603 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 66 HIS~? 3.43 MN MN B 607s coo -27.47 20.45 37.96 -26.70 17.86 36.51 1.24 79.80 7.27 0.69 76.71 7.21 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 14 3 # 14 A 197 ARG B 27 ARG~? 11.60 C2 BME B 602 A 201 HIS B 66 HIS~? 3.43 MN MN B 607s A 204 HIS B 22 HIS~? -3.40 MN MN B 607s coo -27.47 20.45 37.96 -26.70 17.86 36.51 1.97 89.27 10.36 0.81 91.17 12.49 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 15 3 # 15 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 16 3 # 16 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 17 3 # 17 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 18 3 # 18 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 19 3 # 19 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS A 136 HIS~? 3.48 MN MN A 605s A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -0.57 59.60 14.33 0.78 59.36 15.93 coo -15.44 20.23 39.72 -16.43 18.87 38.47 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 20 3 # 20 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 21 3 # 21 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 136 HIS~? 3.50 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 22 3 # 22 A 197 ARG B 166 ARG~? 12.22 S2 BME B 602 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -27.47 20.45 37.96 -26.70 17.86 36.51 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 23 3 # 23 A 197 ARG B 166 ARG~? 12.22 S2 BME B 602 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1g8f_c00 SULFATE ADENYLYLTRANSFERASE user 24 3 # 24 A 197 ARG B 167 ARG~? 6.18 S2 BME B 602 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 67 HIS~? -4.45 CL CL B 609s coo -27.47 20.45 37.96 -26.70 17.86 36.51 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -15.08 14.90 41.58 -16.70 13.64 42.02 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -15.44 20.23 39.72 -16.43 18.87 38.47 -13.16 78.27 11.53 -11.33 78.28 12.55 1g8f_c00 source 1g8f SULFATE ADENYLYLTRANSFERASE : 24 hits 1g8f_c00 naa= 3 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 1 3 # 1 412 GLU A 68 GLU~? 10.93 O1 BME A 601 516 HIS A 66 HIS~? 3.42 MN MN A 604s 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.73 51.66 25.85 5.32 49.97 27.08 coo 41.59 7.83 54.15 41.16 9.87 53.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 2 3 # 2 412 GLU A 68 GLU~? 10.93 O1 BME A 601 516 HIS A 100 HIS~? 8.88 CL CL A 608 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.73 51.66 25.85 5.32 49.97 27.08 coo 41.59 7.83 54.15 41.16 9.87 53.87 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 3 3 # 3 412 GLU A 70 GLU~? -2.54 MN MN A 604s 516 HIS A 136 HIS~? 3.48 MN MN A 605s 559 HIS A 22 HIS~? -3.40 MN MN A 604s coo 49.01 14.50 52.53 46.99 14.61 52.78 6.20 55.25 17.70 4.45 55.72 16.64 coo 41.59 7.83 54.15 41.16 9.87 53.87 -0.57 59.60 14.33 0.78 59.36 15.93 coo 42.22 14.55 52.50 43.91 14.87 53.60 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 4 3 # 4 412 GLU A 70 GLU~? -2.54 MN MN A 604s 516 HIS A 136 HIS~? 3.48 MN MN A 605s 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 6.20 55.25 17.70 4.45 55.72 16.64 coo 41.59 7.83 54.15 41.16 9.87 53.87 -0.57 59.60 14.33 0.78 59.36 15.93 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 5 3 # 5 412 GLU A 70 GLU~? -2.54 MN MN A 604s 516 HIS A 136 HIS~? 3.48 MN MN A 605s 559 HIS A 96 HIS~? -3.41 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 6.20 55.25 17.70 4.45 55.72 16.64 coo 41.59 7.83 54.15 41.16 9.87 53.87 -0.57 59.60 14.33 0.78 59.36 15.93 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 6 3 # 6 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 66 HIS~? 3.42 MN MN A 604s 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 7 3 # 7 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 66 HIS~? 3.42 MN MN A 604s 559 HIS A 96 HIS~? -3.41 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 8 3 # 8 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 100 HIS~? 8.88 CL CL A 608 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 9 3 # 9 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 100 HIS~? 8.88 CL CL A 608 559 HIS A 96 HIS~? -3.41 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 10 3 # 10 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 136 HIS~? 3.48 MN MN A 605s 559 HIS A 67 HIS~? -4.40 CL CL A 608s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 -0.57 59.60 14.33 0.78 59.36 15.93 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 11 3 # 11 412 GLU A 71 GLU~? 7.91 MN MN A 605 516 HIS A 136 HIS~? 3.48 MN MN A 605s 559 HIS A 96 HIS~? -3.41 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 41.59 7.83 54.15 41.16 9.87 53.87 -0.57 59.60 14.33 0.78 59.36 15.93 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 12 3 # 12 412 GLU A 91 GLU~? 5.92 C1 GOL B 603 516 HIS A 96 HIS~? -3.41 MN MN A 605s 559 HIS A 136 HIS~? 3.48 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 0.70 67.61 16.19 -1.02 68.27 17.25 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.59 58.54 20.35 2.20 57.89 19.15 coo 42.22 14.55 52.50 43.91 14.87 53.60 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 13 3 # 13 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 66 HIS~? 3.42 MN MN A 604s 559 HIS A 22 HIS~? -3.40 MN MN A 604s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 42.22 14.55 52.50 43.91 14.87 53.60 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 14 3 # 14 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 66 HIS~? 3.42 MN MN A 604s 559 HIS A 96 HIS~? -3.41 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 3.21 51.23 16.81 3.87 52.43 15.22 coo 42.22 14.55 52.50 43.91 14.87 53.60 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 15 3 # 15 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 67 HIS~? -4.40 CL CL A 608s 559 HIS A 66 HIS~? 3.42 MN MN A 604s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.35 54.22 20.29 -1.10 54.30 18.77 coo 42.22 14.55 52.50 43.91 14.87 53.60 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 16 3 # 16 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 67 HIS~? -4.40 CL CL A 608s 559 HIS A 136 HIS~? 3.48 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.35 54.22 20.29 -1.10 54.30 18.77 coo 42.22 14.55 52.50 43.91 14.87 53.60 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 17 3 # 17 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 96 HIS~? -3.41 MN MN A 605s 559 HIS A 66 HIS~? 3.42 MN MN A 604s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.59 58.54 20.35 2.20 57.89 19.15 coo 42.22 14.55 52.50 43.91 14.87 53.60 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 18 3 # 18 412 GLU A 140 GLU~? -2.42 MN MN A 605s 516 HIS A 96 HIS~? -3.41 MN MN A 605s 559 HIS A 136 HIS~? 3.48 MN MN A 605s coo 49.01 14.50 52.53 46.99 14.61 52.78 5.06 58.75 13.41 3.74 57.63 14.59 coo 41.59 7.83 54.15 41.16 9.87 53.87 0.59 58.54 20.35 2.20 57.89 19.15 coo 42.22 14.55 52.50 43.91 14.87 53.60 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 19 3 # 19 412 GLU B 68 GLU~? 12.41 MN MN B 606 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 20 3 # 20 412 GLU B 68 GLU~? 12.41 MN MN B 606 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 21 3 # 21 412 GLU B 68 GLU~? 12.41 MN MN B 606 516 HIS B 96 HIS~? -3.43 MN MN B 606s 559 HIS B 66 HIS~? 3.43 MN MN B 607s coo 49.01 14.50 52.53 46.99 14.61 52.78 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 42.22 14.55 52.50 43.91 14.87 53.60 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 22 3 # 22 412 GLU B 68 GLU~? 12.41 MN MN B 606 516 HIS B 100 HIS~? 8.87 CL CL B 609 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 23 3 # 23 412 GLU B 68 GLU~? 12.41 MN MN B 606 516 HIS B 100 HIS~? 8.87 CL CL B 609 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 24 3 # 24 412 GLU B 70 GLU~? -2.57 MN MN B 607s 516 HIS B 136 HIS~? 3.50 MN MN B 606s 559 HIS B 22 HIS~? -3.40 MN MN B 607s coo 49.01 14.50 52.53 46.99 14.61 52.78 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 42.22 14.55 52.50 43.91 14.87 53.60 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 25 3 # 25 412 GLU B 70 GLU~? -2.57 MN MN B 607s 516 HIS B 136 HIS~? 3.50 MN MN B 606s 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 26 3 # 26 412 GLU B 70 GLU~? -2.57 MN MN B 607s 516 HIS B 136 HIS~? 3.50 MN MN B 606s 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 27 3 # 27 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 28 3 # 28 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 29 3 # 29 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 100 HIS~? 8.87 CL CL B 609 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 30 3 # 30 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 100 HIS~? 8.87 CL CL B 609 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 31 3 # 31 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 136 HIS~? 3.50 MN MN B 606s 559 HIS B 67 HIS~? -4.45 CL CL B 609s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 32 3 # 32 412 GLU B 71 GLU~? 7.93 MN MN B 606 516 HIS B 136 HIS~? 3.50 MN MN B 606s 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 41.59 7.83 54.15 41.16 9.87 53.87 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 33 3 # 33 412 GLU B 91 GLU~? 11.42 MN MN B 606 516 HIS B 96 HIS~? -3.43 MN MN B 606s 559 HIS B 136 HIS~? 3.50 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 42.22 14.55 52.50 43.91 14.87 53.60 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 34 3 # 34 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 22 HIS~? -3.40 MN MN B 607s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 35 3 # 35 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 66 HIS~? 3.43 MN MN B 607s 559 HIS B 96 HIS~? -3.43 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 42.22 14.55 52.50 43.91 14.87 53.60 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 36 3 # 36 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 67 HIS~? -4.45 CL CL B 609s 559 HIS B 66 HIS~? 3.43 MN MN B 607s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 42.22 14.55 52.50 43.91 14.87 53.60 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 37 3 # 37 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 67 HIS~? -4.45 CL CL B 609s 559 HIS B 136 HIS~? 3.50 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 42.22 14.55 52.50 43.91 14.87 53.60 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 38 3 # 38 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 96 HIS~? -3.43 MN MN B 606s 559 HIS B 66 HIS~? 3.43 MN MN B 607s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 42.22 14.55 52.50 43.91 14.87 53.60 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1gal_c00 GLUCOSE OXIDASE (E.C.1.1.3.4) user 39 3 # 39 412 GLU B 140 GLU~? -2.41 MN MN B 606s 516 HIS B 96 HIS~? -3.43 MN MN B 606s 559 HIS B 136 HIS~? 3.50 MN MN B 606s coo 49.01 14.50 52.53 46.99 14.61 52.78 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 41.59 7.83 54.15 41.16 9.87 53.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 42.22 14.55 52.50 43.91 14.87 53.60 -7.23 73.04 10.16 -9.24 73.26 9.58 1gal_c00 source 1gal GLUCOSE OXIDASE (E.C.1.1.3.4) : 39 hits 1gal_c00 naa= 3 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 A 36 GLU A 16 GLU~? 14.76 S2 BME A 601 A 47 ASP A 69 ASP~? 7.42 O1 BME A 601 A 161 TYR A 19 TYR~? 9.00 MN MN A 604 coo 37.12 18.35 73.76 37.09 16.69 72.44 13.57 48.33 8.05 14.78 46.83 7.14 coo 29.81 8.06 73.13 30.21 10.11 72.95 7.88 51.22 19.98 7.64 49.14 20.25 coo 37.29 15.56 67.90 37.37 13.79 70.08 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 A 36 GLU A 141 GLU~? 7.70 MN MN A 604 A 47 ASP A 69 ASP~? 7.42 O1 BME A 601 A 161 TYR A 19 TYR~? 9.00 MN MN A 604 coo 37.12 18.35 73.76 37.09 16.69 72.44 4.84 56.74 8.27 3.91 55.44 6.87 coo 29.81 8.06 73.13 30.21 10.11 72.95 7.88 51.22 19.98 7.64 49.14 20.25 coo 37.29 15.56 67.90 37.37 13.79 70.08 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 A 36 GLU B 16 GLU~? 10.04 C2 BME B 602 A 47 ASP B 69 ASP~? 7.66 S2 BME B 602 A 161 TYR B 19 TYR~? 9.04 MN MN B 607 coo 37.12 18.35 73.76 37.09 16.69 72.44 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo 29.81 8.06 73.13 30.21 10.11 72.95 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 37.29 15.56 67.90 37.37 13.79 70.08 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1geq_c02 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 A 36 GLU B 141 GLU~? 7.71 MN MN B 607 A 47 ASP B 69 ASP~? 7.66 S2 BME B 602 A 161 TYR B 19 TYR~? 9.04 MN MN B 607 coo 37.12 18.35 73.76 37.09 16.69 72.44 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 29.81 8.06 73.13 30.21 10.11 72.95 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 37.29 15.56 67.90 37.37 13.79 70.08 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1geq_c02 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c02 naa= 3 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 1 3 # 1 B 36 GLU A 16 GLU~? 14.76 S2 BME A 601 B 47 ASP A 69 ASP~? 7.42 O1 BME A 601 B 161 TYR A 19 TYR~? 9.00 MN MN A 604 coo 53.87 35.49 53.22 55.44 35.72 54.61 13.57 48.33 8.05 14.78 46.83 7.14 coo 63.47 43.65 53.95 61.45 43.07 54.06 7.88 51.22 19.98 7.64 49.14 20.25 coo 56.38 35.81 59.19 58.25 35.77 57.10 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 2 3 # 2 B 36 GLU A 141 GLU~? 7.70 MN MN A 604 B 47 ASP A 69 ASP~? 7.42 O1 BME A 601 B 161 TYR A 19 TYR~? 9.00 MN MN A 604 coo 53.87 35.49 53.22 55.44 35.72 54.61 4.84 56.74 8.27 3.91 55.44 6.87 coo 63.47 43.65 53.95 61.45 43.07 54.06 7.88 51.22 19.98 7.64 49.14 20.25 coo 56.38 35.81 59.19 58.25 35.77 57.10 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 3 3 # 3 B 36 GLU B 16 GLU~? 10.04 C2 BME B 602 B 47 ASP B 69 ASP~? 7.66 S2 BME B 602 B 161 TYR B 19 TYR~? 9.04 MN MN B 607 coo 53.87 35.49 53.22 55.44 35.72 54.61 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo 63.47 43.65 53.95 61.45 43.07 54.06 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 56.38 35.81 59.19 58.25 35.77 57.10 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1geq_c03 TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT user 4 3 # 4 B 36 GLU B 141 GLU~? 7.71 MN MN B 607 B 47 ASP B 69 ASP~? 7.66 S2 BME B 602 B 161 TYR B 19 TYR~? 9.04 MN MN B 607 coo 53.87 35.49 53.22 55.44 35.72 54.61 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 63.47 43.65 53.95 61.45 43.07 54.06 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 56.38 35.81 59.19 58.25 35.77 57.10 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1geq_c03 source 1geq TRYPTOPHAN SYNTHASE ALPHA-SUBUNIT : 4 hits 1geq_c03 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 101 ASP~? 14.47 MN MN A 605 A 64 HIS A 100 HIS~? 8.88 CL CL A 608 A 155 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 3.12 38.70 24.20 3.24 38.59 26.33 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 1.90 38.00 29.77 3.91 38.35 29.95 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 9.89 36.55 37.38 9.27 37.99 36.08 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP B 101 ASP~? 14.48 MN MN B 606 A 64 HIS B 100 HIS~? 8.87 CL CL B 609 A 155 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 3.12 38.70 24.20 3.24 38.59 26.33 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 1.90 38.00 29.77 3.91 38.35 29.95 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 9.89 36.55 37.38 9.27 37.99 36.08 -12.53 86.72 19.85 -11.70 86.05 21.72 1gns_c00 source 1gns SUBTILISIN BPN' : 2 hits 1gns_c00 naa= 3 ULMN 3 1gpm_c00 GMP SYNTHETASE user 1 3 # 1 A 86 CYH A 21 CYH~? -2.28 S2 BME A 601s A 181 HIS A 22 HIS~? -3.40 MN MN A 604s A 183 GLU A 140 GLU~? -2.42 MN MN A 605s coo 117.68 94.64 64.02 117.70 92.25 62.50 3.34 47.98 12.34 4.26 47.15 14.87 coo 119.92 89.03 61.19 119.18 89.32 63.12 3.18 53.06 10.64 3.66 54.63 11.95 coo 124.93 87.80 60.99 123.56 89.34 61.53 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1gpm_c00 GMP SYNTHETASE user 2 3 # 2 A 86 CYH A 21 CYH~? -2.28 S2 BME A 601s A 181 HIS A 22 HIS~? -3.40 MN MN A 604s A 183 GLU A 141 GLU~? 7.70 MN MN A 604 coo 117.68 94.64 64.02 117.70 92.25 62.50 3.34 47.98 12.34 4.26 47.15 14.87 coo 119.92 89.03 61.19 119.18 89.32 63.12 3.18 53.06 10.64 3.66 54.63 11.95 coo 124.93 87.80 60.99 123.56 89.34 61.53 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1gpm_c00 GMP SYNTHETASE user 3 3 # 3 A 86 CYH A 21 CYH~? -2.28 S2 BME A 601s A 181 HIS A 66 HIS~? 3.42 MN MN A 604s A 183 GLU A 70 GLU~? -2.54 MN MN A 604s coo 117.68 94.64 64.02 117.70 92.25 62.50 3.34 47.98 12.34 4.26 47.15 14.87 coo 119.92 89.03 61.19 119.18 89.32 63.12 3.21 51.23 16.81 3.87 52.43 15.22 coo 124.93 87.80 60.99 123.56 89.34 61.53 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1gpm_c00 GMP SYNTHETASE user 4 3 # 4 A 86 CYH B 21 CYH~? -2.10 S2 BME B 602s A 181 HIS B 22 HIS~? -3.40 MN MN B 607s A 183 GLU B 140 GLU~? -2.41 MN MN B 606s coo 117.68 94.64 64.02 117.70 92.25 62.50 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 119.92 89.03 61.19 119.18 89.32 63.12 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 124.93 87.80 60.99 123.56 89.34 61.53 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1gpm_c00 GMP SYNTHETASE user 5 3 # 5 A 86 CYH B 21 CYH~? -2.10 S2 BME B 602s A 181 HIS B 22 HIS~? -3.40 MN MN B 607s A 183 GLU B 141 GLU~? 7.71 MN MN B 607 coo 117.68 94.64 64.02 117.70 92.25 62.50 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 119.92 89.03 61.19 119.18 89.32 63.12 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 124.93 87.80 60.99 123.56 89.34 61.53 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1gpm_c00 GMP SYNTHETASE user 6 3 # 6 A 86 CYH B 21 CYH~? -2.10 S2 BME B 602s A 181 HIS B 66 HIS~? 3.43 MN MN B 607s A 183 GLU B 70 GLU~? -2.57 MN MN B 607s coo 117.68 94.64 64.02 117.70 92.25 62.50 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 119.92 89.03 61.19 119.18 89.32 63.12 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 124.93 87.80 60.99 123.56 89.34 61.53 -12.98 77.36 5.11 -11.32 76.90 6.35 1gpm_c00 source 1gpm GMP SYNTHETASE : 6 hits 1gpm_c00 naa= 3 ULMN 3 1gpm_c01 GMP SYNTHETASE user 1 3 # 1 B 86 CYH A 21 CYH~? -2.28 S2 BME A 601s B 181 HIS A 22 HIS~? -3.40 MN MN A 604s B 183 GLU A 140 GLU~? -2.42 MN MN A 605s coo 149.55 66.18 33.25 147.14 66.01 34.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 143.50 67.99 35.75 143.97 67.45 33.78 3.18 53.06 10.64 3.66 54.63 11.95 coo 142.26 72.94 36.43 143.85 71.64 35.84 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1gpm_c01 GMP SYNTHETASE user 2 3 # 2 B 86 CYH A 21 CYH~? -2.28 S2 BME A 601s B 181 HIS A 22 HIS~? -3.40 MN MN A 604s B 183 GLU A 141 GLU~? 7.70 MN MN A 604 coo 149.55 66.18 33.25 147.14 66.01 34.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 143.50 67.99 35.75 143.97 67.45 33.78 3.18 53.06 10.64 3.66 54.63 11.95 coo 142.26 72.94 36.43 143.85 71.64 35.84 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1gpm_c01 GMP SYNTHETASE user 3 3 # 3 B 86 CYH A 21 CYH~? -2.28 S2 BME A 601s B 181 HIS A 66 HIS~? 3.42 MN MN A 604s B 183 GLU A 70 GLU~? -2.54 MN MN A 604s coo 149.55 66.18 33.25 147.14 66.01 34.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 143.50 67.99 35.75 143.97 67.45 33.78 3.21 51.23 16.81 3.87 52.43 15.22 coo 142.26 72.94 36.43 143.85 71.64 35.84 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1gpm_c01 GMP SYNTHETASE user 4 3 # 4 B 86 CYH B 21 CYH~? -2.10 S2 BME B 602s B 181 HIS B 22 HIS~? -3.40 MN MN B 607s B 183 GLU B 140 GLU~? -2.41 MN MN B 606s coo 149.55 66.18 33.25 147.14 66.01 34.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 143.50 67.99 35.75 143.97 67.45 33.78 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 142.26 72.94 36.43 143.85 71.64 35.84 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1gpm_c01 GMP SYNTHETASE user 5 3 # 5 B 86 CYH B 21 CYH~? -2.10 S2 BME B 602s B 181 HIS B 22 HIS~? -3.40 MN MN B 607s B 183 GLU B 141 GLU~? 7.71 MN MN B 607 coo 149.55 66.18 33.25 147.14 66.01 34.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 143.50 67.99 35.75 143.97 67.45 33.78 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 142.26 72.94 36.43 143.85 71.64 35.84 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1gpm_c01 GMP SYNTHETASE user 6 3 # 6 B 86 CYH B 21 CYH~? -2.10 S2 BME B 602s B 181 HIS B 66 HIS~? 3.43 MN MN B 607s B 183 GLU B 70 GLU~? -2.57 MN MN B 607s coo 149.55 66.18 33.25 147.14 66.01 34.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 143.50 67.99 35.75 143.97 67.45 33.78 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 142.26 72.94 36.43 143.85 71.64 35.84 -12.98 77.36 5.11 -11.32 76.90 6.35 1gpm_c01 source 1gpm GMP SYNTHETASE : 6 hits 1gpm_c01 naa= 3 ULMN 3 1gpm_c02 GMP SYNTHETASE user 1 3 # 1 C 86 CYH A 21 CYH~? -2.28 S2 BME A 601s C 181 HIS A 22 HIS~? -3.40 MN MN A 604s C 183 GLU A 140 GLU~? -2.42 MN MN A 605s coo 109.85 19.94 37.46 109.64 22.63 37.96 3.34 47.98 12.34 4.26 47.15 14.87 coo 107.73 25.66 40.36 109.21 24.42 41.17 3.18 53.06 10.64 3.66 54.63 11.95 coo 103.49 25.96 43.17 104.66 24.74 41.89 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1gpm_c02 GMP SYNTHETASE user 2 3 # 2 C 86 CYH A 21 CYH~? -2.28 S2 BME A 601s C 181 HIS A 22 HIS~? -3.40 MN MN A 604s C 183 GLU A 141 GLU~? 7.70 MN MN A 604 coo 109.85 19.94 37.46 109.64 22.63 37.96 3.34 47.98 12.34 4.26 47.15 14.87 coo 107.73 25.66 40.36 109.21 24.42 41.17 3.18 53.06 10.64 3.66 54.63 11.95 coo 103.49 25.96 43.17 104.66 24.74 41.89 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1gpm_c02 GMP SYNTHETASE user 3 3 # 3 C 86 CYH A 21 CYH~? -2.28 S2 BME A 601s C 181 HIS A 66 HIS~? 3.42 MN MN A 604s C 183 GLU A 70 GLU~? -2.54 MN MN A 604s coo 109.85 19.94 37.46 109.64 22.63 37.96 3.34 47.98 12.34 4.26 47.15 14.87 coo 107.73 25.66 40.36 109.21 24.42 41.17 3.21 51.23 16.81 3.87 52.43 15.22 coo 103.49 25.96 43.17 104.66 24.74 41.89 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1gpm_c02 GMP SYNTHETASE user 4 3 # 4 C 86 CYH B 21 CYH~? -2.10 S2 BME B 602s C 181 HIS B 22 HIS~? -3.40 MN MN B 607s C 183 GLU B 140 GLU~? -2.41 MN MN B 606s coo 109.85 19.94 37.46 109.64 22.63 37.96 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 107.73 25.66 40.36 109.21 24.42 41.17 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 103.49 25.96 43.17 104.66 24.74 41.89 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1gpm_c02 GMP SYNTHETASE user 5 3 # 5 C 86 CYH B 21 CYH~? -2.10 S2 BME B 602s C 181 HIS B 22 HIS~? -3.40 MN MN B 607s C 183 GLU B 141 GLU~? 7.71 MN MN B 607 coo 109.85 19.94 37.46 109.64 22.63 37.96 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 107.73 25.66 40.36 109.21 24.42 41.17 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 103.49 25.96 43.17 104.66 24.74 41.89 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1gpm_c02 GMP SYNTHETASE user 6 3 # 6 C 86 CYH B 21 CYH~? -2.10 S2 BME B 602s C 181 HIS B 66 HIS~? 3.43 MN MN B 607s C 183 GLU B 70 GLU~? -2.57 MN MN B 607s coo 109.85 19.94 37.46 109.64 22.63 37.96 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 107.73 25.66 40.36 109.21 24.42 41.17 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 103.49 25.96 43.17 104.66 24.74 41.89 -12.98 77.36 5.11 -11.32 76.90 6.35 1gpm_c02 source 1gpm GMP SYNTHETASE : 6 hits 1gpm_c02 naa= 3 ULMN 3 1gpm_c03 GMP SYNTHETASE user 1 3 # 1 D 86 CYH A 21 CYH~? -2.28 S2 BME A 601s D 181 HIS A 22 HIS~? -3.40 MN MN A 604s D 183 GLU A 140 GLU~? -2.42 MN MN A 605s coo 76.48 57.73 51.96 79.16 57.24 51.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 82.26 55.06 49.56 81.33 56.85 48.97 3.18 53.06 10.64 3.66 54.63 11.95 coo 82.18 51.18 46.15 80.95 52.38 47.40 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1gpm_c03 GMP SYNTHETASE user 2 3 # 2 D 86 CYH A 21 CYH~? -2.28 S2 BME A 601s D 181 HIS A 22 HIS~? -3.40 MN MN A 604s D 183 GLU A 141 GLU~? 7.70 MN MN A 604 coo 76.48 57.73 51.96 79.16 57.24 51.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 82.26 55.06 49.56 81.33 56.85 48.97 3.18 53.06 10.64 3.66 54.63 11.95 coo 82.18 51.18 46.15 80.95 52.38 47.40 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1gpm_c03 GMP SYNTHETASE user 3 3 # 3 D 86 CYH A 21 CYH~? -2.28 S2 BME A 601s D 181 HIS A 66 HIS~? 3.42 MN MN A 604s D 183 GLU A 70 GLU~? -2.54 MN MN A 604s coo 76.48 57.73 51.96 79.16 57.24 51.49 3.34 47.98 12.34 4.26 47.15 14.87 coo 82.26 55.06 49.56 81.33 56.85 48.97 3.21 51.23 16.81 3.87 52.43 15.22 coo 82.18 51.18 46.15 80.95 52.38 47.40 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1gpm_c03 GMP SYNTHETASE user 4 3 # 4 D 86 CYH B 21 CYH~? -2.10 S2 BME B 602s D 181 HIS B 22 HIS~? -3.40 MN MN B 607s D 183 GLU B 140 GLU~? -2.41 MN MN B 606s coo 76.48 57.73 51.96 79.16 57.24 51.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 82.26 55.06 49.56 81.33 56.85 48.97 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 82.18 51.18 46.15 80.95 52.38 47.40 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1gpm_c03 GMP SYNTHETASE user 5 3 # 5 D 86 CYH B 21 CYH~? -2.10 S2 BME B 602s D 181 HIS B 22 HIS~? -3.40 MN MN B 607s D 183 GLU B 141 GLU~? 7.71 MN MN B 607 coo 76.48 57.73 51.96 79.16 57.24 51.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 82.26 55.06 49.56 81.33 56.85 48.97 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 82.18 51.18 46.15 80.95 52.38 47.40 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1gpm_c03 GMP SYNTHETASE user 6 3 # 6 D 86 CYH B 21 CYH~? -2.10 S2 BME B 602s D 181 HIS B 66 HIS~? 3.43 MN MN B 607s D 183 GLU B 70 GLU~? -2.57 MN MN B 607s coo 76.48 57.73 51.96 79.16 57.24 51.49 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 82.26 55.06 49.56 81.33 56.85 48.97 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 82.18 51.18 46.15 80.95 52.38 47.40 -12.98 77.36 5.11 -11.32 76.90 6.35 1gpm_c03 source 1gpm GMP SYNTHETASE : 6 hits 1gpm_c03 naa= 3 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 1 3 # 1 A 106 ASN A 102 ASN~? 12.24 CL CL A 608 A 108 HIS A 100 HIS~? 8.88 CL CL A 608 A 144 ASP A 101 ASP~? 14.47 MN MN A 605 coo 51.28 61.14 17.85 51.16 61.61 19.96 -10.29 57.70 17.47 -10.13 59.75 17.06 coo 52.62 57.63 23.12 50.77 57.51 22.26 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 46.65 56.95 20.09 48.42 58.17 20.01 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1grc_c02 GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMuser 2 3 # 2 A 106 ASN B 102 ASN~? 10.95 O1 GOL B 603 A 108 HIS B 100 HIS~? 8.87 CL CL B 609 A 144 ASP B 101 ASP~? 14.48 MN MN B 606 coo 51.28 61.14 17.85 51.16 61.61 19.96 -6.42 74.86 20.35 -6.05 72.80 20.02 coo 52.62 57.63 23.12 50.77 57.51 22.26 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 46.65 56.95 20.09 48.42 58.17 20.01 -10.99 72.82 22.17 -12.93 72.02 22.11 1grc_c02 source 1grc GLYCINAMIDE RIBONUCLEOTIDE TRANSFORMYLASE (E.C: 2 hits 1grc_c02 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 155 LYS~? 22.50 MN MN A 604 210 ARG A 166 ARG~? 11.02 O1 BME A 601 225 ARG A 167 ARG~? -4.94 O1 BME A 601s coo 17.51 28.50 73.42 17.24 23.02 75.86 21.85 53.55 18.73 24.16 56.83 22.72 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.93 48.25 24.41 9.45 50.10 24.73 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.75 43.81 21.29 6.50 46.65 20.31 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 155 LYS~? 22.50 MN MN A 604 210 ARG A 167 ARG~? -4.94 O1 BME A 601s 225 ARG A 166 ARG~? 11.02 O1 BME A 601 coo 17.51 28.50 73.42 17.24 23.02 75.86 21.85 53.55 18.73 24.16 56.83 22.72 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.75 43.81 21.29 6.50 46.65 20.31 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 155 LYS~? 22.59 MN MN B 607 210 ARG B 166 ARG~? 12.22 S2 BME B 602 225 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 17.51 28.50 73.42 17.24 23.02 75.86 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 27.81 15.44 77.10 25.66 16.50 75.19 -16.44 88.73 6.31 -15.58 85.88 6.16 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 155 LYS~? 22.59 MN MN B 607 210 ARG B 167 ARG~? 6.18 S2 BME B 602 225 ARG B 166 ARG~? 12.22 S2 BME B 602 coo 17.51 28.50 73.42 17.24 23.02 75.86 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 27.81 15.44 77.10 25.66 16.50 75.19 -19.40 84.27 7.18 -20.75 82.43 4.97 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS B 155 LYS~? 22.59 MN MN B 607 210 ARG B 168 ARG.? 14.32 O1 BME B 602 225 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 17.51 28.50 73.42 17.24 23.02 75.86 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 24.74 11.56 73.05 25.29 14.32 71.80 -21.58 94.57 3.17 -23.33 92.58 1.57 coo 27.81 15.44 77.10 25.66 16.50 75.19 -16.44 88.73 6.31 -15.58 85.88 6.16 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 5 hits 1gsa_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 11 PHE.? 7.28 O1 BME A 601 A 298 ASP A 69 ASP~? 7.42 O1 BME A 601 A 329 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 11.74 44.01 17.67 8.98 44.14 18.15 coo 2.59 0.29 25.55 4.65 0.18 25.07 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.42 6.10 23.27 9.95 1.57 20.16 5.93 41.39 29.05 1.02 39.99 32.86 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 11 PHE.? 7.28 O1 BME A 601 B 298 ASP A 69 ASP~? 7.42 O1 BME A 601 B 329 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 11.74 44.01 17.67 8.98 44.14 18.15 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 7.88 51.22 19.98 7.64 49.14 20.25 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 5.93 41.39 29.05 1.02 39.99 32.86 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 11 PHE.? 7.28 O1 BME A 601 C 298 ASP A 69 ASP~? 7.42 O1 BME A 601 C 329 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 17.41 60.57 64.39 18.40 58.12 65.34 11.74 44.01 17.67 8.98 44.14 18.15 coo 24.10 66.43 63.33 24.18 64.30 63.40 7.88 51.22 19.98 7.64 49.14 20.25 coo 27.64 56.61 58.17 22.18 57.92 60.36 5.93 41.39 29.05 1.02 39.99 32.86 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 11 PHE.? 7.28 O1 BME A 601 D 298 ASP A 69 ASP~? 7.42 O1 BME A 601 D 329 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 35.44 53.35 83.81 35.65 54.53 81.28 11.74 44.01 17.67 8.98 44.14 18.15 coo 29.72 46.46 83.60 30.79 47.36 81.99 7.88 51.22 19.98 7.64 49.14 20.25 coo 36.89 44.91 74.55 37.33 48.94 79.01 5.93 41.39 29.05 1.02 39.99 32.86 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 1 hits 1gtx_c03 naa= 3 ULMN 3 1hrk_c00 FERROCHELATASE user 1 3 # 1 A 263 HIS A 22 HIS~? -3.40 MN MN A 604s A 341 HIS A 136 HIS~? 3.48 MN MN A 605s A 343 GLU A 140 GLU~? -2.42 MN MN A 605s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 3.18 53.06 10.64 3.66 54.63 11.95 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -0.57 59.60 14.33 0.78 59.36 15.93 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1hrk_c00 FERROCHELATASE user 2 3 # 2 A 263 HIS A 96 HIS~? -3.41 MN MN A 605s A 341 HIS A 66 HIS~? 3.42 MN MN A 604s A 343 GLU A 70 GLU~? -2.54 MN MN A 604s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 0.59 58.54 20.35 2.20 57.89 19.15 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 3.21 51.23 16.81 3.87 52.43 15.22 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1hrk_c00 FERROCHELATASE user 3 3 # 3 A 263 HIS A 136 HIS~? 3.48 MN MN A 605s A 341 HIS A 22 HIS~? -3.40 MN MN A 604s A 343 GLU A 140 GLU~? -2.42 MN MN A 605s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -0.57 59.60 14.33 0.78 59.36 15.93 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 3.18 53.06 10.64 3.66 54.63 11.95 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1hrk_c00 FERROCHELATASE user 4 3 # 4 A 263 HIS B 22 HIS~? -3.40 MN MN B 607s A 341 HIS B 136 HIS~? 3.50 MN MN B 606s A 343 GLU B 140 GLU~? -2.41 MN MN B 606s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1hrk_c00 FERROCHELATASE user 5 3 # 5 A 263 HIS B 96 HIS~? -3.43 MN MN B 606s A 341 HIS B 66 HIS~? 3.43 MN MN B 607s A 343 GLU B 70 GLU~? -2.57 MN MN B 607s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1hrk_c00 FERROCHELATASE user 6 3 # 6 A 263 HIS B 136 HIS~? 3.50 MN MN B 606s A 341 HIS B 22 HIS~? -3.40 MN MN B 607s A 343 GLU B 140 GLU~? -2.41 MN MN B 606s coo -7.51 11.15 -5.64 -7.46 12.01 -7.55 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -13.42 15.96 -0.70 -12.26 14.22 -0.51 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -12.27 12.54 -3.93 -10.42 12.14 -2.95 -8.44 74.11 4.59 -9.08 75.11 6.26 1hrk_c00 source 1hrk FERROCHELATASE : 6 hits 1hrk_c00 naa= 3 ULMN 3 1hrk_c01 FERROCHELATASE user 1 3 # 1 B 263 HIS A 22 HIS~? -3.40 MN MN A 604s B 341 HIS A 136 HIS~? 3.48 MN MN A 605s B 343 GLU A 140 GLU~? -2.42 MN MN A 605s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 3.18 53.06 10.64 3.66 54.63 11.95 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -0.57 59.60 14.33 0.78 59.36 15.93 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1hrk_c01 FERROCHELATASE user 2 3 # 2 B 263 HIS A 96 HIS~? -3.41 MN MN A 605s B 341 HIS A 66 HIS~? 3.42 MN MN A 604s B 343 GLU A 70 GLU~? -2.54 MN MN A 604s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 0.59 58.54 20.35 2.20 57.89 19.15 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 3.21 51.23 16.81 3.87 52.43 15.22 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1hrk_c01 FERROCHELATASE user 3 3 # 3 B 263 HIS A 136 HIS~? 3.48 MN MN A 605s B 341 HIS A 22 HIS~? -3.40 MN MN A 604s B 343 GLU A 140 GLU~? -2.42 MN MN A 605s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -0.57 59.60 14.33 0.78 59.36 15.93 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 3.18 53.06 10.64 3.66 54.63 11.95 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1hrk_c01 FERROCHELATASE user 4 3 # 4 B 263 HIS B 22 HIS~? -3.40 MN MN B 607s B 341 HIS B 136 HIS~? 3.50 MN MN B 606s B 343 GLU B 140 GLU~? -2.41 MN MN B 606s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1hrk_c01 FERROCHELATASE user 5 3 # 5 B 263 HIS B 96 HIS~? -3.43 MN MN B 606s B 341 HIS B 66 HIS~? 3.43 MN MN B 607s B 343 GLU B 70 GLU~? -2.57 MN MN B 607s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1hrk_c01 FERROCHELATASE user 6 3 # 6 B 263 HIS B 136 HIS~? 3.50 MN MN B 606s B 341 HIS B 22 HIS~? -3.40 MN MN B 607s B 343 GLU B 140 GLU~? -2.41 MN MN B 606s coo 9.02 -11.22 -5.68 8.99 -12.08 -7.60 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 15.00 -16.00 -0.85 13.84 -14.26 -0.68 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 13.74 -12.51 -4.08 11.92 -12.19 -3.04 -8.44 74.11 4.59 -9.08 75.11 6.26 1hrk_c01 source 1hrk FERROCHELATASE : 6 hits 1hrk_c01 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 68 GLU~? 10.93 O1 BME A 601 A 475 GLU A 72 GLU~? 12.86 MN MN A 605 A 477 ARG A 166 ARG~? 11.02 O1 BME A 601 coo 13.27 46.15 59.96 13.96 44.19 59.76 5.73 51.66 25.85 5.32 49.97 27.08 coo 9.69 44.01 59.12 10.58 42.11 58.89 8.16 54.29 26.80 8.10 55.96 28.07 coo 13.49 45.17 55.56 13.84 42.22 54.75 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 2 3 # 2 A 311 GLU B 68 GLU~? 12.41 MN MN B 606 A 475 GLU B 72 GLU~? 13.02 MN MN B 606 A 477 ARG B 166 ARG~? 12.22 S2 BME B 602 coo 13.27 46.15 59.96 13.96 44.19 59.76 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 9.69 44.01 59.12 10.58 42.11 58.89 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 13.49 45.17 55.56 13.84 42.22 54.75 -19.40 84.27 7.18 -20.75 82.43 4.97 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 2 hits 1i19_c00 naa= 3 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 1 3 # 1 B 311 GLU A 68 GLU~? 10.93 O1 BME A 601 B 475 GLU A 72 GLU~? 12.86 MN MN A 605 B 477 ARG A 166 ARG~? 11.02 O1 BME A 601 coo 42.69 29.93 84.57 42.00 28.96 82.83 5.73 51.66 25.85 5.32 49.97 27.08 coo 46.14 28.45 82.89 45.10 27.86 81.15 8.16 54.29 26.80 8.10 55.96 28.07 coo 42.47 25.53 85.29 42.25 23.66 82.85 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1i19_c01 CHOLESTEROL OXIDASE user 2 3 # 2 B 311 GLU B 68 GLU~? 12.41 MN MN B 606 B 475 GLU B 72 GLU~? 13.02 MN MN B 606 B 477 ARG B 166 ARG~? 12.22 S2 BME B 602 coo 42.69 29.93 84.57 42.00 28.96 82.83 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 46.14 28.45 82.89 45.10 27.86 81.15 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 42.47 25.53 85.29 42.25 23.66 82.85 -19.40 84.27 7.18 -20.75 82.43 4.97 1i19_c01 source 1i19 CHOLESTEROL OXIDASE : 2 hits 1i19_c01 naa= 3 ULMN 3 1i29_c01 CSDB user 1 3 # 1 A 123 HIS A 67 HIS~? -4.40 CL CL A 608s A 200 ASP A 69 ASP~? 7.42 O1 BME A 601 A 226 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 23.24 46.58 4.39 24.43 46.59 2.66 0.35 54.22 20.29 -1.10 54.30 18.77 coo 24.51 43.28 11.18 25.17 44.50 9.58 7.88 51.22 19.98 7.64 49.14 20.25 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1i29_c01 CSDB user 2 3 # 2 A 123 HIS A 136 HIS~? 3.48 MN MN A 605s A 200 ASP A 134 ASP~? 12.23 CL CL A 608 A 226 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 23.24 46.58 4.39 24.43 46.59 2.66 -0.57 59.60 14.33 0.78 59.36 15.93 coo 24.51 43.28 11.18 25.17 44.50 9.58 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1i29_c01 CSDB user 3 3 # 3 A 123 HIS B 67 HIS~? -4.45 CL CL B 609s A 200 ASP B 69 ASP~? 7.66 S2 BME B 602 A 226 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 23.24 46.58 4.39 24.43 46.59 2.66 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1i29_c01 CSDB user 4 3 # 4 A 123 HIS B 136 HIS~? 3.50 MN MN B 606s A 200 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 226 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 23.24 46.58 4.39 24.43 46.59 2.66 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 24.51 43.28 11.18 25.17 44.50 9.58 1.27 73.42 12.01 2.60 75.02 12.38 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.23 86.22 8.94 -7.29 90.78 7.55 1i29_c01 source 1i29 CSDB : 4 hits 1i29_c01 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 25 VAL~? 7.08 CL CL A 608 A 200 ASP A 69 ASP~? 7.42 O1 BME A 601 A 226 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -2.56 49.80 11.08 -1.99 51.53 12.27 coo 24.51 43.28 11.18 25.17 44.50 9.58 7.88 51.22 19.98 7.64 49.14 20.25 coo 34.47 51.09 7.19 28.58 51.18 7.53 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 89 VAL~? 8.68 C3 GOL B 603 A 200 ASP A 69 ASP~? 7.42 O1 BME A 601 A 226 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 7.06 64.88 18.21 8.73 63.81 19.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 7.88 51.22 19.98 7.64 49.14 20.25 coo 34.47 51.09 7.19 28.58 51.18 7.53 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 89 VAL~? 8.68 C3 GOL B 603 A 200 ASP A 145 ASP~? 14.76 MN MN A 604 A 226 LYS A 153 LYS~? 20.22 C2 BME A 601 coo 19.13 38.05 1.41 19.72 38.80 -0.53 7.06 64.88 18.21 8.73 63.81 19.10 coo 24.51 43.28 11.18 25.17 44.50 9.58 12.32 59.45 6.26 13.32 58.94 4.48 coo 34.47 51.09 7.19 28.58 51.18 7.53 23.06 52.60 13.46 22.53 47.10 11.88 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL B 25 VAL~? 7.14 CL CL B 609 A 200 ASP B 69 ASP~? 7.66 S2 BME B 602 A 226 LYS B 169 LYS.? 16.77 C1 BME B 602 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -3.49 82.90 10.78 -4.85 81.17 10.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 -23.52 91.35 9.46 -25.45 91.49 15.04 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL B 89 VAL~? 9.02 MN MN B 606 A 200 ASP B 69 ASP~? 7.66 S2 BME B 602 A 226 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.47 67.92 4.34 -14.99 68.90 3.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 34.47 51.09 7.19 28.58 51.18 7.53 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL B 89 VAL~? 9.02 MN MN B 606 A 200 ASP B 145 ASP~? 15.01 MN MN B 607 A 226 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -13.47 67.92 4.34 -14.99 68.90 3.08 coo 24.51 43.28 11.18 25.17 44.50 9.58 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 -15.29 80.48 -11.91 -17.46 85.09 -12.54 1i29_c03 source 1i29 CSDB : 6 hits 1i29_c03 naa= 3 ULMN 3 1i7q_c03 TRPG user 1 3 # 1 D 85 CYH A 21 CYH~? -2.28 S2 BME A 601s D 172 HIS A 22 HIS~? -3.40 MN MN A 604s D 174 GLU A 140 GLU~? -2.42 MN MN A 605s coo 38.44 -29.79 42.52 39.97 -28.79 40.39 3.34 47.98 12.34 4.26 47.15 14.87 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 3.18 53.06 10.64 3.66 54.63 11.95 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1i7q_c03 TRPG user 2 3 # 2 D 85 CYH A 21 CYH~? -2.28 S2 BME A 601s D 172 HIS A 22 HIS~? -3.40 MN MN A 604s D 174 GLU A 141 GLU~? 7.70 MN MN A 604 coo 38.44 -29.79 42.52 39.97 -28.79 40.39 3.34 47.98 12.34 4.26 47.15 14.87 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 3.18 53.06 10.64 3.66 54.63 11.95 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1i7q_c03 TRPG user 3 3 # 3 D 85 CYH A 21 CYH~? -2.28 S2 BME A 601s D 172 HIS A 66 HIS~? 3.42 MN MN A 604s D 174 GLU A 70 GLU~? -2.54 MN MN A 604s coo 38.44 -29.79 42.52 39.97 -28.79 40.39 3.34 47.98 12.34 4.26 47.15 14.87 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 3.21 51.23 16.81 3.87 52.43 15.22 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1i7q_c03 TRPG user 4 3 # 4 D 85 CYH B 21 CYH~? -2.10 S2 BME B 602s D 172 HIS B 22 HIS~? -3.40 MN MN B 607s D 174 GLU B 140 GLU~? -2.41 MN MN B 606s coo 38.44 -29.79 42.52 39.97 -28.79 40.39 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1i7q_c03 TRPG user 5 3 # 5 D 85 CYH B 21 CYH~? -2.10 S2 BME B 602s D 172 HIS B 22 HIS~? -3.40 MN MN B 607s D 174 GLU B 141 GLU~? 7.71 MN MN B 607 coo 38.44 -29.79 42.52 39.97 -28.79 40.39 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1i7q_c03 TRPG user 6 3 # 6 D 85 CYH B 21 CYH~? -2.10 S2 BME B 602s D 172 HIS B 66 HIS~? 3.43 MN MN B 607s D 174 GLU B 70 GLU~? -2.57 MN MN B 607s coo 38.44 -29.79 42.52 39.97 -28.79 40.39 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 37.08 -24.45 39.81 38.95 -25.31 40.23 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 35.57 -20.34 43.24 35.94 -22.32 42.53 -12.98 77.36 5.11 -11.32 76.90 6.35 1i7q_c03 source 1i7q TRPG : 6 hits 1i7q_c03 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 153 LYS~? 20.22 C2 BME A 601 B 74 LYS A 155 LYS~? 22.50 MN MN A 604 B 165 GLU A 70 GLU~? -2.54 MN MN A 604s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 23.06 52.60 13.46 22.53 47.10 11.88 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 21.85 53.55 18.73 24.16 56.83 22.72 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS B 153 LYS~? 21.64 S2 BME B 602 B 74 LYS B 155 LYS~? 22.59 MN MN B 607 B 165 GLU B 70 GLU~? -2.57 MN MN B 607s coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 -12.98 77.36 5.11 -11.32 76.90 6.35 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 2 hits 1idt_c01 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 101 ASP~? 14.47 MN MN A 605 A1134 ALA A 104 ALA~? 15.83 CL CL A 608 A1137 ASN A 102 ASN~? 12.24 CL CL A 608 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -12.51 53.62 22.46 -12.36 54.50 23.69 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP A 101 ASP~? 14.47 MN MN A 605 A1134 ALA A 105 ALA~? 17.22 CL CL A 608 A1137 ASN A 102 ASN~? 12.24 CL CL A 608 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -15.38 54.89 20.37 -15.49 56.26 19.70 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 3 3 # 3 A1132 ASP A 116 ASP~? 31.90 C1 BME A 601 A1134 ALA A 118 ALA.? 33.13 C1 BME A 601 A1137 ASN A 117 ASN.? 27.48 C1 BME A 601 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -27.84 44.25 19.33 -29.63 44.62 18.19 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -29.25 44.12 14.08 -30.74 43.87 14.44 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -26.22 40.51 14.77 -24.81 39.30 15.85 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 4 3 # 4 A1132 ASP B 101 ASP~? 14.48 MN MN B 606 A1134 ALA B 104 ALA~? 15.71 CL CL B 609 A1137 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -10.27 78.94 24.18 -11.44 78.04 24.53 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 5 3 # 5 A1132 ASP B 101 ASP~? 14.48 MN MN B 606 A1134 ALA B 105 ALA~? 15.84 O1 GOL B 603 A1137 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -20.53 36.39 15.81 -20.80 35.01 16.40 -7.22 77.82 26.19 -6.45 76.51 26.05 coo -23.72 34.69 12.49 -24.32 32.83 13.34 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 6 3 # 6 A1132 ASP B 116 ASP~? 29.02 O1 GOL B 603 A1134 ALA B 118 ALA.? 29.04 O1 GOL B 603 A1137 ASN B 117 ASN.? 27.09 C1 BME B 602 coo -27.05 34.58 17.12 -25.81 32.84 17.16 -2.03 88.79 36.93 -0.39 88.32 38.14 coo -20.53 36.39 15.81 -20.80 35.01 16.40 3.48 88.84 36.39 3.65 89.07 37.92 coo -23.72 34.69 12.49 -24.32 32.83 13.34 1.79 92.43 33.70 0.32 93.69 32.69 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 6 hits 1ir3_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 69 ASP~? 7.42 O1 BME A 601 A 204 GLU A 70 GLU~? -2.54 MN MN A 604s A 279 TYR A 19 TYR~? 9.00 MN MN A 604 coo 5.85 5.60 30.32 5.00 7.49 29.88 7.88 51.22 19.98 7.64 49.14 20.25 coo 7.79 1.83 27.81 9.08 3.25 26.92 6.20 55.25 17.70 4.45 55.72 16.64 coo 8.22 7.77 18.64 7.58 8.47 21.28 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP B 69 ASP~? 7.66 S2 BME B 602 A 204 GLU B 70 GLU~? -2.57 MN MN B 607s A 279 TYR B 19 TYR~? 9.04 MN MN B 607 coo 5.85 5.60 30.32 5.00 7.49 29.88 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 7.79 1.83 27.81 9.08 3.25 26.92 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 8.22 7.77 18.64 7.58 8.47 21.28 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 2 hits 1itx_c00 naa= 3 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 1 3 # 1 A 14 GLU A 68 GLU~? 10.93 O1 BME A 601 A 61 GLU A 140 GLU~? -2.42 MN MN A 605s A 162 HIS A 67 HIS~? -4.40 CL CL A 608s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.73 51.66 25.85 5.32 49.97 27.08 coo -4.89 20.85 5.22 -3.95 21.69 6.91 5.06 58.75 13.41 3.74 57.63 14.59 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 2 3 # 2 A 14 GLU A 70 GLU~? -2.54 MN MN A 604s A 61 GLU A 16 GLU~? 14.76 S2 BME A 601 A 162 HIS A 22 HIS~? -3.40 MN MN A 604s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 6.20 55.25 17.70 4.45 55.72 16.64 coo -4.89 20.85 5.22 -3.95 21.69 6.91 13.57 48.33 8.05 14.78 46.83 7.14 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 3 3 # 3 A 14 GLU A 70 GLU~? -2.54 MN MN A 604s A 61 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 162 HIS A 96 HIS~? -3.41 MN MN A 605s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 6.20 55.25 17.70 4.45 55.72 16.64 coo -4.89 20.85 5.22 -3.95 21.69 6.91 0.70 67.61 16.19 -1.02 68.27 17.25 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 4 3 # 4 A 14 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 61 GLU A 71 GLU~? 7.91 MN MN A 605 A 162 HIS A 136 HIS~? 3.48 MN MN A 605s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 0.70 67.61 16.19 -1.02 68.27 17.25 coo -4.89 20.85 5.22 -3.95 21.69 6.91 4.56 57.67 23.22 2.91 58.15 24.47 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 5 3 # 5 A 14 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 61 GLU B 91 GLU~? 11.42 MN MN B 606 A 162 HIS A 136 HIS~? 3.48 MN MN A 605s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 0.70 67.61 16.19 -1.02 68.27 17.25 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 6 3 # 6 A 14 GLU A 140 GLU~? -2.42 MN MN A 605s A 61 GLU A 16 GLU~? 14.76 S2 BME A 601 A 162 HIS A 22 HIS~? -3.40 MN MN A 604s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.06 58.75 13.41 3.74 57.63 14.59 coo -4.89 20.85 5.22 -3.95 21.69 6.91 13.57 48.33 8.05 14.78 46.83 7.14 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 7 3 # 7 A 14 GLU A 140 GLU~? -2.42 MN MN A 605s A 61 GLU A 68 GLU~? 10.93 O1 BME A 601 A 162 HIS A 66 HIS~? 3.42 MN MN A 604s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.06 58.75 13.41 3.74 57.63 14.59 coo -4.89 20.85 5.22 -3.95 21.69 6.91 5.73 51.66 25.85 5.32 49.97 27.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 8 3 # 8 A 14 GLU A 140 GLU~? -2.42 MN MN A 605s A 61 GLU A 68 GLU~? 10.93 O1 BME A 601 A 162 HIS A 96 HIS~? -3.41 MN MN A 605s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.06 58.75 13.41 3.74 57.63 14.59 coo -4.89 20.85 5.22 -3.95 21.69 6.91 5.73 51.66 25.85 5.32 49.97 27.08 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 9 3 # 9 A 14 GLU A 140 GLU~? -2.42 MN MN A 605s A 61 GLU A 72 GLU~? 12.86 MN MN A 605 A 162 HIS A 66 HIS~? 3.42 MN MN A 604s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.06 58.75 13.41 3.74 57.63 14.59 coo -4.89 20.85 5.22 -3.95 21.69 6.91 8.16 54.29 26.80 8.10 55.96 28.07 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 10 3 # 10 A 14 GLU A 140 GLU~? -2.42 MN MN A 605s A 61 GLU A 72 GLU~? 12.86 MN MN A 605 A 162 HIS A 96 HIS~? -3.41 MN MN A 605s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 5.06 58.75 13.41 3.74 57.63 14.59 coo -4.89 20.85 5.22 -3.95 21.69 6.91 8.16 54.29 26.80 8.10 55.96 28.07 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 11 3 # 11 A 14 GLU B 68 GLU~? 12.41 MN MN B 606 A 61 GLU B 140 GLU~? -2.41 MN MN B 606s A 162 HIS B 67 HIS~? -4.45 CL CL B 609s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -19.03 80.53 10.71 -20.46 81.67 11.84 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 12 3 # 12 A 14 GLU B 70 GLU~? -2.57 MN MN B 607s A 61 GLU B 16 GLU~? 10.04 C2 BME B 602 A 162 HIS B 22 HIS~? -3.40 MN MN B 607s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 13 3 # 13 A 14 GLU B 70 GLU~? -2.57 MN MN B 607s A 61 GLU B 16 GLU~? 10.04 C2 BME B 602 A 162 HIS B 66 HIS~? 3.43 MN MN B 607s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 14 3 # 14 A 14 GLU B 70 GLU~? -2.57 MN MN B 607s A 61 GLU B 91 GLU~? 11.42 MN MN B 606 A 162 HIS B 96 HIS~? -3.43 MN MN B 606s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -12.98 77.36 5.11 -11.32 76.90 6.35 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 15 3 # 15 A 14 GLU B 91 GLU~? 11.42 MN MN B 606 A 61 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 162 HIS B 136 HIS~? 3.50 MN MN B 606s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -4.89 20.85 5.22 -3.95 21.69 6.91 0.70 67.61 16.19 -1.02 68.27 17.25 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 16 3 # 16 A 14 GLU B 91 GLU~? 11.42 MN MN B 606 A 61 GLU B 71 GLU~? 7.93 MN MN B 606 A 162 HIS B 136 HIS~? 3.50 MN MN B 606s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -9.23 65.09 9.44 -9.52 64.33 11.38 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -17.41 74.79 8.70 -17.96 74.30 10.67 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 17 3 # 17 A 14 GLU B 140 GLU~? -2.41 MN MN B 606s A 61 GLU B 72 GLU~? 13.02 MN MN B 606 A 162 HIS B 66 HIS~? 3.43 MN MN B 607s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -22.12 78.07 6.79 -23.41 76.46 7.29 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1j53_c00 DNA POLYMERASE III, EPSILON CHAIN user 18 3 # 18 A 14 GLU B 140 GLU~? -2.41 MN MN B 606s A 61 GLU B 72 GLU~? 13.02 MN MN B 606 A 162 HIS B 96 HIS~? -3.43 MN MN B 606s coo -1.50 25.58 -6.20 -2.54 26.76 -4.79 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -4.89 20.85 5.22 -3.95 21.69 6.91 -22.12 78.07 6.79 -23.41 76.46 7.29 coo -7.53 27.82 -3.33 -8.58 28.59 -1.68 -13.24 74.01 11.32 -12.76 74.71 9.40 1j53_c00 source 1j53 DNA POLYMERASE III, EPSILON CHAIN : 18 hits 1j53_c00 naa= 3 ULMN 3 1j70_c00 ATP SULPHURYLASE user 1 3 # 1 A 197 ARG A 26 ARG~? 9.60 MN MN A 604 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 66 HIS~? 3.42 MN MN A 604s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.35 54.22 20.29 -1.10 54.30 18.77 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1j70_c00 ATP SULPHURYLASE user 2 3 # 2 A 197 ARG A 27 ARG~? 11.42 S2 BME A 601 A 201 HIS A 66 HIS~? 3.42 MN MN A 604s A 204 HIS A 22 HIS~? -3.40 MN MN A 604s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 3.21 51.23 16.81 3.87 52.43 15.22 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1j70_c00 ATP SULPHURYLASE user 3 3 # 3 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -0.58 68.78 21.39 1.97 70.41 20.81 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.35 54.22 20.29 -1.10 54.30 18.77 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 4 3 # 4 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 67 HIS~? -4.40 CL CL A 608s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -0.58 68.78 21.39 1.97 70.41 20.81 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.35 54.22 20.29 -1.10 54.30 18.77 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c00 ATP SULPHURYLASE user 5 3 # 5 A 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -0.58 68.78 21.39 1.97 70.41 20.81 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 6 3 # 6 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.59 58.54 20.35 2.20 57.89 19.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c00 ATP SULPHURYLASE user 7 3 # 7 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 136 HIS~? 3.48 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.59 58.54 20.35 2.20 57.89 19.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1j70_c00 ATP SULPHURYLASE user 8 3 # 8 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 9 3 # 9 A 197 ARG A 128 ARG~? 18.10 CL CL A 608 A 201 HIS B 136 HIS~? 3.50 MN MN B 606s A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 10 3 # 10 A 197 ARG A 166 ARG~? 11.02 O1 BME A 601 A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 6.93 48.25 24.41 9.45 50.10 24.73 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.59 58.54 20.35 2.20 57.89 19.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c00 ATP SULPHURYLASE user 11 3 # 11 A 197 ARG A 166 ARG~? 11.02 O1 BME A 601 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 6.93 48.25 24.41 9.45 50.10 24.73 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 12 3 # 12 A 197 ARG A 167 ARG~? -4.94 O1 BME A 601s A 201 HIS A 96 HIS~? -3.41 MN MN A 605s A 204 HIS A 67 HIS~? -4.40 CL CL A 608s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 6.75 43.81 21.29 6.50 46.65 20.31 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 0.59 58.54 20.35 2.20 57.89 19.15 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1j70_c00 ATP SULPHURYLASE user 13 3 # 13 A 197 ARG B 26 ARG~? 8.42 O2 GOL B 603 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 66 HIS~? 3.43 MN MN B 607s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 1.24 79.80 7.27 0.69 76.71 7.21 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1j70_c00 ATP SULPHURYLASE user 14 3 # 14 A 197 ARG B 27 ARG~? 11.60 C2 BME B 602 A 201 HIS B 66 HIS~? 3.43 MN MN B 607s A 204 HIS B 22 HIS~? -3.40 MN MN B 607s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 1.97 89.27 10.36 0.81 91.17 12.49 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1j70_c00 ATP SULPHURYLASE user 15 3 # 15 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 16 3 # 16 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 67 HIS~? -4.45 CL CL B 609s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c00 ATP SULPHURYLASE user 17 3 # 17 A 197 ARG B 94 ARG~? 13.57 MN MN B 606 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 18 3 # 18 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS A 100 HIS~? 8.88 CL CL A 608 A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 19 3 # 19 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS A 136 HIS~? 3.48 MN MN A 605s A 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c00 ATP SULPHURYLASE user 20 3 # 20 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c00 ATP SULPHURYLASE user 21 3 # 21 A 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 136 HIS~? 3.50 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j70_c00 ATP SULPHURYLASE user 22 3 # 22 A 197 ARG B 166 ARG~? 12.22 S2 BME B 602 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c00 ATP SULPHURYLASE user 23 3 # 23 A 197 ARG B 166 ARG~? 12.22 S2 BME B 602 A 201 HIS B 100 HIS~? 8.87 CL CL B 609 A 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c00 ATP SULPHURYLASE user 24 3 # 24 A 197 ARG B 167 ARG~? 6.18 S2 BME B 602 A 201 HIS B 96 HIS~? -3.43 MN MN B 606s A 204 HIS B 67 HIS~? -4.45 CL CL B 609s coo -32.92 141.33 -11.12 -31.04 140.06 -13.21 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -19.36 141.46 -7.82 -20.46 139.73 -7.39 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -21.65 146.14 -9.69 -22.29 144.59 -10.94 -13.16 78.27 11.53 -11.33 78.28 12.55 1j70_c00 source 1j70 ATP SULPHURYLASE : 24 hits 1j70_c00 naa= 3 ULMN 3 1j70_c01 ATP SULPHURYLASE user 1 3 # 1 B 197 ARG A 26 ARG~? 9.60 MN MN A 604 B 201 HIS A 67 HIS~? -4.40 CL CL A 608s B 204 HIS A 66 HIS~? 3.42 MN MN A 604s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.35 54.22 20.29 -1.10 54.30 18.77 coo -6.99 108.94 26.28 -8.54 109.57 27.55 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1j70_c01 ATP SULPHURYLASE user 2 3 # 2 B 197 ARG A 27 ARG~? 11.42 S2 BME A 601 B 201 HIS A 66 HIS~? 3.42 MN MN A 604s B 204 HIS A 22 HIS~? -3.40 MN MN A 604s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -8.48 114.03 24.38 -10.47 114.55 23.97 3.21 51.23 16.81 3.87 52.43 15.22 coo -6.99 108.94 26.28 -8.54 109.57 27.55 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1j70_c01 ATP SULPHURYLASE user 3 3 # 3 B 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 B 201 HIS A 67 HIS~? -4.40 CL CL A 608s B 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -0.58 68.78 21.39 1.97 70.41 20.81 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.35 54.22 20.29 -1.10 54.30 18.77 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c01 ATP SULPHURYLASE user 4 3 # 4 B 197 ARG A 128 ARG~? 18.10 CL CL A 608 B 201 HIS A 96 HIS~? -3.41 MN MN A 605s B 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.59 58.54 20.35 2.20 57.89 19.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c01 ATP SULPHURYLASE user 5 3 # 5 B 197 ARG A 128 ARG~? 18.10 CL CL A 608 B 201 HIS A 96 HIS~? -3.41 MN MN A 605s B 204 HIS A 136 HIS~? 3.48 MN MN A 605s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.59 58.54 20.35 2.20 57.89 19.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1j70_c01 ATP SULPHURYLASE user 6 3 # 6 B 197 ARG A 128 ARG~? 18.10 CL CL A 608 B 201 HIS B 100 HIS~? 8.87 CL CL B 609 B 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c01 ATP SULPHURYLASE user 7 3 # 7 B 197 ARG A 128 ARG~? 18.10 CL CL A 608 B 201 HIS B 136 HIS~? 3.50 MN MN B 606s B 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c01 ATP SULPHURYLASE user 8 3 # 8 B 197 ARG A 166 ARG~? 11.02 O1 BME A 601 B 201 HIS A 96 HIS~? -3.41 MN MN A 605s B 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo -18.85 104.93 27.44 -18.03 106.58 29.88 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.59 58.54 20.35 2.20 57.89 19.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c01 ATP SULPHURYLASE user 9 3 # 9 B 197 ARG A 166 ARG~? 11.02 O1 BME A 601 B 201 HIS A 100 HIS~? 8.88 CL CL A 608 B 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -18.85 104.93 27.44 -18.03 106.58 29.88 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c01 ATP SULPHURYLASE user 10 3 # 10 B 197 ARG A 167 ARG~? -4.94 O1 BME A 601s B 201 HIS A 96 HIS~? -3.41 MN MN A 605s B 204 HIS A 67 HIS~? -4.40 CL CL A 608s coo -18.85 104.93 27.44 -18.03 106.58 29.88 6.75 43.81 21.29 6.50 46.65 20.31 coo -8.48 114.03 24.38 -10.47 114.55 23.97 0.59 58.54 20.35 2.20 57.89 19.15 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1j70_c01 ATP SULPHURYLASE user 11 3 # 11 B 197 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 201 HIS B 67 HIS~? -4.45 CL CL B 609s B 204 HIS B 66 HIS~? 3.43 MN MN B 607s coo -18.85 104.93 27.44 -18.03 106.58 29.88 1.24 79.80 7.27 0.69 76.71 7.21 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1j70_c01 ATP SULPHURYLASE user 12 3 # 12 B 197 ARG B 27 ARG~? 11.60 C2 BME B 602 B 201 HIS B 66 HIS~? 3.43 MN MN B 607s B 204 HIS B 22 HIS~? -3.40 MN MN B 607s coo -18.85 104.93 27.44 -18.03 106.58 29.88 1.97 89.27 10.36 0.81 91.17 12.49 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1j70_c01 ATP SULPHURYLASE user 13 3 # 13 B 197 ARG B 94 ARG~? 13.57 MN MN B 606 B 201 HIS B 67 HIS~? -4.45 CL CL B 609s B 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c01 ATP SULPHURYLASE user 14 3 # 14 B 197 ARG B 94 ARG~? 13.57 MN MN B 606 B 201 HIS B 100 HIS~? 8.87 CL CL B 609 B 204 HIS B 67 HIS~? -4.45 CL CL B 609s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1j70_c01 ATP SULPHURYLASE user 15 3 # 15 B 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 201 HIS A 100 HIS~? 8.88 CL CL A 608 B 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c01 ATP SULPHURYLASE user 16 3 # 16 B 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 201 HIS A 136 HIS~? 3.48 MN MN A 605s B 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -0.57 59.60 14.33 0.78 59.36 15.93 coo -6.99 108.94 26.28 -8.54 109.57 27.55 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c01 ATP SULPHURYLASE user 17 3 # 17 B 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 201 HIS B 96 HIS~? -3.43 MN MN B 606s B 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c01 ATP SULPHURYLASE user 18 3 # 18 B 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 201 HIS B 96 HIS~? -3.43 MN MN B 606s B 204 HIS B 136 HIS~? 3.50 MN MN B 606s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j70_c01 ATP SULPHURYLASE user 19 3 # 19 B 197 ARG B 166 ARG~? 12.22 S2 BME B 602 B 201 HIS B 96 HIS~? -3.43 MN MN B 606s B 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo -18.85 104.93 27.44 -18.03 106.58 29.88 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c01 ATP SULPHURYLASE user 20 3 # 20 B 197 ARG B 166 ARG~? 12.22 S2 BME B 602 B 201 HIS B 100 HIS~? 8.87 CL CL B 609 B 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c01 ATP SULPHURYLASE user 21 3 # 21 B 197 ARG B 167 ARG~? 6.18 S2 BME B 602 B 201 HIS B 96 HIS~? -3.43 MN MN B 606s B 204 HIS B 67 HIS~? -4.45 CL CL B 609s coo -18.85 104.93 27.44 -18.03 106.58 29.88 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -8.48 114.03 24.38 -10.47 114.55 23.97 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -6.99 108.94 26.28 -8.54 109.57 27.55 -13.16 78.27 11.53 -11.33 78.28 12.55 1j70_c01 source 1j70 ATP SULPHURYLASE : 21 hits 1j70_c01 naa= 3 ULMN 3 1j70_c02 ATP SULPHURYLASE user 1 3 # 1 C 197 ARG A 26 ARG~? 9.60 MN MN A 604 C 201 HIS A 67 HIS~? -4.40 CL CL A 608s C 204 HIS A 66 HIS~? 3.42 MN MN A 604s coo 30.92 14.23 15.70 28.82 13.90 13.48 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.35 54.22 20.29 -1.10 54.30 18.77 coo 24.92 3.29 16.90 24.41 4.92 15.69 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1j70_c02 ATP SULPHURYLASE user 2 3 # 2 C 197 ARG A 27 ARG~? 11.42 S2 BME A 601 C 201 HIS A 66 HIS~? 3.42 MN MN A 604s C 204 HIS A 22 HIS~? -3.40 MN MN A 604s coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 20.16 5.55 18.86 20.00 7.59 19.34 3.21 51.23 16.81 3.87 52.43 15.22 coo 24.92 3.29 16.90 24.41 4.92 15.69 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1j70_c02 ATP SULPHURYLASE user 3 3 # 3 C 197 ARG A 94 ARG~? 6.60 C1 GOL B 603 C 201 HIS A 67 HIS~? -4.40 CL CL A 608s C 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo 30.92 14.23 15.70 28.82 13.90 13.48 -0.58 68.78 21.39 1.97 70.41 20.81 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.35 54.22 20.29 -1.10 54.30 18.77 coo 24.92 3.29 16.90 24.41 4.92 15.69 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c02 ATP SULPHURYLASE user 4 3 # 4 C 197 ARG A 128 ARG~? 18.10 CL CL A 608 C 201 HIS A 96 HIS~? -3.41 MN MN A 605s C 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo 30.92 14.23 15.70 28.82 13.90 13.48 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c02 ATP SULPHURYLASE user 5 3 # 5 C 197 ARG A 128 ARG~? 18.10 CL CL A 608 C 201 HIS A 96 HIS~? -3.41 MN MN A 605s C 204 HIS A 136 HIS~? 3.48 MN MN A 605s coo 30.92 14.23 15.70 28.82 13.90 13.48 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1j70_c02 ATP SULPHURYLASE user 6 3 # 6 C 197 ARG A 128 ARG~? 18.10 CL CL A 608 C 201 HIS B 100 HIS~? 8.87 CL CL B 609 C 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo 30.92 14.23 15.70 28.82 13.90 13.48 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c02 ATP SULPHURYLASE user 7 3 # 7 C 197 ARG A 128 ARG~? 18.10 CL CL A 608 C 201 HIS B 136 HIS~? 3.50 MN MN B 606s C 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo 30.92 14.23 15.70 28.82 13.90 13.48 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 20.16 5.55 18.86 20.00 7.59 19.34 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c02 ATP SULPHURYLASE user 8 3 # 8 C 197 ARG A 166 ARG~? 11.02 O1 BME A 601 C 201 HIS A 96 HIS~? -3.41 MN MN A 605s C 204 HIS A 100 HIS~? 8.88 CL CL A 608 coo 30.92 14.23 15.70 28.82 13.90 13.48 6.93 48.25 24.41 9.45 50.10 24.73 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1j70_c02 ATP SULPHURYLASE user 9 3 # 9 C 197 ARG A 166 ARG~? 11.02 O1 BME A 601 C 201 HIS A 100 HIS~? 8.88 CL CL A 608 C 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo 30.92 14.23 15.70 28.82 13.90 13.48 6.93 48.25 24.41 9.45 50.10 24.73 coo 20.16 5.55 18.86 20.00 7.59 19.34 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c02 ATP SULPHURYLASE user 10 3 # 10 C 197 ARG A 167 ARG~? -4.94 O1 BME A 601s C 201 HIS A 96 HIS~? -3.41 MN MN A 605s C 204 HIS A 67 HIS~? -4.40 CL CL A 608s coo 30.92 14.23 15.70 28.82 13.90 13.48 6.75 43.81 21.29 6.50 46.65 20.31 coo 20.16 5.55 18.86 20.00 7.59 19.34 0.59 58.54 20.35 2.20 57.89 19.15 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1j70_c02 ATP SULPHURYLASE user 11 3 # 11 C 197 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 201 HIS B 67 HIS~? -4.45 CL CL B 609s C 204 HIS B 66 HIS~? 3.43 MN MN B 607s coo 30.92 14.23 15.70 28.82 13.90 13.48 1.24 79.80 7.27 0.69 76.71 7.21 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 24.92 3.29 16.90 24.41 4.92 15.69 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1j70_c02 ATP SULPHURYLASE user 12 3 # 12 C 197 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 201 HIS B 96 HIS~? -3.43 MN MN B 606s C 204 HIS B 136 HIS~? 3.50 MN MN B 606s coo 30.92 14.23 15.70 28.82 13.90 13.48 1.24 79.80 7.27 0.69 76.71 7.21 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 24.92 3.29 16.90 24.41 4.92 15.69 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j70_c02 ATP SULPHURYLASE user 13 3 # 13 C 197 ARG B 27 ARG~? 11.60 C2 BME B 602 C 201 HIS B 66 HIS~? 3.43 MN MN B 607s C 204 HIS B 22 HIS~? -3.40 MN MN B 607s coo 30.92 14.23 15.70 28.82 13.90 13.48 1.97 89.27 10.36 0.81 91.17 12.49 coo 20.16 5.55 18.86 20.00 7.59 19.34 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 24.92 3.29 16.90 24.41 4.92 15.69 -5.34 79.70 5.35 -6.67 78.07 5.35 ULMN 3 1j70_c02 ATP SULPHURYLASE user 14 3 # 14 C 197 ARG B 94 ARG~? 13.57 MN MN B 606 C 201 HIS B 67 HIS~? -4.45 CL CL B 609s C 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo 30.92 14.23 15.70 28.82 13.90 13.48 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c02 ATP SULPHURYLASE user 15 3 # 15 C 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 201 HIS A 100 HIS~? 8.88 CL CL A 608 C 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 20.16 5.55 18.86 20.00 7.59 19.34 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c02 ATP SULPHURYLASE user 16 3 # 16 C 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 201 HIS A 136 HIS~? 3.48 MN MN A 605s C 204 HIS A 96 HIS~? -3.41 MN MN A 605s coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 20.16 5.55 18.86 20.00 7.59 19.34 -0.57 59.60 14.33 0.78 59.36 15.93 coo 24.92 3.29 16.90 24.41 4.92 15.69 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1j70_c02 ATP SULPHURYLASE user 17 3 # 17 C 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 201 HIS B 96 HIS~? -3.43 MN MN B 606s C 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c02 ATP SULPHURYLASE user 18 3 # 18 C 197 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 201 HIS B 96 HIS~? -3.43 MN MN B 606s C 204 HIS B 136 HIS~? 3.50 MN MN B 606s coo 30.92 14.23 15.70 28.82 13.90 13.48 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 24.92 3.29 16.90 24.41 4.92 15.69 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1j70_c02 ATP SULPHURYLASE user 19 3 # 19 C 197 ARG B 166 ARG~? 12.22 S2 BME B 602 C 201 HIS B 96 HIS~? -3.43 MN MN B 606s C 204 HIS B 100 HIS~? 8.87 CL CL B 609 coo 30.92 14.23 15.70 28.82 13.90 13.48 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1j70_c02 ATP SULPHURYLASE user 20 3 # 20 C 197 ARG B 166 ARG~? 12.22 S2 BME B 602 C 201 HIS B 100 HIS~? 8.87 CL CL B 609 C 204 HIS B 96 HIS~? -3.43 MN MN B 606s coo 30.92 14.23 15.70 28.82 13.90 13.48 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1j70_c02 ATP SULPHURYLASE user 21 3 # 21 C 197 ARG B 167 ARG~? 6.18 S2 BME B 602 C 201 HIS B 96 HIS~? -3.43 MN MN B 606s C 204 HIS B 67 HIS~? -4.45 CL CL B 609s coo 30.92 14.23 15.70 28.82 13.90 13.48 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 20.16 5.55 18.86 20.00 7.59 19.34 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 24.92 3.29 16.90 24.41 4.92 15.69 -13.16 78.27 11.53 -11.33 78.28 12.55 1j70_c02 source 1j70 ATP SULPHURYLASE : 21 hits 1j70_c02 naa= 3 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 1 3 # 1 A 488 ARG A 166 ARG~? 11.02 O1 BME A 601 A 590 ARG A 167 ARG~? -4.94 O1 BME A 601s A 632 HIS A 66 HIS~? 3.42 MN MN A 604s coo 19.23 7.38 20.83 18.34 7.79 23.74 6.93 48.25 24.41 9.45 50.10 24.73 coo 23.20 10.66 21.48 21.07 10.68 23.70 6.75 43.81 21.29 6.50 46.65 20.31 coo 20.55 9.13 29.66 21.88 8.70 28.08 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 2 3 # 2 A 488 ARG A 167 ARG~? -4.94 O1 BME A 601s A 590 ARG A 166 ARG~? 11.02 O1 BME A 601 A 632 HIS A 66 HIS~? 3.42 MN MN A 604s coo 19.23 7.38 20.83 18.34 7.79 23.74 6.75 43.81 21.29 6.50 46.65 20.31 coo 23.20 10.66 21.48 21.07 10.68 23.70 6.93 48.25 24.41 9.45 50.10 24.73 coo 20.55 9.13 29.66 21.88 8.70 28.08 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 3 3 # 3 A 488 ARG B 166 ARG~? 12.22 S2 BME B 602 A 590 ARG B 167 ARG~? 6.18 S2 BME B 602 A 632 HIS B 66 HIS~? 3.43 MN MN B 607s coo 19.23 7.38 20.83 18.34 7.79 23.74 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 23.20 10.66 21.48 21.07 10.68 23.70 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 20.55 9.13 29.66 21.88 8.70 28.08 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1k4t_c00 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-user 4 3 # 4 A 488 ARG B 167 ARG~? 6.18 S2 BME B 602 A 590 ARG B 166 ARG~? 12.22 S2 BME B 602 A 632 HIS B 66 HIS~? 3.43 MN MN B 607s coo 19.23 7.38 20.83 18.34 7.79 23.74 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 23.20 10.66 21.48 21.07 10.68 23.70 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 20.55 9.13 29.66 21.88 8.70 28.08 -11.11 81.39 7.66 -9.84 80.27 6.41 1k4t_c00 source 1k4t 5'-D(*AP*AP*AP*AP*AP*GP*AP*CP*TP*T)-3' : 4 hits 1k4t_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 109 GLU~? 22.92 CL CL A 608 A 56 LYS A 112 LYS~? 24.85 CL CL A 608 A 258 ARG A 128 ARG~? 18.10 CL CL A 608 coo 42.33 1.56 26.99 42.38 2.91 28.66 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU A 161 GLU~? 18.40 O1 BME A 601 A 56 LYS A 155 LYS~? 22.50 MN MN A 604 A 258 ARG A 166 ARG~? 11.02 O1 BME A 601 coo 42.33 1.56 26.99 42.38 2.91 28.66 19.17 45.23 21.71 20.94 45.20 22.85 coo 38.45 -0.44 19.89 37.36 0.90 25.90 21.85 53.55 18.73 24.16 56.83 22.72 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 A 2 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 56 LYS B 112 LYS~? 25.52 O1 GOL B 603 A 258 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 42.33 1.56 26.99 42.38 2.91 28.66 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -4.73 86.07 32.89 -5.14 81.77 36.42 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 -3.66 71.26 23.11 -3.83 72.79 25.78 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 109 GLU~? 22.92 CL CL A 608 B 56 LYS A 112 LYS~? 24.85 CL CL A 608 B 258 ARG A 128 ARG~? 18.10 CL CL A 608 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 2.64 1.83 34.81 1.56 1.13 32.02 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU A 161 GLU~? 18.40 O1 BME A 601 B 56 LYS A 155 LYS~? 22.50 MN MN A 604 B 258 ARG A 166 ARG~? 11.02 O1 BME A 601 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 19.17 45.23 21.71 20.94 45.20 22.85 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 21.85 53.55 18.73 24.16 56.83 22.72 coo 2.64 1.83 34.81 1.56 1.13 32.02 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 B 2 GLU B 109 GLU~? 18.95 O1 GOL B 603 B 56 LYS B 112 LYS~? 25.52 O1 GOL B 603 B 258 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -4.73 86.07 32.89 -5.14 81.77 36.42 coo 2.64 1.83 34.81 1.56 1.13 32.02 -3.66 71.26 23.11 -3.83 72.79 25.78 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 4 3 # 4 B 2 GLU B 161 GLU~? 19.04 O1 BME B 602 B 56 LYS B 155 LYS~? 22.59 MN MN B 607 B 258 ARG B 166 ARG~? 12.22 S2 BME B 602 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 2.64 1.83 34.81 1.56 1.13 32.02 -19.40 84.27 7.18 -20.75 82.43 4.97 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 4 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 109 GLU~? 22.92 CL CL A 608 C 56 LYS A 112 LYS~? 24.85 CL CL A 608 C 258 ARG A 128 ARG~? 18.10 CL CL A 608 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU A 161 GLU~? 18.40 O1 BME A 601 C 56 LYS A 155 LYS~? 22.50 MN MN A 604 C 258 ARG A 166 ARG~? 11.02 O1 BME A 601 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 19.17 45.23 21.71 20.94 45.20 22.85 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 21.85 53.55 18.73 24.16 56.83 22.72 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 C 2 GLU B 161 GLU~? 19.04 O1 BME B 602 C 56 LYS B 155 LYS~? 22.59 MN MN B 607 C 258 ARG B 166 ARG~? 12.22 S2 BME B 602 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 -19.40 84.27 7.18 -20.75 82.43 4.97 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 109 GLU~? 22.92 CL CL A 608 D 56 LYS A 112 LYS~? 24.85 CL CL A 608 D 258 ARG A 128 ARG~? 18.10 CL CL A 608 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU A 161 GLU~? 18.40 O1 BME A 601 D 56 LYS A 155 LYS~? 22.50 MN MN A 604 D 258 ARG A 166 ARG~? 11.02 O1 BME A 601 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 19.17 45.23 21.71 20.94 45.20 22.85 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 21.85 53.55 18.73 24.16 56.83 22.72 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 6.93 48.25 24.41 9.45 50.10 24.73 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 3 3 # 3 D 2 GLU B 161 GLU~? 19.04 O1 BME B 602 D 56 LYS B 155 LYS~? 22.59 MN MN B 607 D 258 ARG B 166 ARG~? 12.22 S2 BME B 602 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 -21.45 87.83 -5.08 -22.54 87.54 -6.89 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 -19.40 84.27 7.18 -20.75 82.43 4.97 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 3 hits 1k82_c03 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS B 153 LYS~? 21.64 S2 BME B 602 A 74 LYS B 155 LYS~? 22.59 MN MN B 607 A 165 GLU B 70 GLU~? -2.57 MN MN B 607s coo 24.97 5.82 58.78 26.79 1.97 55.46 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 19.46 3.44 61.93 23.95 1.12 60.13 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 -12.98 77.36 5.11 -11.32 76.90 6.35 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 1 hits 1kqc_c00 naa= 3 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 1 3 # 1 A 110 CYH A 21 CYH~? -2.28 S2 BME A 601s A 220 HIS A 22 HIS~? -3.40 MN MN A 604s A 222 GLU A 140 GLU~? -2.42 MN MN A 605s coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 3.34 47.98 12.34 4.26 47.15 14.87 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 3.18 53.06 10.64 3.66 54.63 11.95 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 2 3 # 2 A 110 CYH A 21 CYH~? -2.28 S2 BME A 601s A 220 HIS A 22 HIS~? -3.40 MN MN A 604s A 222 GLU A 141 GLU~? 7.70 MN MN A 604 coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 3.34 47.98 12.34 4.26 47.15 14.87 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 3.18 53.06 10.64 3.66 54.63 11.95 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 3 3 # 3 A 110 CYH A 21 CYH~? -2.28 S2 BME A 601s A 220 HIS A 66 HIS~? 3.42 MN MN A 604s A 222 GLU A 70 GLU~? -2.54 MN MN A 604s coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 3.34 47.98 12.34 4.26 47.15 14.87 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 3.21 51.23 16.81 3.87 52.43 15.22 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 4 3 # 4 A 110 CYH B 21 CYH~? -2.10 S2 BME B 602s A 220 HIS B 22 HIS~? -3.40 MN MN B 607s A 222 GLU B 140 GLU~? -2.41 MN MN B 606s coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 5 3 # 5 A 110 CYH B 21 CYH~? -2.10 S2 BME B 602s A 220 HIS B 22 HIS~? -3.40 MN MN B 607s A 222 GLU B 141 GLU~? 7.71 MN MN B 607 coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1l9x_c00 GAMMA-GLUTAMYL HYDROLASE user 6 3 # 6 A 110 CYH B 21 CYH~? -2.10 S2 BME B 602s A 220 HIS B 66 HIS~? 3.43 MN MN B 607s A 222 GLU B 70 GLU~? -2.57 MN MN B 607s coo -8.91 41.33 -26.79 -11.45 42.13 -25.98 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -11.66 37.25 -23.47 -11.56 39.34 -23.28 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -8.61 34.50 -19.72 -8.98 35.64 -21.47 -12.98 77.36 5.11 -11.32 76.90 6.35 1l9x_c00 source 1l9x GAMMA-GLUTAMYL HYDROLASE : 6 hits 1l9x_c00 naa= 3 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 1 3 # 1 B 110 CYH A 21 CYH~? -2.28 S2 BME A 601s B 220 HIS A 22 HIS~? -3.40 MN MN A 604s B 222 GLU A 140 GLU~? -2.42 MN MN A 605s coo -0.50 9.45 -3.81 1.96 10.11 -2.60 3.34 47.98 12.34 4.26 47.15 14.87 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 3.18 53.06 10.64 3.66 54.63 11.95 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 2 3 # 2 B 110 CYH A 21 CYH~? -2.28 S2 BME A 601s B 220 HIS A 22 HIS~? -3.40 MN MN A 604s B 222 GLU A 141 GLU~? 7.70 MN MN A 604 coo -0.50 9.45 -3.81 1.96 10.11 -2.60 3.34 47.98 12.34 4.26 47.15 14.87 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 3.18 53.06 10.64 3.66 54.63 11.95 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 3 3 # 3 B 110 CYH A 21 CYH~? -2.28 S2 BME A 601s B 220 HIS A 66 HIS~? 3.42 MN MN A 604s B 222 GLU A 70 GLU~? -2.54 MN MN A 604s coo -0.50 9.45 -3.81 1.96 10.11 -2.60 3.34 47.98 12.34 4.26 47.15 14.87 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 3.21 51.23 16.81 3.87 52.43 15.22 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 4 3 # 4 B 110 CYH B 21 CYH~? -2.10 S2 BME B 602s B 220 HIS B 22 HIS~? -3.40 MN MN B 607s B 222 GLU B 140 GLU~? -2.41 MN MN B 606s coo -0.50 9.45 -3.81 1.96 10.11 -2.60 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 5 3 # 5 B 110 CYH B 21 CYH~? -2.10 S2 BME B 602s B 220 HIS B 22 HIS~? -3.40 MN MN B 607s B 222 GLU B 141 GLU~? 7.71 MN MN B 607 coo -0.50 9.45 -3.81 1.96 10.11 -2.60 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1l9x_c01 GAMMA-GLUTAMYL HYDROLASE user 6 3 # 6 B 110 CYH B 21 CYH~? -2.10 S2 BME B 602s B 220 HIS B 66 HIS~? 3.43 MN MN B 607s B 222 GLU B 70 GLU~? -2.57 MN MN B 607s coo -0.50 9.45 -3.81 1.96 10.11 -2.60 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 2.37 14.03 -6.28 2.19 13.50 -4.25 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -0.88 18.35 -7.86 -0.45 16.33 -7.40 -12.98 77.36 5.11 -11.32 76.90 6.35 1l9x_c01 source 1l9x GAMMA-GLUTAMYL HYDROLASE : 6 hits 1l9x_c01 naa= 3 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 1 3 # 1 C 110 CYH A 21 CYH~? -2.28 S2 BME A 601s C 220 HIS A 22 HIS~? -3.40 MN MN A 604s C 222 GLU A 140 GLU~? -2.42 MN MN A 605s coo 26.01 27.87 -53.72 28.60 27.52 -54.73 3.34 47.98 12.34 4.26 47.15 14.87 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 3.18 53.06 10.64 3.66 54.63 11.95 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 2 3 # 2 C 110 CYH A 21 CYH~? -2.28 S2 BME A 601s C 220 HIS A 22 HIS~? -3.40 MN MN A 604s C 222 GLU A 141 GLU~? 7.70 MN MN A 604 coo 26.01 27.87 -53.72 28.60 27.52 -54.73 3.34 47.98 12.34 4.26 47.15 14.87 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 3.18 53.06 10.64 3.66 54.63 11.95 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 3 3 # 3 C 110 CYH A 21 CYH~? -2.28 S2 BME A 601s C 220 HIS A 66 HIS~? 3.42 MN MN A 604s C 222 GLU A 70 GLU~? -2.54 MN MN A 604s coo 26.01 27.87 -53.72 28.60 27.52 -54.73 3.34 47.98 12.34 4.26 47.15 14.87 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 3.21 51.23 16.81 3.87 52.43 15.22 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 4 3 # 4 C 110 CYH B 21 CYH~? -2.10 S2 BME B 602s C 220 HIS B 22 HIS~? -3.40 MN MN B 607s C 222 GLU B 140 GLU~? -2.41 MN MN B 606s coo 26.01 27.87 -53.72 28.60 27.52 -54.73 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 5 3 # 5 C 110 CYH B 21 CYH~? -2.10 S2 BME B 602s C 220 HIS B 22 HIS~? -3.40 MN MN B 607s C 222 GLU B 141 GLU~? 7.71 MN MN B 607 coo 26.01 27.87 -53.72 28.60 27.52 -54.73 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1l9x_c02 GAMMA-GLUTAMYL HYDROLASE user 6 3 # 6 C 110 CYH B 21 CYH~? -2.10 S2 BME B 602s C 220 HIS B 66 HIS~? 3.43 MN MN B 607s C 222 GLU B 70 GLU~? -2.57 MN MN B 607s coo 26.01 27.87 -53.72 28.60 27.52 -54.73 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 28.17 22.35 -53.03 28.38 23.73 -54.60 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 24.56 18.15 -54.00 25.16 20.12 -53.50 -12.98 77.36 5.11 -11.32 76.90 6.35 1l9x_c02 source 1l9x GAMMA-GLUTAMYL HYDROLASE : 6 hits 1l9x_c02 naa= 3 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 1 3 # 1 D 110 CYH A 21 CYH~? -2.28 S2 BME A 601s D 220 HIS A 22 HIS~? -3.40 MN MN A 604s D 222 GLU A 140 GLU~? -2.42 MN MN A 605s coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 3.34 47.98 12.34 4.26 47.15 14.87 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 3.18 53.06 10.64 3.66 54.63 11.95 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 2 3 # 2 D 110 CYH A 21 CYH~? -2.28 S2 BME A 601s D 220 HIS A 22 HIS~? -3.40 MN MN A 604s D 222 GLU A 141 GLU~? 7.70 MN MN A 604 coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 3.34 47.98 12.34 4.26 47.15 14.87 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 3.18 53.06 10.64 3.66 54.63 11.95 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 4.84 56.74 8.27 3.91 55.44 6.87 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 3 3 # 3 D 110 CYH A 21 CYH~? -2.28 S2 BME A 601s D 220 HIS A 66 HIS~? 3.42 MN MN A 604s D 222 GLU A 70 GLU~? -2.54 MN MN A 604s coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 3.34 47.98 12.34 4.26 47.15 14.87 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 3.21 51.23 16.81 3.87 52.43 15.22 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 4 3 # 4 D 110 CYH B 21 CYH~? -2.10 S2 BME B 602s D 220 HIS B 22 HIS~? -3.40 MN MN B 607s D 222 GLU B 140 GLU~? -2.41 MN MN B 606s coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 5 3 # 5 D 110 CYH B 21 CYH~? -2.10 S2 BME B 602s D 220 HIS B 22 HIS~? -3.40 MN MN B 607s D 222 GLU B 141 GLU~? 7.71 MN MN B 607 coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 -3.60 76.13 2.85 -2.01 77.43 3.31 ULMN 3 1l9x_c03 GAMMA-GLUTAMYL HYDROLASE user 6 3 # 6 D 110 CYH B 21 CYH~? -2.10 S2 BME B 602s D 220 HIS B 66 HIS~? 3.43 MN MN B 607s D 222 GLU B 70 GLU~? -2.57 MN MN B 607s coo 12.54 -9.62 -47.89 10.14 -9.71 -49.30 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 10.45 -4.28 -49.60 10.59 -6.11 -50.61 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 14.26 -0.51 -51.35 13.49 -2.20 -50.31 -12.98 77.36 5.11 -11.32 76.90 6.35 1l9x_c03 source 1l9x GAMMA-GLUTAMYL HYDROLASE : 6 hits 1l9x_c03 naa= 3 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 1 3 # 1 166 ASP A 69 ASP~? 7.42 O1 BME A 601 169 ARG A 166 ARG~? 11.02 O1 BME A 601 193 HIS A 66 HIS~? 3.42 MN MN A 604s coo 20.88 15.91 3.60 20.25 17.72 4.50 7.88 51.22 19.98 7.64 49.14 20.25 coo 17.70 17.91 -0.80 15.74 19.74 0.84 6.93 48.25 24.41 9.45 50.10 24.73 coo 18.81 19.85 7.63 17.55 19.89 5.97 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 2 3 # 2 166 ASP A 69 ASP~? 7.42 O1 BME A 601 169 ARG A 167 ARG~? -4.94 O1 BME A 601s 193 HIS A 66 HIS~? 3.42 MN MN A 604s coo 20.88 15.91 3.60 20.25 17.72 4.50 7.88 51.22 19.98 7.64 49.14 20.25 coo 17.70 17.91 -0.80 15.74 19.74 0.84 6.75 43.81 21.29 6.50 46.65 20.31 coo 18.81 19.85 7.63 17.55 19.89 5.97 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 3 3 # 3 166 ASP B 69 ASP~? 7.66 S2 BME B 602 169 ARG B 166 ARG~? 12.22 S2 BME B 602 193 HIS B 66 HIS~? 3.43 MN MN B 607s coo 20.88 15.91 3.60 20.25 17.72 4.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 18.81 19.85 7.63 17.55 19.89 5.97 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1ldm_c01 M4 LACTATE DEHYDROGENASE user 4 3 # 4 166 ASP B 69 ASP~? 7.66 S2 BME B 602 169 ARG B 167 ARG~? 6.18 S2 BME B 602 193 HIS B 66 HIS~? 3.43 MN MN B 607s coo 20.88 15.91 3.60 20.25 17.72 4.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 17.70 17.91 -0.80 15.74 19.74 0.84 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 18.81 19.85 7.63 17.55 19.89 5.97 -11.11 81.39 7.66 -9.84 80.27 6.41 1ldm_c01 source 1ldm M4 LACTATE DEHYDROGENASE : 4 hits 1ldm_c01 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 131 ALA~? 14.03 CL CL A 608 A 317 GLY A 132 GLY~? 10.05 CL CL A 608 A 318 ASP A 134 ASP~? 12.23 CL CL A 608 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 131 ALA~? -3.51 O1 GOL B 603s A 317 GLY B 132 GLY~? 6.66 O1 GOL B 603 A 318 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 144.15 17.54 -4.21 144.96 16.79 -5.26 0.55 72.95 16.09 1.01 71.82 17.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 1.27 73.42 12.01 2.60 75.02 12.38 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 131 ALA~? 14.03 CL CL A 608 A 317 GLY A 132 GLY~? 10.05 CL CL A 608 A 318 ASP A 134 ASP~? 12.23 CL CL A 608 coo 27.04 23.54 41.85 25.72 24.19 42.18 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 27.87 23.16 38.17 28.43 22.97 38.87 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 32.11 22.71 40.58 33.42 24.22 39.78 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 131 ALA~? -3.51 O1 GOL B 603s A 317 GLY B 132 GLY~? 6.66 O1 GOL B 603 A 318 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 27.04 23.54 41.85 25.72 24.19 42.18 0.55 72.95 16.09 1.01 71.82 17.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 32.11 22.71 40.58 33.42 24.22 39.78 1.27 73.42 12.01 2.60 75.02 12.38 1lio_c01 source 1lio ADENOSINE KINASE : 2 hits 1lio_c01 naa= 3 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 1 3 # 1 A 44 HIS A 22 HIS~? -3.40 MN MN A 604s A 45 HIS A 66 HIS~? 3.42 MN MN A 604s A 261 PHE A 11 PHE.? 7.28 O1 BME A 601 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.18 53.06 10.64 3.66 54.63 11.95 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.74 44.01 17.67 8.98 44.14 18.15 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 2 3 # 2 A 44 HIS A 22 HIS~? -3.40 MN MN A 604s A 45 HIS A 66 HIS~? 3.42 MN MN A 604s A 261 PHE A 28 PHE~? 9.03 S2 BME A 601 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.18 53.06 10.64 3.66 54.63 11.95 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 3 3 # 3 A 44 HIS A 22 HIS~? -3.40 MN MN A 604s A 45 HIS A 66 HIS~? 3.42 MN MN A 604s A 261 PHE A 75 PHE~? 5.80 MN MN A 605 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.18 53.06 10.64 3.66 54.63 11.95 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.51 60.03 19.19 6.27 59.59 17.55 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 4 3 # 4 A 44 HIS A 66 HIS~? 3.42 MN MN A 604s A 45 HIS A 22 HIS~? -3.40 MN MN A 604s A 261 PHE A 28 PHE~? 9.03 S2 BME A 601 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.21 51.23 16.81 3.87 52.43 15.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.18 53.06 10.64 3.66 54.63 11.95 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 5 3 # 5 A 44 HIS A 66 HIS~? 3.42 MN MN A 604s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 28 PHE~? 9.03 S2 BME A 601 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.21 51.23 16.81 3.87 52.43 15.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 6 3 # 6 A 44 HIS A 66 HIS~? 3.42 MN MN A 604s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 3.21 51.23 16.81 3.87 52.43 15.22 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 7 3 # 7 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 66 HIS~? 3.42 MN MN A 604s A 261 PHE A 28 PHE~? 9.03 S2 BME A 601 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 8 3 # 8 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 9 3 # 9 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 10 3 # 10 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 144 PHE~? 5.39 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 11 3 # 11 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 100 HIS~? 8.88 CL CL A 608 A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 12 3 # 12 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 13 3 # 13 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 14 3 # 14 A 44 HIS A 67 HIS~? -4.40 CL CL A 608s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 144 PHE~? 5.39 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 15 3 # 15 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 16 3 # 16 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 17 3 # 17 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 144 PHE~? 5.39 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 18 3 # 18 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 100 HIS~? 8.88 CL CL A 608 A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 19 3 # 19 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 59 PHE~? 9.30 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.57 49.40 16.71 -5.70 50.05 14.11 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 20 3 # 20 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 21 3 # 21 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 22 3 # 22 A 44 HIS A 96 HIS~? -3.41 MN MN A 605s A 45 HIS A 136 HIS~? 3.48 MN MN A 605s A 261 PHE A 144 PHE~? 5.39 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 23 3 # 23 A 44 HIS A 100 HIS~? 8.88 CL CL A 608 A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 75 PHE~? 5.80 MN MN A 605 coo 49.89 1.93 30.83 50.54 1.43 32.81 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 8.51 60.03 19.19 6.27 59.59 17.55 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 24 3 # 24 A 44 HIS A 136 HIS~? 3.48 MN MN A 605s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 25 3 # 25 A 44 HIS A 136 HIS~? 3.48 MN MN A 605s A 45 HIS A 67 HIS~? -4.40 CL CL A 608s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 26 3 # 26 A 44 HIS A 136 HIS~? 3.48 MN MN A 605s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 59 PHE~? 9.30 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -6.57 49.40 16.71 -5.70 50.05 14.11 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 27 3 # 27 A 44 HIS A 136 HIS~? 3.48 MN MN A 605s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 74 PHE~? 8.88 MN MN A 604 coo 49.89 1.93 30.83 50.54 1.43 32.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 28 3 # 28 A 44 HIS A 136 HIS~? 3.48 MN MN A 605s A 45 HIS A 96 HIS~? -3.41 MN MN A 605s A 261 PHE A 129 PHE~? 10.87 CL CL A 608 coo 49.89 1.93 30.83 50.54 1.43 32.81 -0.57 59.60 14.33 0.78 59.36 15.93 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 29 3 # 29 A 44 HIS B 22 HIS~? -3.40 MN MN B 607s A 45 HIS B 66 HIS~? 3.43 MN MN B 607s A 261 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 49.89 1.93 30.83 50.54 1.43 32.81 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 30 3 # 30 A 44 HIS B 22 HIS~? -3.40 MN MN B 607s A 45 HIS B 66 HIS~? 3.43 MN MN B 607s A 261 PHE B 75 PHE~? 5.83 MN MN B 606 coo 49.89 1.93 30.83 50.54 1.43 32.81 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -15.10 72.64 3.42 -12.79 73.08 4.96 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 31 3 # 31 A 44 HIS B 66 HIS~? 3.43 MN MN B 607s A 45 HIS B 22 HIS~? -3.40 MN MN B 607s A 261 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 49.89 1.93 30.83 50.54 1.43 32.81 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 32 3 # 32 A 44 HIS B 66 HIS~? 3.43 MN MN B 607s A 45 HIS B 22 HIS~? -3.40 MN MN B 607s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 33 3 # 33 A 44 HIS B 66 HIS~? 3.43 MN MN B 607s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 49.89 1.93 30.83 50.54 1.43 32.81 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 34 3 # 34 A 44 HIS B 66 HIS~? 3.43 MN MN B 607s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 35 3 # 35 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 66 HIS~? 3.43 MN MN B 607s A 261 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 36 3 # 36 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 96 HIS~? -3.43 MN MN B 606s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 37 3 # 37 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 96 HIS~? -3.43 MN MN B 606s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 38 3 # 38 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 96 HIS~? -3.43 MN MN B 606s A 261 PHE B 144 PHE~? 5.38 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 39 3 # 39 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 100 HIS~? 8.87 CL CL B 609 A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 40 3 # 40 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 41 3 # 41 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 42 3 # 42 A 44 HIS B 67 HIS~? -4.45 CL CL B 609s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 144 PHE~? 5.38 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 43 3 # 43 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 44 3 # 44 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 45 3 # 45 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 144 PHE~? 5.38 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 46 3 # 46 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 100 HIS~? 8.87 CL CL B 609 A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 47 3 # 47 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 59 PHE~? 9.18 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.31 83.22 16.56 -5.26 82.55 14.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 48 3 # 48 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 49 3 # 49 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 129 PHE~? 10.86 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 50 3 # 50 A 44 HIS B 96 HIS~? -3.43 MN MN B 606s A 45 HIS B 136 HIS~? 3.50 MN MN B 606s A 261 PHE B 144 PHE~? 5.38 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 51 3 # 51 A 44 HIS B 100 HIS~? 8.87 CL CL B 609 A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 75 PHE~? 5.83 MN MN B 606 coo 49.89 1.93 30.83 50.54 1.43 32.81 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -15.10 72.64 3.42 -12.79 73.08 4.96 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 52 3 # 52 A 44 HIS B 136 HIS~? 3.50 MN MN B 606s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 53 3 # 53 A 44 HIS B 136 HIS~? 3.50 MN MN B 606s A 45 HIS B 67 HIS~? -4.45 CL CL B 609s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 54 3 # 54 A 44 HIS B 136 HIS~? 3.50 MN MN B 606s A 45 HIS B 96 HIS~? -3.43 MN MN B 606s A 261 PHE B 59 PHE~? 9.18 CL CL B 609 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -7.31 83.22 16.56 -5.26 82.55 14.74 ULMN 3 1luc_c00 BACTERIAL LUCIFERASE user 55 3 # 55 A 44 HIS B 136 HIS~? 3.50 MN MN B 606s A 45 HIS B 96 HIS~? -3.43 MN MN B 606s A 261 PHE B 74 PHE~? 8.86 MN MN B 607 coo 49.89 1.93 30.83 50.54 1.43 32.81 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 45.01 -1.52 29.84 44.56 -2.07 27.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.05 -5.25 41.21 44.22 -4.43 39.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 1luc_c00 source 1luc BACTERIAL LUCIFERASE : 55 hits 1luc_c00 naa= 3 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 295 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 369 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 11.74 38.14 80.19 10.63 36.40 80.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 16.11 33.72 80.99 14.10 33.54 81.63 7.70 72.78 18.03 7.03 72.92 20.00 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 295 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 369 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 11.74 38.14 80.19 10.63 36.40 80.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 16.11 33.72 80.99 14.10 33.54 81.63 0.70 67.61 16.19 -1.02 68.27 17.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 134 ASP~? 12.23 CL CL A 608 A 295 GLU B 91 GLU~? 11.42 MN MN B 606 A 369 ASP B 90 ASP~? 13.30 MN MN B 606 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 16.11 33.72 80.99 14.10 33.54 81.63 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 90 ASP~? 13.30 MN MN B 606 A 295 GLU B 87 GLU~? 16.36 MN MN B 606 A 369 ASP A 134 ASP~? 12.23 CL CL A 608 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 16.11 33.72 80.99 14.10 33.54 81.63 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 90 ASP~? 13.30 MN MN B 606 A 295 GLU B 91 GLU~? 11.42 MN MN B 606 A 369 ASP A 134 ASP~? 12.23 CL CL A 608 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 16.11 33.72 80.99 14.10 33.54 81.63 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1m53_c03 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 295 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 369 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 16.11 33.72 80.99 14.10 33.54 81.63 0.70 67.61 16.19 -1.02 68.27 17.25 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.32 68.36 21.17 7.09 68.49 22.34 1m53_c03 source 1m53 ISOMALTULOSE SYNTHASE : 6 hits 1m53_c03 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 265 GLU A 141 GLU~? 7.70 MN MN A 604 A 369 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 11.74 38.14 80.19 10.63 36.40 80.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.84 56.74 8.27 3.91 55.44 6.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 265 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 369 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 11.74 38.14 80.19 10.63 36.40 80.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 134 ASP~? 12.23 CL CL A 608 A 265 GLU A 109 GLU~? 22.92 CL CL A 608 A 369 ASP B 90 ASP~? 13.30 MN MN B 606 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 17.36 23.57 72.04 18.68 21.92 71.98 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 134 ASP~? 12.23 CL CL A 608 A 265 GLU B 141 GLU~? 7.71 MN MN B 607 A 369 ASP B 90 ASP~? 13.30 MN MN B 606 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 17.36 23.57 72.04 18.68 21.92 71.98 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP B 90 ASP~? 13.30 MN MN B 606 A 265 GLU A 109 GLU~? 22.92 CL CL A 608 A 369 ASP A 134 ASP~? 12.23 CL CL A 608 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP B 90 ASP~? 13.30 MN MN B 606 A 265 GLU B 141 GLU~? 7.71 MN MN B 607 A 369 ASP A 134 ASP~? 12.23 CL CL A 608 coo 11.74 38.14 80.19 10.63 36.40 80.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 12.19 31.08 87.29 11.13 32.66 86.38 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 265 GLU A 141 GLU~? 7.70 MN MN A 604 A 369 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 4.84 56.74 8.27 3.91 55.44 6.87 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.32 68.36 21.17 7.09 68.49 22.34 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 265 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 369 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 17.36 23.57 72.04 18.68 21.92 71.98 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.32 68.36 21.17 7.09 68.49 22.34 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 8 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 134 ASP~? 12.23 CL CL A 608 A 279 GLU A 71 GLU~? 7.91 MN MN A 605 A 369 ASP B 90 ASP~? 13.30 MN MN B 606 coo 11.74 38.14 80.19 10.63 36.40 80.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 16.54 46.37 63.94 14.77 45.79 62.95 4.56 57.67 23.22 2.91 58.15 24.47 coo 12.19 31.08 87.29 11.13 32.66 86.38 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 279 GLU B 71 GLU~? 7.93 MN MN B 606 A 369 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 11.74 38.14 80.19 10.63 36.40 80.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 16.54 46.37 63.94 14.77 45.79 62.95 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.32 68.36 21.17 7.09 68.49 22.34 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c06 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 94 ARG~? 6.60 C1 GOL B 603 229 SER A 88 SER~? 4.20 C3 GOL B 603 325 GLU A 91 GLU~? 5.92 C1 GOL B 603 coo 2.54 15.84 18.57 3.24 17.85 16.30 -0.58 68.78 21.39 1.97 70.41 20.81 coo 10.17 13.48 15.92 9.61 15.76 15.27 6.33 67.41 15.47 7.25 67.93 13.23 coo 5.42 13.04 19.75 5.74 13.81 17.79 0.70 67.61 16.19 -1.02 68.27 17.25 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 94 ARG~? 13.57 MN MN B 606 229 SER B 88 SER~? 11.77 MN MN B 606 325 GLU B 91 GLU~? 11.42 MN MN B 606 coo 2.54 15.84 18.57 3.24 17.85 16.30 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 10.17 13.48 15.92 9.61 15.76 15.27 -10.49 65.58 3.90 -8.66 65.20 2.38 coo 5.42 13.04 19.75 5.74 13.81 17.79 -9.23 65.09 9.44 -9.52 64.33 11.38 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 2 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 155 LYS~? 22.50 MN MN A 604 166 LYS A 153 LYS~? 20.22 C2 BME A 601 324 SER A 88 SER~? 4.20 C3 GOL B 603 coo 25.93 8.11 25.51 26.40 7.80 19.66 21.85 53.55 18.73 24.16 56.83 22.72 coo 27.27 1.43 25.09 29.18 5.25 22.89 23.06 52.60 13.46 22.53 47.10 11.88 coo 46.32 14.55 19.93 45.95 12.72 21.27 6.33 67.41 15.47 7.25 67.93 13.23 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 155 LYS~? 22.59 MN MN B 607 166 LYS B 153 LYS~? 21.64 S2 BME B 602 324 SER B 88 SER~? 11.77 MN MN B 606 coo 25.93 8.11 25.51 26.40 7.80 19.66 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 27.27 1.43 25.09 29.18 5.25 22.89 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 46.32 14.55 19.93 45.95 12.72 21.27 -10.49 65.58 3.90 -8.66 65.20 2.38 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c01 naa= 3 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 A 199 HIS A 67 HIS~? -4.40 CL CL A 608s A 246 HIS A 22 HIS~? -3.40 MN MN A 604s A 255 TYR A 19 TYR~? 9.00 MN MN A 604 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 0.35 54.22 20.29 -1.10 54.30 18.77 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.18 53.06 10.64 3.66 54.63 11.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 A 199 HIS A 96 HIS~? -3.41 MN MN A 605s A 246 HIS A 66 HIS~? 3.42 MN MN A 604s A 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 0.59 58.54 20.35 2.20 57.89 19.15 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.21 51.23 16.81 3.87 52.43 15.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 A 199 HIS A 100 HIS~? 8.88 CL CL A 608 A 246 HIS A 66 HIS~? 3.42 MN MN A 604s A 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.21 51.23 16.81 3.87 52.43 15.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 A 199 HIS A 136 HIS~? 3.48 MN MN A 605s A 246 HIS A 22 HIS~? -3.40 MN MN A 604s A 255 TYR A 19 TYR~? 9.00 MN MN A 604 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -0.57 59.60 14.33 0.78 59.36 15.93 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.18 53.06 10.64 3.66 54.63 11.95 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 A 199 HIS A 136 HIS~? 3.48 MN MN A 605s A 246 HIS A 66 HIS~? 3.42 MN MN A 604s A 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -0.57 59.60 14.33 0.78 59.36 15.93 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 3.21 51.23 16.81 3.87 52.43 15.22 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 A 199 HIS B 67 HIS~? -4.45 CL CL B 609s A 246 HIS B 22 HIS~? -3.40 MN MN B 607s A 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 A 199 HIS B 96 HIS~? -3.43 MN MN B 606s A 246 HIS B 66 HIS~? 3.43 MN MN B 607s A 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 A 199 HIS B 100 HIS~? 8.87 CL CL B 609 A 246 HIS B 66 HIS~? 3.43 MN MN B 607s A 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 9 3 # 9 A 199 HIS B 136 HIS~? 3.50 MN MN B 606s A 246 HIS B 22 HIS~? -3.40 MN MN B 607s A 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c00 CATECHOL 2,3-DIOXYGENASE user 10 3 # 10 A 199 HIS B 136 HIS~? 3.50 MN MN B 606s A 246 HIS B 66 HIS~? 3.43 MN MN B 607s A 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 93.73 21.39 -6.05 92.24 22.72 -5.44 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 85.83 25.80 -8.70 86.18 27.15 -7.14 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 84.84 30.41 -2.58 86.81 29.07 -4.09 -7.48 86.83 13.23 -7.97 85.45 10.86 1mpy_c00 source 1mpy CATECHOL 2,3-DIOXYGENASE : 10 hits 1mpy_c00 naa= 3 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 B 199 HIS A 96 HIS~? -3.41 MN MN A 605s B 246 HIS A 66 HIS~? 3.42 MN MN A 604s B 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 0.59 58.54 20.35 2.20 57.89 19.15 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 3.21 51.23 16.81 3.87 52.43 15.22 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 B 199 HIS A 100 HIS~? 8.88 CL CL A 608 B 246 HIS A 66 HIS~? 3.42 MN MN A 604s B 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 3.21 51.23 16.81 3.87 52.43 15.22 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 B 199 HIS A 136 HIS~? 3.48 MN MN A 605s B 246 HIS A 66 HIS~? 3.42 MN MN A 604s B 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -0.57 59.60 14.33 0.78 59.36 15.93 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 3.21 51.23 16.81 3.87 52.43 15.22 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 B 199 HIS B 67 HIS~? -4.45 CL CL B 609s B 246 HIS B 22 HIS~? -3.40 MN MN B 607s B 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 B 199 HIS B 96 HIS~? -3.43 MN MN B 606s B 246 HIS B 66 HIS~? 3.43 MN MN B 607s B 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 B 199 HIS B 100 HIS~? 8.87 CL CL B 609 B 246 HIS B 66 HIS~? 3.43 MN MN B 607s B 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 B 199 HIS B 136 HIS~? 3.50 MN MN B 606s B 246 HIS B 22 HIS~? -3.40 MN MN B 607s B 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c01 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 B 199 HIS B 136 HIS~? 3.50 MN MN B 606s B 246 HIS B 66 HIS~? 3.43 MN MN B 607s B 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 53.99 30.51 -6.27 55.94 30.59 -7.04 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 63.25 31.40 -4.63 63.50 32.04 -6.62 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 65.74 33.16 -11.89 63.54 33.33 -10.19 -7.48 86.83 13.23 -7.97 85.45 10.86 1mpy_c01 source 1mpy CATECHOL 2,3-DIOXYGENASE : 8 hits 1mpy_c01 naa= 3 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 C 199 HIS A 96 HIS~? -3.41 MN MN A 605s C 246 HIS A 66 HIS~? 3.42 MN MN A 604s C 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 0.59 58.54 20.35 2.20 57.89 19.15 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 3.21 51.23 16.81 3.87 52.43 15.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 C 199 HIS A 100 HIS~? 8.88 CL CL A 608 C 246 HIS A 66 HIS~? 3.42 MN MN A 604s C 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 3.21 51.23 16.81 3.87 52.43 15.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 C 199 HIS A 136 HIS~? 3.48 MN MN A 605s C 246 HIS A 66 HIS~? 3.42 MN MN A 604s C 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -0.57 59.60 14.33 0.78 59.36 15.93 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 3.21 51.23 16.81 3.87 52.43 15.22 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 C 199 HIS B 96 HIS~? -3.43 MN MN B 606s C 246 HIS B 66 HIS~? 3.43 MN MN B 607s C 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 C 199 HIS B 100 HIS~? 8.87 CL CL B 609 C 246 HIS B 66 HIS~? 3.43 MN MN B 607s C 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c02 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 C 199 HIS B 136 HIS~? 3.50 MN MN B 606s C 246 HIS B 66 HIS~? 3.43 MN MN B 607s C 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 88.23 -2.44 -2.31 86.28 -2.49 -3.06 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 79.18 -3.01 0.51 78.86 -4.28 -1.13 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 76.37 -6.84 -5.95 78.54 -6.39 -4.23 -7.48 86.83 13.23 -7.97 85.45 10.86 1mpy_c02 source 1mpy CATECHOL 2,3-DIOXYGENASE : 6 hits 1mpy_c02 naa= 3 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 1 3 # 1 D 199 HIS A 96 HIS~? -3.41 MN MN A 605s D 246 HIS A 66 HIS~? 3.42 MN MN A 604s D 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 0.59 58.54 20.35 2.20 57.89 19.15 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 2 3 # 2 D 199 HIS A 100 HIS~? 8.88 CL CL A 608 D 246 HIS A 66 HIS~? 3.42 MN MN A 604s D 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 3 3 # 3 D 199 HIS A 136 HIS~? 3.48 MN MN A 605s D 246 HIS A 66 HIS~? 3.42 MN MN A 604s D 255 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -0.57 59.60 14.33 0.78 59.36 15.93 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 4 3 # 4 D 199 HIS B 67 HIS~? -4.45 CL CL B 609s D 246 HIS B 22 HIS~? -3.40 MN MN B 607s D 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 5 3 # 5 D 199 HIS B 96 HIS~? -3.43 MN MN B 606s D 246 HIS B 66 HIS~? 3.43 MN MN B 607s D 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 6 3 # 6 D 199 HIS B 100 HIS~? 8.87 CL CL B 609 D 246 HIS B 66 HIS~? 3.43 MN MN B 607s D 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 7 3 # 7 D 199 HIS B 136 HIS~? 3.50 MN MN B 606s D 246 HIS B 22 HIS~? -3.40 MN MN B 607s D 255 TYR B 19 TYR~? 9.04 MN MN B 607 coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1mpy_c03 CATECHOL 2,3-DIOXYGENASE user 8 3 # 8 D 199 HIS B 136 HIS~? 3.50 MN MN B 606s D 246 HIS B 66 HIS~? 3.43 MN MN B 607s D 255 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 48.45 6.59 -2.19 50.13 5.63 -1.41 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 56.33 1.43 -3.93 56.30 0.87 -1.91 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.78 -0.98 3.43 55.81 -0.18 1.59 -7.48 86.83 13.23 -7.97 85.45 10.86 1mpy_c03 source 1mpy CATECHOL 2,3-DIOXYGENASE : 8 hits 1mpy_c03 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 23 GLY~? 8.40 S2 BME A 601 A 501 ASP B 90 ASP~? 13.30 MN MN B 606 B 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.32 48.34 7.45 1.06 48.38 8.26 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 30 GLY~? 15.40 CL CL A 608 A 501 ASP A 145 ASP~? 14.76 MN MN A 604 B 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -8.98 49.82 5.50 -9.25 49.53 6.25 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 12.32 59.45 6.26 13.32 58.94 4.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY A 98 GLY~? 10.67 MN MN A 605 A 501 ASP A 145 ASP~? 14.76 MN MN A 604 B 367 TYR A 38 TYR~? 24.60 S2 BME A 601 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -6.79 61.25 20.29 -6.32 60.57 20.44 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 12.32 59.45 6.26 13.32 58.94 4.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -19.15 43.63 4.59 -19.32 40.84 4.29 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY A 132 GLY~? 10.05 CL CL A 608 A 501 ASP A 145 ASP~? 14.76 MN MN A 604 B 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 12.32 59.45 6.26 13.32 58.94 4.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 5 3 # 5 A 465 GLY A 132 GLY~? 10.05 CL CL A 608 A 501 ASP B 145 ASP~? 15.01 MN MN B 607 B 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 6 3 # 6 A 465 GLY B 23 GLY~? 8.34 S2 BME B 602 A 501 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 5.32 68.36 21.17 7.09 68.49 22.34 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 7 3 # 7 A 465 GLY B 30 GLY~? 10.80 O1 GOL B 603 A 501 ASP B 145 ASP~? 15.01 MN MN B 607 B 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 4.09 82.83 14.51 3.51 83.12 15.05 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 8 3 # 8 A 465 GLY B 132 GLY~? 6.66 O1 GOL B 603 A 501 ASP A 145 ASP~? 14.76 MN MN A 604 B 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 12.32 59.45 6.26 13.32 58.94 4.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 9 3 # 9 A 465 GLY B 132 GLY~? 6.66 O1 GOL B 603 A 501 ASP B 145 ASP~? 15.01 MN MN B 607 B 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 21.25 61.48 16.87 23.18 60.31 18.55 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 9 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 23 GLY~? 8.40 S2 BME A 601 D 501 ASP B 90 ASP~? 13.30 MN MN B 606 E 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.32 48.34 7.45 1.06 48.38 8.26 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 30 GLY~? 15.40 CL CL A 608 D 501 ASP A 145 ASP~? 14.76 MN MN A 604 E 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -8.98 49.82 5.50 -9.25 49.53 6.25 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.32 59.45 6.26 13.32 58.94 4.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY A 98 GLY~? 10.67 MN MN A 605 D 501 ASP A 145 ASP~? 14.76 MN MN A 604 E 367 TYR A 38 TYR~? 24.60 S2 BME A 601 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -6.79 61.25 20.29 -6.32 60.57 20.44 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.32 59.45 6.26 13.32 58.94 4.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -19.15 43.63 4.59 -19.32 40.84 4.29 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY A 132 GLY~? 10.05 CL CL A 608 D 501 ASP A 145 ASP~? 14.76 MN MN A 604 E 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.32 59.45 6.26 13.32 58.94 4.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 5 3 # 5 D 465 GLY A 132 GLY~? 10.05 CL CL A 608 D 501 ASP B 145 ASP~? 15.01 MN MN B 607 E 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 6 3 # 6 D 465 GLY B 23 GLY~? 8.34 S2 BME B 602 D 501 ASP A 90 ASP~? 8.93 C1 GOL B 603 E 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 5.32 68.36 21.17 7.09 68.49 22.34 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 7 3 # 7 D 465 GLY B 30 GLY~? 10.80 O1 GOL B 603 D 501 ASP B 145 ASP~? 15.01 MN MN B 607 E 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 4.09 82.83 14.51 3.51 83.12 15.05 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.25 61.48 16.87 23.18 60.31 18.55 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 8 3 # 8 D 465 GLY B 98 GLY~? 10.76 MN MN B 606 D 501 ASP B 145 ASP~? 15.01 MN MN B 607 E 367 TYR B 38 TYR~? 21.27 O1 GOL B 603 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -10.36 71.24 18.20 -10.64 71.91 17.78 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 8.78 89.03 23.51 9.07 91.81 23.56 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 9 3 # 9 D 465 GLY B 132 GLY~? 6.66 O1 GOL B 603 D 501 ASP A 145 ASP~? 14.76 MN MN A 604 E 367 TYR B 81 TYR~? 20.14 MN MN B 607 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 12.32 59.45 6.26 13.32 58.94 4.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -17.71 71.48 -9.36 -20.01 72.70 -10.43 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 10 3 # 10 D 465 GLY B 132 GLY~? 6.66 O1 GOL B 603 D 501 ASP B 145 ASP~? 15.01 MN MN B 607 E 367 TYR A 81 TYR~? 20.10 MN MN A 604 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 21.25 61.48 16.87 23.18 60.31 18.55 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 10 hits 1mro_c01 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 153 LYS~? 20.22 C2 BME A 601 A 169 LYS A 155 LYS~? 22.50 MN MN A 604 A 327 GLU A 13 GLU~? 14.48 C2 BME A 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 23.06 52.60 13.46 22.53 47.10 11.88 coo 24.31 10.25 23.71 29.02 12.05 20.75 21.85 53.55 18.73 24.16 56.83 22.72 coo 21.86 20.40 18.59 22.12 18.33 18.33 16.66 45.80 10.16 16.30 43.75 10.43 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS A 155 LYS~? 22.50 MN MN A 604 A 169 LYS A 153 LYS~? 20.22 C2 BME A 601 A 327 GLU A 161 GLU~? 18.40 O1 BME A 601 coo 20.73 15.53 25.54 22.09 15.64 19.40 21.85 53.55 18.73 24.16 56.83 22.72 coo 24.31 10.25 23.71 29.02 12.05 20.75 23.06 52.60 13.46 22.53 47.10 11.88 coo 21.86 20.40 18.59 22.12 18.33 18.33 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 3 3 # 3 A 167 LYS B 153 LYS~? 21.64 S2 BME B 602 A 169 LYS B 155 LYS~? 22.59 MN MN B 607 A 327 GLU B 13 GLU~? 14.49 C2 BME B 602 coo 20.73 15.53 25.54 22.09 15.64 19.40 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 24.31 10.25 23.71 29.02 12.05 20.75 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 21.86 20.40 18.59 22.12 18.33 18.33 -10.54 87.21 -7.31 -10.84 89.32 -6.98 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 4 3 # 4 A 167 LYS B 155 LYS~? 22.59 MN MN B 607 A 169 LYS B 153 LYS~? 21.64 S2 BME B 602 A 327 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 20.73 15.53 25.54 22.09 15.64 19.40 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 24.31 10.25 23.71 29.02 12.05 20.75 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 21.86 20.40 18.59 22.12 18.33 18.33 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 153 LYS~? 20.22 C2 BME A 601 B 169 LYS A 155 LYS~? 22.50 MN MN A 604 B 327 GLU A 13 GLU~? 14.48 C2 BME A 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 23.06 52.60 13.46 22.53 47.10 11.88 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 21.85 53.55 18.73 24.16 56.83 22.72 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 16.66 45.80 10.16 16.30 43.75 10.43 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS A 155 LYS~? 22.50 MN MN A 604 B 169 LYS A 153 LYS~? 20.22 C2 BME A 601 B 327 GLU A 161 GLU~? 18.40 O1 BME A 601 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 21.85 53.55 18.73 24.16 56.83 22.72 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 23.06 52.60 13.46 22.53 47.10 11.88 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 3 3 # 3 B 167 LYS B 153 LYS~? 21.64 S2 BME B 602 B 169 LYS B 155 LYS~? 22.59 MN MN B 607 B 327 GLU B 13 GLU~? 14.49 C2 BME B 602 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -10.54 87.21 -7.31 -10.84 89.32 -6.98 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 4 3 # 4 B 167 LYS B 155 LYS~? 22.59 MN MN B 607 B 169 LYS B 153 LYS~? 21.64 S2 BME B 602 B 327 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 4 hits 1muc_c01 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 67 HIS~? -4.40 CL CL A 608s A 197 ASP A 69 ASP~? 7.42 O1 BME A 601 A 223 ALA A 20 ALA~? 6.78 S2 BME A 601 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 0.35 54.22 20.29 -1.10 54.30 18.77 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 7.88 51.22 19.98 7.64 49.14 20.25 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS A 100 HIS~? 8.88 CL CL A 608 A 197 ASP A 101 ASP~? 14.47 MN MN A 605 A 223 ALA A 56 ALA~? 13.66 C1 BME A 601 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -10.00 44.91 18.30 -11.30 44.53 19.04 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS A 100 HIS~? 8.88 CL CL A 608 A 197 ASP A 101 ASP~? 14.47 MN MN A 605 A 223 ALA A 108 ALA~? 20.95 CL CL A 608 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -17.92 50.65 21.89 -18.27 51.97 22.49 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 A 114 HIS A 100 HIS~? 8.88 CL CL A 608 A 197 ASP A 101 ASP~? 14.47 MN MN A 605 A 223 ALA A 131 ALA~? 14.03 CL CL A 608 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -9.04 59.66 9.42 -10.10 60.80 9.30 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 A 114 HIS A 136 HIS~? 3.48 MN MN A 605s A 197 ASP A 134 ASP~? 12.23 CL CL A 608 A 223 ALA B 138 ALA~? 6.55 O3 GOL B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -0.57 59.60 14.33 0.78 59.36 15.93 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -1.39 71.52 5.72 -0.38 70.66 6.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 A 114 HIS B 100 HIS~? 8.87 CL CL B 609 A 197 ASP B 101 ASP~? 14.48 MN MN B 606 A 223 ALA B 108 ALA~? 20.82 CL CL B 609 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -7.86 82.27 28.90 -8.27 80.95 29.48 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 A 114 HIS B 100 HIS~? 8.87 CL CL B 609 A 197 ASP B 101 ASP~? 14.48 MN MN B 606 A 223 ALA B 131 ALA~? -3.51 O1 GOL B 603s coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 0.55 72.95 16.09 1.01 71.82 17.02 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 A 114 HIS B 136 HIS~? 3.50 MN MN B 606s A 197 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 223 ALA A 138 ALA~? 8.43 O3 GOL B 603 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 1.27 73.42 12.01 2.60 75.02 12.38 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 1.31 61.33 7.33 0.25 62.15 6.66 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 67 HIS~? -4.40 CL CL A 608s B 197 ASP A 69 ASP~? 7.42 O1 BME A 601 B 223 ALA A 20 ALA~? 6.78 S2 BME A 601 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 0.35 54.22 20.29 -1.10 54.30 18.77 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 7.88 51.22 19.98 7.64 49.14 20.25 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS A 100 HIS~? 8.88 CL CL A 608 B 197 ASP A 101 ASP~? 14.47 MN MN A 605 B 223 ALA A 56 ALA~? 13.66 C1 BME A 601 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -10.00 44.91 18.30 -11.30 44.53 19.04 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS A 100 HIS~? 8.88 CL CL A 608 B 197 ASP A 101 ASP~? 14.47 MN MN A 605 B 223 ALA A 108 ALA~? 20.95 CL CL A 608 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -17.92 50.65 21.89 -18.27 51.97 22.49 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 4 3 # 4 B 114 HIS A 100 HIS~? 8.88 CL CL A 608 B 197 ASP A 101 ASP~? 14.47 MN MN A 605 B 223 ALA A 131 ALA~? 14.03 CL CL A 608 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -9.04 59.66 9.42 -10.10 60.80 9.30 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 5 3 # 5 B 114 HIS A 136 HIS~? 3.48 MN MN A 605s B 197 ASP A 134 ASP~? 12.23 CL CL A 608 B 223 ALA B 138 ALA~? 6.55 O3 GOL B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -0.57 59.60 14.33 0.78 59.36 15.93 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -1.39 71.52 5.72 -0.38 70.66 6.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 6 3 # 6 B 114 HIS B 100 HIS~? 8.87 CL CL B 609 B 197 ASP B 101 ASP~? 14.48 MN MN B 606 B 223 ALA B 108 ALA~? 20.82 CL CL B 609 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -7.86 82.27 28.90 -8.27 80.95 29.48 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 7 3 # 7 B 114 HIS B 100 HIS~? 8.87 CL CL B 609 B 197 ASP B 101 ASP~? 14.48 MN MN B 606 B 223 ALA B 131 ALA~? -3.51 O1 GOL B 603s coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 0.55 72.95 16.09 1.01 71.82 17.02 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 8 3 # 8 B 114 HIS B 136 HIS~? 3.50 MN MN B 606s B 197 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 223 ALA A 138 ALA~? 8.43 O3 GOL B 603 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 1.27 73.42 12.01 2.60 75.02 12.38 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 1.31 61.33 7.33 0.25 62.15 6.66 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 8 hits 1n2t_c03 naa= 3 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 205 ASP A 69 ASP~? 7.42 O1 BME A 601 A 208 HIS A 66 HIS~? 3.42 MN MN A 604s C 104 HIS A 67 HIS~? -4.40 CL CL A 608s coo 20.72 31.33 73.27 20.15 33.36 73.56 7.88 51.22 19.98 7.64 49.14 20.25 coo 17.00 33.82 71.84 16.59 31.98 70.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 20.06 38.06 74.21 21.19 36.81 72.96 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1ndo_c00 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 205 ASP B 69 ASP~? 7.66 S2 BME B 602 A 208 HIS B 66 HIS~? 3.43 MN MN B 607s C 104 HIS B 67 HIS~? -4.45 CL CL B 609s coo 20.72 31.33 73.27 20.15 33.36 73.56 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 17.00 33.82 71.84 16.59 31.98 70.88 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 20.06 38.06 74.21 21.19 36.81 72.96 -13.16 78.27 11.53 -11.33 78.28 12.55 1ndo_c00 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c00 naa= 3 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 A 104 HIS A 67 HIS~? -4.40 CL CL A 608s E 205 ASP A 69 ASP~? 7.42 O1 BME A 601 E 208 HIS A 66 HIS~? 3.42 MN MN A 604s coo 36.32 11.24 30.83 37.00 13.22 30.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 38.79 15.70 26.44 37.66 14.35 27.62 7.88 51.22 19.98 7.64 49.14 20.25 coo 34.24 14.63 26.81 34.14 16.25 25.49 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1ndo_c01 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 A 104 HIS B 67 HIS~? -4.45 CL CL B 609s E 205 ASP B 69 ASP~? 7.66 S2 BME B 602 E 208 HIS B 66 HIS~? 3.43 MN MN B 607s coo 36.32 11.24 30.83 37.00 13.22 30.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 38.79 15.70 26.44 37.66 14.35 27.62 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 34.24 14.63 26.81 34.14 16.25 25.49 -11.11 81.39 7.66 -9.84 80.27 6.41 1ndo_c01 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c01 naa= 3 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 1 3 # 1 C 205 ASP A 69 ASP~? 7.42 O1 BME A 601 C 208 HIS A 66 HIS~? 3.42 MN MN A 604s E 104 HIS A 67 HIS~? -4.40 CL CL A 608s coo 36.50 67.03 37.59 36.77 66.38 35.61 7.88 51.22 19.98 7.64 49.14 20.25 coo 33.45 66.12 34.16 32.13 66.40 35.76 3.21 51.23 16.81 3.87 52.43 15.22 coo 38.29 64.94 31.33 38.08 64.16 33.27 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1ndo_c02 NAPTHALENE 1,2-DIOXYGENASE user 2 3 # 2 C 205 ASP B 69 ASP~? 7.66 S2 BME B 602 C 208 HIS B 66 HIS~? 3.43 MN MN B 607s E 104 HIS B 67 HIS~? -4.45 CL CL B 609s coo 36.50 67.03 37.59 36.77 66.38 35.61 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 33.45 66.12 34.16 32.13 66.40 35.76 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 38.29 64.94 31.33 38.08 64.16 33.27 -13.16 78.27 11.53 -11.33 78.28 12.55 1ndo_c02 source 1ndo NAPTHALENE 1,2-DIOXYGENASE : 2 hits 1ndo_c02 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 22 HIS~? -3.40 MN MN A 604s A 290 LYS A 24 LYS~? 4.08 C2 BME A 601 A 405 ARG A 167 ARG~? -4.94 O1 BME A 601s coo 41.33 25.99 28.05 41.95 26.95 29.80 3.18 53.06 10.64 3.66 54.63 11.95 coo 37.11 33.75 31.82 38.72 27.95 29.90 -0.91 46.54 9.97 2.66 42.32 12.44 coo 42.28 27.98 41.30 43.16 28.14 38.35 6.75 43.81 21.29 6.50 46.65 20.31 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 22 HIS~? -3.40 MN MN B 607s A 290 LYS B 24 LYS~? -3.00 C2 BME B 602s A 405 ARG B 167 ARG~? 6.18 S2 BME B 602 coo 41.33 25.99 28.05 41.95 26.95 29.80 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 37.11 33.75 31.82 38.72 27.95 29.90 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 42.28 27.98 41.30 43.16 28.14 38.35 -16.44 88.73 6.31 -15.58 85.88 6.16 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 B 59 GLU A 72 GLU~? 12.86 MN MN A 605 B 128 HIS A 96 HIS~? -3.41 MN MN A 605s C 263 HIS A 22 HIS~? -3.40 MN MN A 604s coo 6.12 5.94 82.00 7.16 6.32 83.81 8.16 54.29 26.80 8.10 55.96 28.07 coo 12.51 16.35 80.99 13.16 14.90 82.37 0.59 58.54 20.35 2.20 57.89 19.15 coo 11.58 14.94 93.26 12.25 14.03 91.50 3.18 53.06 10.64 3.66 54.63 11.95 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 B 59 GLU B 72 GLU~? 13.02 MN MN B 606 B 128 HIS B 66 HIS~? 3.43 MN MN B 607s C 263 HIS B 100 HIS~? 8.87 CL CL B 609 coo 6.12 5.94 82.00 7.16 6.32 83.81 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 12.51 16.35 80.99 13.16 14.90 82.37 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 11.58 14.94 93.26 12.25 14.03 91.50 -13.86 76.47 17.25 -14.56 76.87 15.30 ULMN 3 1ni4_c00 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 B 59 GLU B 72 GLU~? 13.02 MN MN B 606 B 128 HIS B 96 HIS~? -3.43 MN MN B 606s C 263 HIS B 22 HIS~? -3.40 MN MN B 607s coo 6.12 5.94 82.00 7.16 6.32 83.81 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 12.51 16.35 80.99 13.16 14.90 82.37 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 11.58 14.94 93.26 12.25 14.03 91.50 -5.34 79.70 5.35 -6.67 78.07 5.35 1ni4_c00 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 3 hits 1ni4_c00 naa= 3 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 1 3 # 1 A 263 HIS A 22 HIS~? -3.40 MN MN A 604s D 59 GLU A 72 GLU~? 12.86 MN MN A 605 D 128 HIS A 96 HIS~? -3.41 MN MN A 605s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 3.18 53.06 10.64 3.66 54.63 11.95 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.16 54.29 26.80 8.10 55.96 28.07 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 2 3 # 2 A 263 HIS A 100 HIS~? 8.88 CL CL A 608 D 59 GLU A 72 GLU~? 12.86 MN MN A 605 D 128 HIS A 66 HIS~? 3.42 MN MN A 604s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.16 54.29 26.80 8.10 55.96 28.07 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 3 3 # 3 A 263 HIS A 100 HIS~? 8.88 CL CL A 608 D 59 GLU B 91 GLU~? 11.42 MN MN B 606 D 128 HIS A 136 HIS~? 3.48 MN MN A 605s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 4 3 # 4 A 263 HIS A 136 HIS~? 3.48 MN MN A 605s D 59 GLU A 68 GLU~? 10.93 O1 BME A 601 D 128 HIS A 100 HIS~? 8.88 CL CL A 608 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 5.73 51.66 25.85 5.32 49.97 27.08 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 5 3 # 5 A 263 HIS A 136 HIS~? 3.48 MN MN A 605s D 59 GLU A 72 GLU~? 12.86 MN MN A 605 D 128 HIS A 100 HIS~? 8.88 CL CL A 608 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 8.16 54.29 26.80 8.10 55.96 28.07 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 6 3 # 6 A 263 HIS B 22 HIS~? -3.40 MN MN B 607s D 59 GLU B 72 GLU~? 13.02 MN MN B 606 D 128 HIS B 96 HIS~? -3.43 MN MN B 606s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 7 3 # 7 A 263 HIS B 100 HIS~? 8.87 CL CL B 609 D 59 GLU A 91 GLU~? 5.92 C1 GOL B 603 D 128 HIS B 136 HIS~? 3.50 MN MN B 606s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 0.70 67.61 16.19 -1.02 68.27 17.25 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 8 3 # 8 A 263 HIS B 100 HIS~? 8.87 CL CL B 609 D 59 GLU B 72 GLU~? 13.02 MN MN B 606 D 128 HIS B 66 HIS~? 3.43 MN MN B 607s coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1ni4_c01 PYRUVATE DEHYDROGENASE E1 COMPONENT:user 9 3 # 9 A 263 HIS B 136 HIS~? 3.50 MN MN B 606s D 59 GLU B 72 GLU~? 13.02 MN MN B 606 D 128 HIS B 100 HIS~? 8.87 CL CL B 609 coo 8.65 -19.64 67.59 7.76 -17.92 68.39 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 12.72 -5.58 71.72 12.08 -7.54 72.22 -22.12 78.07 6.79 -23.41 76.46 7.29 coo 4.03 -8.95 63.85 3.80 -9.89 65.71 -13.86 76.47 17.25 -14.56 76.87 15.30 1ni4_c01 source 1ni4 PYRUVATE DEHYDROGENASE E1 COMPONENT: ALPHA SUB: 9 hits 1ni4_c01 naa= 3 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 1 3 # 1 B 237 HIS A 22 HIS~? -3.40 MN MN A 604s B 238 GLY A 23 GLY~? 8.40 S2 BME A 601 B 287 CYH A 21 CYH~? -2.28 S2 BME A 601s coo 51.19 11.65 88.44 53.07 12.52 88.13 3.18 53.06 10.64 3.66 54.63 11.95 coo 45.40 11.66 89.13 45.79 11.98 88.49 1.32 48.34 7.45 1.06 48.38 8.26 coo 48.33 16.15 90.44 50.61 16.80 91.98 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 3 1nw9_c02 CASPASE 9, APOPTOSIS-RELATED CYSTEINuser 2 3 # 2 B 237 HIS B 22 HIS~? -3.40 MN MN B 607s B 238 GLY B 23 GLY~? 8.34 S2 BME B 602 B 287 CYH B 21 CYH~? -2.10 S2 BME B 602s coo 51.19 11.65 88.44 53.07 12.52 88.13 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 45.40 11.66 89.13 45.79 11.98 88.49 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 48.33 16.15 90.44 50.61 16.80 91.98 -7.07 84.75 5.98 -9.76 85.47 5.91 1nw9_c02 source 1nw9 CASPASE 9, APOPTOSIS-RELATED CYSTEINE PROTEASE: 2 hits 1nw9_c02 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 69 ASP~? 7.42 O1 BME A 601 A 146 TYR A 58 TYR~? -4.88 S2 BME A 601s A 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -3.50 124.89 25.05 -2.25 124.77 23.26 7.88 51.22 19.98 7.64 49.14 20.25 coo 1.87 119.38 16.45 1.41 122.11 16.84 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP B 69 ASP~? 7.66 S2 BME B 602 A 146 TYR B 58 TYR~? -4.91 S2 BME B 602s A 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -3.50 124.89 25.05 -2.25 124.77 23.26 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 1.87 119.38 16.45 1.41 122.11 16.84 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -2.59 124.07 12.67 -0.91 126.17 18.42 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 69 ASP~? 7.42 O1 BME A 601 B 146 TYR A 58 TYR~? -4.88 S2 BME A 601s B 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -7.43 109.06 51.23 -5.84 110.54 50.86 7.88 51.22 19.98 7.64 49.14 20.25 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP B 69 ASP~? 7.66 S2 BME B 602 B 146 TYR B 58 TYR~? -4.91 S2 BME B 602s B 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -7.43 109.06 51.23 -5.84 110.54 50.86 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 0.22 114.56 44.62 -0.76 115.18 47.18 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -4.18 120.17 46.85 -4.02 115.31 51.00 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 69 ASP~? 7.42 O1 BME A 601 C 146 TYR A 58 TYR~? -4.88 S2 BME A 601s C 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -13.49 79.65 43.90 -12.13 80.29 45.45 7.88 51.22 19.98 7.64 49.14 20.25 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP B 69 ASP~? 7.66 S2 BME B 602 C 146 TYR B 58 TYR~? -4.91 S2 BME B 602s C 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -13.49 79.65 43.90 -12.13 80.29 45.45 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -5.65 86.78 48.49 -7.16 84.72 49.65 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -11.22 87.18 53.49 -10.94 81.64 50.31 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 69 ASP~? 7.42 O1 BME A 601 D 146 TYR A 58 TYR~? -4.88 S2 BME A 601s D 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -13.44 77.36 13.12 -12.53 75.97 14.48 7.88 51.22 19.98 7.64 49.14 20.25 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP B 69 ASP~? 7.66 S2 BME B 602 D 146 TYR B 58 TYR~? -4.91 S2 BME B 602s D 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -13.44 77.36 13.12 -12.53 75.97 14.48 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -7.85 74.44 22.75 -9.22 72.86 20.89 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -14.24 70.61 23.48 -12.55 71.73 17.42 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 69 ASP~? 7.42 O1 BME A 601 E 146 TYR A 58 TYR~? -4.88 S2 BME A 601s E 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -7.12 105.25 1.43 -6.30 103.34 0.77 7.88 51.22 19.98 7.64 49.14 20.25 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP B 69 ASP~? 7.66 S2 BME B 602 E 146 TYR B 58 TYR~? -4.91 S2 BME B 602s E 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -7.12 105.25 1.43 -6.30 103.34 0.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -3.11 94.55 3.01 -3.83 95.92 0.66 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 69 ASP~? 7.42 O1 BME A 601 F 146 TYR A 58 TYR~? -4.88 S2 BME A 601s F 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -44.75 128.15 10.28 -45.68 129.67 11.55 7.88 51.22 19.98 7.64 49.14 20.25 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP B 69 ASP~? 7.66 S2 BME B 602 F 146 TYR B 58 TYR~? -4.91 S2 BME B 602s F 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -44.75 128.15 10.28 -45.68 129.67 11.55 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -50.43 131.90 19.60 -49.04 133.31 17.60 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -44.10 135.86 19.99 -45.67 134.21 14.07 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 69 ASP~? 7.42 O1 BME A 601 G 146 TYR A 58 TYR~? -4.88 S2 BME A 601s G 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -44.97 128.78 41.20 -46.32 128.26 42.83 7.88 51.22 19.98 7.64 49.14 20.25 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP B 69 ASP~? 7.66 S2 BME B 602 G 146 TYR B 58 TYR~? -4.91 S2 BME B 602s G 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -44.97 128.78 41.20 -46.32 128.26 42.83 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -52.83 122.13 46.42 -51.31 124.30 47.39 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -47.30 122.24 51.49 -47.46 127.44 47.81 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 69 ASP~? 7.42 O1 BME A 601 H 146 TYR A 58 TYR~? -4.88 S2 BME A 601s H 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -51.11 100.30 51.41 -52.67 98.82 51.12 7.88 51.22 19.98 7.64 49.14 20.25 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP B 69 ASP~? 7.66 S2 BME B 602 H 146 TYR B 58 TYR~? -4.91 S2 BME B 602s H 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -51.11 100.30 51.41 -52.67 98.82 51.12 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -58.70 94.17 45.32 -57.76 93.82 47.92 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -54.32 88.79 48.13 -54.61 94.04 51.74 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 69 ASP~? 7.42 O1 BME A 601 I 146 TYR A 58 TYR~? -4.88 S2 BME A 601s I 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -54.65 81.97 26.87 -55.88 81.89 25.07 7.88 51.22 19.98 7.64 49.14 20.25 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP B 69 ASP~? 7.66 S2 BME B 602 I 146 TYR B 58 TYR~? -4.91 S2 BME B 602s I 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -54.65 81.97 26.87 -55.88 81.89 25.07 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -59.92 86.62 17.74 -59.42 83.94 18.40 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -55.38 81.61 14.50 -57.11 80.05 20.41 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 69 ASP~? 7.42 O1 BME A 601 J 146 TYR A 58 TYR~? -4.88 S2 BME A 601s J 177 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -50.64 99.08 1.52 -51.52 100.83 0.67 7.88 51.22 19.98 7.64 49.14 20.25 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -3.46 45.81 15.49 -1.06 47.20 15.11 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP B 69 ASP~? 7.66 S2 BME B 602 J 146 TYR B 58 TYR~? -4.91 S2 BME B 602s J 177 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -50.64 99.08 1.52 -51.52 100.83 0.67 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 -7.48 86.83 13.23 -7.97 85.45 10.86 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 -3.23 86.22 8.94 -7.29 90.78 7.55 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 2 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 69 ASP~? 7.42 O1 BME A 601 A 96 GLU A 158 GLU~? 21.27 MN MN A 604 A 132 LYS A 155 LYS~? 22.50 MN MN A 604 coo 31.23 12.29 16.44 30.82 11.56 18.39 7.88 51.22 19.98 7.64 49.14 20.25 coo 26.82 3.20 24.36 27.99 4.86 24.98 20.85 50.69 23.17 22.14 52.15 24.00 coo 29.99 0.62 22.18 30.38 6.69 20.81 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 101 ASP~? 14.47 MN MN A 605 A 96 GLU A 124 GLU~? 15.58 MN MN B 606 A 132 LYS A 127 LYS~? 18.61 MN MN B 606 coo 31.23 12.29 16.44 30.82 11.56 18.39 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 26.82 3.20 24.36 27.99 4.86 24.98 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 29.99 0.62 22.18 30.38 6.69 20.81 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP B 69 ASP~? 7.66 S2 BME B 602 A 96 GLU B 158 GLU~? 21.38 MN MN B 607 A 132 LYS B 155 LYS~? 22.59 MN MN B 607 coo 31.23 12.29 16.44 30.82 11.56 18.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 26.82 3.20 24.36 27.99 4.86 24.98 -23.65 82.01 -6.24 -24.87 80.63 -7.27 coo 29.99 0.62 22.18 30.38 6.69 20.81 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP B 101 ASP~? 14.48 MN MN B 606 A 96 GLU B 124 GLU~? 10.55 C1 GOL B 603 A 132 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 31.23 12.29 16.44 30.82 11.56 18.39 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 26.82 3.20 24.36 27.99 4.86 24.98 0.65 71.77 26.43 1.32 70.82 24.72 coo 29.99 0.62 22.18 30.38 6.69 20.81 2.32 75.24 21.44 7.34 73.34 24.59 1onr_c00 source 1onr TRANSALDOLASE B : 4 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 69 ASP~? 7.42 O1 BME A 601 B 96 GLU A 158 GLU~? 21.27 MN MN A 604 B 132 LYS A 155 LYS~? 22.50 MN MN A 604 coo 31.16 57.31 -0.94 30.73 56.64 1.01 7.88 51.22 19.98 7.64 49.14 20.25 coo 26.69 48.45 7.18 27.85 50.13 7.74 20.85 50.69 23.17 22.14 52.15 24.00 coo 29.82 45.80 5.07 30.26 51.81 3.56 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 101 ASP~? 14.47 MN MN A 605 B 96 GLU A 124 GLU~? 15.58 MN MN B 606 B 132 LYS A 127 LYS~? 18.61 MN MN B 606 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 26.69 48.45 7.18 27.85 50.13 7.74 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 29.82 45.80 5.07 30.26 51.81 3.56 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP B 69 ASP~? 7.66 S2 BME B 602 B 96 GLU B 158 GLU~? 21.38 MN MN B 607 B 132 LYS B 155 LYS~? 22.59 MN MN B 607 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 26.69 48.45 7.18 27.85 50.13 7.74 -23.65 82.01 -6.24 -24.87 80.63 -7.27 coo 29.82 45.80 5.07 30.26 51.81 3.56 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP B 101 ASP~? 14.48 MN MN B 606 B 96 GLU B 124 GLU~? 10.55 C1 GOL B 603 B 132 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 31.16 57.31 -0.94 30.73 56.64 1.01 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 26.69 48.45 7.18 27.85 50.13 7.74 0.65 71.77 26.43 1.32 70.82 24.72 coo 29.82 45.80 5.07 30.26 51.81 3.56 2.32 75.24 21.44 7.34 73.34 24.59 1onr_c01 source 1onr TRANSALDOLASE B : 4 hits 1onr_c01 naa= 3 ULMN 3 1opm_c00 1.14.17.0003 user 1 3 # 1 A 108 HIS A 136 HIS~? 3.48 MN MN A 605s A 170 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 242 HIS A 67 HIS~? -4.40 CL CL A 608s coo 36.16 34.36 39.40 38.12 34.09 40.00 -0.57 59.60 14.33 0.78 59.36 15.93 coo 40.85 35.41 43.73 41.85 33.73 42.88 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 40.72 26.15 37.61 42.10 27.69 37.19 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1opm_c00 1.14.17.0003 user 2 3 # 2 A 108 HIS A 136 HIS~? 3.48 MN MN A 605s A 170 GLN A 95 GLN~? 6.65 C3 GOL B 603 A 242 HIS A 100 HIS~? 8.88 CL CL A 608 coo 36.16 34.36 39.40 38.12 34.09 40.00 -0.57 59.60 14.33 0.78 59.36 15.93 coo 40.85 35.41 43.73 41.85 33.73 42.88 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 40.72 26.15 37.61 42.10 27.69 37.19 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1opm_c00 1.14.17.0003 user 3 3 # 3 A 108 HIS B 136 HIS~? 3.50 MN MN B 606s A 170 GLN B 95 GLN~? 8.04 MN MN B 606 A 242 HIS B 67 HIS~? -4.45 CL CL B 609s coo 36.16 34.36 39.40 38.12 34.09 40.00 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 40.85 35.41 43.73 41.85 33.73 42.88 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 40.72 26.15 37.61 42.10 27.69 37.19 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1opm_c00 1.14.17.0003 user 4 3 # 4 A 108 HIS B 136 HIS~? 3.50 MN MN B 606s A 170 GLN B 95 GLN~? 8.04 MN MN B 606 A 242 HIS B 100 HIS~? 8.87 CL CL B 609 coo 36.16 34.36 39.40 38.12 34.09 40.00 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 40.85 35.41 43.73 41.85 33.73 42.88 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 40.72 26.15 37.61 42.10 27.69 37.19 -13.86 76.47 17.25 -14.56 76.87 15.30 1opm_c00 source 1opm 1.14.17.0003 : 4 hits 1opm_c00 naa= 3 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 1 3 # 1 A 225 HIS A 67 HIS~? -4.40 CL CL A 608s A 259 TYR A 133 TYR~? 5.56 CL CL A 608 A 552 ASP B 116 ASP~? 29.02 O1 GOL B 603 coo 11.34 95.90 25.54 12.13 96.42 23.67 0.35 54.22 20.29 -1.10 54.30 18.77 coo 14.91 97.39 18.63 13.39 95.60 20.20 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 46.37 82.54 38.83 45.97 84.66 38.77 -2.03 88.79 36.93 -0.39 88.32 38.14 ULMN 3 1pj5_c00 N,N-DIMETHYLGLYCINE OXIDASE user 2 3 # 2 A 225 HIS B 67 HIS~? -4.45 CL CL B 609s A 259 TYR B 133 TYR~? 5.56 CL CL B 609 A 552 ASP A 116 ASP~? 31.90 C1 BME A 601 coo 11.34 95.90 25.54 12.13 96.42 23.67 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 14.91 97.39 18.63 13.39 95.60 20.20 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 46.37 82.54 38.83 45.97 84.66 38.77 -27.84 44.25 19.33 -29.63 44.62 18.19 1pj5_c00 source 1pj5 N,N-DIMETHYLGLYCINE OXIDASE : 2 hits 1pj5_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 20 ALA~? 6.78 S2 BME A 601 A 126 LEU A 18 LEU~? 5.98 MN MN A 604 A 158 GLU A 70 GLU~? -2.54 MN MN A 604s coo -2.29 37.66 144.73 -1.46 37.12 145.87 5.75 47.12 9.54 6.62 45.86 9.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 8.39 52.00 13.45 9.02 52.71 15.41 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA A 62 ALA~? -3.33 C1 BME A 601s A 126 LEU A 65 LEU~? 5.32 O1 BME A 601 A 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -4.62 32.83 147.14 -5.50 32.85 149.12 3.13 47.13 22.25 2.94 45.61 23.80 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 A 70 ALA A 63 ALA~? 7.13 CL CL A 608 A 126 LEU A 65 LEU~? 5.32 O1 BME A 601 A 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -4.62 32.83 147.14 -5.50 32.85 149.12 3.13 47.13 22.25 2.94 45.61 23.80 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 A 70 ALA A 85 ALA~? 9.47 C3 GOL B 603 A 126 LEU A 143 LEU~? 8.40 O3 GOL B 603 A 158 GLU A 140 GLU~? -2.42 MN MN A 605s coo -2.29 37.66 144.73 -1.46 37.12 145.87 11.62 67.36 15.14 11.92 65.86 14.96 coo -4.62 32.83 147.14 -5.50 32.85 149.12 9.48 61.60 12.46 8.60 63.55 13.03 coo -0.83 29.57 149.77 -0.39 31.47 148.95 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 A 70 ALA B 20 ALA~? 6.16 C2 BME B 602 A 126 LEU B 18 LEU~? 6.01 MN MN B 607 A 158 GLU B 70 GLU~? -2.57 MN MN B 607s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.51 85.82 2.70 -6.35 87.03 2.21 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.98 80.83 1.62 -12.03 79.97 1.76 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 A 70 ALA B 62 ALA~? 4.29 C1 BME B 602 A 126 LEU B 65 LEU~? 7.79 C1 BME B 602 A 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 A 70 ALA B 63 ALA~? 7.11 CL CL B 609 A 126 LEU B 65 LEU~? 7.79 C1 BME B 602 A 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 A 70 ALA B 85 ALA~? 12.60 MN MN B 606 A 126 LEU B 143 LEU~? 9.25 MN MN B 606 A 158 GLU B 140 GLU~? -2.41 MN MN B 606s coo -2.29 37.66 144.73 -1.46 37.12 145.87 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -9.21 71.32 0.05 -9.28 69.27 0.98 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 A 70 ALA B 118 ALA.? 29.04 O1 GOL B 603 A 126 LEU B 113 LEU~? 21.93 O1 GOL B 603 A 158 GLU B 114 GLU~? 19.60 C1 BME B 602 coo -2.29 37.66 144.73 -1.46 37.12 145.87 3.48 88.84 36.39 3.65 89.07 37.92 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -1.12 87.87 30.05 0.51 86.53 29.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -4.83 91.16 28.65 -6.46 91.34 27.26 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 9 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 20 ALA~? 6.78 S2 BME A 601 B 126 LEU A 18 LEU~? 5.98 MN MN A 604 B 158 GLU A 70 GLU~? -2.54 MN MN A 604s coo -39.79 4.61 147.27 -39.61 5.56 148.47 5.75 47.12 9.54 6.62 45.86 9.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 8.39 52.00 13.45 9.02 52.71 15.41 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA A 62 ALA~? -3.33 C1 BME A 601s B 126 LEU A 65 LEU~? 5.32 O1 BME A 601 B 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -34.22 5.06 149.25 -33.65 4.24 151.15 3.13 47.13 22.25 2.94 45.61 23.80 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 B 70 ALA A 63 ALA~? 7.13 CL CL A 608 B 126 LEU A 65 LEU~? 5.32 O1 BME A 601 B 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -34.22 5.06 149.25 -33.65 4.24 151.15 3.13 47.13 22.25 2.94 45.61 23.80 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 B 70 ALA A 85 ALA~? 9.47 C3 GOL B 603 B 126 LEU A 143 LEU~? 8.40 O3 GOL B 603 B 158 GLU A 140 GLU~? -2.42 MN MN A 605s coo -39.79 4.61 147.27 -39.61 5.56 148.47 11.62 67.36 15.14 11.92 65.86 14.96 coo -34.22 5.06 149.25 -33.65 4.24 151.15 9.48 61.60 12.46 8.60 63.55 13.03 coo -33.03 9.93 151.71 -34.98 9.38 151.11 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 B 70 ALA B 20 ALA~? 6.16 C2 BME B 602 B 126 LEU B 18 LEU~? 6.01 MN MN B 607 B 158 GLU B 70 GLU~? -2.57 MN MN B 607s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.51 85.82 2.70 -6.35 87.03 2.21 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.98 80.83 1.62 -12.03 79.97 1.76 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 B 70 ALA B 62 ALA~? 4.29 C1 BME B 602 B 126 LEU B 65 LEU~? 7.79 C1 BME B 602 B 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 B 70 ALA B 63 ALA~? 7.11 CL CL B 609 B 126 LEU B 65 LEU~? 7.79 C1 BME B 602 B 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -16.24 85.22 9.96 -17.65 86.66 10.74 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 B 70 ALA B 85 ALA~? 12.60 MN MN B 606 B 126 LEU B 143 LEU~? 9.25 MN MN B 606 B 158 GLU B 140 GLU~? -2.41 MN MN B 606s coo -39.79 4.61 147.27 -39.61 5.56 148.47 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -9.21 71.32 0.05 -9.28 69.27 0.98 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -8.44 74.11 4.59 -9.08 75.11 6.26 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 9 3 # 9 B 70 ALA B 118 ALA.? 29.04 O1 GOL B 603 B 126 LEU B 113 LEU~? 21.93 O1 GOL B 603 B 158 GLU B 114 GLU~? 19.60 C1 BME B 602 coo -39.79 4.61 147.27 -39.61 5.56 148.47 3.48 88.84 36.39 3.65 89.07 37.92 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -1.12 87.87 30.05 0.51 86.53 29.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -4.83 91.16 28.65 -6.46 91.34 27.26 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 9 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 20 ALA~? 6.78 S2 BME A 601 C 126 LEU A 18 LEU~? 5.98 MN MN A 604 C 158 GLU A 70 GLU~? -2.54 MN MN A 604s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 5.75 47.12 9.54 6.62 45.86 9.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 8.39 52.00 13.45 9.02 52.71 15.41 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA A 62 ALA~? -3.33 C1 BME A 601s C 126 LEU A 65 LEU~? 5.32 O1 BME A 601 C 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 3.13 47.13 22.25 2.94 45.61 23.80 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 3 3 # 3 C 70 ALA A 63 ALA~? 7.13 CL CL A 608 C 126 LEU A 65 LEU~? 5.32 O1 BME A 601 C 158 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 3.13 47.13 22.25 2.94 45.61 23.80 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 4 3 # 4 C 70 ALA A 85 ALA~? 9.47 C3 GOL B 603 C 126 LEU A 143 LEU~? 8.40 O3 GOL B 603 C 158 GLU A 140 GLU~? -2.42 MN MN A 605s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 11.62 67.36 15.14 11.92 65.86 14.96 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 9.48 61.60 12.46 8.60 63.55 13.03 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 5 3 # 5 C 70 ALA B 20 ALA~? 6.16 C2 BME B 602 C 126 LEU B 18 LEU~? 6.01 MN MN B 607 C 158 GLU B 70 GLU~? -2.57 MN MN B 607s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.51 85.82 2.70 -6.35 87.03 2.21 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.98 80.83 1.62 -12.03 79.97 1.76 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 6 3 # 6 C 70 ALA B 62 ALA~? 4.29 C1 BME B 602 C 126 LEU B 65 LEU~? 7.79 C1 BME B 602 C 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -16.24 85.22 9.96 -17.65 86.66 10.74 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 7 3 # 7 C 70 ALA B 63 ALA~? 7.11 CL CL B 609 C 126 LEU B 65 LEU~? 7.79 C1 BME B 602 C 158 GLU B 68 GLU~? 12.41 MN MN B 606 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -16.24 85.22 9.96 -17.65 86.66 10.74 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -19.03 80.53 10.71 -20.46 81.67 11.84 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 8 3 # 8 C 70 ALA B 85 ALA~? 12.60 MN MN B 606 C 126 LEU B 143 LEU~? 9.25 MN MN B 606 C 158 GLU B 140 GLU~? -2.41 MN MN B 606s coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -9.21 71.32 0.05 -9.28 69.27 0.98 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -8.44 74.11 4.59 -9.08 75.11 6.26 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 8 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 122 ASP~? 22.01 MN MN B 606 A 270 LYS A 112 LYS~? 24.85 CL CL A 608 A 382 MET A 34 MET?? 20.63 S2 BME A 601 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -21.79 55.48 15.36 -21.54 57.57 15.22 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -22.90 46.94 20.43 -23.03 53.11 20.55 coo -23.75 127.89 58.42 -26.02 128.79 55.12 -15.42 49.19 4.69 -12.99 47.10 1.84 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 270 LYS B 112 LYS~? 25.52 O1 GOL B 603 A 382 MET B 34 MET?? 15.08 O1 GOL B 603 coo -27.63 121.99 45.48 -26.66 123.86 45.68 -0.15 77.17 30.18 -0.01 75.13 29.61 coo -32.20 115.91 49.56 -31.37 121.03 53.12 -4.73 86.07 32.89 -5.14 81.77 36.42 coo -23.75 127.89 58.42 -26.02 128.79 55.12 7.26 83.48 20.20 7.86 86.21 16.91 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 2 hits 1pjq_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 95 GLN~? 6.65 C3 GOL B 603 294 GLU A 70 GLU~? -2.54 MN MN A 604s 304 ARG A 94 ARG~? 6.60 C1 GOL B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 22.84 13.44 52.91 20.84 13.18 52.38 6.20 55.25 17.70 4.45 55.72 16.64 coo 8.71 17.11 46.51 7.23 17.64 49.20 -0.58 68.78 21.39 1.97 70.41 20.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN A 95 GLN~? 6.65 C3 GOL B 603 294 GLU A 140 GLU~? -2.42 MN MN A 605s 304 ARG A 94 ARG~? 6.60 C1 GOL B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 22.84 13.44 52.91 20.84 13.18 52.38 5.06 58.75 13.41 3.74 57.63 14.59 coo 8.71 17.11 46.51 7.23 17.64 49.20 -0.58 68.78 21.39 1.97 70.41 20.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 3 3 # 3 111 GLN A 95 GLN~? 6.65 C3 GOL B 603 294 GLU B 91 GLU~? 11.42 MN MN B 606 304 ARG A 94 ARG~? 6.60 C1 GOL B 603 coo 15.89 18.45 46.53 15.82 16.91 48.02 -2.08 64.08 16.74 -1.36 64.23 14.73 coo 22.84 13.44 52.91 20.84 13.18 52.38 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 8.71 17.11 46.51 7.23 17.64 49.20 -0.58 68.78 21.39 1.97 70.41 20.81 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 4 3 # 4 111 GLN B 95 GLN~? 8.04 MN MN B 606 294 GLU A 91 GLU~? 5.92 C1 GOL B 603 304 ARG B 94 ARG~? 13.57 MN MN B 606 coo 15.89 18.45 46.53 15.82 16.91 48.02 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 22.84 13.44 52.91 20.84 13.18 52.38 0.70 67.61 16.19 -1.02 68.27 17.25 coo 8.71 17.11 46.51 7.23 17.64 49.20 -13.47 63.76 12.41 -13.96 62.24 9.77 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 5 3 # 5 111 GLN B 95 GLN~? 8.04 MN MN B 606 294 GLU B 70 GLU~? -2.57 MN MN B 607s 304 ARG B 94 ARG~? 13.57 MN MN B 606 coo 15.89 18.45 46.53 15.82 16.91 48.02 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 22.84 13.44 52.91 20.84 13.18 52.38 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 8.71 17.11 46.51 7.23 17.64 49.20 -13.47 63.76 12.41 -13.96 62.24 9.77 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 6 3 # 6 111 GLN B 95 GLN~? 8.04 MN MN B 606 294 GLU B 140 GLU~? -2.41 MN MN B 606s 304 ARG B 94 ARG~? 13.57 MN MN B 606 coo 15.89 18.45 46.53 15.82 16.91 48.02 -8.78 68.50 12.35 -7.20 68.45 10.97 coo 22.84 13.44 52.91 20.84 13.18 52.38 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 8.71 17.11 46.51 7.23 17.64 49.20 -13.47 63.76 12.41 -13.96 62.24 9.77 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 6 hits 1pmi_c00 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 60 ASN~? 13.23 C1 BME A 601 A 192 ASP A 101 ASP~? 14.47 MN MN A 605 A 195 HIS A 100 HIS~? 8.88 CL CL A 608 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -7.52 45.83 22.75 -9.56 46.47 22.75 coo 2.03 47.14 19.75 1.72 46.26 21.64 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 60 ASN~? 14.04 C1 BME B 602 A 192 ASP B 101 ASP~? 14.48 MN MN B 606 A 195 HIS B 100 HIS~? 8.87 CL CL B 609 coo -4.84 51.77 30.37 -3.89 50.12 29.46 -12.53 86.72 19.85 -11.70 86.05 21.72 coo 2.03 47.14 19.75 1.72 46.26 21.64 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -13.86 76.47 17.25 -14.56 76.87 15.30 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 60 ASN~? 13.23 C1 BME A 601 B 192 ASP A 101 ASP~? 14.47 MN MN A 605 B 195 HIS A 100 HIS~? 8.88 CL CL A 608 coo -1.08 51.41 10.34 0.65 52.62 10.17 -7.52 45.83 22.75 -9.56 46.47 22.75 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 7.99 56.74 7.55 6.88 55.39 8.70 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 60 ASN~? 14.04 C1 BME B 602 B 192 ASP B 101 ASP~? 14.48 MN MN B 606 B 195 HIS B 100 HIS~? 8.87 CL CL B 609 coo -1.08 51.41 10.34 0.65 52.62 10.17 -12.53 86.72 19.85 -11.70 86.05 21.72 coo 11.36 52.33 5.59 10.18 53.87 6.47 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 7.99 56.74 7.55 6.88 55.39 8.70 -13.86 76.47 17.25 -14.56 76.87 15.30 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c03 naa= 3 ULMN 3 1pyl_c00 RIBONUCLEASE user 1 3 # 1 A 56 GLU A 68 GLU~? 10.93 O1 BME A 601 A 67 ARG A 167 ARG~? -4.94 O1 BME A 601s A 86 HIS A 66 HIS~? 3.42 MN MN A 604s coo 18.15 3.28 18.56 20.10 2.92 19.20 5.73 51.66 25.85 5.32 49.97 27.08 coo 21.52 6.83 26.64 21.22 5.53 23.85 6.75 43.81 21.29 6.50 46.65 20.31 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1pyl_c00 RIBONUCLEASE user 2 3 # 2 A 56 GLU A 71 GLU~? 7.91 MN MN A 605 A 67 ARG A 166 ARG~? 11.02 O1 BME A 601 A 86 HIS A 66 HIS~? 3.42 MN MN A 604s coo 18.15 3.28 18.56 20.10 2.92 19.20 4.56 57.67 23.22 2.91 58.15 24.47 coo 21.52 6.83 26.64 21.22 5.53 23.85 6.93 48.25 24.41 9.45 50.10 24.73 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1pyl_c00 RIBONUCLEASE user 3 3 # 3 A 56 GLU B 68 GLU~? 12.41 MN MN B 606 A 67 ARG B 167 ARG~? 6.18 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s coo 18.15 3.28 18.56 20.10 2.92 19.20 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 21.52 6.83 26.64 21.22 5.53 23.85 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1pyl_c00 RIBONUCLEASE user 4 3 # 4 A 56 GLU B 71 GLU~? 7.93 MN MN B 606 A 67 ARG B 166 ARG~? 12.22 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s coo 18.15 3.28 18.56 20.10 2.92 19.20 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 21.52 6.83 26.64 21.22 5.53 23.85 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 22.36 -1.88 25.52 23.57 -0.73 24.25 -11.11 81.39 7.66 -9.84 80.27 6.41 1pyl_c00 source 1pyl RIBONUCLEASE : 4 hits 1pyl_c00 naa= 3 ULMN 3 1pyl_c01 RIBONUCLEASE user 1 3 # 1 B 56 GLU A 68 GLU~? 10.93 O1 BME A 601 B 67 ARG A 167 ARG~? -4.94 O1 BME A 601s B 86 HIS A 66 HIS~? 3.42 MN MN A 604s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 5.73 51.66 25.85 5.32 49.97 27.08 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 6.75 43.81 21.29 6.50 46.65 20.31 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1pyl_c01 RIBONUCLEASE user 2 3 # 2 B 56 GLU A 71 GLU~? 7.91 MN MN A 605 B 67 ARG A 166 ARG~? 11.02 O1 BME A 601 B 86 HIS A 66 HIS~? 3.42 MN MN A 604s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 4.56 57.67 23.22 2.91 58.15 24.47 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 6.93 48.25 24.41 9.45 50.10 24.73 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1pyl_c01 RIBONUCLEASE user 3 3 # 3 B 56 GLU B 68 GLU~? 12.41 MN MN B 606 B 67 ARG B 167 ARG~? 6.18 S2 BME B 602 B 86 HIS B 66 HIS~? 3.43 MN MN B 607s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1pyl_c01 RIBONUCLEASE user 4 3 # 4 B 56 GLU B 71 GLU~? 7.93 MN MN B 606 B 67 ARG B 166 ARG~? 12.22 S2 BME B 602 B 86 HIS B 66 HIS~? 3.43 MN MN B 607s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1pyl_c01 RIBONUCLEASE user 5 3 # 5 B 56 GLU B 141 GLU~? 7.71 MN MN B 607 B 67 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 86 HIS B 136 HIS~? 3.50 MN MN B 606s coo 33.14 -5.53 11.32 32.45 -5.14 9.39 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 31.86 -4.62 2.25 31.08 -4.78 5.21 1.24 79.80 7.27 0.69 76.71 7.21 coo 25.42 -9.42 7.20 25.63 -7.36 7.52 -7.23 73.04 10.16 -9.24 73.26 9.58 1pyl_c01 source 1pyl RIBONUCLEASE : 5 hits 1pyl_c01 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 93 LEU~? 8.21 MN MN A 605 A 58 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 120 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 34.02 69.29 75.26 34.82 67.82 76.74 3.29 63.12 22.43 5.19 62.12 22.85 coo 34.46 72.45 78.57 32.82 72.75 77.28 5.32 68.36 21.17 7.09 68.49 22.34 coo 28.96 77.64 81.19 29.05 74.53 77.51 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU B 93 LEU~? 8.10 MN MN B 606 A 58 ASP B 90 ASP~? 13.30 MN MN B 606 A 120 LYS A 127 LYS~? 18.61 MN MN B 606 coo 34.02 69.29 75.26 34.82 67.82 76.74 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 34.46 72.45 78.57 32.82 72.75 77.28 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 28.96 77.64 81.19 29.05 74.53 77.51 -14.62 57.47 9.74 -19.33 59.04 5.94 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 93 LEU~? 8.21 MN MN A 605 B 58 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 120 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 54.50 104.32 58.69 55.83 105.69 59.81 3.29 63.12 22.43 5.19 62.12 22.85 coo 57.63 101.19 59.83 56.60 100.89 57.99 5.32 68.36 21.17 7.09 68.49 22.34 coo 61.58 95.88 55.22 58.18 99.30 54.71 2.32 75.24 21.44 7.34 73.34 24.59 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU B 93 LEU~? 8.10 MN MN B 606 B 58 ASP B 90 ASP~? 13.30 MN MN B 606 B 120 LYS A 127 LYS~? 18.61 MN MN B 606 coo 54.50 104.32 58.69 55.83 105.69 59.81 -16.08 69.43 9.43 -17.09 70.46 7.78 coo 57.63 101.19 59.83 56.60 100.89 57.99 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 61.58 95.88 55.22 58.18 99.30 54.71 -14.62 57.47 9.74 -19.33 59.04 5.94 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 2 hits 1pym_c01 naa= 3 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 3 # 1 A 67 ASP A 116 ASP~? 31.90 C1 BME A 601 A 68 ALA A 115 ALA~? 27.34 C1 BME A 601 A 72 LEU A 113 LEU~? 24.12 C1 BME A 601 coo 46.76 7.59 18.65 45.27 6.01 18.52 -27.84 44.25 19.33 -29.63 44.62 18.19 coo 48.88 4.35 16.59 48.73 5.09 15.20 -24.52 42.26 21.58 -24.59 43.36 22.60 coo 53.89 6.25 15.09 52.88 7.92 14.14 -21.63 45.06 16.08 -21.76 46.29 14.34 ULMN 3 1q6l_c05 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 3 # 2 A 67 ASP B 116 ASP~? 29.02 O1 GOL B 603 A 68 ALA B 115 ALA~? 27.24 C1 BME B 602 A 72 LEU B 113 LEU~? 21.93 O1 GOL B 603 coo 46.76 7.59 18.65 45.27 6.01 18.52 -2.03 88.79 36.93 -0.39 88.32 38.14 coo 48.88 4.35 16.59 48.73 5.09 15.20 -5.26 90.90 34.63 -6.23 89.88 35.07 coo 53.89 6.25 15.09 52.88 7.92 14.14 -1.12 87.87 30.05 0.51 86.53 29.62 1q6l_c05 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 2 hits 1q6l_c05 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 141 GLU~? 7.70 MN MN A 604 A 143 HIS A 22 HIS~? -3.40 MN MN A 604s A 170 LYS A 24 LYS~? 4.08 C2 BME A 601 coo -2.40 27.37 52.92 -1.22 29.09 52.71 4.84 56.74 8.27 3.91 55.44 6.87 coo 1.36 26.79 49.43 3.17 26.89 50.50 3.18 53.06 10.64 3.66 54.63 11.95 coo 7.24 31.80 48.14 6.27 25.92 49.70 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU B 141 GLU~? 7.71 MN MN B 607 A 143 HIS B 22 HIS~? -3.40 MN MN B 607s A 170 LYS B 24 LYS~? -3.00 C2 BME B 602s coo -2.40 27.37 52.92 -1.22 29.09 52.71 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 1.36 26.79 49.43 3.17 26.89 50.50 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 7.24 31.80 48.14 6.27 25.92 49.70 -3.23 86.22 8.94 -7.29 90.78 7.55 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 2 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 70 GLU~? -2.54 MN MN A 604s B 143 HIS A 66 HIS~? 3.42 MN MN A 604s B 170 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 13.90 37.16 5.96 12.00 36.26 6.12 6.20 55.25 17.70 4.45 55.72 16.64 coo 13.52 33.69 9.79 13.20 31.83 8.88 3.21 51.23 16.81 3.87 52.43 15.22 coo 7.52 28.83 11.02 13.59 28.74 9.95 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU A 141 GLU~? 7.70 MN MN A 604 B 143 HIS A 22 HIS~? -3.40 MN MN A 604s B 170 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 13.90 37.16 5.96 12.00 36.26 6.12 4.84 56.74 8.27 3.91 55.44 6.87 coo 13.52 33.69 9.79 13.20 31.83 8.88 3.18 53.06 10.64 3.66 54.63 11.95 coo 7.52 28.83 11.02 13.59 28.74 9.95 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU B 141 GLU~? 7.71 MN MN B 607 B 143 HIS B 22 HIS~? -3.40 MN MN B 607s B 170 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 13.90 37.16 5.96 12.00 36.26 6.12 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 13.52 33.69 9.79 13.20 31.83 8.88 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 7.52 28.83 11.02 13.59 28.74 9.95 -3.23 86.22 8.94 -7.29 90.78 7.55 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 3 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 96 HIS~? -3.41 MN MN A 605s A 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 55.45 46.76 42.08 57.34 46.16 42.75 0.59 58.54 20.35 2.20 57.89 19.15 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.27 73.42 12.01 2.60 75.02 12.38 coo 47.58 17.35 41.83 51.40 20.85 40.83 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 96 HIS~? -3.43 MN MN B 606s A 236 ASP A 134 ASP~? 12.23 CL CL A 608 A 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 55.45 46.76 42.08 57.34 46.16 42.75 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 48.87 29.19 44.63 49.10 27.34 43.63 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 47.58 17.35 41.83 51.40 20.85 40.83 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 96 HIS~? -3.41 MN MN A 605s B 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 17.23 -29.05 11.63 18.63 -29.78 10.25 0.59 58.54 20.35 2.20 57.89 19.15 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.27 73.42 12.01 2.60 75.02 12.38 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 96 HIS~? -3.43 MN MN B 606s B 236 ASP A 134 ASP~? 12.23 CL CL A 608 B 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 96 HIS~? -3.41 MN MN A 605s C 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s C 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 55.11 47.10 12.61 53.44 47.85 11.58 0.59 58.54 20.35 2.20 57.89 19.15 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.27 73.42 12.01 2.60 75.02 12.38 coo 37.54 22.37 12.10 37.83 27.55 13.24 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 96 HIS~? -3.43 MN MN B 606s C 236 ASP A 134 ASP~? 12.23 CL CL A 608 C 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 55.11 47.10 12.61 53.44 47.85 11.58 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 45.78 31.11 9.51 44.25 30.06 10.53 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 37.54 22.37 12.10 37.83 27.55 13.24 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 96 HIS~? -3.41 MN MN A 605s D 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s D 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 21.65 -31.73 40.91 19.91 -31.10 41.91 0.59 58.54 20.35 2.20 57.89 19.15 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.27 73.42 12.01 2.60 75.02 12.38 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 96 HIS~? -3.43 MN MN B 606s D 236 ASP A 134 ASP~? 12.23 CL CL A 608 D 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 96 HIS~? -3.41 MN MN A 605s E 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s E 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 0.59 58.54 20.35 2.20 57.89 19.15 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 1.27 73.42 12.01 2.60 75.02 12.38 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 96 HIS~? -3.43 MN MN B 606s E 236 ASP A 134 ASP~? 12.23 CL CL A 608 E 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 96 HIS~? -3.41 MN MN A 605s F 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s F 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 3.13 15.54 -65.72 2.08 14.15 -66.89 0.59 58.54 20.35 2.20 57.89 19.15 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.27 73.42 12.01 2.60 75.02 12.38 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 96 HIS~? -3.43 MN MN B 606s F 236 ASP A 134 ASP~? 12.23 CL CL A 608 F 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 96 HIS~? -3.41 MN MN A 605s G 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s G 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 0.59 58.54 20.35 2.20 57.89 19.15 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.27 73.42 12.01 2.60 75.02 12.38 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 96 HIS~? -3.43 MN MN B 606s G 236 ASP A 134 ASP~? 12.23 CL CL A 608 G 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 96 HIS~? -3.41 MN MN A 605s H 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s H 261 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 0.50 11.68 -36.58 0.99 13.43 -35.52 0.59 58.54 20.35 2.20 57.89 19.15 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.27 73.42 12.01 2.60 75.02 12.38 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 96 HIS~? -3.43 MN MN B 606s H 236 ASP A 134 ASP~? 12.23 CL CL A 608 H 261 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -0.91 46.54 9.97 2.66 42.32 12.44 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 26 ARG~? 9.60 MN MN A 604 C 163 TYR A 19 TYR~? 9.00 MN MN A 604 C 236 ASP A 145 ASP~? 14.76 MN MN A 604 coo 39.01 29.77 22.02 37.48 31.30 19.84 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 39.51 34.34 13.63 37.63 32.61 14.79 8.27 52.26 7.85 9.08 54.84 7.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 163 TYR B 19 TYR~? 9.04 MN MN B 607 C 236 ASP B 145 ASP~? 15.01 MN MN B 607 coo 39.01 29.77 22.02 37.48 31.30 19.84 1.24 79.80 7.27 0.69 76.71 7.21 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 45.78 31.11 9.51 44.25 30.06 10.53 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 C 163 TYR B 133 TYR~? 5.56 CL CL B 609 C 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 39.01 29.77 22.02 37.48 31.30 19.84 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 45.78 31.11 9.51 44.25 30.06 10.53 1.27 73.42 12.01 2.60 75.02 12.38 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 26 ARG~? 9.60 MN MN A 604 D 163 TYR A 19 TYR~? 9.00 MN MN A 604 D 236 ASP A 145 ASP~? 14.76 MN MN A 604 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 8.27 52.26 7.85 9.08 54.84 7.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 D 163 TYR B 19 TYR~? 9.04 MN MN B 607 D 236 ASP B 145 ASP~? 15.01 MN MN B 607 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 1.24 79.80 7.27 0.69 76.71 7.21 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 D 163 TYR B 133 TYR~? 5.56 CL CL B 609 D 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 1.27 73.42 12.01 2.60 75.02 12.38 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 19 TYR~? 9.00 MN MN A 604 A 236 ASP A 145 ASP~? 14.76 MN MN A 604 C 110 ARG A 26 ARG~? 9.60 MN MN A 604 coo 55.48 26.51 40.65 55.39 23.99 39.43 8.27 52.26 7.85 9.08 54.84 7.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 12.32 59.45 6.26 13.32 58.94 4.48 coo 52.39 23.42 32.10 54.51 23.27 34.29 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 19 TYR~? 9.04 MN MN B 607 A 236 ASP B 145 ASP~? 15.01 MN MN B 607 C 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 48.87 29.19 44.63 49.10 27.34 43.63 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 52.39 23.42 32.10 54.51 23.27 34.29 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 A 163 TYR B 133 TYR~? 5.56 CL CL B 609 A 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s C 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 48.87 29.19 44.63 49.10 27.34 43.63 1.27 73.42 12.01 2.60 75.02 12.38 coo 52.39 23.42 32.10 54.51 23.27 34.29 -3.66 71.26 23.11 -3.83 72.79 25.78 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 19 TYR~? 9.00 MN MN A 604 B 236 ASP A 145 ASP~? 14.76 MN MN A 604 D 110 ARG A 26 ARG~? 9.60 MN MN A 604 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 8.27 52.26 7.85 9.08 54.84 7.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 12.32 59.45 6.26 13.32 58.94 4.48 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 19 TYR~? 9.04 MN MN B 607 B 236 ASP B 145 ASP~? 15.01 MN MN B 607 D 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 B 163 TYR B 133 TYR~? 5.56 CL CL B 609 B 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s D 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 1.27 73.42 12.01 2.60 75.02 12.38 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -3.66 71.26 23.11 -3.83 72.79 25.78 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 26 ARG~? 9.60 MN MN A 604 G 163 TYR A 19 TYR~? 9.00 MN MN A 604 G 236 ASP A 145 ASP~? 14.76 MN MN A 604 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 8.27 52.26 7.85 9.08 54.84 7.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 G 163 TYR B 19 TYR~? 9.04 MN MN B 607 G 236 ASP B 145 ASP~? 15.01 MN MN B 607 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 1.24 79.80 7.27 0.69 76.71 7.21 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 E 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 G 163 TYR B 133 TYR~? 5.56 CL CL B 609 G 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 1.27 73.42 12.01 2.60 75.02 12.38 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 26 ARG~? 9.60 MN MN A 604 H 163 TYR A 19 TYR~? 9.00 MN MN A 604 H 236 ASP A 145 ASP~? 14.76 MN MN A 604 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 8.27 52.26 7.85 9.08 54.84 7.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 H 163 TYR B 19 TYR~? 9.04 MN MN B 607 H 236 ASP B 145 ASP~? 15.01 MN MN B 607 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 1.24 79.80 7.27 0.69 76.71 7.21 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 H 163 TYR B 133 TYR~? 5.56 CL CL B 609 H 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 1.27 73.42 12.01 2.60 75.02 12.38 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 19 TYR~? 9.00 MN MN A 604 E 236 ASP A 145 ASP~? 14.76 MN MN A 604 G 110 ARG A 26 ARG~? 9.60 MN MN A 604 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 8.27 52.26 7.85 9.08 54.84 7.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 12.32 59.45 6.26 13.32 58.94 4.48 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 19 TYR~? 9.04 MN MN B 607 E 236 ASP B 145 ASP~? 15.01 MN MN B 607 G 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 1.24 79.80 7.27 0.69 76.71 7.21 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 19 TYR~? 9.00 MN MN A 604 F 236 ASP A 145 ASP~? 14.76 MN MN A 604 H 110 ARG A 26 ARG~? 9.60 MN MN A 604 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 8.27 52.26 7.85 9.08 54.84 7.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 12.32 59.45 6.26 13.32 58.94 4.48 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 19 TYR~? 9.04 MN MN B 607 F 236 ASP B 145 ASP~? 15.01 MN MN B 607 H 110 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 1.24 79.80 7.27 0.69 76.71 7.21 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 3 3 # 3 F 163 TYR B 133 TYR~? 5.56 CL CL B 609 F 236 ASP B 134 ASP~? -3.66 O1 GOL B 603s H 110 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 1.27 73.42 12.01 2.60 75.02 12.38 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -3.66 71.26 23.11 -3.83 72.79 25.78 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 3 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c04 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 256 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 28.46 69.88 26.74 30.40 70.70 26.53 5.32 68.36 21.17 7.09 68.49 22.34 coo 30.54 71.65 32.58 31.73 72.26 30.92 7.70 72.78 18.03 7.03 72.92 20.00 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 256 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 28.46 69.88 26.74 30.40 70.70 26.53 5.32 68.36 21.17 7.09 68.49 22.34 coo 30.54 71.65 32.58 31.73 72.26 30.92 0.70 67.61 16.19 -1.02 68.27 17.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1qho_c04 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 134 ASP~? 12.23 CL CL A 608 A 256 GLU B 91 GLU~? 11.42 MN MN B 606 A 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 30.54 71.65 32.58 31.73 72.26 30.92 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1qho_c04 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 90 ASP~? 13.30 MN MN B 606 A 256 GLU B 87 GLU~? 16.36 MN MN B 606 A 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qho_c04 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 90 ASP~? 13.30 MN MN B 606 A 256 GLU B 91 GLU~? 11.42 MN MN B 606 A 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qho_c04 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 256 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.27 73.42 12.01 2.60 75.02 12.38 coo 30.54 71.65 32.58 31.73 72.26 30.92 0.70 67.61 16.19 -1.02 68.27 17.25 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.32 68.36 21.17 7.09 68.49 22.34 1qho_c04 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c04 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 261 ASP A 134 ASP~? 12.23 CL CL A 608 A 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 28.46 69.88 26.74 30.40 70.70 26.53 5.32 68.36 21.17 7.09 68.49 22.34 coo 34.02 79.89 42.60 34.73 78.01 41.86 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 134 ASP~? 12.23 CL CL A 608 A 261 ASP A 37 ASP~? 25.83 CL CL A 608 A 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 -20.38 49.92 2.66 -20.55 51.94 2.14 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 134 ASP~? 12.23 CL CL A 608 A 261 ASP A 122 ASP~? 22.01 MN MN B 606 A 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 28.46 69.88 26.74 30.40 70.70 26.53 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 34.02 79.89 42.60 34.73 78.01 41.86 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 37.87 70.12 31.80 36.61 69.74 30.15 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 90 ASP~? 13.30 MN MN B 606 A 261 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 1.27 73.42 12.01 2.60 75.02 12.38 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 261 ASP B 37 ASP~? 15.37 O1 GOL B 603 A 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.27 73.42 12.01 2.60 75.02 12.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 11.04 82.75 24.13 11.46 80.73 24.12 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.32 68.36 21.17 7.09 68.49 22.34 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 261 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 28.46 69.88 26.74 30.40 70.70 26.53 1.27 73.42 12.01 2.60 75.02 12.38 coo 34.02 79.89 42.60 34.73 78.01 41.86 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.32 68.36 21.17 7.09 68.49 22.34 1qho_c05 source 1qho ALPHA-AMYLASE : 6 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 260 ASP B 101 ASP~? 14.48 MN MN B 606 A 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 28.46 69.88 26.74 30.40 70.70 26.53 5.32 68.36 21.17 7.09 68.49 22.34 coo 30.73 81.29 37.61 31.23 82.07 35.69 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 37.87 70.12 31.80 36.61 69.74 30.15 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 90 ASP~? 13.30 MN MN B 606 A 260 ASP A 101 ASP~? 14.47 MN MN A 605 A 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 30.73 81.29 37.61 31.23 82.07 35.69 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 37.87 70.12 31.80 36.61 69.74 30.15 -5.53 59.28 7.24 -6.39 57.64 6.27 1qho_c07 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c07 naa= 3 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 A 51 ALA A 62 ALA~? -3.33 C1 BME A 601s A 148 HIS A 66 HIS~? 3.42 MN MN A 604s A 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 1.42 19.18 21.84 1.11 19.57 23.28 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 0.71 19.67 27.92 2.43 19.16 26.83 3.21 51.23 16.81 3.87 52.43 15.22 coo 7.15 16.22 27.50 6.15 18.00 27.94 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 A 51 ALA A 63 ALA~? 7.13 CL CL A 608 A 148 HIS A 66 HIS~? 3.42 MN MN A 604s A 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 1.42 19.18 21.84 1.11 19.57 23.28 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 0.71 19.67 27.92 2.43 19.16 26.83 3.21 51.23 16.81 3.87 52.43 15.22 coo 7.15 16.22 27.50 6.15 18.00 27.94 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 A 51 ALA A 63 ALA~? 7.13 CL CL A 608 A 148 HIS A 67 HIS~? -4.40 CL CL A 608s A 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 1.42 19.18 21.84 1.11 19.57 23.28 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 0.71 19.67 27.92 2.43 19.16 26.83 0.35 54.22 20.29 -1.10 54.30 18.77 coo 7.15 16.22 27.50 6.15 18.00 27.94 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 A 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 A 148 HIS A 136 HIS~? 3.48 MN MN A 605s A 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo 1.42 19.18 21.84 1.11 19.57 23.28 1.31 61.33 7.33 0.25 62.15 6.66 coo 0.71 19.67 27.92 2.43 19.16 26.83 -0.57 59.60 14.33 0.78 59.36 15.93 coo 7.15 16.22 27.50 6.15 18.00 27.94 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 A 51 ALA B 62 ALA~? 4.29 C1 BME B 602 A 148 HIS B 66 HIS~? 3.43 MN MN B 607s A 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 1.42 19.18 21.84 1.11 19.57 23.28 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 0.71 19.67 27.92 2.43 19.16 26.83 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 7.15 16.22 27.50 6.15 18.00 27.94 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 A 51 ALA B 63 ALA~? 7.11 CL CL B 609 A 148 HIS B 66 HIS~? 3.43 MN MN B 607s A 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 1.42 19.18 21.84 1.11 19.57 23.28 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 0.71 19.67 27.92 2.43 19.16 26.83 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 7.15 16.22 27.50 6.15 18.00 27.94 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 A 51 ALA B 63 ALA~? 7.11 CL CL B 609 A 148 HIS B 67 HIS~? -4.45 CL CL B 609s A 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 1.42 19.18 21.84 1.11 19.57 23.28 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 0.71 19.67 27.92 2.43 19.16 26.83 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 7.15 16.22 27.50 6.15 18.00 27.94 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c00 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 A 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 A 148 HIS B 136 HIS~? 3.50 MN MN B 606s A 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 1.42 19.18 21.84 1.11 19.57 23.28 -1.39 71.52 5.72 -0.38 70.66 6.48 coo 0.71 19.67 27.92 2.43 19.16 26.83 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 7.15 16.22 27.50 6.15 18.00 27.94 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c00 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c00 naa= 3 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 B 51 ALA A 62 ALA~? -3.33 C1 BME A 601s B 148 HIS A 66 HIS~? 3.42 MN MN A 604s B 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -33.17 20.01 48.16 -34.95 19.37 49.06 3.21 51.23 16.81 3.87 52.43 15.22 coo -39.82 16.62 48.85 -38.59 18.24 48.48 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 B 51 ALA A 63 ALA~? 7.13 CL CL A 608 B 148 HIS A 66 HIS~? 3.42 MN MN A 604s B 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -33.17 20.01 48.16 -34.95 19.37 49.06 3.21 51.23 16.81 3.87 52.43 15.22 coo -39.82 16.62 48.85 -38.59 18.24 48.48 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 B 51 ALA A 63 ALA~? 7.13 CL CL A 608 B 148 HIS A 67 HIS~? -4.40 CL CL A 608s B 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -33.17 20.01 48.16 -34.95 19.37 49.06 0.35 54.22 20.29 -1.10 54.30 18.77 coo -39.82 16.62 48.85 -38.59 18.24 48.48 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 B 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 B 148 HIS A 136 HIS~? 3.48 MN MN A 605s B 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo -33.97 19.78 54.18 -33.40 20.11 52.82 1.31 61.33 7.33 0.25 62.15 6.66 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -0.57 59.60 14.33 0.78 59.36 15.93 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 B 51 ALA B 62 ALA~? 4.29 C1 BME B 602 B 148 HIS B 66 HIS~? 3.43 MN MN B 607s B 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 B 51 ALA B 63 ALA~? 7.11 CL CL B 609 B 148 HIS B 66 HIS~? 3.43 MN MN B 607s B 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 B 51 ALA B 63 ALA~? 7.11 CL CL B 609 B 148 HIS B 67 HIS~? -4.45 CL CL B 609s B 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 19.78 54.18 -33.40 20.11 52.82 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -39.82 16.62 48.85 -38.59 18.24 48.48 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c01 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 B 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 B 148 HIS B 136 HIS~? 3.50 MN MN B 606s B 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -33.97 19.78 54.18 -33.40 20.11 52.82 -1.39 71.52 5.72 -0.38 70.66 6.48 coo -33.17 20.01 48.16 -34.95 19.37 49.06 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -39.82 16.62 48.85 -38.59 18.24 48.48 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c01 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c01 naa= 3 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 C 51 ALA A 62 ALA~? -3.33 C1 BME A 601s C 148 HIS A 66 HIS~? 3.42 MN MN A 604s C 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 3.21 51.23 16.81 3.87 52.43 15.22 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 C 51 ALA A 63 ALA~? 7.13 CL CL A 608 C 148 HIS A 66 HIS~? 3.42 MN MN A 604s C 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 3.21 51.23 16.81 3.87 52.43 15.22 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 C 51 ALA A 63 ALA~? 7.13 CL CL A 608 C 148 HIS A 67 HIS~? -4.40 CL CL A 608s C 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 0.35 54.22 20.29 -1.10 54.30 18.77 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 C 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 C 148 HIS A 136 HIS~? 3.48 MN MN A 605s C 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 1.31 61.33 7.33 0.25 62.15 6.66 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -0.57 59.60 14.33 0.78 59.36 15.93 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 C 51 ALA B 62 ALA~? 4.29 C1 BME B 602 C 148 HIS B 66 HIS~? 3.43 MN MN B 607s C 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 C 51 ALA B 63 ALA~? 7.11 CL CL B 609 C 148 HIS B 66 HIS~? 3.43 MN MN B 607s C 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 C 51 ALA B 63 ALA~? 7.11 CL CL B 609 C 148 HIS B 67 HIS~? -4.45 CL CL B 609s C 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c02 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 C 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 C 148 HIS B 136 HIS~? 3.50 MN MN B 606s C 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -26.36 -19.12 21.15 -25.71 -19.49 22.47 -1.39 71.52 5.72 -0.38 70.66 6.48 coo -25.01 -20.21 26.78 -26.91 -20.55 25.93 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -32.17 -20.34 27.36 -30.15 -20.93 27.54 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c02 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c02 naa= 3 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 D 51 ALA A 62 ALA~? -3.33 C1 BME A 601s D 148 HIS A 66 HIS~? 3.42 MN MN A 604s D 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 3.21 51.23 16.81 3.87 52.43 15.22 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 D 51 ALA A 63 ALA~? 7.13 CL CL A 608 D 148 HIS A 66 HIS~? 3.42 MN MN A 604s D 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 3.21 51.23 16.81 3.87 52.43 15.22 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 D 51 ALA A 63 ALA~? 7.13 CL CL A 608 D 148 HIS A 67 HIS~? -4.40 CL CL A 608s D 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 0.35 54.22 20.29 -1.10 54.30 18.77 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 D 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 D 148 HIS A 136 HIS~? 3.48 MN MN A 605s D 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 1.31 61.33 7.33 0.25 62.15 6.66 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -0.57 59.60 14.33 0.78 59.36 15.93 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 D 51 ALA B 62 ALA~? 4.29 C1 BME B 602 D 148 HIS B 66 HIS~? 3.43 MN MN B 607s D 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 D 51 ALA B 63 ALA~? 7.11 CL CL B 609 D 148 HIS B 66 HIS~? 3.43 MN MN B 607s D 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 D 51 ALA B 63 ALA~? 7.11 CL CL B 609 D 148 HIS B 67 HIS~? -4.45 CL CL B 609s D 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c03 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 D 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 D 148 HIS B 136 HIS~? 3.50 MN MN B 606s D 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -6.15 -19.18 55.49 -6.70 -19.60 54.15 -1.39 71.52 5.72 -0.38 70.66 6.48 coo -7.62 -20.32 49.70 -5.89 -20.86 50.74 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -0.41 -20.05 49.27 -2.21 -21.16 49.24 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c03 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c03 naa= 3 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 E 51 ALA A 62 ALA~? -3.33 C1 BME A 601s E 148 HIS A 66 HIS~? 3.42 MN MN A 604s E 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 3.21 51.23 16.81 3.87 52.43 15.22 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 E 51 ALA A 63 ALA~? 7.13 CL CL A 608 E 148 HIS A 66 HIS~? 3.42 MN MN A 604s E 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 3.21 51.23 16.81 3.87 52.43 15.22 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 E 51 ALA A 63 ALA~? 7.13 CL CL A 608 E 148 HIS A 67 HIS~? -4.40 CL CL A 608s E 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 0.35 54.22 20.29 -1.10 54.30 18.77 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 E 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 E 148 HIS A 136 HIS~? 3.48 MN MN A 605s E 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 1.31 61.33 7.33 0.25 62.15 6.66 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -0.57 59.60 14.33 0.78 59.36 15.93 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 E 51 ALA B 62 ALA~? 4.29 C1 BME B 602 E 148 HIS B 66 HIS~? 3.43 MN MN B 607s E 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 E 51 ALA B 63 ALA~? 7.11 CL CL B 609 E 148 HIS B 66 HIS~? 3.43 MN MN B 607s E 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 E 51 ALA B 63 ALA~? 7.11 CL CL B 609 E 148 HIS B 67 HIS~? -4.45 CL CL B 609s E 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c04 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 E 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 E 148 HIS B 136 HIS~? 3.50 MN MN B 606s E 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 5.48 -16.06 -47.92 6.03 -15.45 -46.65 -1.39 71.52 5.72 -0.38 70.66 6.48 coo 5.81 -16.05 -42.05 5.54 -17.84 -43.11 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 2.75 -22.21 -43.08 4.67 -21.31 -42.96 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c04 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c04 naa= 3 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 F 51 ALA A 62 ALA~? -3.33 C1 BME A 601s F 148 HIS A 66 HIS~? 3.42 MN MN A 604s F 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 3.21 51.23 16.81 3.87 52.43 15.22 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 F 51 ALA A 63 ALA~? 7.13 CL CL A 608 F 148 HIS A 66 HIS~? 3.42 MN MN A 604s F 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 3.21 51.23 16.81 3.87 52.43 15.22 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 F 51 ALA A 63 ALA~? 7.13 CL CL A 608 F 148 HIS A 67 HIS~? -4.40 CL CL A 608s F 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 0.35 54.22 20.29 -1.10 54.30 18.77 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 F 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 F 148 HIS A 136 HIS~? 3.48 MN MN A 605s F 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 1.31 61.33 7.33 0.25 62.15 6.66 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -0.57 59.60 14.33 0.78 59.36 15.93 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 F 51 ALA B 62 ALA~? 4.29 C1 BME B 602 F 148 HIS B 66 HIS~? 3.43 MN MN B 607s F 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 F 51 ALA B 63 ALA~? 7.11 CL CL B 609 F 148 HIS B 66 HIS~? 3.43 MN MN B 607s F 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 F 51 ALA B 63 ALA~? 7.11 CL CL B 609 F 148 HIS B 67 HIS~? -4.45 CL CL B 609s F 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c05 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 F 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 F 148 HIS B 136 HIS~? 3.50 MN MN B 606s F 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 5.33 15.59 -14.28 5.80 15.15 -15.64 -1.39 71.52 5.72 -0.38 70.66 6.48 coo 5.79 15.50 -20.13 5.50 17.28 -19.05 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 2.42 22.00 -18.97 4.23 20.92 -19.18 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c05 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c05 naa= 3 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 G 51 ALA A 62 ALA~? -3.33 C1 BME A 601s G 148 HIS A 66 HIS~? 3.42 MN MN A 604s G 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 3.21 51.23 16.81 3.87 52.43 15.22 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 G 51 ALA A 63 ALA~? 7.13 CL CL A 608 G 148 HIS A 66 HIS~? 3.42 MN MN A 604s G 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 3.21 51.23 16.81 3.87 52.43 15.22 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 G 51 ALA A 63 ALA~? 7.13 CL CL A 608 G 148 HIS A 67 HIS~? -4.40 CL CL A 608s G 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 0.35 54.22 20.29 -1.10 54.30 18.77 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 G 51 ALA A 104 ALA~? 15.83 CL CL A 608 G 148 HIS A 100 HIS~? 8.88 CL CL A 608 G 163 ASP A 101 ASP~? 14.47 MN MN A 605 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -12.51 53.62 22.46 -12.36 54.50 23.69 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 G 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 G 148 HIS A 136 HIS~? 3.48 MN MN A 605s G 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 1.31 61.33 7.33 0.25 62.15 6.66 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -0.57 59.60 14.33 0.78 59.36 15.93 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 G 51 ALA B 62 ALA~? 4.29 C1 BME B 602 G 148 HIS B 66 HIS~? 3.43 MN MN B 607s G 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 G 51 ALA B 63 ALA~? 7.11 CL CL B 609 G 148 HIS B 66 HIS~? 3.43 MN MN B 607s G 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 G 51 ALA B 63 ALA~? 7.11 CL CL B 609 G 148 HIS B 67 HIS~? -4.45 CL CL B 609s G 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 9 3 # 9 G 51 ALA B 104 ALA~? 15.71 CL CL B 609 G 148 HIS B 100 HIS~? 8.87 CL CL B 609 G 163 ASP B 101 ASP~? 14.48 MN MN B 606 coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -10.27 78.94 24.18 -11.44 78.04 24.53 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 -10.99 72.82 22.17 -12.93 72.02 22.11 ULMN 3 1qol_c06 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 10 3 # 10 G 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 G 148 HIS B 136 HIS~? 3.50 MN MN B 606s G 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -33.28 -11.88 -14.46 -33.66 -11.38 -15.87 -1.39 71.52 5.72 -0.38 70.66 6.48 coo -34.88 -9.77 -20.15 -35.41 -11.60 -19.26 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -34.41 -16.73 -21.11 -35.66 -15.03 -20.96 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c06 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 10 hits 1qol_c06 naa= 3 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 1 3 # 1 H 51 ALA A 62 ALA~? -3.33 C1 BME A 601s H 148 HIS A 66 HIS~? 3.42 MN MN A 604s H 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -0.61 45.64 19.79 -0.68 44.97 18.47 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 3.21 51.23 16.81 3.87 52.43 15.22 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 2 3 # 2 H 51 ALA A 63 ALA~? 7.13 CL CL A 608 H 148 HIS A 66 HIS~? 3.42 MN MN A 604s H 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 3.21 51.23 16.81 3.87 52.43 15.22 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 3 3 # 3 H 51 ALA A 63 ALA~? 7.13 CL CL A 608 H 148 HIS A 67 HIS~? -4.40 CL CL A 608s H 163 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -1.18 49.29 19.00 -2.43 50.00 18.46 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 0.35 54.22 20.29 -1.10 54.30 18.77 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 4 3 # 4 H 51 ALA A 138 ALA~? 8.43 O3 GOL B 603 H 148 HIS A 136 HIS~? 3.48 MN MN A 605s H 163 ASP A 134 ASP~? 12.23 CL CL A 608 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 1.31 61.33 7.33 0.25 62.15 6.66 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -0.57 59.60 14.33 0.78 59.36 15.93 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 5 3 # 5 H 51 ALA B 62 ALA~? 4.29 C1 BME B 602 H 148 HIS B 66 HIS~? 3.43 MN MN B 607s H 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -12.56 86.77 12.36 -11.38 87.53 11.88 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 6 3 # 6 H 51 ALA B 63 ALA~? 7.11 CL CL B 609 H 148 HIS B 66 HIS~? 3.43 MN MN B 607s H 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 7 3 # 7 H 51 ALA B 63 ALA~? 7.11 CL CL B 609 H 148 HIS B 67 HIS~? -4.45 CL CL B 609s H 163 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -11.48 83.15 12.59 -10.47 82.51 13.58 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 -15.81 81.35 4.53 -16.00 83.45 4.93 ULMN 3 1qol_c07 PROTEASE (NONSTRUCTURAL PROTEIN P20Auser 8 3 # 8 H 51 ALA B 138 ALA~? 6.55 O3 GOL B 603 H 148 HIS B 136 HIS~? 3.50 MN MN B 606s H 163 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo -33.97 9.40 -47.46 -34.31 8.55 -46.23 -1.39 71.52 5.72 -0.38 70.66 6.48 coo -35.28 7.86 -41.76 -36.20 9.51 -42.67 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -35.25 15.19 -41.05 -35.81 13.11 -41.05 1.27 73.42 12.01 2.60 75.02 12.38 1qol_c07 source 1qol PROTEASE (NONSTRUCTURAL PROTEIN P20A) : 8 hits 1qol_c07 naa= 3 ULMN 3 1qrz_c20 PLASMINOGEN user 1 3 # 1 A 603 HIS A 67 HIS~? -4.40 CL CL A 608s A 646 ASP A 69 ASP~? 7.42 O1 BME A 601 A 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -20.72 2.99 34.37 -21.94 1.82 35.61 0.35 54.22 20.29 -1.10 54.30 18.77 coo -18.83 7.68 26.86 -20.89 7.78 26.56 7.88 51.22 19.98 7.64 49.14 20.25 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1qrz_c20 PLASMINOGEN user 2 3 # 2 A 603 HIS A 136 HIS~? 3.48 MN MN A 605s A 646 ASP A 134 ASP~? 12.23 CL CL A 608 A 739 GLY B 132 GLY~? 6.66 O1 GOL B 603 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -0.57 59.60 14.33 0.78 59.36 15.93 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -3.20 72.50 15.64 -2.65 73.03 15.24 ULMN 3 1qrz_c20 PLASMINOGEN user 3 3 # 3 A 603 HIS B 67 HIS~? -4.45 CL CL B 609s A 646 ASP B 69 ASP~? 7.66 S2 BME B 602 A 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -18.83 7.68 26.86 -20.89 7.78 26.56 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -1.78 84.52 5.86 -2.42 84.42 6.43 ULMN 3 1qrz_c20 PLASMINOGEN user 4 3 # 4 A 603 HIS B 136 HIS~? 3.50 MN MN B 606s A 646 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 739 GLY A 132 GLY~? 10.05 CL CL A 608 coo -20.72 2.99 34.37 -21.94 1.82 35.61 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -18.83 7.68 26.86 -20.89 7.78 26.56 1.27 73.42 12.01 2.60 75.02 12.38 coo -13.44 -7.35 30.08 -14.24 -7.41 30.34 -7.17 60.13 12.71 -7.01 59.60 12.06 1qrz_c20 source 1qrz PLASMINOGEN : 4 hits 1qrz_c20 naa= 3 ULMN 3 1qrz_c21 PLASMINOGEN user 1 3 # 1 B 603 HIS A 67 HIS~? -4.40 CL CL A 608s B 646 ASP A 69 ASP~? 7.42 O1 BME A 601 B 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 0.35 54.22 20.29 -1.10 54.30 18.77 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 7.88 51.22 19.98 7.64 49.14 20.25 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1qrz_c21 PLASMINOGEN user 2 3 # 2 B 603 HIS A 136 HIS~? 3.48 MN MN A 605s B 646 ASP A 134 ASP~? 12.23 CL CL A 608 B 739 GLY B 132 GLY~? 6.66 O1 GOL B 603 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -0.57 59.60 14.33 0.78 59.36 15.93 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -3.20 72.50 15.64 -2.65 73.03 15.24 ULMN 3 1qrz_c21 PLASMINOGEN user 3 3 # 3 B 603 HIS B 67 HIS~? -4.45 CL CL B 609s B 646 ASP B 69 ASP~? 7.66 S2 BME B 602 B 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -1.78 84.52 5.86 -2.42 84.42 6.43 ULMN 3 1qrz_c21 PLASMINOGEN user 4 3 # 4 B 603 HIS B 136 HIS~? 3.50 MN MN B 606s B 646 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 739 GLY A 98 GLY~? 10.67 MN MN A 605 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.27 73.42 12.01 2.60 75.02 12.38 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -6.79 61.25 20.29 -6.32 60.57 20.44 ULMN 3 1qrz_c21 PLASMINOGEN user 5 3 # 5 B 603 HIS B 136 HIS~? 3.50 MN MN B 606s B 646 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 739 GLY A 132 GLY~? 10.05 CL CL A 608 coo -48.36 3.10 -3.91 -49.78 2.04 -2.80 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -46.10 7.71 -10.96 -48.16 8.01 -11.35 1.27 73.42 12.01 2.60 75.02 12.38 coo -41.48 -7.57 -8.71 -42.26 -7.67 -8.41 -7.17 60.13 12.71 -7.01 59.60 12.06 1qrz_c21 source 1qrz PLASMINOGEN : 5 hits 1qrz_c21 naa= 3 ULMN 3 1qrz_c22 PLASMINOGEN user 1 3 # 1 C 603 HIS A 67 HIS~? -4.40 CL CL A 608s C 646 ASP A 69 ASP~? 7.42 O1 BME A 601 C 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 0.35 54.22 20.29 -1.10 54.30 18.77 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 7.88 51.22 19.98 7.64 49.14 20.25 coo 7.82 1.25 3.03 7.30 1.31 3.65 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1qrz_c22 PLASMINOGEN user 2 3 # 2 C 603 HIS A 136 HIS~? 3.48 MN MN A 605s C 646 ASP A 134 ASP~? 12.23 CL CL A 608 C 739 GLY B 132 GLY~? 6.66 O1 GOL B 603 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -0.57 59.60 14.33 0.78 59.36 15.93 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 7.82 1.25 3.03 7.30 1.31 3.65 -3.20 72.50 15.64 -2.65 73.03 15.24 ULMN 3 1qrz_c22 PLASMINOGEN user 3 3 # 3 C 603 HIS B 67 HIS~? -4.45 CL CL B 609s C 646 ASP B 69 ASP~? 7.66 S2 BME B 602 C 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 7.82 1.25 3.03 7.30 1.31 3.65 -1.78 84.52 5.86 -2.42 84.42 6.43 ULMN 3 1qrz_c22 PLASMINOGEN user 4 3 # 4 C 603 HIS B 136 HIS~? 3.50 MN MN B 606s C 646 ASP B 134 ASP~? -3.66 O1 GOL B 603s C 739 GLY A 132 GLY~? 10.05 CL CL A 608 coo 1.49 -9.23 8.48 -0.19 -8.40 9.43 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 9.05 -13.82 8.74 8.78 -14.02 10.85 1.27 73.42 12.01 2.60 75.02 12.38 coo 7.82 1.25 3.03 7.30 1.31 3.65 -7.17 60.13 12.71 -7.01 59.60 12.06 1qrz_c22 source 1qrz PLASMINOGEN : 4 hits 1qrz_c22 naa= 3 ULMN 3 1qrz_c23 PLASMINOGEN user 1 3 # 1 D 603 HIS A 67 HIS~? -4.40 CL CL A 608s D 646 ASP A 69 ASP~? 7.42 O1 BME A 601 D 739 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 0.35 54.22 20.29 -1.10 54.30 18.77 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 7.88 51.22 19.98 7.64 49.14 20.25 coo -45.82 1.31 41.67 -46.38 1.39 42.31 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1qrz_c23 PLASMINOGEN user 2 3 # 2 D 603 HIS A 136 HIS~? 3.48 MN MN A 605s D 646 ASP A 134 ASP~? 12.23 CL CL A 608 D 739 GLY B 132 GLY~? 6.66 O1 GOL B 603 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -3.20 72.50 15.64 -2.65 73.03 15.24 ULMN 3 1qrz_c23 PLASMINOGEN user 3 3 # 3 D 603 HIS B 67 HIS~? -4.45 CL CL B 609s D 646 ASP B 69 ASP~? 7.66 S2 BME B 602 D 739 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -1.78 84.52 5.86 -2.42 84.42 6.43 ULMN 3 1qrz_c23 PLASMINOGEN user 4 3 # 4 D 603 HIS B 136 HIS~? 3.50 MN MN B 606s D 646 ASP B 134 ASP~? -3.66 O1 GOL B 603s D 739 GLY A 132 GLY~? 10.05 CL CL A 608 coo -52.57 -8.94 46.70 -54.06 -7.64 47.39 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -45.30 -14.04 46.94 -45.65 -14.15 49.00 1.27 73.42 12.01 2.60 75.02 12.38 coo -45.82 1.31 41.67 -46.38 1.39 42.31 -7.17 60.13 12.71 -7.01 59.60 12.06 1qrz_c23 source 1qrz PLASMINOGEN : 4 hits 1qrz_c23 naa= 3 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 1 3 # 1 A 317 HIS A 22 HIS~? -3.40 MN MN A 604s A 318 GLY A 23 GLY~? 8.40 S2 BME A 601 A 360 CYH A 21 CYH~? -2.28 S2 BME A 601s coo -8.43 39.80 36.26 -8.18 39.59 38.31 3.18 53.06 10.64 3.66 54.63 11.95 coo -11.14 38.10 31.61 -11.46 38.10 32.37 1.32 48.34 7.45 1.06 48.38 8.26 coo -11.95 34.09 34.07 -11.89 34.73 36.80 3.34 47.98 12.34 4.26 47.15 14.87 ULMN 3 1qtn_c02 ACETYL-ILE-GLU-THR-ASP-ALDEHYDE user 2 3 # 2 A 317 HIS B 22 HIS~? -3.40 MN MN B 607s A 318 GLY B 23 GLY~? 8.34 S2 BME B 602 A 360 CYH B 21 CYH~? -2.10 S2 BME B 602s coo -8.43 39.80 36.26 -8.18 39.59 38.31 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -11.14 38.10 31.61 -11.46 38.10 32.37 -1.78 84.52 5.86 -2.42 84.42 6.43 coo -11.95 34.09 34.07 -11.89 34.73 36.80 -7.07 84.75 5.98 -9.76 85.47 5.91 1qtn_c02 source 1qtn ACETYL-ILE-GLU-THR-ASP-ALDEHYDE : 2 hits 1qtn_c02 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 11 PHE.? 7.28 O1 BME A 601 A 201 ASP A 69 ASP~? 7.42 O1 BME A 601 A 227 LYS A 155 LYS~? 22.50 MN MN A 604 coo 23.39 49.81 32.16 21.33 51.68 32.26 11.74 44.01 17.67 8.98 44.14 18.15 coo 25.52 45.12 37.98 23.98 46.65 37.85 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.68 46.83 36.69 18.26 48.67 34.51 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 11 PHE.? 7.28 O1 BME A 601 A 201 ASP A 69 ASP~? 7.42 O1 BME A 601 A 227 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 23.39 49.81 32.16 21.33 51.68 32.26 11.74 44.01 17.67 8.98 44.14 18.15 coo 25.52 45.12 37.98 23.98 46.65 37.85 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.68 46.83 36.69 18.26 48.67 34.51 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE A 74 PHE~? 8.88 MN MN A 604 A 201 ASP A 69 ASP~? 7.42 O1 BME A 601 A 227 LYS A 155 LYS~? 22.50 MN MN A 604 coo 23.39 49.81 32.16 21.33 51.68 32.26 11.59 56.31 16.73 12.14 57.65 14.39 coo 25.52 45.12 37.98 23.98 46.65 37.85 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.68 46.83 36.69 18.26 48.67 34.51 21.85 53.55 18.73 24.16 56.83 22.72 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE A 150 PHE~? 16.24 O2 GOL B 603 A 201 ASP A 145 ASP~? 14.76 MN MN A 604 A 227 LYS A 153 LYS~? 20.22 C2 BME A 601 coo 23.39 49.81 32.16 21.33 51.68 32.26 19.27 63.28 11.08 18.70 65.33 9.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 12.32 59.45 6.26 13.32 58.94 4.48 coo 12.68 46.83 36.69 18.26 48.67 34.51 23.06 52.60 13.46 22.53 47.10 11.88 ULMN 3 1qz9_c02 KYNURENINASE user 5 3 # 5 A 129 PHE B 74 PHE~? 8.86 MN MN B 607 A 201 ASP B 69 ASP~? 7.66 S2 BME B 602 A 227 LYS B 155 LYS~? 22.59 MN MN B 607 coo 23.39 49.81 32.16 21.33 51.68 32.26 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo 25.52 45.12 37.98 23.98 46.65 37.85 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 12.68 46.83 36.69 18.26 48.67 34.51 -19.72 79.32 -9.05 -24.26 76.03 -9.81 ULMN 3 1qz9_c02 KYNURENINASE user 6 3 # 6 A 129 PHE B 150 PHE~? 19.25 MN MN B 607 A 201 ASP B 145 ASP~? 15.01 MN MN B 607 A 227 LYS B 153 LYS~? 21.64 S2 BME B 602 coo 23.39 49.81 32.16 21.33 51.68 32.26 -11.34 69.63 -9.95 -9.41 67.65 -10.43 coo 25.52 45.12 37.98 23.98 46.65 37.85 -4.45 73.67 -4.82 -3.36 73.65 -6.63 coo 12.68 46.83 36.69 18.26 48.67 34.51 -15.29 80.48 -11.91 -17.46 85.09 -12.54 1qz9_c02 source 1qz9 KYNURENINASE : 6 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 116 ASP~? 31.90 C1 BME A 601 A 186 ASN A 117 ASN.? 27.48 C1 BME A 601 A 260 ALA A 40 ALA~? 29.67 CL CL A 608 coo 11.81 33.10 11.71 13.07 31.45 11.40 -27.84 44.25 19.33 -29.63 44.62 18.19 coo 11.43 26.53 7.41 13.01 27.56 8.43 -26.22 40.51 14.77 -24.81 39.30 15.85 coo 21.53 26.33 6.96 20.26 25.69 7.52 -25.59 47.36 5.27 -25.56 48.74 4.67 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP B 116 ASP~? 29.02 O1 GOL B 603 A 186 ASN B 117 ASN.? 27.09 C1 BME B 602 A 260 ALA B 40 ALA~? 20.75 O1 GOL B 603 coo 11.81 33.10 11.71 13.07 31.45 11.40 -2.03 88.79 36.93 -0.39 88.32 38.14 coo 11.43 26.53 7.41 13.01 27.56 8.43 1.79 92.43 33.70 0.32 93.69 32.69 coo 21.53 26.33 6.96 20.26 25.69 7.52 10.41 85.38 29.86 10.98 84.00 29.54 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 2 hits 1r4f_c00 naa= 3 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 1 3 # 1 A 12 HIS A 67 HIS~? -4.40 CL CL A 608s A 41 LYS A 24 LYS~? 4.08 C2 BME A 601 A 119 HIS A 136 HIS~? 3.48 MN MN A 605s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 0.35 54.22 20.29 -1.10 54.30 18.77 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -0.91 46.54 9.97 2.66 42.32 12.44 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 2 3 # 2 A 12 HIS A 136 HIS~? 3.48 MN MN A 605s A 41 LYS A 24 LYS~? 4.08 C2 BME A 601 A 119 HIS A 100 HIS~? 8.88 CL CL A 608 coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -0.57 59.60 14.33 0.78 59.36 15.93 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -0.91 46.54 9.97 2.66 42.32 12.44 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 1rbn_c01 RIBONUCLEASE A (E.C.3.1.27.5) DERIVAuser 3 3 # 3 A 12 HIS B 67 HIS~? -4.45 CL CL B 609s A 41 LYS B 24 LYS~? -3.00 C2 BME B 602s A 119 HIS B 136 HIS~? 3.50 MN MN B 606s coo 27.25 41.76 -6.97 28.67 40.32 -7.25 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 35.53 36.24 -0.58 31.10 37.46 -4.56 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 26.49 34.97 -12.73 26.25 33.07 -12.07 -7.23 73.04 10.16 -9.24 73.26 9.58 1rbn_c01 source 1rbn RIBONUCLEASE A (E.C.3.1.27.5) DERIVATIVE II CO: 3 hits 1rbn_c01 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 66 HIS~? 3.42 MN MN A 604s B 84 ASP A 69 ASP~? 7.42 O1 BME A 601 B 140 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 3.21 51.23 16.81 3.87 52.43 15.22 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 7.88 51.22 19.98 7.64 49.14 20.25 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 66 HIS~? 3.43 MN MN B 607s B 84 ASP B 69 ASP~? 7.66 S2 BME B 602 B 140 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -1.78 84.52 5.86 -2.42 84.42 6.43 1rgq_c01 source 1rgq NS4A PEPTIDE : 2 hits 1rgq_c01 naa= 3 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 A 137 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 288 HIS A 22 HIS~? -3.40 MN MN A 604s A 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.18 53.06 10.64 3.66 54.63 11.95 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 A 137 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 288 HIS A 66 HIS~? 3.42 MN MN A 604s A 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 A 137 GLU A 124 GLU~? 15.58 MN MN B 606 A 288 HIS B 22 HIS~? -3.40 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 49.52 10.06 10.36 50.99 9.65 8.92 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 A 137 GLU A 124 GLU~? 15.58 MN MN B 606 A 288 HIS B 66 HIS~? 3.43 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 49.52 10.06 10.36 50.99 9.65 8.92 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 A 137 GLU A 154 GLU~? 24.22 MN MN A 604 A 288 HIS A 22 HIS~? -3.40 MN MN A 604s A 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 26.81 50.98 16.47 27.37 52.31 14.88 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.18 53.06 10.64 3.66 54.63 11.95 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 A 137 GLU A 154 GLU~? 24.22 MN MN A 604 A 288 HIS A 66 HIS~? 3.42 MN MN A 604s A 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 26.81 50.98 16.47 27.37 52.31 14.88 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 A 137 GLU B 87 GLU~? 16.36 MN MN B 606 A 288 HIS B 22 HIS~? -3.40 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.52 10.06 10.36 50.99 9.65 8.92 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 A 137 GLU B 87 GLU~? 16.36 MN MN B 606 A 288 HIS B 66 HIS~? 3.43 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.52 10.06 10.36 50.99 9.65 8.92 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 A 137 GLU B 124 GLU~? 10.55 C1 GOL B 603 A 288 HIS A 66 HIS~? 3.42 MN MN A 604s A 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 29.27 18.78 14.99 27.16 18.62 14.76 0.65 71.77 26.43 1.32 70.82 24.72 coo 49.52 10.06 10.36 50.99 9.65 8.92 3.21 51.23 16.81 3.87 52.43 15.22 coo 57.80 12.92 13.83 53.77 8.42 12.15 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 A 137 GLU B 154 GLU~? 24.38 MN MN B 607 A 288 HIS B 22 HIS~? -3.40 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -19.39 82.12 -14.43 -18.34 80.66 -15.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c00 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 A 137 GLU B 154 GLU~? 24.38 MN MN B 607 A 288 HIS B 66 HIS~? 3.43 MN MN B 607s A 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 29.27 18.78 14.99 27.16 18.62 14.76 -19.39 82.12 -14.43 -18.34 80.66 -15.62 coo 49.52 10.06 10.36 50.99 9.65 8.92 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 57.80 12.92 13.83 53.77 8.42 12.15 -3.23 86.22 8.94 -7.29 90.78 7.55 1roz_c00 source 1roz DEOXYHYPUSINE SYNTHASE : 11 hits 1roz_c00 naa= 3 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 1 3 # 1 B 137 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 288 HIS A 22 HIS~? -3.40 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 7.70 72.78 18.03 7.03 72.92 20.00 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.18 53.06 10.64 3.66 54.63 11.95 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 2 3 # 2 B 137 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 288 HIS A 66 HIS~? 3.42 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 7.70 72.78 18.03 7.03 72.92 20.00 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.21 51.23 16.81 3.87 52.43 15.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 3 3 # 3 B 137 GLU A 124 GLU~? 15.58 MN MN B 606 B 288 HIS B 22 HIS~? -3.40 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 4 3 # 4 B 137 GLU A 124 GLU~? 15.58 MN MN B 606 B 288 HIS B 66 HIS~? 3.43 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 5 3 # 5 B 137 GLU A 140 GLU~? -2.42 MN MN A 605s B 288 HIS B 22 HIS~? -3.40 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 5.06 58.75 13.41 3.74 57.63 14.59 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 6 3 # 6 B 137 GLU A 154 GLU~? 24.22 MN MN A 604 B 288 HIS A 22 HIS~? -3.40 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 26.81 50.98 16.47 27.37 52.31 14.88 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.18 53.06 10.64 3.66 54.63 11.95 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 7 3 # 7 B 137 GLU A 154 GLU~? 24.22 MN MN A 604 B 288 HIS A 66 HIS~? 3.42 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 26.81 50.98 16.47 27.37 52.31 14.88 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.21 51.23 16.81 3.87 52.43 15.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 8 3 # 8 B 137 GLU B 87 GLU~? 16.36 MN MN B 606 B 288 HIS B 22 HIS~? -3.40 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 9 3 # 9 B 137 GLU B 87 GLU~? 16.36 MN MN B 606 B 288 HIS B 66 HIS~? 3.43 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 10 3 # 10 B 137 GLU B 124 GLU~? 10.55 C1 GOL B 603 B 288 HIS A 22 HIS~? -3.40 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 0.65 71.77 26.43 1.32 70.82 24.72 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.18 53.06 10.64 3.66 54.63 11.95 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 11 3 # 11 B 137 GLU B 124 GLU~? 10.55 C1 GOL B 603 B 288 HIS A 66 HIS~? 3.42 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 0.65 71.77 26.43 1.32 70.82 24.72 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.21 51.23 16.81 3.87 52.43 15.22 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 12 3 # 12 B 137 GLU B 140 GLU~? -2.41 MN MN B 606s B 288 HIS A 22 HIS~? -3.40 MN MN A 604s B 329 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 3.18 53.06 10.64 3.66 54.63 11.95 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -0.91 46.54 9.97 2.66 42.32 12.44 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 13 3 # 13 B 137 GLU B 154 GLU~? 24.38 MN MN B 607 B 288 HIS B 22 HIS~? -3.40 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -19.39 82.12 -14.43 -18.34 80.66 -15.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 ULMN 3 1roz_c01 DEOXYHYPUSINE SYNTHASE user 14 3 # 14 B 137 GLU B 154 GLU~? 24.38 MN MN B 607 B 288 HIS B 66 HIS~? 3.43 MN MN B 607s B 329 LYS B 24 LYS~? -3.00 C2 BME B 602s coo 51.99 -1.20 48.77 51.89 -0.93 46.67 -19.39 82.12 -14.43 -18.34 80.66 -15.62 coo 31.44 -9.36 43.35 29.98 -10.83 43.65 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 23.19 -4.89 44.25 27.28 -8.41 40.97 -3.23 86.22 8.94 -7.29 90.78 7.55 1roz_c01 source 1roz DEOXYHYPUSINE SYNTHASE : 14 hits 1roz_c01 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 66 HIS~? 3.42 MN MN A 604s B 102 ASP A 69 ASP~? 7.42 O1 BME A 601 B 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo -4.60 27.52 42.88 -4.63 27.41 40.76 3.21 51.23 16.81 3.87 52.43 15.22 coo -0.27 31.24 43.51 -1.49 29.62 42.98 7.88 51.22 19.98 7.64 49.14 20.25 coo -6.81 22.81 34.74 -6.42 23.54 34.62 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 3 # 2 B 57 HIS B 66 HIS~? 3.43 MN MN B 607s B 102 ASP B 69 ASP~? 7.66 S2 BME B 602 B 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -1.78 84.52 5.86 -2.42 84.42 6.43 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 2 hits 1rtf_c06 naa= 3 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 1 3 # 1 41 HIS A 22 HIS~? -3.40 MN MN A 604s 62 GLU A 140 GLU~? -2.42 MN MN A 605s 101 HIS A 67 HIS~? -4.40 CL CL A 608s coo 13.91 26.31 13.70 14.98 27.08 12.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 9.15 26.32 13.85 8.75 28.20 13.02 5.06 58.75 13.41 3.74 57.63 14.59 coo 7.90 34.31 7.89 9.24 33.73 9.42 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 2 3 # 2 41 HIS A 22 HIS~? -3.40 MN MN A 604s 62 GLU A 140 GLU~? -2.42 MN MN A 605s 101 HIS A 96 HIS~? -3.41 MN MN A 605s coo 13.91 26.31 13.70 14.98 27.08 12.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 9.15 26.32 13.85 8.75 28.20 13.02 5.06 58.75 13.41 3.74 57.63 14.59 coo 7.90 34.31 7.89 9.24 33.73 9.42 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 3 3 # 3 41 HIS B 22 HIS~? -3.40 MN MN B 607s 62 GLU B 140 GLU~? -2.41 MN MN B 606s 101 HIS B 67 HIS~? -4.45 CL CL B 609s coo 13.91 26.31 13.70 14.98 27.08 12.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 9.15 26.32 13.85 8.75 28.20 13.02 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 7.90 34.31 7.89 9.24 33.73 9.42 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 1rtu_c00 RIBONUCLEASE U2 user 4 3 # 4 41 HIS B 22 HIS~? -3.40 MN MN B 607s 62 GLU B 140 GLU~? -2.41 MN MN B 606s 101 HIS B 96 HIS~? -3.43 MN MN B 606s coo 13.91 26.31 13.70 14.98 27.08 12.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 9.15 26.32 13.85 8.75 28.20 13.02 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 7.90 34.31 7.89 9.24 33.73 9.42 -13.24 74.01 11.32 -12.76 74.71 9.40 1rtu_c00 source 1rtu RIBONUCLEASE U2 : 4 hits 1rtu_c00 naa= 3 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 3 # 1 A 104 ILE A 97 ILE~? 11.51 MN MN A 605 A 106 HIS A 100 HIS~? 8.88 CL CL A 608 A 142 ASP A 101 ASP~? 14.47 MN MN A 605 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -4.33 61.79 24.03 -4.24 62.43 25.30 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -10.28 59.57 22.50 -9.46 60.36 24.30 ULMN 3 1s3i_c00 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 3 # 2 A 104 ILE B 97 ILE~? 11.42 MN MN B 606 A 106 HIS B 100 HIS~? 8.87 CL CL B 609 A 142 ASP B 101 ASP~? 14.48 MN MN B 606 coo -15.54 60.72 29.56 -16.71 61.53 30.10 -14.72 70.62 17.19 -15.88 69.95 17.41 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -10.99 72.82 22.17 -12.93 72.02 22.11 1s3i_c00 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 2 hits 1s3i_c00 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 101 ASP~? 14.47 MN MN A 605 64 HIS A 100 HIS~? 8.88 CL CL A 608 155 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 78.27 67.69 61.83 79.58 67.76 60.19 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 80.34 61.88 52.75 81.25 63.19 54.35 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP B 101 ASP~? 14.48 MN MN B 606 64 HIS B 100 HIS~? 8.87 CL CL B 609 155 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 80.16 73.25 62.48 80.01 71.25 61.82 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 78.27 67.69 61.83 79.58 67.76 60.19 -13.86 76.47 17.25 -14.56 76.87 15.30 coo 80.34 61.88 52.75 81.25 63.19 54.35 -12.53 86.72 19.85 -11.70 86.05 21.72 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 2 hits 1sca_c01 naa= 3 ULMN 3 1sll_c00 SIALIDASE L user 1 3 # 1 318 ASP A 69 ASP~? 7.42 O1 BME A 601 595 GLU A 140 GLU~? -2.42 MN MN A 605s 713 TYR A 19 TYR~? 9.00 MN MN A 604 coo 5.64 2.82 38.49 4.59 4.19 37.25 7.88 51.22 19.98 7.64 49.14 20.25 coo 4.35 13.73 37.63 3.39 12.18 36.55 5.06 58.75 13.41 3.74 57.63 14.59 coo 3.76 10.25 31.38 3.16 9.87 34.10 8.27 52.26 7.85 9.08 54.84 7.01 ULMN 3 1sll_c00 SIALIDASE L user 2 3 # 2 318 ASP B 69 ASP~? 7.66 S2 BME B 602 595 GLU B 16 GLU~? 10.04 C2 BME B 602 713 TYR B 19 TYR~? 9.04 MN MN B 607 coo 5.64 2.82 38.49 4.59 4.19 37.25 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 4.35 13.73 37.63 3.39 12.18 36.55 -8.79 86.61 -3.48 -7.90 88.30 -2.54 coo 3.76 10.25 31.38 3.16 9.87 34.10 -4.68 80.80 -0.42 -3.93 78.29 -1.36 ULMN 3 1sll_c00 SIALIDASE L user 3 3 # 3 318 ASP B 69 ASP~? 7.66 S2 BME B 602 595 GLU B 140 GLU~? -2.41 MN MN B 606s 713 TYR B 19 TYR~? 9.04 MN MN B 607 coo 5.64 2.82 38.49 4.59 4.19 37.25 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 4.35 13.73 37.63 3.39 12.18 36.55 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 3.76 10.25 31.38 3.16 9.87 34.10 -4.68 80.80 -0.42 -3.93 78.29 -1.36 1sll_c00 source 1sll SIALIDASE L : 3 hits 1sll_c00 naa= 3 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 A 87 ARG A 167 ARG~? -4.94 O1 BME A 601s A 89 HIS A 66 HIS~? 3.42 MN MN A 604s A 119 ASN A 73 ASN~? 13.47 MN MN A 605 coo 28.44 23.52 73.95 30.13 24.84 76.11 6.75 43.81 21.29 6.50 46.65 20.31 coo 21.34 20.13 69.47 22.14 19.11 71.12 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.69 29.00 71.61 19.80 26.98 72.20 12.56 53.31 22.50 12.18 52.20 24.34 ULMN 3 1smn_c00 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 A 87 ARG B 167 ARG~? 6.18 S2 BME B 602 A 89 HIS B 66 HIS~? 3.43 MN MN B 607s A 119 ASN B 73 ASN~? 13.50 MN MN B 606 coo 28.44 23.52 73.95 30.13 24.84 76.11 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 21.34 20.13 69.47 22.14 19.11 71.12 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 19.69 29.00 71.61 19.80 26.98 72.20 -19.90 79.31 1.05 -21.42 80.32 2.14 1smn_c00 source 1smn EXTRACELLULAR ENDONUCLEASE : 2 hits 1smn_c00 naa= 3 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 1 3 # 1 B 87 ARG A 167 ARG~? -4.94 O1 BME A 601s B 89 HIS A 66 HIS~? 3.42 MN MN A 604s B 119 ASN A 73 ASN~? 13.47 MN MN A 605 coo -30.08 23.20 29.48 -31.80 24.60 27.35 6.75 43.81 21.29 6.50 46.65 20.31 coo -22.85 19.92 33.92 -23.63 18.94 32.24 3.21 51.23 16.81 3.87 52.43 15.22 coo -21.28 28.91 31.84 -21.35 26.90 31.17 12.56 53.31 22.50 12.18 52.20 24.34 ULMN 3 1smn_c01 EXTRACELLULAR ENDONUCLEASE user 2 3 # 2 B 87 ARG B 167 ARG~? 6.18 S2 BME B 602 B 89 HIS B 66 HIS~? 3.43 MN MN B 607s B 119 ASN B 73 ASN~? 13.50 MN MN B 606 coo -30.08 23.20 29.48 -31.80 24.60 27.35 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -22.85 19.92 33.92 -23.63 18.94 32.24 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -21.28 28.91 31.84 -21.35 26.90 31.17 -19.90 79.31 1.05 -21.42 80.32 2.14 1smn_c01 source 1smn EXTRACELLULAR ENDONUCLEASE : 2 hits 1smn_c01 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 66 HIS~? 3.42 MN MN A 604s A 102 ASP A 69 ASP~? 7.42 O1 BME A 601 A 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 15.02 29.17 19.44 15.63 29.96 17.60 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.67 30.58 22.61 18.30 29.87 21.17 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.52 29.10 10.01 15.08 29.66 10.19 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 66 HIS~? 3.43 MN MN B 607s A 102 ASP B 69 ASP~? 7.66 S2 BME B 602 A 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 19.67 30.58 22.61 18.30 29.87 21.17 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 14.52 29.10 10.01 15.08 29.66 10.19 -1.78 84.52 5.86 -2.42 84.42 6.43 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 2 hits 1ssx_c02 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 96 HIS~? -3.41 MN MN A 605s B 80 GLU A 71 GLU~? 7.91 MN MN A 605 B 223 ARG B 27 ARG~? 11.60 C2 BME B 602 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 0.59 58.54 20.35 2.20 57.89 19.15 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 4.56 57.67 23.22 2.91 58.15 24.47 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 1.97 89.27 10.36 0.81 91.17 12.49 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS A 136 HIS~? 3.48 MN MN A 605s B 80 GLU A 140 GLU~? -2.42 MN MN A 605s B 223 ARG B 27 ARG~? 11.60 C2 BME B 602 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -0.57 59.60 14.33 0.78 59.36 15.93 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 5.06 58.75 13.41 3.74 57.63 14.59 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 1.97 89.27 10.36 0.81 91.17 12.49 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 3 3 # 3 B 8 HIS B 96 HIS~? -3.43 MN MN B 606s B 80 GLU B 71 GLU~? 7.93 MN MN B 606 B 223 ARG A 27 ARG~? 11.42 S2 BME A 601 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -17.41 74.79 8.70 -17.96 74.30 10.67 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -3.68 43.51 6.20 -5.32 41.74 8.07 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 4 3 # 4 B 8 HIS B 136 HIS~? 3.50 MN MN B 606s B 80 GLU B 140 GLU~? -2.41 MN MN B 606s B 223 ARG A 27 ARG~? 11.42 S2 BME A 601 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 -8.44 74.11 4.59 -9.08 75.11 6.26 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 -3.68 43.51 6.20 -5.32 41.74 8.07 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c01 naa= 3 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 A 144 HIS A 22 HIS~? -3.40 MN MN A 604s A 174 ASP A 69 ASP~? 7.42 O1 BME A 601 A 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 3.18 53.06 10.64 3.66 54.63 11.95 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 A 144 HIS A 67 HIS~? -4.40 CL CL A 608s A 174 ASP A 69 ASP~? 7.42 O1 BME A 601 A 404 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 0.35 54.22 20.29 -1.10 54.30 18.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 A 144 HIS A 67 HIS~? -4.40 CL CL A 608s A 174 ASP A 69 ASP~? 7.42 O1 BME A 601 A 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 0.35 54.22 20.29 -1.10 54.30 18.77 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 A 144 HIS A 96 HIS~? -3.41 MN MN A 605s A 174 ASP A 69 ASP~? 7.42 O1 BME A 601 A 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 0.59 58.54 20.35 2.20 57.89 19.15 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 A 144 HIS B 22 HIS~? -3.40 MN MN B 607s A 174 ASP B 69 ASP~? 7.66 S2 BME B 602 A 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 A 144 HIS B 67 HIS~? -4.45 CL CL B 609s A 174 ASP B 69 ASP~? 7.66 S2 BME B 602 A 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c06 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 A 144 HIS B 96 HIS~? -3.43 MN MN B 606s A 174 ASP B 69 ASP~? 7.66 S2 BME B 602 A 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 18.51 -77.38 -39.07 19.76 -78.71 -38.04 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 27.58 -77.64 -39.00 25.78 -78.57 -39.64 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 14.43 -85.16 -40.78 16.47 -83.93 -39.31 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c06 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c06 naa= 3 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 C 144 HIS A 22 HIS~? -3.40 MN MN A 604s C 174 ASP A 69 ASP~? 7.42 O1 BME A 601 C 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 3.18 53.06 10.64 3.66 54.63 11.95 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 7.88 51.22 19.98 7.64 49.14 20.25 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 C 144 HIS A 67 HIS~? -4.40 CL CL A 608s C 174 ASP A 69 ASP~? 7.42 O1 BME A 601 C 404 TYR A 58 TYR~? -4.88 S2 BME A 601s coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 0.35 54.22 20.29 -1.10 54.30 18.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 7.88 51.22 19.98 7.64 49.14 20.25 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 C 144 HIS A 67 HIS~? -4.40 CL CL A 608s C 174 ASP A 69 ASP~? 7.42 O1 BME A 601 C 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 0.35 54.22 20.29 -1.10 54.30 18.77 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 7.88 51.22 19.98 7.64 49.14 20.25 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 C 144 HIS A 96 HIS~? -3.41 MN MN A 605s C 174 ASP A 69 ASP~? 7.42 O1 BME A 601 C 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 0.59 58.54 20.35 2.20 57.89 19.15 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 7.88 51.22 19.98 7.64 49.14 20.25 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 C 144 HIS B 22 HIS~? -3.40 MN MN B 607s C 174 ASP B 69 ASP~? 7.66 S2 BME B 602 C 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 C 144 HIS B 67 HIS~? -4.45 CL CL B 609s C 174 ASP B 69 ASP~? 7.66 S2 BME B 602 C 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c07 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 C 144 HIS B 96 HIS~? -3.43 MN MN B 606s C 174 ASP B 69 ASP~? 7.66 S2 BME B 602 C 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -15.55 89.08 -13.38 -16.05 90.98 -14.11 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -23.98 91.31 -16.16 -21.94 90.86 -16.65 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -8.89 91.06 -18.89 -11.23 91.99 -17.67 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c07 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c07 naa= 3 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 E 144 HIS A 22 HIS~? -3.40 MN MN A 604s E 174 ASP A 69 ASP~? 7.42 O1 BME A 601 E 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -7.53-107.59 75.19 -8.14-106.04 76.47 3.18 53.06 10.64 3.66 54.63 11.95 coo -3.55-105.39 83.13 -5.21-106.24 82.09 7.88 51.22 19.98 7.64 49.14 20.25 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 E 144 HIS A 67 HIS~? -4.40 CL CL A 608s E 174 ASP A 69 ASP~? 7.42 O1 BME A 601 E 404 TYR A 58 TYR~? -4.88 S2 BME A 601s coo -7.53-107.59 75.19 -8.14-106.04 76.47 0.35 54.22 20.29 -1.10 54.30 18.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 7.88 51.22 19.98 7.64 49.14 20.25 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 E 144 HIS A 67 HIS~? -4.40 CL CL A 608s E 174 ASP A 69 ASP~? 7.42 O1 BME A 601 E 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -7.53-107.59 75.19 -8.14-106.04 76.47 0.35 54.22 20.29 -1.10 54.30 18.77 coo -3.55-105.39 83.13 -5.21-106.24 82.09 7.88 51.22 19.98 7.64 49.14 20.25 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 E 144 HIS A 96 HIS~? -3.41 MN MN A 605s E 174 ASP A 69 ASP~? 7.42 O1 BME A 601 E 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -7.53-107.59 75.19 -8.14-106.04 76.47 0.59 58.54 20.35 2.20 57.89 19.15 coo -3.55-105.39 83.13 -5.21-106.24 82.09 7.88 51.22 19.98 7.64 49.14 20.25 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 E 144 HIS B 22 HIS~? -3.40 MN MN B 607s E 174 ASP B 69 ASP~? 7.66 S2 BME B 602 E 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 E 144 HIS B 67 HIS~? -4.45 CL CL B 609s E 174 ASP B 69 ASP~? 7.66 S2 BME B 602 E 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c08 PYROGALLOL HYDROXYTRANSFERASE SMALL user 7 3 # 7 E 144 HIS B 96 HIS~? -3.43 MN MN B 606s E 174 ASP B 69 ASP~? 7.66 S2 BME B 602 E 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -7.53-107.59 75.19 -8.14-106.04 76.47 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -3.55-105.39 83.13 -5.21-106.24 82.09 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -16.31-108.78 75.35 -14.20-107.14 76.16 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c08 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 7 hits 1ti6_c08 naa= 3 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 G 144 HIS A 22 HIS~? -3.40 MN MN A 604s G 174 ASP A 69 ASP~? 7.42 O1 BME A 601 G 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 60.48-101.16 45.95 60.56-101.20 43.85 3.18 53.06 10.64 3.66 54.63 11.95 coo 58.10-108.15 40.62 59.57-106.86 41.51 7.88 51.22 19.98 7.64 49.14 20.25 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 G 144 HIS A 67 HIS~? -4.40 CL CL A 608s G 174 ASP A 69 ASP~? 7.42 O1 BME A 601 G 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 60.48-101.16 45.95 60.56-101.20 43.85 0.35 54.22 20.29 -1.10 54.30 18.77 coo 58.10-108.15 40.62 59.57-106.86 41.51 7.88 51.22 19.98 7.64 49.14 20.25 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 G 144 HIS A 96 HIS~? -3.41 MN MN A 605s G 174 ASP A 69 ASP~? 7.42 O1 BME A 601 G 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 60.48-101.16 45.95 60.56-101.20 43.85 0.59 58.54 20.35 2.20 57.89 19.15 coo 58.10-108.15 40.62 59.57-106.86 41.51 7.88 51.22 19.98 7.64 49.14 20.25 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 G 144 HIS B 22 HIS~? -3.40 MN MN B 607s G 174 ASP B 69 ASP~? 7.66 S2 BME B 602 G 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 60.48-101.16 45.95 60.56-101.20 43.85 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 58.10-108.15 40.62 59.57-106.86 41.51 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 G 144 HIS B 67 HIS~? -4.45 CL CL B 609s G 174 ASP B 69 ASP~? 7.66 S2 BME B 602 G 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 60.48-101.16 45.95 60.56-101.20 43.85 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 58.10-108.15 40.62 59.57-106.86 41.51 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c09 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 G 144 HIS B 96 HIS~? -3.43 MN MN B 606s G 174 ASP B 69 ASP~? 7.66 S2 BME B 602 G 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 60.48-101.16 45.95 60.56-101.20 43.85 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 58.10-108.15 40.62 59.57-106.86 41.51 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 68.57 -97.60 44.49 66.22 -98.53 43.28 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c09 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c09 naa= 3 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 I 144 HIS A 22 HIS~? -3.40 MN MN A 604s I 174 ASP A 69 ASP~? 7.42 O1 BME A 601 I 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 3.18 53.06 10.64 3.66 54.63 11.95 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 7.88 51.22 19.98 7.64 49.14 20.25 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 I 144 HIS A 67 HIS~? -4.40 CL CL A 608s I 174 ASP A 69 ASP~? 7.42 O1 BME A 601 I 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 0.35 54.22 20.29 -1.10 54.30 18.77 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 7.88 51.22 19.98 7.64 49.14 20.25 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 I 144 HIS A 96 HIS~? -3.41 MN MN A 605s I 174 ASP A 69 ASP~? 7.42 O1 BME A 601 I 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 0.59 58.54 20.35 2.20 57.89 19.15 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 7.88 51.22 19.98 7.64 49.14 20.25 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 I 144 HIS B 22 HIS~? -3.40 MN MN B 607s I 174 ASP B 69 ASP~? 7.66 S2 BME B 602 I 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -5.34 79.70 5.35 -6.67 78.07 5.35 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 I 144 HIS B 67 HIS~? -4.45 CL CL B 609s I 174 ASP B 69 ASP~? 7.66 S2 BME B 602 I 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c10 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 I 144 HIS B 96 HIS~? -3.43 MN MN B 606s I 174 ASP B 69 ASP~? 7.66 S2 BME B 602 I 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo -12.68 -17.50 91.59 -12.79 -19.47 92.31 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -20.27 -21.99 93.95 -18.47 -20.99 94.50 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -5.95 -17.59 97.43 -7.86 -19.17 96.13 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c10 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c10 naa= 3 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 1 3 # 1 K 144 HIS A 22 HIS~? -3.40 MN MN A 604s K 174 ASP A 69 ASP~? 7.42 O1 BME A 601 K 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 100.18 26.45 -1.32 99.24 26.12 0.53 3.18 53.06 10.64 3.66 54.63 11.95 coo 102.36 30.86 6.31 102.45 29.08 5.12 7.88 51.22 19.98 7.64 49.14 20.25 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 2 3 # 2 K 144 HIS A 67 HIS~? -4.40 CL CL A 608s K 174 ASP A 69 ASP~? 7.42 O1 BME A 601 K 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 100.18 26.45 -1.32 99.24 26.12 0.53 0.35 54.22 20.29 -1.10 54.30 18.77 coo 102.36 30.86 6.31 102.45 29.08 5.12 7.88 51.22 19.98 7.64 49.14 20.25 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 3 3 # 3 K 144 HIS A 96 HIS~? -3.41 MN MN A 605s K 174 ASP A 69 ASP~? 7.42 O1 BME A 601 K 404 TYR A 133 TYR~? 5.56 CL CL A 608 coo 100.18 26.45 -1.32 99.24 26.12 0.53 0.59 58.54 20.35 2.20 57.89 19.15 coo 102.36 30.86 6.31 102.45 29.08 5.12 7.88 51.22 19.98 7.64 49.14 20.25 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 4 3 # 4 K 144 HIS B 22 HIS~? -3.40 MN MN B 607s K 174 ASP B 69 ASP~? 7.66 S2 BME B 602 K 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 102.36 30.86 6.31 102.45 29.08 5.12 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 5 3 # 5 K 144 HIS B 67 HIS~? -4.45 CL CL B 609s K 174 ASP B 69 ASP~? 7.66 S2 BME B 602 K 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 102.36 30.86 6.31 102.45 29.08 5.12 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1ti6_c11 PYROGALLOL HYDROXYTRANSFERASE SMALL user 6 3 # 6 K 144 HIS B 96 HIS~? -3.43 MN MN B 606s K 174 ASP B 69 ASP~? 7.66 S2 BME B 602 K 404 TYR B 133 TYR~? 5.56 CL CL B 609 coo 100.18 26.45 -1.32 99.24 26.12 0.53 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 102.36 30.86 6.31 102.45 29.08 5.12 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 99.93 17.48 -0.85 99.14 19.86 0.39 -4.49 77.34 13.29 -7.09 78.39 13.51 1ti6_c11 source 1ti6 PYROGALLOL HYDROXYTRANSFERASE SMALL SUBUNIT : 6 hits 1ti6_c11 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 131 ALA~? 14.03 CL CL A 608 A 251 GLY A 132 GLY~? 10.05 CL CL A 608 A 252 ASP A 134 ASP~? 12.23 CL CL A 608 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 131 ALA~? -3.51 O1 GOL B 603s A 251 GLY B 132 GLY~? 6.66 O1 GOL B 603 A 252 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 0.55 72.95 16.09 1.01 71.82 17.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 1.27 73.42 12.01 2.60 75.02 12.38 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 131 ALA~? 14.03 CL CL A 608 B 251 GLY A 132 GLY~? 10.05 CL CL A 608 B 252 ASP A 134 ASP~? 12.23 CL CL A 608 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -7.17 60.13 12.71 -7.01 59.60 12.06 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 131 ALA~? -3.51 O1 GOL B 603s B 251 GLY B 132 GLY~? 6.66 O1 GOL B 603 B 252 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 0.55 72.95 16.09 1.01 71.82 17.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 -3.20 72.50 15.64 -2.65 73.03 15.24 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 1.27 73.42 12.01 2.60 75.02 12.38 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 1 3 # 1 115 LYS A 127 LYS~? 18.61 MN MN B 606 138 ASN A 102 ASN~? 12.24 CL CL A 608 183 HIS A 136 HIS~? 3.48 MN MN A 605s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 -14.62 57.47 9.74 -19.33 59.04 5.94 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -10.29 57.70 17.47 -10.13 59.75 17.06 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 1uag_c01 UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLuser 2 3 # 2 115 LYS B 127 LYS~? 11.03 O1 GOL B 603 138 ASN B 102 ASN~? 10.95 O1 GOL B 603 183 HIS B 136 HIS~? 3.50 MN MN B 606s coo 36.44 -9.55 24.75 39.00 -9.24 20.52 2.32 75.24 21.44 7.34 73.34 24.59 coo 42.86 -4.84 22.91 42.38 -4.90 20.84 -6.42 74.86 20.35 -6.05 72.80 20.02 coo 43.51 -9.99 13.57 42.49 -8.60 14.69 -7.23 73.04 10.16 -9.24 73.26 9.58 1uag_c01 source 1uag UDP-N-ACETYLMURAMOYL-L-ALANINE-:D-GLUTAMATE LI: 2 hits 1uag_c01 naa= 3 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 A 46 GLU A 13 GLU~? 14.48 C2 BME A 601 A 126 LYS A 153 LYS~? 20.22 C2 BME A 601 A 171 ALA A 12 ALA.? 15.24 C2 BME A 601 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 16.66 45.80 10.16 16.30 43.75 10.43 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 23.06 52.60 13.46 22.53 47.10 11.88 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 17.26 44.50 14.80 18.08 43.34 14.19 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 A 46 GLU A 109 GLU~? 22.92 CL CL A 608 A 126 LYS A 112 LYS~? 24.85 CL CL A 608 A 171 ALA A 108 ALA~? 20.95 CL CL A 608 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -17.92 50.65 21.89 -18.27 51.97 22.49 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 A 46 GLU B 13 GLU~? 14.49 C2 BME B 602 A 126 LYS B 153 LYS~? 21.64 S2 BME B 602 A 171 ALA B 12 ALA.? 15.00 O1 BME B 602 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -10.54 87.21 -7.31 -10.84 89.32 -6.98 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -14.85 88.36 -5.85 -14.69 89.48 -6.87 ULMN 3 1uf7_c00 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 A 46 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 126 LYS B 112 LYS~? 25.52 O1 GOL B 603 A 171 ALA B 108 ALA~? 20.82 CL CL B 609 coo 52.87 81.38 -9.32 53.05 81.09 -7.22 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 51.43 89.29 -7.19 53.08 83.69 -4.74 -4.73 86.07 32.89 -5.14 81.77 36.42 coo 48.80 81.73 -5.45 50.30 81.43 -5.45 -7.86 82.27 28.90 -8.27 80.95 29.48 1uf7_c00 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 4 hits 1uf7_c00 naa= 3 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 1 3 # 1 B 46 GLU A 13 GLU~? 14.48 C2 BME A 601 B 126 LYS A 153 LYS~? 20.22 C2 BME A 601 B 171 ALA A 12 ALA.? 15.24 C2 BME A 601 coo 20.47 87.42 16.54 20.16 87.17 14.45 16.66 45.80 10.16 16.30 43.75 10.43 coo 24.73 94.37 14.59 21.08 89.84 11.98 23.06 52.60 13.46 22.53 47.10 11.88 coo 24.38 86.32 12.71 22.88 86.54 12.71 17.26 44.50 14.80 18.08 43.34 14.19 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 2 3 # 2 B 46 GLU A 109 GLU~? 22.92 CL CL A 608 B 126 LYS A 112 LYS~? 24.85 CL CL A 608 B 171 ALA A 108 ALA~? 20.95 CL CL A 608 coo 20.47 87.42 16.54 20.16 87.17 14.45 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 24.73 94.37 14.59 21.08 89.84 11.98 -22.90 46.94 20.43 -23.03 53.11 20.55 coo 24.38 86.32 12.71 22.88 86.54 12.71 -17.92 50.65 21.89 -18.27 51.97 22.49 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 3 3 # 3 B 46 GLU B 13 GLU~? 14.49 C2 BME B 602 B 126 LYS B 153 LYS~? 21.64 S2 BME B 602 B 171 ALA B 12 ALA.? 15.00 O1 BME B 602 coo 20.47 87.42 16.54 20.16 87.17 14.45 -10.54 87.21 -7.31 -10.84 89.32 -6.98 coo 24.73 94.37 14.59 21.08 89.84 11.98 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 24.38 86.32 12.71 22.88 86.54 12.71 -14.85 88.36 -5.85 -14.69 89.48 -6.87 ULMN 3 1uf7_c01 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLAuser 4 3 # 4 B 46 GLU B 109 GLU~? 18.95 O1 GOL B 603 B 126 LYS B 112 LYS~? 25.52 O1 GOL B 603 B 171 ALA B 108 ALA~? 20.82 CL CL B 609 coo 20.47 87.42 16.54 20.16 87.17 14.45 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 24.73 94.37 14.59 21.08 89.84 11.98 -4.73 86.07 32.89 -5.14 81.77 36.42 coo 24.38 86.32 12.71 22.88 86.54 12.71 -7.86 82.27 28.90 -8.27 80.95 29.48 1uf7_c01 source 1uf7 N-CARBAMYL-D-AMINO ACID AMIDOHYDROLASE : 4 hits 1uf7_c01 naa= 3 ULMN 3 1uk7_c00 3.07.01.0009 user 1 3 # 1 A 103 ALA A 62 ALA~? -3.33 C1 BME A 601s A 224 ASP A 69 ASP~? 7.42 O1 BME A 601 A 252 HIS A 66 HIS~? 3.42 MN MN A 604s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 7.88 51.22 19.98 7.64 49.14 20.25 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1uk7_c00 3.07.01.0009 user 2 3 # 2 A 103 ALA A 63 ALA~? 7.13 CL CL A 608 A 224 ASP A 69 ASP~? 7.42 O1 BME A 601 A 252 HIS A 66 HIS~? 3.42 MN MN A 604s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 7.88 51.22 19.98 7.64 49.14 20.25 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1uk7_c00 3.07.01.0009 user 3 3 # 3 A 103 ALA B 62 ALA~? 4.29 C1 BME B 602 A 224 ASP B 69 ASP~? 7.66 S2 BME B 602 A 252 HIS B 66 HIS~? 3.43 MN MN B 607s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1uk7_c00 3.07.01.0009 user 4 3 # 4 A 103 ALA B 63 ALA~? 7.11 CL CL B 609 A 224 ASP B 69 ASP~? 7.66 S2 BME B 602 A 252 HIS B 66 HIS~? 3.43 MN MN B 607s coo 10.74 41.88 -3.62 10.55 41.61 -5.11 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 7.52 49.49 -8.72 7.95 47.43 -8.44 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 9.83 44.81 -9.44 9.32 43.66 -7.77 -11.11 81.39 7.66 -9.84 80.27 6.41 1uk7_c00 source 1uk7 3.07.01.0009 : 4 hits 1uk7_c00 naa= 3 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 1 3 # 1 86 HIS A 22 HIS~? -3.40 MN MN A 604s 89 GLU A 140 GLU~? -2.42 MN MN A 605s 243 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 5.83 15.74 17.38 6.41 17.70 17.86 3.18 53.06 10.64 3.66 54.63 11.95 coo 3.11 16.19 13.44 4.96 17.09 13.42 5.06 58.75 13.41 3.74 57.63 14.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 2 3 # 2 86 HIS A 22 HIS~? -3.40 MN MN A 604s 89 GLU A 141 GLU~? 7.70 MN MN A 604 243 ASN A 102 ASN~? 12.24 CL CL A 608 coo 5.83 15.74 17.38 6.41 17.70 17.86 3.18 53.06 10.64 3.66 54.63 11.95 coo 3.11 16.19 13.44 4.96 17.09 13.42 4.84 56.74 8.27 3.91 55.44 6.87 coo 0.53 21.81 31.33 1.05 20.47 29.70 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 3 3 # 3 86 HIS A 96 HIS~? -3.41 MN MN A 605s 89 GLU A 71 GLU~? 7.91 MN MN A 605 243 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 5.83 15.74 17.38 6.41 17.70 17.86 0.59 58.54 20.35 2.20 57.89 19.15 coo 3.11 16.19 13.44 4.96 17.09 13.42 4.56 57.67 23.22 2.91 58.15 24.47 coo 0.53 21.81 31.33 1.05 20.47 29.70 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 4 3 # 4 86 HIS A 96 HIS~? -3.41 MN MN A 605s 89 GLU A 71 GLU~? 7.91 MN MN A 605 243 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 5.83 15.74 17.38 6.41 17.70 17.86 0.59 58.54 20.35 2.20 57.89 19.15 coo 3.11 16.19 13.44 4.96 17.09 13.42 4.56 57.67 23.22 2.91 58.15 24.47 coo 0.53 21.81 31.33 1.05 20.47 29.70 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 5 3 # 5 86 HIS A 136 HIS~? 3.48 MN MN A 605s 89 GLU A 140 GLU~? -2.42 MN MN A 605s 243 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 5.83 15.74 17.38 6.41 17.70 17.86 -0.57 59.60 14.33 0.78 59.36 15.93 coo 3.11 16.19 13.44 4.96 17.09 13.42 5.06 58.75 13.41 3.74 57.63 14.59 coo 0.53 21.81 31.33 1.05 20.47 29.70 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 6 3 # 6 86 HIS B 22 HIS~? -3.40 MN MN B 607s 89 GLU B 140 GLU~? -2.41 MN MN B 606s 243 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 5.83 15.74 17.38 6.41 17.70 17.86 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 3.11 16.19 13.44 4.96 17.09 13.42 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 0.53 21.81 31.33 1.05 20.47 29.70 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 7 3 # 7 86 HIS B 22 HIS~? -3.40 MN MN B 607s 89 GLU B 141 GLU~? 7.71 MN MN B 607 243 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 5.83 15.74 17.38 6.41 17.70 17.86 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 3.11 16.19 13.44 4.96 17.09 13.42 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 0.53 21.81 31.33 1.05 20.47 29.70 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 8 3 # 8 86 HIS B 96 HIS~? -3.43 MN MN B 606s 89 GLU B 71 GLU~? 7.93 MN MN B 606 243 ASN A 102 ASN~? 12.24 CL CL A 608 coo 5.83 15.74 17.38 6.41 17.70 17.86 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 3.11 16.19 13.44 4.96 17.09 13.42 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 0.53 21.81 31.33 1.05 20.47 29.70 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 9 3 # 9 86 HIS B 96 HIS~? -3.43 MN MN B 606s 89 GLU B 71 GLU~? 7.93 MN MN B 606 243 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 5.83 15.74 17.38 6.41 17.70 17.86 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 3.11 16.19 13.44 4.96 17.09 13.42 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 0.53 21.81 31.33 1.05 20.47 29.70 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 1ula_c00 PURINE NUCLEOSIDE PHOSPHORYLASE (E.Cuser 10 3 # 10 86 HIS B 136 HIS~? 3.50 MN MN B 606s 89 GLU B 140 GLU~? -2.41 MN MN B 606s 243 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 5.83 15.74 17.38 6.41 17.70 17.86 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 3.11 16.19 13.44 4.96 17.09 13.42 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 0.53 21.81 31.33 1.05 20.47 29.70 -12.53 86.72 19.85 -11.70 86.05 21.72 1ula_c00 source 1ula PURINE NUCLEOSIDE PHOSPHORYLASE (E.C.2.4.2.1) : 10 hits 1ula_c00 naa= 3 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 A 85 GLU A 68 GLU~? 10.93 O1 BME A 601 A 87 ASP A 69 ASP~? 7.42 O1 BME A 601 A 89 GLU A 70 GLU~? -2.54 MN MN A 604s coo 22.84 137.30 -8.23 24.70 136.75 -9.08 5.73 51.66 25.85 5.32 49.97 27.08 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 7.88 51.22 19.98 7.64 49.14 20.25 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 A 85 GLU A 70 GLU~? -2.54 MN MN A 604s A 87 ASP A 69 ASP~? 7.42 O1 BME A 601 A 89 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 6.20 55.25 17.70 4.45 55.72 16.64 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 7.88 51.22 19.98 7.64 49.14 20.25 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 A 85 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 87 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 89 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 0.70 67.61 16.19 -1.02 68.27 17.25 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 5.32 68.36 21.17 7.09 68.49 22.34 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 A 85 GLU A 109 GLU~? 22.92 CL CL A 608 A 87 ASP A 122 ASP~? 22.01 MN MN B 606 A 89 GLU A 124 GLU~? 15.58 MN MN B 606 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 A 85 GLU A 124 GLU~? 15.58 MN MN B 606 A 87 ASP A 122 ASP~? 22.01 MN MN B 606 A 89 GLU A 109 GLU~? 22.92 CL CL A 608 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 6 3 # 6 A 85 GLU B 91 GLU~? 11.42 MN MN B 606 A 87 ASP B 90 ASP~? 13.30 MN MN B 606 A 89 GLU B 87 GLU~? 16.36 MN MN B 606 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 1un1_c00 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 7 3 # 7 A 85 GLU B 124 GLU~? 10.55 C1 GOL B 603 A 87 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 89 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 22.84 137.30 -8.23 24.70 136.75 -9.08 0.65 71.77 26.43 1.32 70.82 24.72 coo 25.07 140.95 -5.73 24.98 139.34 -7.10 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 29.50 140.95 -4.45 30.03 140.88 -6.51 -2.95 80.34 28.65 -2.60 79.82 30.64 1un1_c00 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 7 hits 1un1_c00 naa= 3 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 1 3 # 1 B 85 GLU A 68 GLU~? 10.93 O1 BME A 601 B 87 ASP A 69 ASP~? 7.42 O1 BME A 601 B 89 GLU A 70 GLU~? -2.54 MN MN A 604s coo 19.32 178.30 3.72 20.56 176.87 2.77 5.73 51.66 25.85 5.32 49.97 27.08 coo 22.91 179.81 6.56 22.10 178.65 5.00 7.88 51.22 19.98 7.64 49.14 20.25 coo 26.74 177.55 7.48 27.16 177.47 5.41 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 2 3 # 2 B 85 GLU A 70 GLU~? -2.54 MN MN A 604s B 87 ASP A 69 ASP~? 7.42 O1 BME A 601 B 89 GLU A 68 GLU~? 10.93 O1 BME A 601 coo 19.32 178.30 3.72 20.56 176.87 2.77 6.20 55.25 17.70 4.45 55.72 16.64 coo 22.91 179.81 6.56 22.10 178.65 5.00 7.88 51.22 19.98 7.64 49.14 20.25 coo 26.74 177.55 7.48 27.16 177.47 5.41 5.73 51.66 25.85 5.32 49.97 27.08 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 3 3 # 3 B 85 GLU A 124 GLU~? 15.58 MN MN B 606 B 87 ASP A 122 ASP~? 22.01 MN MN B 606 B 89 GLU A 109 GLU~? 22.92 CL CL A 608 coo 19.32 178.30 3.72 20.56 176.87 2.77 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 22.91 179.81 6.56 22.10 178.65 5.00 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 26.74 177.55 7.48 27.16 177.47 5.41 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 4 3 # 4 B 85 GLU B 91 GLU~? 11.42 MN MN B 606 B 87 ASP B 90 ASP~? 13.30 MN MN B 606 B 89 GLU B 87 GLU~? 16.36 MN MN B 606 coo 19.32 178.30 3.72 20.56 176.87 2.77 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 22.91 179.81 6.56 22.10 178.65 5.00 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 26.74 177.55 7.48 27.16 177.47 5.41 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 1un1_c01 XYLOGLUCAN ENDOTRANSGLYCOSYLASE user 5 3 # 5 B 85 GLU B 124 GLU~? 10.55 C1 GOL B 603 B 87 ASP B 122 ASP~? 15.88 O1 GOL B 603 B 89 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 19.32 178.30 3.72 20.56 176.87 2.77 0.65 71.77 26.43 1.32 70.82 24.72 coo 22.91 179.81 6.56 22.10 178.65 5.00 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 26.74 177.55 7.48 27.16 177.47 5.41 -2.95 80.34 28.65 -2.60 79.82 30.64 1un1_c01 source 1un1 XYLOGLUCAN ENDOTRANSGLYCOSYLASE : 5 hits 1un1_c01 naa= 3 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 90 ASP~? 8.93 C1 GOL B 603 255 GLU A 87 GLU~? 6.78 O1 GOL B 603 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 49.16 35.16 15.19 51.08 34.43 15.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 52.57 37.12 10.17 53.37 35.95 11.75 7.70 72.78 18.03 7.03 72.92 20.00 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 90 ASP~? 8.93 C1 GOL B 603 255 GLU A 91 GLU~? 5.92 C1 GOL B 603 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 49.16 35.16 15.19 51.08 34.43 15.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 52.57 37.12 10.17 53.37 35.95 11.75 0.70 67.61 16.19 -1.02 68.27 17.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 134 ASP~? 12.23 CL CL A 608 255 GLU B 91 GLU~? 11.42 MN MN B 606 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 49.16 35.16 15.19 51.08 34.43 15.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 52.57 37.12 10.17 53.37 35.95 11.75 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 90 ASP~? 13.30 MN MN B 606 255 GLU B 87 GLU~? 16.36 MN MN B 606 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 90 ASP~? 13.30 MN MN B 606 255 GLU B 91 GLU~? 11.42 MN MN B 606 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1uok_c03 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 134 ASP~? -3.66 O1 GOL B 603s 255 GLU A 91 GLU~? 5.92 C1 GOL B 603 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 52.57 37.12 10.17 53.37 35.95 11.75 0.70 67.61 16.19 -1.02 68.27 17.25 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.32 68.36 21.17 7.09 68.49 22.34 1uok_c03 source 1uok OLIGO-1,6-GLUCOSIDASE : 6 hits 1uok_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 90 ASP~? 8.93 C1 GOL B 603 218 GLU A 123 GLU~? 22.37 MN MN B 606 329 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 49.16 35.16 15.19 51.08 34.43 15.65 5.32 68.36 21.17 7.09 68.49 22.34 coo 70.09 11.71 8.46 70.56 12.89 6.77 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 59.16 37.82 13.95 57.63 37.03 15.12 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 134 ASP~? 12.23 CL CL A 608 218 GLU B 13 GLU~? 14.49 C2 BME B 602 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 49.16 35.16 15.19 51.08 34.43 15.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 -10.54 87.21 -7.31 -10.84 89.32 -6.98 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 134 ASP~? 12.23 CL CL A 608 218 GLU B 109 GLU~? 18.95 O1 GOL B 603 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 49.16 35.16 15.19 51.08 34.43 15.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 70.09 11.71 8.46 70.56 12.89 6.77 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 90 ASP~? 13.30 MN MN B 606 218 GLU B 123 GLU~? 13.36 O1 GOL B 603 329 ASP A 134 ASP~? 12.23 CL CL A 608 coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 5.68 77.05 25.89 7.75 77.09 25.94 coo 59.16 37.82 13.95 57.63 37.03 15.12 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 134 ASP~? -3.66 O1 GOL B 603s 218 GLU A 13 GLU~? 14.48 C2 BME A 601 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 70.09 11.71 8.46 70.56 12.89 6.77 16.66 45.80 10.16 16.30 43.75 10.43 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.32 68.36 21.17 7.09 68.49 22.34 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 5 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 134 ASP~? 12.23 CL CL A 608 242 GLU A 68 GLU~? 10.93 O1 BME A 601 329 ASP B 90 ASP~? 13.30 MN MN B 606 coo 49.16 35.16 15.19 51.08 34.43 15.65 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 30.42 34.74 5.00 29.09 35.09 3.38 5.73 51.66 25.85 5.32 49.97 27.08 coo 59.16 37.82 13.95 57.63 37.03 15.12 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP B 134 ASP~? -3.66 O1 GOL B 603s 242 GLU B 68 GLU~? 12.41 MN MN B 606 329 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 49.16 35.16 15.19 51.08 34.43 15.65 1.27 73.42 12.01 2.60 75.02 12.38 coo 30.42 34.74 5.00 29.09 35.09 3.38 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.32 68.36 21.17 7.09 68.49 22.34 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 2 hits 1uok_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 73 ASN~? 13.47 MN MN A 605 457 GLY A 160 GLY~? 13.13 O1 BME A 601 459 GLU A 158 GLU~? 21.27 MN MN A 604 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 12.56 53.31 22.50 12.18 52.20 24.34 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 15.62 47.56 18.93 15.86 47.64 19.72 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 20.85 50.69 23.17 22.14 52.15 24.00 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 73 ASN~? 13.47 MN MN A 605 457 GLY A 160 GLY~? 13.13 O1 BME A 601 459 GLU A 161 GLU~? 18.40 O1 BME A 601 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 12.56 53.31 22.50 12.18 52.20 24.34 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 15.62 47.56 18.93 15.86 47.64 19.72 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN B 73 ASN~? 13.50 MN MN B 606 457 GLY B 160 GLY~? 13.29 S2 BME B 602 459 GLU B 158 GLU~? 21.38 MN MN B 607 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -19.90 79.31 1.05 -21.42 80.32 2.14 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -23.65 82.01 -6.24 -24.87 80.63 -7.27 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 73 ASN~? 13.50 MN MN B 606 457 GLY B 160 GLY~? 13.29 S2 BME B 602 459 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -19.90 79.31 1.05 -21.42 80.32 2.14 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.76 85.15 -2.82 -18.58 85.08 -2.82 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1vom_c00 source 1vom MYOSIN : 4 hits 1vom_c00 naa= 3 ULMN 3 1vzx_c02 2.04.01.0087 user 1 3 # 1 A 314 TYR A 19 TYR~? 9.00 MN MN A 604 A 317 GLU A 141 GLU~? 7.70 MN MN A 604 A 365 ARG A 27 ARG~? 11.42 S2 BME A 601 coo 1.77 6.56 57.05 3.05 7.44 59.37 8.27 52.26 7.85 9.08 54.84 7.01 coo 3.06 2.85 52.79 4.83 3.89 53.24 4.84 56.74 8.27 3.91 55.44 6.87 coo 3.82 17.09 49.56 4.09 14.32 50.84 -3.68 43.51 6.20 -5.32 41.74 8.07 1vzx_c02 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c02 naa= 3 ULMN 3 1vzx_c03 2.04.01.0087 user 1 3 # 1 B1314 TYR A 19 TYR~? 9.00 MN MN A 604 B1317 GLU A 141 GLU~? 7.70 MN MN A 604 B1365 ARG A 27 ARG~? 11.42 S2 BME A 601 coo 13.32 10.15 -9.20 12.07 11.36 -11.38 8.27 52.26 7.85 9.08 54.84 7.01 coo 12.13 5.84 -5.49 10.31 6.88 -5.76 4.84 56.74 8.27 3.91 55.44 6.87 coo 11.24 19.69 -0.67 10.92 17.07 -2.21 -3.68 43.51 6.20 -5.32 41.74 8.07 1vzx_c03 source 1vzx 2.04.01.0087 : 1 hits 1vzx_c03 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 19 TYR~? 9.00 MN MN A 604 A 40 ASP A 69 ASP~? 7.42 O1 BME A 601 A 103 LEU A 18 LEU~? 5.98 MN MN A 604 coo 12.09 16.13 10.57 11.28 18.80 10.73 8.27 52.26 7.85 9.08 54.84 7.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 7.88 51.22 19.98 7.64 49.14 20.25 coo 11.83 18.73 16.99 10.99 19.71 15.26 8.39 52.00 13.45 9.02 52.71 15.41 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 133 TYR~? 5.56 CL CL A 608 A 40 ASP A 101 ASP~? 14.47 MN MN A 605 A 103 LEU A 99 LEU~? 6.07 CL CL A 608 coo 12.09 16.13 10.57 11.28 18.80 10.73 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 7.55 25.51 14.34 9.65 25.73 14.24 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 11.83 18.73 16.99 10.99 19.71 15.26 -4.65 57.36 18.32 -3.62 57.88 16.49 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 19 TYR~? 9.04 MN MN B 607 A 40 ASP B 69 ASP~? 7.66 S2 BME B 602 A 103 LEU B 18 LEU~? 6.01 MN MN B 607 coo 12.09 16.13 10.57 11.28 18.80 10.73 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 7.55 25.51 14.34 9.65 25.73 14.24 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 11.83 18.73 16.99 10.99 19.71 15.26 -9.98 80.83 1.62 -12.03 79.97 1.76 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 133 TYR~? 5.56 CL CL B 609 A 40 ASP B 101 ASP~? 14.48 MN MN B 606 A 103 LEU B 99 LEU~? 6.07 CL CL B 609 coo 12.09 16.13 10.57 11.28 18.80 10.73 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 7.55 25.51 14.34 9.65 25.73 14.24 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 11.83 18.73 16.99 10.99 19.71 15.26 -9.33 75.11 15.40 -7.99 74.65 13.76 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 19 TYR~? 9.00 MN MN A 604 B 40 ASP A 69 ASP~? 7.42 O1 BME A 601 B 103 LEU A 18 LEU~? 5.98 MN MN A 604 coo 14.25 20.09 37.35 13.48 17.40 37.38 8.27 52.26 7.85 9.08 54.84 7.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.89 17.60 31.13 12.34 16.51 32.90 8.39 52.00 13.45 9.02 52.71 15.41 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 133 TYR~? 5.56 CL CL A 608 B 40 ASP A 101 ASP~? 14.47 MN MN A 605 B 103 LEU A 99 LEU~? 6.07 CL CL A 608 coo 14.25 20.09 37.35 13.48 17.40 37.38 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 9.39 10.77 34.53 11.50 10.63 34.41 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 12.89 17.60 31.13 12.34 16.51 32.90 -4.65 57.36 18.32 -3.62 57.88 16.49 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 19 TYR~? 9.04 MN MN B 607 B 40 ASP B 69 ASP~? 7.66 S2 BME B 602 B 103 LEU B 18 LEU~? 6.01 MN MN B 607 coo 14.25 20.09 37.35 13.48 17.40 37.38 -4.68 80.80 -0.42 -3.93 78.29 -1.36 coo 9.39 10.77 34.53 11.50 10.63 34.41 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 12.89 17.60 31.13 12.34 16.51 32.90 -9.98 80.83 1.62 -12.03 79.97 1.76 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 133 TYR~? 5.56 CL CL B 609 B 40 ASP B 101 ASP~? 14.48 MN MN B 606 B 103 LEU B 99 LEU~? 6.07 CL CL B 609 coo 14.25 20.09 37.35 13.48 17.40 37.38 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 9.39 10.77 34.53 11.50 10.63 34.41 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 12.89 17.60 31.13 12.34 16.51 32.90 -9.33 75.11 15.40 -7.99 74.65 13.76 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 22 HIS~? -3.40 MN MN A 604s A 169 ASP A 69 ASP~? 7.42 O1 BME A 601 A 288 GLU A 72 GLU~? 12.86 MN MN A 605 coo 67.72 35.99 30.87 69.77 36.13 31.33 3.18 53.06 10.64 3.66 54.63 11.95 coo 73.17 30.66 22.56 72.87 30.30 20.46 7.88 51.22 19.98 7.64 49.14 20.25 coo 74.06 28.51 15.92 73.77 29.56 17.73 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS A 22 HIS~? -3.40 MN MN A 604s A 169 ASP A 134 ASP~? 12.23 CL CL A 608 A 288 GLU B 87 GLU~? 16.36 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 3.18 53.06 10.64 3.66 54.63 11.95 coo 73.17 30.66 22.56 72.87 30.30 20.46 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 74.06 28.51 15.92 73.77 29.56 17.73 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 3 3 # 3 A 105 HIS A 22 HIS~? -3.40 MN MN A 604s A 169 ASP A 134 ASP~? 12.23 CL CL A 608 A 288 GLU B 91 GLU~? 11.42 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 3.18 53.06 10.64 3.66 54.63 11.95 coo 73.17 30.66 22.56 72.87 30.30 20.46 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 74.06 28.51 15.92 73.77 29.56 17.73 -9.23 65.09 9.44 -9.52 64.33 11.38 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 4 3 # 4 A 105 HIS A 96 HIS~? -3.41 MN MN A 605s A 169 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 288 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 67.72 35.99 30.87 69.77 36.13 31.33 0.59 58.54 20.35 2.20 57.89 19.15 coo 73.17 30.66 22.56 72.87 30.30 20.46 5.32 68.36 21.17 7.09 68.49 22.34 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 5 3 # 5 A 105 HIS A 136 HIS~? 3.48 MN MN A 605s A 169 ASP A 69 ASP~? 7.42 O1 BME A 601 A 288 GLU A 72 GLU~? 12.86 MN MN A 605 coo 67.72 35.99 30.87 69.77 36.13 31.33 -0.57 59.60 14.33 0.78 59.36 15.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 7.88 51.22 19.98 7.64 49.14 20.25 coo 74.06 28.51 15.92 73.77 29.56 17.73 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 6 3 # 6 A 105 HIS A 136 HIS~? 3.48 MN MN A 605s A 169 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 288 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 67.72 35.99 30.87 69.77 36.13 31.33 -0.57 59.60 14.33 0.78 59.36 15.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 5.32 68.36 21.17 7.09 68.49 22.34 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 7 3 # 7 A 105 HIS A 136 HIS~? 3.48 MN MN A 605s A 169 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 288 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 67.72 35.99 30.87 69.77 36.13 31.33 -0.57 59.60 14.33 0.78 59.36 15.93 coo 73.17 30.66 22.56 72.87 30.30 20.46 5.32 68.36 21.17 7.09 68.49 22.34 coo 74.06 28.51 15.92 73.77 29.56 17.73 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 8 3 # 8 A 105 HIS B 22 HIS~? -3.40 MN MN B 607s A 169 ASP B 69 ASP~? 7.66 S2 BME B 602 A 288 GLU B 72 GLU~? 13.02 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 73.17 30.66 22.56 72.87 30.30 20.46 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 74.06 28.51 15.92 73.77 29.56 17.73 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 9 3 # 9 A 105 HIS B 22 HIS~? -3.40 MN MN B 607s A 169 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 288 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 73.17 30.66 22.56 72.87 30.30 20.46 1.27 73.42 12.01 2.60 75.02 12.38 coo 74.06 28.51 15.92 73.77 29.56 17.73 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 10 3 # 10 A 105 HIS B 22 HIS~? -3.40 MN MN B 607s A 169 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 288 GLU A 91 GLU~? 5.92 C1 GOL B 603 coo 67.72 35.99 30.87 69.77 36.13 31.33 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 73.17 30.66 22.56 72.87 30.30 20.46 1.27 73.42 12.01 2.60 75.02 12.38 coo 74.06 28.51 15.92 73.77 29.56 17.73 0.70 67.61 16.19 -1.02 68.27 17.25 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 11 3 # 11 A 105 HIS B 96 HIS~? -3.43 MN MN B 606s A 169 ASP B 90 ASP~? 13.30 MN MN B 606 A 288 GLU B 87 GLU~? 16.36 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 73.17 30.66 22.56 72.87 30.30 20.46 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 74.06 28.51 15.92 73.77 29.56 17.73 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 12 3 # 12 A 105 HIS B 136 HIS~? 3.50 MN MN B 606s A 169 ASP B 69 ASP~? 7.66 S2 BME B 602 A 288 GLU B 72 GLU~? 13.02 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 73.17 30.66 22.56 72.87 30.30 20.46 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 74.06 28.51 15.92 73.77 29.56 17.73 -22.12 78.07 6.79 -23.41 76.46 7.29 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 13 3 # 13 A 105 HIS B 136 HIS~? 3.50 MN MN B 606s A 169 ASP B 90 ASP~? 13.30 MN MN B 606 A 288 GLU A 124 GLU~? 15.58 MN MN B 606 coo 67.72 35.99 30.87 69.77 36.13 31.33 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 73.17 30.66 22.56 72.87 30.30 20.46 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 74.06 28.51 15.92 73.77 29.56 17.73 -18.72 60.92 13.26 -17.30 61.76 11.93 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 13 hits 1w1o_c00 naa= 3 ULMN 3 1xqd_c02 CYTOCHROME P450 55A1 user 1 3 # 1 A 243 THR A 51 THR~? 17.46 S2 BME A 601 A 345 PHE A 28 PHE~? 9.03 S2 BME A 601 A 352 CYH A 29 CYH~? 9.71 CL CL A 608 coo 9.58 21.79 21.50 11.25 23.03 20.90 -13.11 40.84 11.29 -13.34 41.71 9.31 coo 19.40 19.75 18.58 17.39 17.81 18.80 -6.17 45.72 11.50 -5.16 43.17 12.10 coo 21.57 22.52 22.79 19.20 21.13 23.26 -8.10 50.91 9.05 -6.68 52.72 10.63 1xqd_c02 source 1xqd CYTOCHROME P450 55A1 : 1 hits 1xqd_c02 naa= 3 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 1 3 # 1 A 105 ALA A 62 ALA~? -3.33 C1 BME A 601s A 244 ASP A 69 ASP~? 7.42 O1 BME A 601 A 271 HIS A 66 HIS~? 3.42 MN MN A 604s coo 15.05 3.71 6.93 14.58 4.88 7.78 -0.61 45.64 19.79 -0.68 44.97 18.47 coo 9.85 8.15 0.76 10.61 7.04 2.39 7.88 51.22 19.98 7.64 49.14 20.25 coo 10.61 7.65 6.01 12.39 6.55 6.23 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 2 3 # 2 A 105 ALA A 63 ALA~? 7.13 CL CL A 608 A 244 ASP A 69 ASP~? 7.42 O1 BME A 601 A 271 HIS A 66 HIS~? 3.42 MN MN A 604s coo 15.05 3.71 6.93 14.58 4.88 7.78 -1.18 49.29 19.00 -2.43 50.00 18.46 coo 9.85 8.15 0.76 10.61 7.04 2.39 7.88 51.22 19.98 7.64 49.14 20.25 coo 10.61 7.65 6.01 12.39 6.55 6.23 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 3 3 # 3 A 105 ALA B 62 ALA~? 4.29 C1 BME B 602 A 244 ASP B 69 ASP~? 7.66 S2 BME B 602 A 271 HIS B 66 HIS~? 3.43 MN MN B 607s coo 15.05 3.71 6.93 14.58 4.88 7.78 -12.56 86.77 12.36 -11.38 87.53 11.88 coo 9.85 8.15 0.76 10.61 7.04 2.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 10.61 7.65 6.01 12.39 6.55 6.23 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 1xqw_c00 PROLINE IMINOPEPTIDASE user 4 3 # 4 A 105 ALA B 63 ALA~? 7.11 CL CL B 609 A 244 ASP B 69 ASP~? 7.66 S2 BME B 602 A 271 HIS B 66 HIS~? 3.43 MN MN B 607s coo 15.05 3.71 6.93 14.58 4.88 7.78 -11.48 83.15 12.59 -10.47 82.51 13.58 coo 9.85 8.15 0.76 10.61 7.04 2.39 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 10.61 7.65 6.01 12.39 6.55 6.23 -11.11 81.39 7.66 -9.84 80.27 6.41 1xqw_c00 source 1xqw PROLINE IMINOPEPTIDASE : 4 hits 1xqw_c00 naa= 3 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 B 124 ALA A 20 ALA~? 6.78 S2 BME A 601 B 126 ARG A 26 ARG~? 9.60 MN MN A 604 B 138 GLU A 16 GLU~? 14.76 S2 BME A 601 coo 2.11 4.00 19.31 3.14 4.86 19.99 5.75 47.12 9.54 6.62 45.86 9.91 coo 2.45 5.53 11.28 3.59 7.56 13.29 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 6.10 2.00 25.24 6.12 1.84 23.13 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 B 124 ALA A 125 ALA~? 18.76 CL CL A 608 B 126 ARG B 94 ARG~? 13.57 MN MN B 606 B 138 GLU A 109 GLU~? 22.92 CL CL A 608 coo 2.11 4.00 19.31 3.14 4.86 19.99 -16.97 56.66 14.75 -17.54 55.68 15.76 coo 2.45 5.53 11.28 3.59 7.56 13.29 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 6.10 2.00 25.24 6.12 1.84 23.13 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 B 124 ALA B 20 ALA~? 6.16 C2 BME B 602 B 126 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 138 GLU B 16 GLU~? 10.04 C2 BME B 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 -5.51 85.82 2.70 -6.35 87.03 2.21 coo 2.45 5.53 11.28 3.59 7.56 13.29 1.24 79.80 7.27 0.69 76.71 7.21 coo 6.10 2.00 25.24 6.12 1.84 23.13 -8.79 86.61 -3.48 -7.90 88.30 -2.54 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 B 124 ALA B 125 ALA~? 14.10 O1 GOL B 603 B 126 ARG A 94 ARG~? 6.60 C1 GOL B 603 B 138 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 2.11 4.00 19.31 3.14 4.86 19.99 -1.46 75.97 25.50 -2.22 76.93 26.41 coo 2.45 5.53 11.28 3.59 7.56 13.29 -0.58 68.78 21.39 1.97 70.41 20.81 coo 6.10 2.00 25.24 6.12 1.84 23.13 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 B 124 ALA B 164 ALA~? 11.00 O1 BME B 602 B 126 ARG B 166 ARG~? 12.22 S2 BME B 602 B 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 -18.67 89.30 1.59 -18.68 90.00 0.23 coo 2.45 5.53 11.28 3.59 7.56 13.29 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1xs1_c07 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 B 124 ALA B 165 ALA~? 14.02 O1 BME B 602 B 126 ARG B 166 ARG~? 12.22 S2 BME B 602 B 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 2.11 4.00 19.31 3.14 4.86 19.99 -22.15 89.69 3.17 -23.48 89.22 2.57 coo 2.45 5.53 11.28 3.59 7.56 13.29 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 6.10 2.00 25.24 6.12 1.84 23.13 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1xs1_c07 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c07 naa= 3 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 C 124 ALA A 20 ALA~? 6.78 S2 BME A 601 C 126 ARG A 26 ARG~? 9.60 MN MN A 604 C 138 GLU A 16 GLU~? 14.76 S2 BME A 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 5.75 47.12 9.54 6.62 45.86 9.91 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 C 124 ALA A 125 ALA~? 18.76 CL CL A 608 C 126 ARG B 94 ARG~? 13.57 MN MN B 606 C 138 GLU A 109 GLU~? 22.92 CL CL A 608 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -16.97 56.66 14.75 -17.54 55.68 15.76 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 C 124 ALA A 164 ALA~? 10.35 O1 BME A 601 C 126 ARG A 166 ARG~? 11.02 O1 BME A 601 C 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 11.84 43.25 21.44 13.14 42.59 21.00 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 C 124 ALA A 165 ALA~? 12.24 O1 BME A 601 C 126 ARG A 166 ARG~? 11.02 O1 BME A 601 C 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 11.59 42.83 25.29 12.62 43.38 26.27 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 C 124 ALA B 20 ALA~? 6.16 C2 BME B 602 C 126 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 138 GLU B 16 GLU~? 10.04 C2 BME B 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -5.51 85.82 2.70 -6.35 87.03 2.21 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 1.24 79.80 7.27 0.69 76.71 7.21 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -8.79 86.61 -3.48 -7.90 88.30 -2.54 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 C 124 ALA B 125 ALA~? 14.10 O1 GOL B 603 C 126 ARG A 94 ARG~? 6.60 C1 GOL B 603 C 138 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -1.46 75.97 25.50 -2.22 76.93 26.41 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -0.58 68.78 21.39 1.97 70.41 20.81 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 C 124 ALA B 164 ALA~? 11.00 O1 BME B 602 C 126 ARG B 166 ARG~? 12.22 S2 BME B 602 C 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -18.67 89.30 1.59 -18.68 90.00 0.23 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1xs1_c08 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 C 124 ALA B 165 ALA~? 14.02 O1 BME B 602 C 126 ARG B 166 ARG~? 12.22 S2 BME B 602 C 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -4.54 -7.50 19.94 -4.33 -8.73 20.82 -22.15 89.69 3.17 -23.48 89.22 2.57 coo -3.14 -9.40 12.05 -1.75 -11.23 14.08 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.56 -9.50 25.72 -8.77 -9.47 23.62 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1xs1_c08 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 8 hits 1xs1_c08 naa= 3 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 D 124 ALA A 20 ALA~? 6.78 S2 BME A 601 D 126 ARG A 26 ARG~? 9.60 MN MN A 604 D 138 GLU A 16 GLU~? 14.76 S2 BME A 601 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 5.75 47.12 9.54 6.62 45.86 9.91 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 6.23 0.50 57.10 5.93 0.72 59.19 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 D 124 ALA A 125 ALA~? 18.76 CL CL A 608 D 126 ARG B 94 ARG~? 13.57 MN MN B 606 D 138 GLU A 109 GLU~? 22.92 CL CL A 608 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -16.97 56.66 14.75 -17.54 55.68 15.76 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 6.23 0.50 57.10 5.93 0.72 59.19 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 D 124 ALA A 164 ALA~? 10.35 O1 BME A 601 D 126 ARG A 166 ARG~? 11.02 O1 BME A 601 D 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 11.84 43.25 21.44 13.14 42.59 21.00 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 6.93 48.25 24.41 9.45 50.10 24.73 coo 6.23 0.50 57.10 5.93 0.72 59.19 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 D 124 ALA A 165 ALA~? 12.24 O1 BME A 601 D 126 ARG A 166 ARG~? 11.02 O1 BME A 601 D 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 11.59 42.83 25.29 12.62 43.38 26.27 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 6.93 48.25 24.41 9.45 50.10 24.73 coo 6.23 0.50 57.10 5.93 0.72 59.19 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 D 124 ALA B 125 ALA~? 14.10 O1 GOL B 603 D 126 ARG A 94 ARG~? 6.60 C1 GOL B 603 D 138 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -1.46 75.97 25.50 -2.22 76.93 26.41 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -0.58 68.78 21.39 1.97 70.41 20.81 coo 6.23 0.50 57.10 5.93 0.72 59.19 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 D 124 ALA B 164 ALA~? 11.00 O1 BME B 602 D 126 ARG B 166 ARG~? 12.22 S2 BME B 602 D 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -18.67 89.30 1.59 -18.68 90.00 0.23 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1xs1_c09 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 D 124 ALA B 165 ALA~? 14.02 O1 BME B 602 D 126 ARG B 166 ARG~? 12.22 S2 BME B 602 D 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo 2.08 -1.49 62.94 3.12 -2.39 62.28 -22.15 89.69 3.17 -23.48 89.22 2.57 coo 2.52 -3.11 70.84 3.63 -5.24 68.92 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 6.23 0.50 57.10 5.93 0.72 59.19 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1xs1_c09 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 7 hits 1xs1_c09 naa= 3 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 E 124 ALA A 20 ALA~? 6.78 S2 BME A 601 E 126 ARG A 26 ARG~? 9.60 MN MN A 604 E 138 GLU A 16 GLU~? 14.76 S2 BME A 601 coo -4.56 10.03 62.36 -4.38 11.31 61.55 5.75 47.12 9.54 6.62 45.86 9.91 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -8.67 12.22 56.54 -8.68 12.09 58.65 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 E 124 ALA A 164 ALA~? 10.35 O1 BME A 601 E 126 ARG A 166 ARG~? 11.02 O1 BME A 601 E 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -4.56 10.03 62.36 -4.38 11.31 61.55 11.84 43.25 21.44 13.14 42.59 21.00 coo -3.02 12.00 70.07 -1.94 13.84 67.82 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.67 12.22 56.54 -8.68 12.09 58.65 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 E 124 ALA A 165 ALA~? 12.24 O1 BME A 601 E 126 ARG A 166 ARG~? 11.02 O1 BME A 601 E 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -4.56 10.03 62.36 -4.38 11.31 61.55 11.59 42.83 25.29 12.62 43.38 26.27 coo -3.02 12.00 70.07 -1.94 13.84 67.82 6.93 48.25 24.41 9.45 50.10 24.73 coo -8.67 12.22 56.54 -8.68 12.09 58.65 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 E 124 ALA B 125 ALA~? 14.10 O1 GOL B 603 E 126 ARG A 94 ARG~? 6.60 C1 GOL B 603 E 138 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -1.46 75.97 25.50 -2.22 76.93 26.41 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -0.58 68.78 21.39 1.97 70.41 20.81 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 E 124 ALA B 164 ALA~? 11.00 O1 BME B 602 E 126 ARG B 166 ARG~? 12.22 S2 BME B 602 E 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -18.67 89.30 1.59 -18.68 90.00 0.23 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1xs1_c10 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 E 124 ALA B 165 ALA~? 14.02 O1 BME B 602 E 126 ARG B 166 ARG~? 12.22 S2 BME B 602 E 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -4.56 10.03 62.36 -4.38 11.31 61.55 -22.15 89.69 3.17 -23.48 89.22 2.57 coo -3.02 12.00 70.07 -1.94 13.84 67.82 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -8.67 12.22 56.54 -8.68 12.09 58.65 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1xs1_c10 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 6 hits 1xs1_c10 naa= 3 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 3 # 1 F 124 ALA A 20 ALA~? 6.78 S2 BME A 601 F 126 ARG A 26 ARG~? 9.60 MN MN A 604 F 138 GLU A 16 GLU~? 14.76 S2 BME A 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 5.75 47.12 9.54 6.62 45.86 9.91 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -0.69 52.60 5.29 -0.15 55.65 5.60 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 3 # 2 F 124 ALA A 125 ALA~? 18.76 CL CL A 608 F 126 ARG B 94 ARG~? 13.57 MN MN B 606 F 138 GLU A 109 GLU~? 22.92 CL CL A 608 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -16.97 56.66 14.75 -17.54 55.68 15.76 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 3 # 3 F 124 ALA A 164 ALA~? 10.35 O1 BME A 601 F 126 ARG A 166 ARG~? 11.02 O1 BME A 601 F 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 11.84 43.25 21.44 13.14 42.59 21.00 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.93 48.25 24.41 9.45 50.10 24.73 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 3 # 4 F 124 ALA A 165 ALA~? 12.24 O1 BME A 601 F 126 ARG A 166 ARG~? 11.02 O1 BME A 601 F 138 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 11.59 42.83 25.29 12.62 43.38 26.27 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 6.93 48.25 24.41 9.45 50.10 24.73 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 3 # 5 F 124 ALA B 20 ALA~? 6.16 C2 BME B 602 F 126 ARG B 26 ARG~? 8.42 O2 GOL B 603 F 138 GLU B 16 GLU~? 10.04 C2 BME B 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -5.51 85.82 2.70 -6.35 87.03 2.21 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 1.24 79.80 7.27 0.69 76.71 7.21 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -8.79 86.61 -3.48 -7.90 88.30 -2.54 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 3 # 6 F 124 ALA B 125 ALA~? 14.10 O1 GOL B 603 F 126 ARG A 94 ARG~? 6.60 C1 GOL B 603 F 138 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -1.46 75.97 25.50 -2.22 76.93 26.41 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -0.58 68.78 21.39 1.97 70.41 20.81 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 3 # 7 F 124 ALA B 164 ALA~? 11.00 O1 BME B 602 F 126 ARG B 166 ARG~? 12.22 S2 BME B 602 F 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -18.67 89.30 1.59 -18.68 90.00 0.23 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 1xs1_c11 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 3 # 8 F 124 ALA B 165 ALA~? 14.02 O1 BME B 602 F 126 ARG B 166 ARG~? 12.22 S2 BME B 602 F 138 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -11.15 -1.53 62.85 -12.44 -2.03 62.23 -22.15 89.69 3.17 -23.48 89.22 2.57 coo -13.16 -0.52 70.77 -15.41 -0.40 68.66 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -11.26 -6.31 57.37 -11.02 -6.31 59.47 -21.45 87.83 -5.08 -22.54 87.54 -6.89 1xs1_c11 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 8 hits 1xs1_c11 naa= 3 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 1 3 # 1 B 137 GLY A 23 GLY~? 8.40 S2 BME A 601 B 175 ARG A 27 ARG~? 11.42 S2 BME A 601 B 242 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 99.45 58.28 3.33 99.57 58.61 4.10 1.32 48.34 7.45 1.06 48.38 8.26 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 100.93 69.04 4.38 99.52 68.48 2.09 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 2 3 # 2 B 137 GLY A 30 GLY~? 15.40 CL CL A 608 B 175 ARG A 26 ARG~? 9.60 MN MN A 604 B 242 TYR A 133 TYR~? 5.56 CL CL A 608 coo 99.45 58.28 3.33 99.57 58.61 4.10 -8.98 49.82 5.50 -9.25 49.53 6.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 100.93 69.04 4.38 99.52 68.48 2.09 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 3 3 # 3 B 137 GLY A 30 GLY~? 15.40 CL CL A 608 B 175 ARG A 27 ARG~? 11.42 S2 BME A 601 B 242 TYR A 58 TYR~? -4.88 S2 BME A 601s coo 99.45 58.28 3.33 99.57 58.61 4.10 -8.98 49.82 5.50 -9.25 49.53 6.25 coo 106.37 63.53 0.89 108.02 63.40 -1.62 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 100.93 69.04 4.38 99.52 68.48 2.09 -3.46 45.81 15.49 -1.06 47.20 15.11 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 4 3 # 4 B 137 GLY B 23 GLY~? 8.34 S2 BME B 602 B 175 ARG B 27 ARG~? 11.60 C2 BME B 602 B 242 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 99.45 58.28 3.33 99.57 58.61 4.10 -1.78 84.52 5.86 -2.42 84.42 6.43 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.97 89.27 10.36 0.81 91.17 12.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 -7.48 86.83 13.23 -7.97 85.45 10.86 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 5 3 # 5 B 137 GLY B 30 GLY~? 10.80 O1 GOL B 603 B 175 ARG B 26 ARG~? 8.42 O2 GOL B 603 B 242 TYR B 133 TYR~? 5.56 CL CL B 609 coo 99.45 58.28 3.33 99.57 58.61 4.10 4.09 82.83 14.51 3.51 83.12 15.05 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.24 79.80 7.27 0.69 76.71 7.21 coo 100.93 69.04 4.38 99.52 68.48 2.09 -4.49 77.34 13.29 -7.09 78.39 13.51 ULMN 3 1xva_c03 GLYCINE N-METHYLTRANSFERASE user 6 3 # 6 B 137 GLY B 30 GLY~? 10.80 O1 GOL B 603 B 175 ARG B 27 ARG~? 11.60 C2 BME B 602 B 242 TYR B 58 TYR~? -4.91 S2 BME B 602s coo 99.45 58.28 3.33 99.57 58.61 4.10 4.09 82.83 14.51 3.51 83.12 15.05 coo 106.37 63.53 0.89 108.02 63.40 -1.62 1.97 89.27 10.36 0.81 91.17 12.49 coo 100.93 69.04 4.38 99.52 68.48 2.09 -7.48 86.83 13.23 -7.97 85.45 10.86 1xva_c03 source 1xva GLYCINE N-METHYLTRANSFERASE : 6 hits 1xva_c03 naa= 3 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 1 3 # 1 142 TRP A 103 TRP~? 13.04 CL CL A 608 223 ASP A 101 ASP~? 14.47 MN MN A 605 258 ALA A 131 ALA~? 14.03 CL CL A 608 coo 128.40 33.01 26.67 128.12 36.28 28.81 -8.87 50.94 21.19 -10.72 48.76 18.46 coo 127.91 41.73 23.55 129.18 40.35 24.44 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 141.00 37.49 25.74 139.80 37.53 24.78 -9.04 59.66 9.42 -10.10 60.80 9.30 ULMN 3 2aat_c01 ASPARTATE AMINOTRANSFERASE (E.C.2.6.user 2 3 # 2 142 TRP B 103 TRP~? 12.92 CL CL B 609 223 ASP B 101 ASP~? 14.48 MN MN B 606 258 ALA B 131 ALA~? -3.51 O1 GOL B 603s coo 128.40 33.01 26.67 128.12 36.28 28.81 -10.49 81.55 20.44 -7.30 83.78 21.03 coo 127.91 41.73 23.55 129.18 40.35 24.44 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 141.00 37.49 25.74 139.80 37.53 24.78 0.55 72.95 16.09 1.01 71.82 17.02 2aat_c01 source 2aat ASPARTATE AMINOTRANSFERASE (E.C.2.6.1.1) MUTAN: 2 hits 2aat_c01 naa= 3 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 96 HIS~? -3.41 MN MN A 605s B 50 GLU A 141 GLU~? 7.70 MN MN A 604 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 4.84 56.74 8.27 3.91 55.44 6.87 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 136 HIS~? 3.48 MN MN A 605s B 50 GLU A 71 GLU~? 7.91 MN MN A 605 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 4.56 57.67 23.22 2.91 58.15 24.47 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS A 136 HIS~? 3.48 MN MN A 605s B 50 GLU B 91 GLU~? 11.42 MN MN B 606 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 96 HIS~? -3.43 MN MN B 606s B 50 GLU B 141 GLU~? 7.71 MN MN B 607 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 136 HIS~? 3.50 MN MN B 606s B 50 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 0.70 67.61 16.19 -1.02 68.27 17.25 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c04 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS B 136 HIS~? 3.50 MN MN B 606s B 50 GLU B 71 GLU~? 7.93 MN MN B 606 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 2ag0_c04 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c04 naa= 3 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 1 3 # 1 B 29 HIS A 96 HIS~? -3.41 MN MN A 605s B 50 GLU A 141 GLU~? 7.70 MN MN A 604 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 0.59 58.54 20.35 2.20 57.89 19.15 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 4.84 56.74 8.27 3.91 55.44 6.87 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 2 3 # 2 B 29 HIS A 136 HIS~? 3.48 MN MN A 605s B 50 GLU A 71 GLU~? 7.91 MN MN A 605 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 4.56 57.67 23.22 2.91 58.15 24.47 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 3 3 # 3 B 29 HIS A 136 HIS~? 3.48 MN MN A 605s B 50 GLU B 91 GLU~? 11.42 MN MN B 606 B 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -0.57 59.60 14.33 0.78 59.36 15.93 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 4 3 # 4 B 29 HIS B 96 HIS~? -3.43 MN MN B 606s B 50 GLU B 141 GLU~? 7.71 MN MN B 607 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 5 3 # 5 B 29 HIS B 136 HIS~? 3.50 MN MN B 606s B 50 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 0.70 67.61 16.19 -1.02 68.27 17.25 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c08 BENZALDEHYDE LYASE user 6 3 # 6 B 29 HIS B 136 HIS~? 3.50 MN MN B 606s B 50 GLU B 71 GLU~? 7.93 MN MN B 606 B 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 37.74 -17.01 11.59 38.11 -17.83 13.49 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 46.64 -18.37 3.41 46.45 -20.27 4.34 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 42.38 -20.40 13.90 41.08 -20.72 12.22 -8.78 68.50 12.35 -7.20 68.45 10.97 2ag0_c08 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c08 naa= 3 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 1 3 # 1 A 29 HIS A 96 HIS~? -3.41 MN MN A 605s A 50 GLU A 141 GLU~? 7.70 MN MN A 604 A 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 0.59 58.54 20.35 2.20 57.89 19.15 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 4.84 56.74 8.27 3.91 55.44 6.87 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 2 3 # 2 A 29 HIS A 136 HIS~? 3.48 MN MN A 605s A 50 GLU A 71 GLU~? 7.91 MN MN A 605 A 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 4.56 57.67 23.22 2.91 58.15 24.47 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 3 3 # 3 A 29 HIS A 136 HIS~? 3.48 MN MN A 605s A 50 GLU B 91 GLU~? 11.42 MN MN B 606 A 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -0.57 59.60 14.33 0.78 59.36 15.93 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 4 3 # 4 A 29 HIS B 96 HIS~? -3.43 MN MN B 606s A 50 GLU B 141 GLU~? 7.71 MN MN B 607 A 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 5 3 # 5 A 29 HIS B 136 HIS~? 3.50 MN MN B 606s A 50 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 0.70 67.61 16.19 -1.02 68.27 17.25 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c09 BENZALDEHYDE LYASE user 6 3 # 6 A 29 HIS B 136 HIS~? 3.50 MN MN B 606s A 50 GLU B 71 GLU~? 7.93 MN MN B 606 A 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 73.37 -13.43 4.64 73.06 -11.77 3.39 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 63.97 -21.08 5.81 64.12 -20.78 3.71 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 68.60 -11.76 1.04 69.76 -13.55 1.03 -8.78 68.50 12.35 -7.20 68.45 10.97 2ag0_c09 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c09 naa= 3 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 1 3 # 1 C 29 HIS A 96 HIS~? -3.41 MN MN A 605s C 50 GLU A 141 GLU~? 7.70 MN MN A 604 C 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 74.92 8.52 28.42 74.88 6.86 29.70 0.59 58.54 20.35 2.20 57.89 19.15 coo 65.25 15.95 28.73 65.73 15.63 30.78 4.84 56.74 8.27 3.91 55.44 6.87 coo 70.80 6.73 32.72 71.88 8.55 32.53 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 2 3 # 2 C 29 HIS A 136 HIS~? 3.48 MN MN A 605s C 50 GLU A 71 GLU~? 7.91 MN MN A 605 C 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 74.92 8.52 28.42 74.88 6.86 29.70 -0.57 59.60 14.33 0.78 59.36 15.93 coo 65.25 15.95 28.73 65.73 15.63 30.78 4.56 57.67 23.22 2.91 58.15 24.47 coo 70.80 6.73 32.72 71.88 8.55 32.53 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 3 3 # 3 C 29 HIS A 136 HIS~? 3.48 MN MN A 605s C 50 GLU B 91 GLU~? 11.42 MN MN B 606 C 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 74.92 8.52 28.42 74.88 6.86 29.70 -0.57 59.60 14.33 0.78 59.36 15.93 coo 65.25 15.95 28.73 65.73 15.63 30.78 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 70.80 6.73 32.72 71.88 8.55 32.53 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 4 3 # 4 C 29 HIS B 96 HIS~? -3.43 MN MN B 606s C 50 GLU B 141 GLU~? 7.71 MN MN B 607 C 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 74.92 8.52 28.42 74.88 6.86 29.70 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 65.25 15.95 28.73 65.73 15.63 30.78 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 70.80 6.73 32.72 71.88 8.55 32.53 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 5 3 # 5 C 29 HIS B 136 HIS~? 3.50 MN MN B 606s C 50 GLU A 91 GLU~? 5.92 C1 GOL B 603 C 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 74.92 8.52 28.42 74.88 6.86 29.70 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 65.25 15.95 28.73 65.73 15.63 30.78 0.70 67.61 16.19 -1.02 68.27 17.25 coo 70.80 6.73 32.72 71.88 8.55 32.53 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c10 BENZALDEHYDE LYASE user 6 3 # 6 C 29 HIS B 136 HIS~? 3.50 MN MN B 606s C 50 GLU B 71 GLU~? 7.93 MN MN B 606 C 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 74.92 8.52 28.42 74.88 6.86 29.70 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 65.25 15.95 28.73 65.73 15.63 30.78 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 70.80 6.73 32.72 71.88 8.55 32.53 -8.78 68.50 12.35 -7.20 68.45 10.97 2ag0_c10 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c10 naa= 3 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 1 3 # 1 D 29 HIS A 96 HIS~? -3.41 MN MN A 605s D 50 GLU A 141 GLU~? 7.70 MN MN A 604 D 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 38.66 11.31 27.15 38.67 12.13 25.22 0.59 58.54 20.35 2.20 57.89 19.15 coo 48.72 12.85 33.83 48.36 14.77 32.95 4.84 56.74 8.27 3.91 55.44 6.87 coo 42.85 14.77 24.15 41.85 15.11 26.02 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 2 3 # 2 D 29 HIS A 136 HIS~? 3.48 MN MN A 605s D 50 GLU A 71 GLU~? 7.91 MN MN A 605 D 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 38.66 11.31 27.15 38.67 12.13 25.22 -0.57 59.60 14.33 0.78 59.36 15.93 coo 48.72 12.85 33.83 48.36 14.77 32.95 4.56 57.67 23.22 2.91 58.15 24.47 coo 42.85 14.77 24.15 41.85 15.11 26.02 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 3 3 # 3 D 29 HIS A 136 HIS~? 3.48 MN MN A 605s D 50 GLU B 91 GLU~? 11.42 MN MN B 606 D 113 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo 38.66 11.31 27.15 38.67 12.13 25.22 -0.57 59.60 14.33 0.78 59.36 15.93 coo 48.72 12.85 33.83 48.36 14.77 32.95 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 42.85 14.77 24.15 41.85 15.11 26.02 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 4 3 # 4 D 29 HIS B 96 HIS~? -3.43 MN MN B 606s D 50 GLU B 141 GLU~? 7.71 MN MN B 607 D 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 38.66 11.31 27.15 38.67 12.13 25.22 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 48.72 12.85 33.83 48.36 14.77 32.95 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 42.85 14.77 24.15 41.85 15.11 26.02 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 5 3 # 5 D 29 HIS B 136 HIS~? 3.50 MN MN B 606s D 50 GLU A 91 GLU~? 5.92 C1 GOL B 603 D 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 38.66 11.31 27.15 38.67 12.13 25.22 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 48.72 12.85 33.83 48.36 14.77 32.95 0.70 67.61 16.19 -1.02 68.27 17.25 coo 42.85 14.77 24.15 41.85 15.11 26.02 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 2ag0_c11 BENZALDEHYDE LYASE user 6 3 # 6 D 29 HIS B 136 HIS~? 3.50 MN MN B 606s D 50 GLU B 71 GLU~? 7.93 MN MN B 606 D 113 GLN B 95 GLN~? 8.04 MN MN B 606 coo 38.66 11.31 27.15 38.67 12.13 25.22 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 48.72 12.85 33.83 48.36 14.77 32.95 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 42.85 14.77 24.15 41.85 15.11 26.02 -8.78 68.50 12.35 -7.20 68.45 10.97 2ag0_c11 source 2ag0 BENZALDEHYDE LYASE : 6 hits 2ag0_c11 naa= 3 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 90 ASP~? 8.93 C1 GOL B 603 219 GLU A 87 GLU~? 6.78 O1 GOL B 603 294 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 27.89 102.52 14.98 29.35 101.92 13.57 5.32 68.36 21.17 7.09 68.49 22.34 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.70 72.78 18.03 7.03 72.92 20.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 90 ASP~? 8.93 C1 GOL B 603 219 GLU A 91 GLU~? 5.92 C1 GOL B 603 294 ASP B 134 ASP~? -3.66 O1 GOL B 603s coo 27.89 102.52 14.98 29.35 101.92 13.57 5.32 68.36 21.17 7.09 68.49 22.34 coo 25.84 105.87 9.06 27.86 105.55 8.74 0.70 67.61 16.19 -1.02 68.27 17.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 1.27 73.42 12.01 2.60 75.02 12.38 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 134 ASP~? 12.23 CL CL A 608 219 GLU B 87 GLU~? 16.36 MN MN B 606 294 ASP B 90 ASP~? 13.30 MN MN B 606 coo 27.89 102.52 14.98 29.35 101.92 13.57 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP A 134 ASP~? 12.23 CL CL A 608 219 GLU B 91 GLU~? 11.42 MN MN B 606 294 ASP B 90 ASP~? 13.30 MN MN B 606 coo 27.89 102.52 14.98 29.35 101.92 13.57 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 25.84 105.87 9.06 27.86 105.55 8.74 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 -15.47 64.24 6.89 -17.14 64.04 5.63 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 90 ASP~? 13.30 MN MN B 606 219 GLU B 87 GLU~? 16.36 MN MN B 606 294 ASP A 134 ASP~? 12.23 CL CL A 608 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 33.16 106.80 7.72 33.34 104.87 6.92 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 90 ASP~? 13.30 MN MN B 606 219 GLU B 91 GLU~? 11.42 MN MN B 606 294 ASP A 134 ASP~? 12.23 CL CL A 608 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 33.16 106.80 7.72 33.34 104.87 6.92 -5.53 59.28 7.24 -6.39 57.64 6.27 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 134 ASP~? -3.66 O1 GOL B 603s 219 GLU A 87 GLU~? 6.78 O1 GOL B 603 294 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 1.27 73.42 12.01 2.60 75.02 12.38 coo 25.84 105.87 9.06 27.86 105.55 8.74 7.70 72.78 18.03 7.03 72.92 20.00 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.32 68.36 21.17 7.09 68.49 22.34 ULMN 3 2amg_c02 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 3 # 8 193 ASP B 134 ASP~? -3.66 O1 GOL B 603s 219 GLU A 91 GLU~? 5.92 C1 GOL B 603 294 ASP A 90 ASP~? 8.93 C1 GOL B 603 coo 27.89 102.52 14.98 29.35 101.92 13.57 1.27 73.42 12.01 2.60 75.02 12.38 coo 25.84 105.87 9.06 27.86 105.55 8.74 0.70 67.61 16.19 -1.02 68.27 17.25 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.32 68.36 21.17 7.09 68.49 22.34 2amg_c02 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 8 hits 2amg_c02 naa= 3 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 1 3 # 1 105 GLU A 68 GLU~? 10.93 O1 BME A 601 107 ASP A 69 ASP~? 7.42 O1 BME A 601 109 GLU A 70 GLU~? -2.54 MN MN A 604s coo 15.97 13.58 10.29 15.12 15.36 9.48 5.73 51.66 25.85 5.32 49.97 27.08 coo 20.07 16.34 11.47 18.03 16.15 11.04 7.88 51.22 19.98 7.64 49.14 20.25 coo 20.99 19.84 9.56 19.07 20.34 10.22 6.20 55.25 17.70 4.45 55.72 16.64 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 2 3 # 2 105 GLU A 91 GLU~? 5.92 C1 GOL B 603 107 ASP A 90 ASP~? 8.93 C1 GOL B 603 109 GLU A 87 GLU~? 6.78 O1 GOL B 603 coo 15.97 13.58 10.29 15.12 15.36 9.48 0.70 67.61 16.19 -1.02 68.27 17.25 coo 20.07 16.34 11.47 18.03 16.15 11.04 5.32 68.36 21.17 7.09 68.49 22.34 coo 20.99 19.84 9.56 19.07 20.34 10.22 7.70 72.78 18.03 7.03 72.92 20.00 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 3 3 # 3 105 GLU A 124 GLU~? 15.58 MN MN B 606 107 ASP A 122 ASP~? 22.01 MN MN B 606 109 GLU A 109 GLU~? 22.92 CL CL A 608 coo 15.97 13.58 10.29 15.12 15.36 9.48 -18.72 60.92 13.26 -17.30 61.76 11.93 coo 20.07 16.34 11.47 18.03 16.15 11.04 -21.79 55.48 15.36 -21.54 57.57 15.22 coo 20.99 19.84 9.56 19.07 20.34 10.22 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 4 3 # 4 105 GLU B 68 GLU~? 12.41 MN MN B 606 107 ASP B 69 ASP~? 7.66 S2 BME B 602 109 GLU B 70 GLU~? -2.57 MN MN B 607s coo 15.97 13.58 10.29 15.12 15.36 9.48 -19.03 80.53 10.71 -20.46 81.67 11.84 coo 20.07 16.34 11.47 18.03 16.15 11.04 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 20.99 19.84 9.56 19.07 20.34 10.22 -12.98 77.36 5.11 -11.32 76.90 6.35 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 5 3 # 5 105 GLU B 91 GLU~? 11.42 MN MN B 606 107 ASP B 90 ASP~? 13.30 MN MN B 606 109 GLU B 87 GLU~? 16.36 MN MN B 606 coo 15.97 13.58 10.29 15.12 15.36 9.48 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 20.07 16.34 11.47 18.03 16.15 11.04 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 20.99 19.84 9.56 19.07 20.34 10.22 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 2ayh_c00 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROuser 6 3 # 6 105 GLU B 124 GLU~? 10.55 C1 GOL B 603 107 ASP B 122 ASP~? 15.88 O1 GOL B 603 109 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo 15.97 13.58 10.29 15.12 15.36 9.48 0.65 71.77 26.43 1.32 70.82 24.72 coo 20.07 16.34 11.47 18.03 16.15 11.04 -0.15 77.17 30.18 -0.01 75.13 29.61 coo 20.99 19.84 9.56 19.07 20.34 10.22 -2.95 80.34 28.65 -2.60 79.82 30.64 2ayh_c00 source 2ayh 1,3-1,4-BETA-D-GLUCAN 4 GLUCANOHYDROLASE (E.C.: 6 hits 2ayh_c00 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 27 ARG~? 11.42 S2 BME A 601 A 161 ASP A 134 ASP~? 12.23 CL CL A 608 A 174 TYR A 133 TYR~? 5.56 CL CL A 608 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 27 ARG~? 11.60 C2 BME B 602 A 161 ASP B 134 ASP~? -3.66 O1 GOL B 603s A 174 TYR B 133 TYR~? 5.56 CL CL B 609 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 1.97 89.27 10.36 0.81 91.17 12.49 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 1.27 73.42 12.01 2.60 75.02 12.38 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -4.49 77.34 13.29 -7.09 78.39 13.51 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 27 ARG~? 11.42 S2 BME A 601 B 161 ASP A 134 ASP~? 12.23 CL CL A 608 B 174 TYR A 133 TYR~? 5.56 CL CL A 608 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 27 ARG~? 11.60 C2 BME B 602 B 161 ASP B 134 ASP~? -3.66 O1 GOL B 603s B 174 TYR B 133 TYR~? 5.56 CL CL B 609 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 1.97 89.27 10.36 0.81 91.17 12.49 coo -14.86 10.19 8.14 -14.82 12.31 8.42 1.27 73.42 12.01 2.60 75.02 12.38 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -4.49 77.34 13.29 -7.09 78.39 13.51 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 27 ARG~? 11.42 S2 BME A 601 C 161 ASP A 134 ASP~? 12.23 CL CL A 608 C 174 TYR A 133 TYR~? 5.56 CL CL A 608 coo 2.84 19.43 40.34 1.59 20.35 37.65 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 5.94 13.28 27.17 3.53 13.05 28.58 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 27 ARG~? 11.60 C2 BME B 602 C 161 ASP B 134 ASP~? -3.66 O1 GOL B 603s C 174 TYR B 133 TYR~? 5.56 CL CL B 609 coo 2.84 19.43 40.34 1.59 20.35 37.65 1.97 89.27 10.36 0.81 91.17 12.49 coo -0.62 11.10 28.05 -0.65 13.15 27.46 1.27 73.42 12.01 2.60 75.02 12.38 coo 5.94 13.28 27.17 3.53 13.05 28.58 -4.49 77.34 13.29 -7.09 78.39 13.51 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 27 ARG~? 11.42 S2 BME A 601 D 161 ASP A 134 ASP~? 12.23 CL CL A 608 D 174 TYR A 133 TYR~? 5.56 CL CL A 608 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -3.68 43.51 6.20 -5.32 41.74 8.07 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -5.53 59.28 7.24 -6.39 57.64 6.27 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -4.49 55.31 12.95 -3.78 54.23 15.43 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 27 ARG~? 11.60 C2 BME B 602 D 161 ASP B 134 ASP~? -3.66 O1 GOL B 603s D 174 TYR B 133 TYR~? 5.56 CL CL B 609 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 1.97 89.27 10.36 0.81 91.17 12.49 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 1.27 73.42 12.01 2.60 75.02 12.38 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -4.49 77.34 13.29 -7.09 78.39 13.51 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 1 3 # 1 65 THR A 51 THR~? 17.46 S2 BME A 601 242 CYH A 29 CYH~? 9.71 CL CL A 608 270 PHE A 28 PHE~? 9.03 S2 BME A 601 coo 12.97 28.35 3.84 11.81 28.07 2.09 -13.11 40.84 11.29 -13.34 41.71 9.31 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 -8.10 50.91 9.05 -6.68 52.72 10.63 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2cnd_c01 NADH-DEPENDENT NITRATE REDUCTASE (CYuser 2 3 # 2 65 THR B 51 THR~? 17.05 C2 BME B 602 242 CYH B 29 CYH~? 9.17 O1 GOL B 603 270 PHE B 28 PHE~? 9.03 C2 BME B 602 coo 12.97 28.35 3.84 11.81 28.07 2.09 0.21 91.77 20.35 2.10 90.94 19.87 coo 8.65 19.49 -2.27 10.50 20.91 -0.59 0.50 81.71 15.06 -1.49 79.86 14.33 coo 9.41 24.60 -3.66 7.52 26.57 -4.16 -2.63 86.84 14.28 -3.66 89.36 13.73 2cnd_c01 source 2cnd NADH-DEPENDENT NITRATE REDUCTASE (CYTOCHROME B: 2 hits 2cnd_c01 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 37 ASP~? 25.83 CL CL A 608 A 233 GLU A 41 GLU~? 29.61 S2 BME A 601 A 300 ASN A 42 ASN~? 28.57 S2 BME A 601 coo 12.51 17.07 49.46 12.44 16.89 47.35 -20.38 49.92 2.66 -20.55 51.94 2.14 coo 6.52 19.14 48.16 7.77 18.42 46.61 -23.83 46.41 0.54 -22.24 46.41 -0.85 coo 9.30 22.40 41.76 10.10 20.96 40.36 -23.24 41.26 4.00 -22.40 41.46 2.08 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 37 ASP~? 15.37 O1 GOL B 603 A 233 GLU B 41 GLU~? 20.43 O1 GOL B 603 A 300 ASN B 42 ASN~? 23.97 O1 GOL B 603 coo 12.51 17.07 49.46 12.44 16.89 47.35 11.04 82.75 24.13 11.46 80.73 24.12 coo 6.52 19.14 48.16 7.77 18.42 46.61 14.65 86.53 26.90 14.45 85.39 25.16 coo 9.30 22.40 41.76 10.10 20.96 40.36 10.75 91.50 27.13 12.28 91.20 25.69 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 156 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 7.70 72.78 18.03 7.03 72.92 20.00 coo 67.47 20.07 1.34 65.99 20.06 2.88 5.68 77.05 25.89 7.75 77.09 25.94 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 0.70 67.61 16.19 -1.02 68.27 17.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 7.70 72.78 18.03 7.03 72.92 20.00 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 156 GLU B 91 GLU~? 11.42 MN MN B 606 A 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 0.70 67.61 16.19 -1.02 68.27 17.25 coo 67.47 20.07 1.34 65.99 20.06 2.88 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU A 114 GLU~? 19.73 C1 BME A 601 A 156 GLU A 109 GLU~? 22.92 CL CL A 608 A 194 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 74.14 15.91 8.55 72.08 15.36 8.63 -19.10 41.71 19.03 -17.20 41.71 19.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 67.44 25.26 13.91 67.54 23.65 15.28 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 2dbt_c00 CHITINASE C user 5 3 # 5 A 147 GLU A 123 GLU~? 22.37 MN MN B 606 A 156 GLU B 87 GLU~? 16.36 MN MN B 606 A 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 74.14 15.91 8.55 72.08 15.36 8.63 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 67.47 20.07 1.34 65.99 20.06 2.88 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c00 CHITINASE C user 6 3 # 6 A 147 GLU A 141 GLU~? 7.70 MN MN A 604 A 156 GLU A 70 GLU~? -2.54 MN MN A 604s A 194 ASN A 148 ASN~? 13.72 MN MN A 604 coo 74.14 15.91 8.55 72.08 15.36 8.63 4.84 56.74 8.27 3.91 55.44 6.87 coo 67.47 20.07 1.34 65.99 20.06 2.88 6.20 55.25 17.70 4.45 55.72 16.64 coo 67.44 25.26 13.91 67.54 23.65 15.28 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 2dbt_c00 CHITINASE C user 7 3 # 7 A 147 GLU B 70 GLU~? -2.57 MN MN B 607s A 156 GLU B 141 GLU~? 7.71 MN MN B 607 A 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 74.14 15.91 8.55 72.08 15.36 8.63 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 67.47 20.07 1.34 65.99 20.06 2.88 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 67.44 25.26 13.91 67.54 23.65 15.28 -7.72 77.03 -8.08 -7.79 78.86 -6.95 ULMN 3 2dbt_c00 CHITINASE C user 8 3 # 8 A 147 GLU B 87 GLU~? 16.36 MN MN B 606 A 156 GLU A 123 GLU~? 22.37 MN MN B 606 A 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 74.14 15.91 8.55 72.08 15.36 8.63 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 67.47 20.07 1.34 65.99 20.06 2.88 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 67.44 25.26 13.91 67.54 23.65 15.28 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c00 CHITINASE C user 9 3 # 9 A 147 GLU B 91 GLU~? 11.42 MN MN B 606 A 156 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 74.14 15.91 8.55 72.08 15.36 8.63 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 0.70 67.61 16.19 -1.02 68.27 17.25 coo 67.44 25.26 13.91 67.54 23.65 15.28 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c00 CHITINASE C user 10 3 # 10 A 147 GLU B 91 GLU~? 11.42 MN MN B 606 A 156 GLU B 87 GLU~? 16.36 MN MN B 606 A 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 74.14 15.91 8.55 72.08 15.36 8.63 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 67.47 20.07 1.34 65.99 20.06 2.88 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 67.44 25.26 13.91 67.54 23.65 15.28 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c00 CHITINASE C user 11 3 # 11 A 147 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 156 GLU B 114 GLU~? 19.60 C1 BME B 602 A 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 74.14 15.91 8.55 72.08 15.36 8.63 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 67.47 20.07 1.34 65.99 20.06 2.88 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 67.44 25.26 13.91 67.54 23.65 15.28 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c00 CHITINASE C user 12 3 # 12 A 147 GLU B 114 GLU~? 19.60 C1 BME B 602 A 156 GLU B 109 GLU~? 18.95 O1 GOL B 603 A 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 74.14 15.91 8.55 72.08 15.36 8.63 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 67.47 20.07 1.34 65.99 20.06 2.88 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 67.44 25.26 13.91 67.54 23.65 15.28 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c00 CHITINASE C user 13 3 # 13 A 147 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 A 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 74.14 15.91 8.55 72.08 15.36 8.63 5.68 77.05 25.89 7.75 77.09 25.94 coo 67.47 20.07 1.34 65.99 20.06 2.88 7.70 72.78 18.03 7.03 72.92 20.00 coo 67.44 25.26 13.91 67.54 23.65 15.28 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c00 CHITINASE C user 14 3 # 14 A 147 GLU B 141 GLU~? 7.71 MN MN B 607 A 156 GLU B 70 GLU~? -2.57 MN MN B 607s A 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 74.14 15.91 8.55 72.08 15.36 8.63 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 67.47 20.07 1.34 65.99 20.06 2.88 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 67.44 25.26 13.91 67.54 23.65 15.28 -7.72 77.03 -8.08 -7.79 78.86 -6.95 2dbt_c00 source 2dbt CHITINASE C : 14 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 70 GLU~? -2.54 MN MN A 604s B 156 GLU A 141 GLU~? 7.70 MN MN A 604 B 194 ASN A 148 ASN~? 13.72 MN MN A 604 coo 45.64 63.11 17.20 47.48 62.43 16.45 6.20 55.25 17.70 4.45 55.72 16.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 4.84 56.74 8.27 3.91 55.44 6.87 coo 49.79 70.75 7.78 50.10 68.90 6.86 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 156 GLU B 123 GLU~? 13.36 O1 GOL B 603 B 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 7.70 72.78 18.03 7.03 72.92 20.00 coo 54.43 67.89 19.82 55.62 67.90 18.07 5.68 77.05 25.89 7.75 77.09 25.94 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 0.70 67.61 16.19 -1.02 68.27 17.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 156 GLU B 91 GLU~? 11.42 MN MN B 606 B 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 0.70 67.61 16.19 -1.02 68.27 17.25 coo 54.43 67.89 19.82 55.62 67.90 18.07 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c01 CHITINASE C user 5 3 # 5 B 147 GLU A 109 GLU~? 22.92 CL CL A 608 B 156 GLU A 114 GLU~? 19.73 C1 BME A 601 B 194 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.10 41.71 19.03 -17.20 41.71 19.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 2dbt_c01 CHITINASE C user 6 3 # 6 B 147 GLU A 114 GLU~? 19.73 C1 BME A 601 B 156 GLU A 109 GLU~? 22.92 CL CL A 608 B 194 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.10 41.71 19.03 -17.20 41.71 19.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 49.79 70.75 7.78 50.10 68.90 6.86 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 2dbt_c01 CHITINASE C user 7 3 # 7 B 147 GLU A 123 GLU~? 22.37 MN MN B 606 B 156 GLU B 87 GLU~? 16.36 MN MN B 606 B 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 45.64 63.11 17.20 47.48 62.43 16.45 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 54.43 67.89 19.82 55.62 67.90 18.07 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c01 CHITINASE C user 8 3 # 8 B 147 GLU A 141 GLU~? 7.70 MN MN A 604 B 156 GLU A 70 GLU~? -2.54 MN MN A 604s B 194 ASN A 148 ASN~? 13.72 MN MN A 604 coo 45.64 63.11 17.20 47.48 62.43 16.45 4.84 56.74 8.27 3.91 55.44 6.87 coo 54.43 67.89 19.82 55.62 67.90 18.07 6.20 55.25 17.70 4.45 55.72 16.64 coo 49.79 70.75 7.78 50.10 68.90 6.86 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 2dbt_c01 CHITINASE C user 9 3 # 9 B 147 GLU B 70 GLU~? -2.57 MN MN B 607s B 156 GLU B 141 GLU~? 7.71 MN MN B 607 B 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 45.64 63.11 17.20 47.48 62.43 16.45 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 54.43 67.89 19.82 55.62 67.90 18.07 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 49.79 70.75 7.78 50.10 68.90 6.86 -7.72 77.03 -8.08 -7.79 78.86 -6.95 ULMN 3 2dbt_c01 CHITINASE C user 10 3 # 10 B 147 GLU B 87 GLU~? 16.36 MN MN B 606 B 156 GLU A 123 GLU~? 22.37 MN MN B 606 B 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 45.64 63.11 17.20 47.48 62.43 16.45 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 54.43 67.89 19.82 55.62 67.90 18.07 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 49.79 70.75 7.78 50.10 68.90 6.86 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c01 CHITINASE C user 11 3 # 11 B 147 GLU B 91 GLU~? 11.42 MN MN B 606 B 156 GLU A 91 GLU~? 5.92 C1 GOL B 603 B 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 45.64 63.11 17.20 47.48 62.43 16.45 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 54.43 67.89 19.82 55.62 67.90 18.07 0.70 67.61 16.19 -1.02 68.27 17.25 coo 49.79 70.75 7.78 50.10 68.90 6.86 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c01 CHITINASE C user 12 3 # 12 B 147 GLU B 91 GLU~? 11.42 MN MN B 606 B 156 GLU B 87 GLU~? 16.36 MN MN B 606 B 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 45.64 63.11 17.20 47.48 62.43 16.45 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 54.43 67.89 19.82 55.62 67.90 18.07 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.79 70.75 7.78 50.10 68.90 6.86 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c01 CHITINASE C user 13 3 # 13 B 147 GLU B 109 GLU~? 18.95 O1 GOL B 603 B 156 GLU B 114 GLU~? 19.60 C1 BME B 602 B 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 54.43 67.89 19.82 55.62 67.90 18.07 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 49.79 70.75 7.78 50.10 68.90 6.86 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c01 CHITINASE C user 14 3 # 14 B 147 GLU B 114 GLU~? 19.60 C1 BME B 602 B 156 GLU B 109 GLU~? 18.95 O1 GOL B 603 B 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 45.64 63.11 17.20 47.48 62.43 16.45 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 54.43 67.89 19.82 55.62 67.90 18.07 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 49.79 70.75 7.78 50.10 68.90 6.86 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c01 CHITINASE C user 15 3 # 15 B 147 GLU B 123 GLU~? 13.36 O1 GOL B 603 B 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 B 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 45.64 63.11 17.20 47.48 62.43 16.45 5.68 77.05 25.89 7.75 77.09 25.94 coo 54.43 67.89 19.82 55.62 67.90 18.07 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.79 70.75 7.78 50.10 68.90 6.86 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c01 CHITINASE C user 16 3 # 16 B 147 GLU B 141 GLU~? 7.71 MN MN B 607 B 156 GLU B 70 GLU~? -2.57 MN MN B 607s B 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 45.64 63.11 17.20 47.48 62.43 16.45 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 54.43 67.89 19.82 55.62 67.90 18.07 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 49.79 70.75 7.78 50.10 68.90 6.86 -7.72 77.03 -8.08 -7.79 78.86 -6.95 2dbt_c01 source 2dbt CHITINASE C : 16 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 87 GLU~? 6.78 O1 GOL B 603 C 156 GLU B 123 GLU~? 13.36 O1 GOL B 603 C 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 7.70 72.78 18.03 7.03 72.92 20.00 coo 44.75 23.09 5.51 46.77 22.91 6.12 5.68 77.05 25.89 7.75 77.09 25.94 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 C 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 C 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 0.70 67.61 16.19 -1.02 68.27 17.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU A 91 GLU~? 5.92 C1 GOL B 603 C 156 GLU B 91 GLU~? 11.42 MN MN B 606 C 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 0.70 67.61 16.19 -1.02 68.27 17.25 coo 44.75 23.09 5.51 46.77 22.91 6.12 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU A 109 GLU~? 22.92 CL CL A 608 C 156 GLU A 114 GLU~? 19.73 C1 BME A 601 C 194 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.10 41.71 19.03 -17.20 41.71 19.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 2dbt_c02 CHITINASE C user 5 3 # 5 C 147 GLU A 114 GLU~? 19.73 C1 BME A 601 C 156 GLU A 109 GLU~? 22.92 CL CL A 608 C 194 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.10 41.71 19.03 -17.20 41.71 19.98 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.48 52.51 17.23 -21.47 52.95 17.83 coo 49.75 21.00 18.12 50.45 23.02 18.26 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 2dbt_c02 CHITINASE C user 6 3 # 6 C 147 GLU A 123 GLU~? 22.37 MN MN B 606 C 156 GLU B 87 GLU~? 16.36 MN MN B 606 C 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 41.23 29.31 13.28 43.03 29.85 12.29 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 44.75 23.09 5.51 46.77 22.91 6.12 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c02 CHITINASE C user 7 3 # 7 C 147 GLU A 141 GLU~? 7.70 MN MN A 604 C 156 GLU A 70 GLU~? -2.54 MN MN A 604s C 194 ASN A 148 ASN~? 13.72 MN MN A 604 coo 41.23 29.31 13.28 43.03 29.85 12.29 4.84 56.74 8.27 3.91 55.44 6.87 coo 44.75 23.09 5.51 46.77 22.91 6.12 6.20 55.25 17.70 4.45 55.72 16.64 coo 49.75 21.00 18.12 50.45 23.02 18.26 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 3 2dbt_c02 CHITINASE C user 8 3 # 8 C 147 GLU B 70 GLU~? -2.57 MN MN B 607s C 156 GLU B 141 GLU~? 7.71 MN MN B 607 C 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 41.23 29.31 13.28 43.03 29.85 12.29 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 44.75 23.09 5.51 46.77 22.91 6.12 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 49.75 21.00 18.12 50.45 23.02 18.26 -7.72 77.03 -8.08 -7.79 78.86 -6.95 ULMN 3 2dbt_c02 CHITINASE C user 9 3 # 9 C 147 GLU B 87 GLU~? 16.36 MN MN B 606 C 156 GLU A 123 GLU~? 22.37 MN MN B 606 C 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 41.23 29.31 13.28 43.03 29.85 12.29 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 44.75 23.09 5.51 46.77 22.91 6.12 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 49.75 21.00 18.12 50.45 23.02 18.26 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c02 CHITINASE C user 10 3 # 10 C 147 GLU B 91 GLU~? 11.42 MN MN B 606 C 156 GLU A 91 GLU~? 5.92 C1 GOL B 603 C 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 0.70 67.61 16.19 -1.02 68.27 17.25 coo 49.75 21.00 18.12 50.45 23.02 18.26 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c02 CHITINASE C user 11 3 # 11 C 147 GLU B 91 GLU~? 11.42 MN MN B 606 C 156 GLU B 87 GLU~? 16.36 MN MN B 606 C 194 ASN A 102 ASN~? 12.24 CL CL A 608 coo 41.23 29.31 13.28 43.03 29.85 12.29 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 44.75 23.09 5.51 46.77 22.91 6.12 -13.10 59.94 3.57 -14.71 59.81 4.92 coo 49.75 21.00 18.12 50.45 23.02 18.26 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 3 2dbt_c02 CHITINASE C user 12 3 # 12 C 147 GLU B 109 GLU~? 18.95 O1 GOL B 603 C 156 GLU B 114 GLU~? 19.60 C1 BME B 602 C 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 41.23 29.31 13.28 43.03 29.85 12.29 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 44.75 23.09 5.51 46.77 22.91 6.12 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 49.75 21.00 18.12 50.45 23.02 18.26 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c02 CHITINASE C user 13 3 # 13 C 147 GLU B 114 GLU~? 19.60 C1 BME B 602 C 156 GLU B 109 GLU~? 18.95 O1 GOL B 603 C 194 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 41.23 29.31 13.28 43.03 29.85 12.29 -4.83 91.16 28.65 -6.46 91.34 27.26 coo 44.75 23.09 5.51 46.77 22.91 6.12 -2.95 80.34 28.65 -2.60 79.82 30.64 coo 49.75 21.00 18.12 50.45 23.02 18.26 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 3 2dbt_c02 CHITINASE C user 14 3 # 14 C 147 GLU B 123 GLU~? 13.36 O1 GOL B 603 C 156 GLU A 87 GLU~? 6.78 O1 GOL B 603 C 194 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 41.23 29.31 13.28 43.03 29.85 12.29 5.68 77.05 25.89 7.75 77.09 25.94 coo 44.75 23.09 5.51 46.77 22.91 6.12 7.70 72.78 18.03 7.03 72.92 20.00 coo 49.75 21.00 18.12 50.45 23.02 18.26 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 3 2dbt_c02 CHITINASE C user 15 3 # 15 C 147 GLU B 141 GLU~? 7.71 MN MN B 607 C 156 GLU B 70 GLU~? -2.57 MN MN B 607s C 194 ASN B 148 ASN~? 13.72 MN MN B 607 coo 41.23 29.31 13.28 43.03 29.85 12.29 -3.60 76.13 2.85 -2.01 77.43 3.31 coo 44.75 23.09 5.51 46.77 22.91 6.12 -12.98 77.36 5.11 -11.32 76.90 6.35 coo 49.75 21.00 18.12 50.45 23.02 18.26 -7.72 77.03 -8.08 -7.79 78.86 -6.95 2dbt_c02 source 2dbt CHITINASE C : 15 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 153 LYS~? 20.22 C2 BME A 601 B 184 LYS A 155 LYS~? 22.50 MN MN A 604 B 345 ASP A 145 ASP~? 14.76 MN MN A 604 coo 38.76 2.27 4.00 34.00 5.99 4.37 23.06 52.60 13.46 22.53 47.10 11.88 coo 40.63 7.13 9.06 35.85 7.36 8.95 21.85 53.55 18.73 24.16 56.83 22.72 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 155 LYS~? 22.50 MN MN A 604 B 184 LYS A 153 LYS~? 20.22 C2 BME A 601 B 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 38.76 2.27 4.00 34.00 5.99 4.37 21.85 53.55 18.73 24.16 56.83 22.72 coo 40.63 7.13 9.06 35.85 7.36 8.95 23.06 52.60 13.46 22.53 47.10 11.88 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 153 LYS~? 21.64 S2 BME B 602 B 184 LYS B 155 LYS~? 22.59 MN MN B 607 B 345 ASP B 145 ASP~? 15.01 MN MN B 607 coo 38.76 2.27 4.00 34.00 5.99 4.37 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 40.63 7.13 9.06 35.85 7.36 8.95 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 155 LYS~? 22.59 MN MN B 607 B 184 LYS B 153 LYS~? 21.64 S2 BME B 602 B 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 38.76 2.27 4.00 34.00 5.99 4.37 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 40.63 7.13 9.06 35.85 7.36 8.95 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS B 155 LYS~? 22.59 MN MN B 607 C 184 LYS B 153 LYS~? 21.64 S2 BME B 602 C 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -5.66 12.40 71.13 -2.66 9.98 66.50 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 0.95 12.72 73.51 1.58 12.72 68.31 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS B 155 LYS~? 22.59 MN MN B 607 D 184 LYS B 153 LYS~? 21.64 S2 BME B 602 D 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS B 155 LYS~? 22.59 MN MN B 607 E 184 LYS B 153 LYS~? 21.64 S2 BME B 602 E 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -21.16 62.58 121.86 -16.35 60.33 119.23 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo -23.22 55.98 120.74 -18.11 55.31 120.43 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -17.15 59.71 133.33 -17.96 61.54 134.01 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS B 155 LYS~? 22.59 MN MN B 607 I 184 LYS B 153 LYS~? 21.64 S2 BME B 602 I 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 60.20 96.92 42.53 57.60 93.13 38.67 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 54.31 95.46 46.01 55.34 91.59 42.65 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 66.35 87.81 48.53 68.10 89.01 48.77 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 153 LYS~? 20.22 C2 BME A 601 J 184 LYS A 155 LYS~? 22.50 MN MN A 604 J 345 ASP A 145 ASP~? 14.76 MN MN A 604 coo 25.22 70.55 14.03 27.64 73.07 18.65 23.06 52.60 13.46 22.53 47.10 11.88 coo 31.73 69.87 11.50 32.73 70.19 16.40 21.85 53.55 18.73 24.16 56.83 22.72 coo 25.87 58.42 18.79 23.95 58.54 17.90 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS A 155 LYS~? 22.50 MN MN A 604 J 184 LYS A 153 LYS~? 20.22 C2 BME A 601 J 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 25.22 70.55 14.03 27.64 73.07 18.65 21.85 53.55 18.73 24.16 56.83 22.72 coo 31.73 69.87 11.50 32.73 70.19 16.40 23.06 52.60 13.46 22.53 47.10 11.88 coo 25.87 58.42 18.79 23.95 58.54 17.90 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 3 3 # 3 J 182 LYS B 155 LYS~? 22.59 MN MN B 607 J 184 LYS B 153 LYS~? 21.64 S2 BME B 602 J 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 25.22 70.55 14.03 27.64 73.07 18.65 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 31.73 69.87 11.50 32.73 70.19 16.40 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 25.87 58.42 18.79 23.95 58.54 17.90 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 3 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 155 LYS~? 22.50 MN MN A 604 K 184 LYS A 153 LYS~? 20.22 C2 BME A 601 K 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 21.85 53.55 18.73 24.16 56.83 22.72 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 23.06 52.60 13.46 22.53 47.10 11.88 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS B 155 LYS~? 22.59 MN MN B 607 K 184 LYS B 153 LYS~? 21.64 S2 BME B 602 K 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 153 LYS~? 20.22 C2 BME A 601 L 184 LYS A 155 LYS~? 22.50 MN MN A 604 L 345 ASP A 145 ASP~? 14.76 MN MN A 604 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 23.06 52.60 13.46 22.53 47.10 11.88 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 21.85 53.55 18.73 24.16 56.83 22.72 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 155 LYS~? 22.50 MN MN A 604 L 184 LYS A 153 LYS~? 20.22 C2 BME A 601 L 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 21.85 53.55 18.73 24.16 56.83 22.72 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 23.06 52.60 13.46 22.53 47.10 11.88 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 153 LYS~? 21.64 S2 BME B 602 L 184 LYS B 155 LYS~? 22.59 MN MN B 607 L 345 ASP B 145 ASP~? 15.01 MN MN B 607 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 155 LYS~? 22.59 MN MN B 607 L 184 LYS B 153 LYS~? 21.64 S2 BME B 602 L 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 153 LYS~? 20.22 C2 BME A 601 M 184 LYS A 155 LYS~? 22.50 MN MN A 604 M 345 ASP A 145 ASP~? 14.76 MN MN A 604 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 23.06 52.60 13.46 22.53 47.10 11.88 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 21.85 53.55 18.73 24.16 56.83 22.72 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 155 LYS~? 22.50 MN MN A 604 M 184 LYS A 153 LYS~? 20.22 C2 BME A 601 M 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 21.85 53.55 18.73 24.16 56.83 22.72 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 23.06 52.60 13.46 22.53 47.10 11.88 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 153 LYS~? 21.64 S2 BME B 602 M 184 LYS B 155 LYS~? 22.59 MN MN B 607 M 345 ASP B 145 ASP~? 15.01 MN MN B 607 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 155 LYS~? 22.59 MN MN B 607 M 184 LYS B 153 LYS~? 21.64 S2 BME B 602 M 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 155 LYS~? 22.50 MN MN A 604 O 184 LYS A 153 LYS~? 20.22 C2 BME A 601 O 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 21.85 53.55 18.73 24.16 56.83 22.72 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 23.06 52.60 13.46 22.53 47.10 11.88 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS B 155 LYS~? 22.59 MN MN B 607 O 184 LYS B 153 LYS~? 21.64 S2 BME B 602 O 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 153 LYS~? 20.22 C2 BME A 601 P 184 LYS A 155 LYS~? 22.50 MN MN A 604 P 345 ASP A 145 ASP~? 14.76 MN MN A 604 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 23.06 52.60 13.46 22.53 47.10 11.88 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 21.85 53.55 18.73 24.16 56.83 22.72 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 12.32 59.45 6.26 13.32 58.94 4.48 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 155 LYS~? 22.50 MN MN A 604 P 184 LYS A 153 LYS~? 20.22 C2 BME A 601 P 345 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 21.85 53.55 18.73 24.16 56.83 22.72 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 23.06 52.60 13.46 22.53 47.10 11.88 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 153 LYS~? 21.64 S2 BME B 602 P 184 LYS B 155 LYS~? 22.59 MN MN B 607 P 345 ASP B 145 ASP~? 15.01 MN MN B 607 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -4.45 73.67 -4.82 -3.36 73.65 -6.63 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 155 LYS~? 22.59 MN MN B 607 P 184 LYS B 153 LYS~? 21.64 S2 BME B 602 P 345 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -15.81 81.35 4.53 -16.00 83.45 4.93 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c47 naa= 3 ULMN 3 2esd_c00 1.02.01.0009 user 1 3 # 1 A 154 ASN A 42 ASN~? 28.57 S2 BME A 601 A 250 ALA A 118 ALA.? 33.13 C1 BME A 601 A 284 CYH A 44 CYH.? 25.03 C1 BME A 601 coo -98.31 19.25 26.95 -99.27 21.10 26.57 -23.24 41.26 4.00 -22.40 41.46 2.08 coo -102.90 29.72 23.02 -103.69 28.50 23.43 -29.25 44.12 14.08 -30.74 43.87 14.44 coo -98.59 26.45 29.50 -99.24 25.73 26.84 -23.50 41.83 10.75 -22.38 42.24 13.24 ULMN 3 2esd_c00 1.02.01.0009 user 2 3 # 2 A 154 ASN B 42 ASN~? 23.97 O1 GOL B 603 A 250 ALA B 118 ALA.? 29.04 O1 GOL B 603 A 284 CYH B 44 CYH.? 24.08 O1 GOL B 603 coo -98.31 19.25 26.95 -99.27 21.10 26.57 10.75 91.50 27.13 12.28 91.20 25.69 coo -102.90 29.72 23.02 -103.69 28.50 23.43 3.48 88.84 36.39 3.65 89.07 37.92 coo -98.59 26.45 29.50 -99.24 25.73 26.84 4.59 91.00 29.83 1.85 90.60 29.68 2esd_c00 source 2esd 1.02.01.0009 : 2 hits 2esd_c00 naa= 3 ULMN 3 2esd_c01 1.02.01.0009 user 1 3 # 1 B 154 ASN A 42 ASN~? 28.57 S2 BME A 601 B 250 ALA A 118 ALA.? 33.13 C1 BME A 601 B 284 CYH A 44 CYH.? 25.03 C1 BME A 601 coo -116.62 58.12 2.11 -116.17 56.24 3.01 -23.24 41.26 4.00 -22.40 41.46 2.08 coo -114.20 47.61 7.65 -114.88 48.80 8.33 -29.25 44.12 14.08 -30.74 43.87 14.44 coo -118.73 50.90 1.30 -116.61 51.76 2.87 -23.50 41.83 10.75 -22.38 42.24 13.24 ULMN 3 2esd_c01 1.02.01.0009 user 2 3 # 2 B 154 ASN B 42 ASN~? 23.97 O1 GOL B 603 B 250 ALA B 118 ALA.? 29.04 O1 GOL B 603 B 284 CYH B 44 CYH.? 24.08 O1 GOL B 603 coo -116.62 58.12 2.11 -116.17 56.24 3.01 10.75 91.50 27.13 12.28 91.20 25.69 coo -114.20 47.61 7.65 -114.88 48.80 8.33 3.48 88.84 36.39 3.65 89.07 37.92 coo -118.73 50.90 1.30 -116.61 51.76 2.87 4.59 91.00 29.83 1.85 90.60 29.68 2esd_c01 source 2esd 1.02.01.0009 : 2 hits 2esd_c01 naa= 3 ULMN 3 2esd_c02 1.02.01.0009 user 1 3 # 1 C 154 ASN A 42 ASN~? 28.57 S2 BME A 601 C 250 ALA A 118 ALA.? 33.13 C1 BME A 601 C 284 CYH A 44 CYH.? 25.03 C1 BME A 601 coo -155.36 18.42 28.93 -154.49 20.30 29.39 -23.24 41.26 4.00 -22.40 41.46 2.08 coo -150.95 29.02 32.87 -150.10 27.86 32.40 -29.25 44.12 14.08 -30.74 43.87 14.44 coo -155.22 25.64 26.33 -154.78 25.20 29.09 -23.50 41.83 10.75 -22.38 42.24 13.24 ULMN 3 2esd_c02 1.02.01.0009 user 2 3 # 2 C 154 ASN B 42 ASN~? 23.97 O1 GOL B 603 C 250 ALA B 118 ALA.? 29.04 O1 GOL B 603 C 284 CYH B 44 CYH.? 24.08 O1 GOL B 603 coo -155.36 18.42 28.93 -154.49 20.30 29.39 10.75 91.50 27.13 12.28 91.20 25.69 coo -150.95 29.02 32.87 -150.10 27.86 32.40 3.48 88.84 36.39 3.65 89.07 37.92 coo -155.22 25.64 26.33 -154.78 25.20 29.09 4.59 91.00 29.83 1.85 90.60 29.68 2esd_c02 source 2esd 1.02.01.0009 : 2 hits 2esd_c02 naa= 3 ULMN 3 2esd_c03 1.02.01.0009 user 1 3 # 1 D 154 ASN A 42 ASN~? 28.57 S2 BME A 601 D 250 ALA A 118 ALA.? 33.13 C1 BME A 601 D 284 CYH A 44 CYH.? 25.03 C1 BME A 601 coo -138.05 57.23 54.59 -137.96 55.47 53.43 -23.24 41.26 4.00 -22.40 41.46 2.08 coo -139.97 46.71 48.80 -139.25 47.90 48.19 -29.25 44.12 14.08 -30.74 43.87 14.44 coo -135.22 50.13 55.22 -137.25 50.94 53.65 -23.50 41.83 10.75 -22.38 42.24 13.24 ULMN 3 2esd_c03 1.02.01.0009 user 2 3 # 2 D 154 ASN B 42 ASN~? 23.97 O1 GOL B 603 D 250 ALA B 118 ALA.? 29.04 O1 GOL B 603 D 284 CYH B 44 CYH.? 24.08 O1 GOL B 603 coo -138.05 57.23 54.59 -137.96 55.47 53.43 10.75 91.50 27.13 12.28 91.20 25.69 coo -139.97 46.71 48.80 -139.25 47.90 48.19 3.48 88.84 36.39 3.65 89.07 37.92 coo -135.22 50.13 55.22 -137.25 50.94 53.65 4.59 91.00 29.83 1.85 90.60 29.68 2esd_c03 source 2esd 1.02.01.0009 : 2 hits 2esd_c03 naa= 3 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 A 311 HIS A 22 HIS~? -3.40 MN MN A 604s A 341 GLU A 140 GLU~? -2.42 MN MN A 605s A 356 HIS A 67 HIS~? -4.40 CL CL A 608s coo 121.00 36.37 19.26 121.57 38.37 19.56 3.18 53.06 10.64 3.66 54.63 11.95 coo 125.72 32.70 19.75 124.44 34.16 18.84 5.06 58.75 13.41 3.74 57.63 14.59 coo 124.34 41.73 25.55 123.79 42.60 23.72 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 A 311 HIS A 67 HIS~? -4.40 CL CL A 608s A 341 GLU A 71 GLU~? 7.91 MN MN A 605 A 356 HIS A 136 HIS~? 3.48 MN MN A 605s coo 121.00 36.37 19.26 121.57 38.37 19.56 0.35 54.22 20.29 -1.10 54.30 18.77 coo 125.72 32.70 19.75 124.44 34.16 18.84 4.56 57.67 23.22 2.91 58.15 24.47 coo 124.34 41.73 25.55 123.79 42.60 23.72 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 A 311 HIS A 96 HIS~? -3.41 MN MN A 605s A 341 GLU A 71 GLU~? 7.91 MN MN A 605 A 356 HIS A 66 HIS~? 3.42 MN MN A 604s coo 121.00 36.37 19.26 121.57 38.37 19.56 0.59 58.54 20.35 2.20 57.89 19.15 coo 125.72 32.70 19.75 124.44 34.16 18.84 4.56 57.67 23.22 2.91 58.15 24.47 coo 124.34 41.73 25.55 123.79 42.60 23.72 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 A 311 HIS A 136 HIS~? 3.48 MN MN A 605s A 341 GLU A 140 GLU~? -2.42 MN MN A 605s A 356 HIS A 67 HIS~? -4.40 CL CL A 608s coo 121.00 36.37 19.26 121.57 38.37 19.56 -0.57 59.60 14.33 0.78 59.36 15.93 coo 125.72 32.70 19.75 124.44 34.16 18.84 5.06 58.75 13.41 3.74 57.63 14.59 coo 124.34 41.73 25.55 123.79 42.60 23.72 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 A 311 HIS B 22 HIS~? -3.40 MN MN B 607s A 341 GLU B 140 GLU~? -2.41 MN MN B 606s A 356 HIS B 67 HIS~? -4.45 CL CL B 609s coo 121.00 36.37 19.26 121.57 38.37 19.56 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 125.72 32.70 19.75 124.44 34.16 18.84 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 124.34 41.73 25.55 123.79 42.60 23.72 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 A 311 HIS B 67 HIS~? -4.45 CL CL B 609s A 341 GLU B 71 GLU~? 7.93 MN MN B 606 A 356 HIS B 136 HIS~? 3.50 MN MN B 606s coo 121.00 36.37 19.26 121.57 38.37 19.56 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 125.72 32.70 19.75 124.44 34.16 18.84 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 124.34 41.73 25.55 123.79 42.60 23.72 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 A 311 HIS B 96 HIS~? -3.43 MN MN B 606s A 341 GLU B 71 GLU~? 7.93 MN MN B 606 A 356 HIS B 66 HIS~? 3.43 MN MN B 607s coo 121.00 36.37 19.26 121.57 38.37 19.56 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 125.72 32.70 19.75 124.44 34.16 18.84 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 124.34 41.73 25.55 123.79 42.60 23.72 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 2isd_c00 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 A 311 HIS B 136 HIS~? 3.50 MN MN B 606s A 341 GLU B 140 GLU~? -2.41 MN MN B 606s A 356 HIS B 67 HIS~? -4.45 CL CL B 609s coo 121.00 36.37 19.26 121.57 38.37 19.56 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 125.72 32.70 19.75 124.44 34.16 18.84 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 124.34 41.73 25.55 123.79 42.60 23.72 -13.16 78.27 11.53 -11.33 78.28 12.55 2isd_c00 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 8 hits 2isd_c00 naa= 3 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 1 3 # 1 B 311 HIS A 22 HIS~? -3.40 MN MN A 604s B 341 GLU A 140 GLU~? -2.42 MN MN A 605s B 356 HIS A 67 HIS~? -4.40 CL CL A 608s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 5.06 58.75 13.41 3.74 57.63 14.59 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 2 3 # 2 B 311 HIS A 67 HIS~? -4.40 CL CL A 608s B 341 GLU A 71 GLU~? 7.91 MN MN A 605 B 356 HIS A 136 HIS~? 3.48 MN MN A 605s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 0.35 54.22 20.29 -1.10 54.30 18.77 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 4.56 57.67 23.22 2.91 58.15 24.47 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 3 3 # 3 B 311 HIS A 96 HIS~? -3.41 MN MN A 605s B 341 GLU A 71 GLU~? 7.91 MN MN A 605 B 356 HIS A 66 HIS~? 3.42 MN MN A 604s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 0.59 58.54 20.35 2.20 57.89 19.15 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 4.56 57.67 23.22 2.91 58.15 24.47 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 4 3 # 4 B 311 HIS A 136 HIS~? 3.48 MN MN A 605s B 341 GLU A 140 GLU~? -2.42 MN MN A 605s B 356 HIS A 67 HIS~? -4.40 CL CL A 608s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -0.57 59.60 14.33 0.78 59.36 15.93 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 5.06 58.75 13.41 3.74 57.63 14.59 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 5 3 # 5 B 311 HIS B 22 HIS~? -3.40 MN MN B 607s B 341 GLU B 140 GLU~? -2.41 MN MN B 606s B 356 HIS B 67 HIS~? -4.45 CL CL B 609s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -13.16 78.27 11.53 -11.33 78.28 12.55 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 6 3 # 6 B 311 HIS B 67 HIS~? -4.45 CL CL B 609s B 341 GLU B 71 GLU~? 7.93 MN MN B 606 B 356 HIS B 136 HIS~? 3.50 MN MN B 606s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 7 3 # 7 B 311 HIS B 96 HIS~? -3.43 MN MN B 606s B 341 GLU B 71 GLU~? 7.93 MN MN B 606 B 356 HIS B 66 HIS~? 3.43 MN MN B 607s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -17.41 74.79 8.70 -17.96 74.30 10.67 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 2isd_c01 PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPuser 8 3 # 8 B 311 HIS B 136 HIS~? 3.50 MN MN B 606s B 341 GLU B 140 GLU~? -2.41 MN MN B 606s B 356 HIS B 67 HIS~? -4.45 CL CL B 609s coo 77.20 37.63 -25.62 77.60 39.62 -25.06 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 79.41 33.66 -21.62 79.55 35.10 -23.14 -8.44 74.11 4.59 -9.08 75.11 6.26 coo 75.11 43.37 -19.22 76.23 44.10 -20.84 -13.16 78.27 11.53 -11.33 78.28 12.55 2isd_c01 source 2isd PHOSPHOINOSITIDE-SPECIFIC PHOSPHOLIPASE C, ISO: 8 hits 2isd_c01 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 66 HIS~? 3.42 MN MN A 604s A 102 ASP A 69 ASP~? 7.42 O1 BME A 601 A 193 GLY A 23 GLY~? 8.40 S2 BME A 601 coo 14.96 29.22 19.55 15.62 29.93 17.67 3.21 51.23 16.81 3.87 52.43 15.22 coo 19.64 30.69 22.61 18.18 29.94 21.25 7.88 51.22 19.98 7.64 49.14 20.25 coo 14.54 28.99 9.76 15.06 29.59 10.02 1.32 48.34 7.45 1.06 48.38 8.26 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 2 3 # 2 A 57 HIS B 66 HIS~? 3.43 MN MN B 607s A 102 ASP B 69 ASP~? 7.66 S2 BME B 602 A 193 GLY B 23 GLY~? 8.34 S2 BME B 602 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 19.64 30.69 22.61 18.18 29.94 21.25 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 14.54 28.99 9.76 15.06 29.59 10.02 -1.78 84.52 5.86 -2.42 84.42 6.43 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 2 hits 2lpr_c02 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 11 PHE.? 7.28 O1 BME A 601 A 263 ASP A 69 ASP~? 7.42 O1 BME A 601 A 292 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 51.51 50.32 16.39 52.13 49.68 13.75 11.74 44.01 17.67 8.98 44.14 18.15 coo 54.43 44.82 23.74 55.21 45.06 21.80 7.88 51.22 19.98 7.64 49.14 20.25 coo 63.95 45.30 16.71 59.11 49.15 16.05 5.93 41.39 29.05 1.02 39.99 32.86 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 11 PHE.? 7.28 O1 BME A 601 B 263 ASP A 69 ASP~? 7.42 O1 BME A 601 B 292 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 49.99 26.05 6.28 51.46 26.87 8.49 11.74 44.01 17.67 8.98 44.14 18.15 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 7.88 51.22 19.98 7.64 49.14 20.25 coo 60.53 31.67 0.97 57.79 27.51 3.63 5.93 41.39 29.05 1.02 39.99 32.86 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 11 PHE.? 7.28 O1 BME A 601 C 263 ASP A 69 ASP~? 7.42 O1 BME A 601 C 292 LYS A 169 LYS.? 14.89 O1 BME A 601 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 11.74 44.01 17.67 8.98 44.14 18.15 coo 19.84 12.02 9.33 18.68 11.23 7.75 7.88 51.22 19.98 7.64 49.14 20.25 coo 12.82 3.49 4.98 17.80 5.59 1.90 5.93 41.39 29.05 1.02 39.99 32.86 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 129 PHE~? 10.87 CL CL A 608 C 263 ASP A 134 ASP~? 12.23 CL CL A 608 C 292 LYS A 24 LYS~? 4.08 C2 BME A 601 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 -10.38 54.19 14.28 -8.39 52.30 14.83 coo 19.84 12.02 9.33 18.68 11.23 7.75 -5.53 59.28 7.24 -6.39 57.64 6.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 -0.91 46.54 9.97 2.66 42.32 12.44 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c05 naa= 3 ULMN 3 2oat_c06 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 178 TRP A 103 TRP~? 13.04 CL CL A 608 A 263 ASP A 101 ASP~? 14.47 MN MN A 605 A 292 LYS A 127 LYS~? 18.61 MN MN B 606 coo 48.96 45.07 19.49 48.62 41.39 18.16 -8.87 50.94 21.19 -10.72 48.76 18.46 coo 54.43 44.82 23.74 55.21 45.06 21.80 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 63.95 45.30 16.71 59.11 49.15 16.05 -14.62 57.47 9.74 -19.33 59.04 5.94 2oat_c06 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c06 naa= 3 ULMN 3 2oat_c07 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 178 TRP A 103 TRP~? 13.04 CL CL A 608 B 263 ASP A 101 ASP~? 14.47 MN MN A 605 B 292 LYS A 127 LYS~? 18.61 MN MN B 606 coo 45.83 31.15 4.65 45.88 34.74 6.24 -8.87 50.94 21.19 -10.72 48.76 18.46 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 60.53 31.67 0.97 57.79 27.51 3.63 -14.62 57.47 9.74 -19.33 59.04 5.94 2oat_c07 source 2oat ORNITHINE AMINOTRANSFERASE : 1 hits 2oat_c07 naa= 3 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 178 TRP A 103 TRP~? 13.04 CL CL A 608 C 263 ASP A 101 ASP~? 14.47 MN MN A 605 C 292 LYS A 127 LYS~? 18.61 MN MN B 606 coo 20.52 16.65 4.15 17.32 18.91 4.39 -8.87 50.94 21.19 -10.72 48.76 18.46 coo 19.84 12.02 9.33 18.68 11.23 7.75 -10.28 59.57 22.50 -9.46 60.36 24.30 coo 12.82 3.49 4.98 17.80 5.59 1.90 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 2oat_c08 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 178 TRP B 103 TRP~? 12.92 CL CL B 609 C 263 ASP B 101 ASP~? 14.48 MN MN B 606 C 292 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 20.52 16.65 4.15 17.32 18.91 4.39 -10.49 81.55 20.44 -7.30 83.78 21.03 coo 19.84 12.02 9.33 18.68 11.23 7.75 -10.99 72.82 22.17 -12.93 72.02 22.11 coo 12.82 3.49 4.98 17.80 5.59 1.90 2.32 75.24 21.44 7.34 73.34 24.59 2oat_c08 source 2oat ORNITHINE AMINOTRANSFERASE : 2 hits 2oat_c08 naa= 3 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 1 3 # 1 A 12 HIS A 67 HIS~? -4.40 CL CL A 608s A 40 LYS A 24 LYS~? 4.08 C2 BME A 601 A 116 HIS A 136 HIS~? 3.48 MN MN A 605s coo 12.34 -0.45 10.80 13.53 1.19 11.34 0.35 54.22 20.29 -1.10 54.30 18.77 coo 18.50 3.53 20.10 16.17 2.61 14.41 -0.91 46.54 9.97 2.66 42.32 12.44 coo 14.70 6.01 5.61 14.27 7.69 6.78 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 2 3 # 2 A 12 HIS A 136 HIS~? 3.48 MN MN A 605s A 40 LYS A 24 LYS~? 4.08 C2 BME A 601 A 116 HIS A 100 HIS~? 8.88 CL CL A 608 coo 12.34 -0.45 10.80 13.53 1.19 11.34 -0.57 59.60 14.33 0.78 59.36 15.93 coo 18.50 3.53 20.10 16.17 2.61 14.41 -0.91 46.54 9.97 2.66 42.32 12.44 coo 14.70 6.01 5.61 14.27 7.69 6.78 -4.62 56.01 23.20 -2.61 55.48 22.88 ULMN 3 2rnf_c02 RIBONUCLEASE 4 user 3 3 # 3 A 12 HIS B 67 HIS~? -4.45 CL CL B 609s A 40 LYS B 24 LYS~? -3.00 C2 BME B 602s A 116 HIS B 136 HIS~? 3.50 MN MN B 606s coo 12.34 -0.45 10.80 13.53 1.19 11.34 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 18.50 3.53 20.10 16.17 2.61 14.41 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 14.70 6.01 5.61 14.27 7.69 6.78 -7.23 73.04 10.16 -9.24 73.26 9.58 2rnf_c02 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c02 naa= 3 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 1 3 # 1 B 12 HIS A 67 HIS~? -4.40 CL CL A 608s B 40 LYS A 24 LYS~? 4.08 C2 BME A 601 B 116 HIS A 136 HIS~? 3.48 MN MN A 605s coo -6.35 21.42 14.69 -6.06 23.46 15.04 0.35 54.22 20.29 -1.10 54.30 18.77 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -0.91 46.54 9.97 2.66 42.32 12.44 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 2 3 # 2 B 12 HIS B 67 HIS~? -4.45 CL CL B 609s B 40 LYS B 24 LYS~? -3.00 C2 BME B 602s B 116 HIS B 136 HIS~? 3.50 MN MN B 606s coo -6.35 21.42 14.69 -6.06 23.46 15.04 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -3.23 86.22 8.94 -7.29 90.78 7.55 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 2rnf_c03 RIBONUCLEASE 4 user 3 3 # 3 B 12 HIS B 136 HIS~? 3.50 MN MN B 606s B 40 LYS B 24 LYS~? -3.00 C2 BME B 602s B 116 HIS B 100 HIS~? 8.87 CL CL B 609 coo -6.35 21.42 14.69 -6.06 23.46 15.04 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -10.61 31.45 9.72 -8.75 26.69 13.45 -3.23 86.22 8.94 -7.29 90.78 7.55 coo -0.95 25.22 19.68 -0.68 26.73 18.24 -13.86 76.47 17.25 -14.56 76.87 15.30 2rnf_c03 source 2rnf RIBONUCLEASE 4 : 3 hits 2rnf_c03 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 90 ASP~? 8.93 C1 GOL B 603 166 GLY A 132 GLY~? 10.05 CL CL A 608 169 GLU A 124 GLU~? 15.58 MN MN B 606 coo 8.28 6.87 1.62 10.08 5.77 1.34 5.32 68.36 21.17 7.09 68.49 22.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.17 60.13 12.71 -7.01 59.60 12.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -18.72 60.92 13.26 -17.30 61.76 11.93 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 90 ASP~? 8.93 C1 GOL B 603 166 GLY A 132 GLY~? 10.05 CL CL A 608 169 GLU B 87 GLU~? 16.36 MN MN B 606 coo 8.28 6.87 1.62 10.08 5.77 1.34 5.32 68.36 21.17 7.09 68.49 22.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -7.17 60.13 12.71 -7.01 59.60 12.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.10 59.94 3.57 -14.71 59.81 4.92 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 90 ASP~? 8.93 C1 GOL B 603 166 GLY A 147 GLY~? 13.13 MN MN A 604 169 GLU A 16 GLU~? 14.76 S2 BME A 601 coo 8.28 6.87 1.62 10.08 5.77 1.34 5.32 68.36 21.17 7.09 68.49 22.34 coo -8.58 13.22 3.21 -8.90 13.15 4.05 15.60 58.74 12.01 15.70 58.76 11.21 coo -16.67 7.89 2.78 -17.65 6.56 1.49 13.57 48.33 8.05 14.78 46.83 7.14 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 122 ASP~? 22.01 MN MN B 606 166 GLY A 98 GLY~? 10.67 MN MN A 605 169 GLU A 91 GLU~? 5.92 C1 GOL B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 -21.79 55.48 15.36 -21.54 57.57 15.22 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -6.79 61.25 20.29 -6.32 60.57 20.44 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.70 67.61 16.19 -1.02 68.27 17.25 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP B 90 ASP~? 13.30 MN MN B 606 166 GLY B 132 GLY~? 6.66 O1 GOL B 603 169 GLU B 124 GLU~? 10.55 C1 GOL B 603 coo 8.28 6.87 1.62 10.08 5.77 1.34 -15.47 64.24 6.89 -17.14 64.04 5.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -3.20 72.50 15.64 -2.65 73.03 15.24 coo -16.67 7.89 2.78 -17.65 6.56 1.49 0.65 71.77 26.43 1.32 70.82 24.72 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP B 122 ASP~? 15.88 O1 GOL B 603 166 GLY B 98 GLY~? 10.76 MN MN B 606 169 GLU B 91 GLU~? 11.42 MN MN B 606 coo 8.28 6.87 1.62 10.08 5.77 1.34 -0.15 77.17 30.18 -0.01 75.13 29.61 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -10.36 71.24 18.20 -10.64 71.91 17.78 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -9.23 65.09 9.44 -9.52 64.33 11.38 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 6 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 58 TYR~? -4.88 S2 BME A 601s A 172 HIS A 66 HIS~? 3.42 MN MN A 604s A 267 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 26.78 20.44 0.03 28.51 18.26 0.09 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 3.21 51.23 16.81 3.87 52.43 15.22 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 58 TYR~? -4.91 S2 BME B 602s A 172 HIS B 66 HIS~? 3.43 MN MN B 607s A 267 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 26.78 20.44 0.03 28.51 18.26 0.09 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -15.81 81.35 4.53 -16.00 83.45 4.93 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 58 TYR~? -4.88 S2 BME A 601s B 172 HIS A 66 HIS~? 3.42 MN MN A 604s B 267 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 44.86 1.98 33.27 42.75 1.12 31.67 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 3.21 51.23 16.81 3.87 52.43 15.22 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 58 TYR~? -4.91 S2 BME B 602s B 172 HIS B 66 HIS~? 3.43 MN MN B 607s B 267 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 44.86 1.98 33.27 42.75 1.12 31.67 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -15.81 81.35 4.53 -16.00 83.45 4.93 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c01 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 128 ARG~? 18.10 CL CL A 608 A 130 SER A 107 SER~? 17.07 CL CL A 608 A 159 LYS A 127 LYS~? 18.61 MN MN B 606 coo 18.35 45.84 20.99 16.20 47.83 21.89 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 15.14 43.67 10.77 15.61 44.43 13.04 -14.58 49.59 20.39 -13.79 50.81 22.29 coo 11.57 48.49 22.18 13.51 49.99 17.21 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 128 ARG~? 13.47 O1 GOL B 603 A 130 SER B 107 SER~? 17.45 CL CL B 609 A 159 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 18.35 45.84 20.99 16.20 47.83 21.89 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 15.14 43.67 10.77 15.61 44.43 13.04 -7.70 83.12 25.20 -9.96 84.03 25.06 coo 11.57 48.49 22.18 13.51 49.99 17.21 2.32 75.24 21.44 7.34 73.34 24.59 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 128 ARG~? 18.10 CL CL A 608 B 130 SER A 107 SER~? 17.07 CL CL A 608 B 159 LYS A 127 LYS~? 18.61 MN MN B 606 coo 58.72 31.58 20.45 60.80 29.39 20.94 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 61.66 35.17 10.39 61.29 34.14 12.56 -14.58 49.59 20.39 -13.79 50.81 22.29 coo 65.38 28.77 21.17 63.49 28.03 16.12 -14.62 57.47 9.74 -19.33 59.04 5.94 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 128 ARG~? 13.47 O1 GOL B 603 B 130 SER B 107 SER~? 17.45 CL CL B 609 B 159 LYS B 127 LYS~? 11.03 O1 GOL B 603 coo 58.72 31.58 20.45 60.80 29.39 20.94 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 61.66 35.17 10.39 61.29 34.14 12.56 -7.70 83.12 25.20 -9.96 84.03 25.06 coo 65.38 28.77 21.17 63.49 28.03 16.12 2.32 75.24 21.44 7.34 73.34 24.59 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 1 3 # 1 18 ARG A 166 ARG~? 11.02 O1 BME A 601 195 HIS A 66 HIS~? 3.42 MN MN A 604s 199 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 21.96 2.03 15.24 19.33 1.86 13.55 6.93 48.25 24.41 9.45 50.10 24.73 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 3.21 51.23 16.81 3.87 52.43 15.22 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 3cla_c00 TYPE III CHLORAMPHENICOL ACETYLTRANSuser 2 3 # 2 18 ARG B 166 ARG~? 12.22 S2 BME B 602 195 HIS B 66 HIS~? 3.43 MN MN B 607s 199 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 21.96 2.03 15.24 19.33 1.86 13.55 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 13.48 -0.87 14.56 14.47 -2.14 15.92 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 17.92 -0.05 18.55 18.90 -0.38 16.73 -15.81 81.35 4.53 -16.00 83.45 4.93 3cla_c00 source 3cla TYPE III CHLORAMPHENICOL ACETYLTRANSFERASE ( C: 2 hits 3cla_c00 naa= 3 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 1 3 # 1 A 202 HIS A 22 HIS~? -3.40 MN MN A 604s A 295 HIS A 67 HIS~? -4.40 CL CL A 608s A 296 HIS A 96 HIS~? -3.41 MN MN A 605s coo 65.34 65.04 50.22 63.95 63.70 51.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 63.46 53.34 50.98 63.08 55.39 51.17 0.35 54.22 20.29 -1.10 54.30 18.77 coo 64.71 54.80 47.28 63.92 56.57 48.06 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 2 3 # 2 A 202 HIS A 22 HIS~? -3.40 MN MN A 604s A 295 HIS A 96 HIS~? -3.41 MN MN A 605s A 296 HIS A 67 HIS~? -4.40 CL CL A 608s coo 65.34 65.04 50.22 63.95 63.70 51.06 3.18 53.06 10.64 3.66 54.63 11.95 coo 63.46 53.34 50.98 63.08 55.39 51.17 0.59 58.54 20.35 2.20 57.89 19.15 coo 64.71 54.80 47.28 63.92 56.57 48.06 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 3 3 # 3 A 202 HIS B 22 HIS~? -3.40 MN MN B 607s A 295 HIS B 67 HIS~? -4.45 CL CL B 609s A 296 HIS B 96 HIS~? -3.43 MN MN B 606s coo 65.34 65.04 50.22 63.95 63.70 51.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 63.46 53.34 50.98 63.08 55.39 51.17 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 64.71 54.80 47.28 63.92 56.57 48.06 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 4kbp_c00 PURPLE ACID PHOSPHATASE user 4 3 # 4 A 202 HIS B 22 HIS~? -3.40 MN MN B 607s A 295 HIS B 96 HIS~? -3.43 MN MN B 606s A 296 HIS B 67 HIS~? -4.45 CL CL B 609s coo 65.34 65.04 50.22 63.95 63.70 51.06 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 63.46 53.34 50.98 63.08 55.39 51.17 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 64.71 54.80 47.28 63.92 56.57 48.06 -13.16 78.27 11.53 -11.33 78.28 12.55 4kbp_c00 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c00 naa= 3 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 1 3 # 1 B 202 HIS A 22 HIS~? -3.40 MN MN A 604s B 295 HIS A 67 HIS~? -4.40 CL CL A 608s B 296 HIS A 96 HIS~? -3.41 MN MN A 605s coo 20.09 23.80 58.44 19.07 25.34 59.44 3.18 53.06 10.64 3.66 54.63 11.95 coo 19.00 35.58 58.05 18.83 33.61 58.74 0.35 54.22 20.29 -1.10 54.30 18.77 coo 22.88 34.01 57.66 22.04 32.37 58.63 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 2 3 # 2 B 202 HIS A 22 HIS~? -3.40 MN MN A 604s B 295 HIS A 96 HIS~? -3.41 MN MN A 605s B 296 HIS A 67 HIS~? -4.40 CL CL A 608s coo 20.09 23.80 58.44 19.07 25.34 59.44 3.18 53.06 10.64 3.66 54.63 11.95 coo 19.00 35.58 58.05 18.83 33.61 58.74 0.59 58.54 20.35 2.20 57.89 19.15 coo 22.88 34.01 57.66 22.04 32.37 58.63 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 3 3 # 3 B 202 HIS B 22 HIS~? -3.40 MN MN B 607s B 295 HIS B 67 HIS~? -4.45 CL CL B 609s B 296 HIS B 96 HIS~? -3.43 MN MN B 606s coo 20.09 23.80 58.44 19.07 25.34 59.44 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 19.00 35.58 58.05 18.83 33.61 58.74 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 22.88 34.01 57.66 22.04 32.37 58.63 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 4kbp_c01 PURPLE ACID PHOSPHATASE user 4 3 # 4 B 202 HIS B 22 HIS~? -3.40 MN MN B 607s B 295 HIS B 96 HIS~? -3.43 MN MN B 606s B 296 HIS B 67 HIS~? -4.45 CL CL B 609s coo 20.09 23.80 58.44 19.07 25.34 59.44 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 19.00 35.58 58.05 18.83 33.61 58.74 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 22.88 34.01 57.66 22.04 32.37 58.63 -13.16 78.27 11.53 -11.33 78.28 12.55 4kbp_c01 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c01 naa= 3 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 1 3 # 1 C 202 HIS A 22 HIS~? -3.40 MN MN A 604s C 295 HIS A 67 HIS~? -4.40 CL CL A 608s C 296 HIS A 96 HIS~? -3.41 MN MN A 605s coo 56.07 24.38 61.64 57.15 25.46 60.21 3.18 53.06 10.64 3.66 54.63 11.95 coo 57.19 35.56 57.82 57.34 33.47 57.88 0.35 54.22 20.29 -1.10 54.30 18.77 coo 53.24 34.19 58.78 54.08 32.31 58.44 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 2 3 # 2 C 202 HIS A 22 HIS~? -3.40 MN MN A 604s C 295 HIS A 96 HIS~? -3.41 MN MN A 605s C 296 HIS A 67 HIS~? -4.40 CL CL A 608s coo 56.07 24.38 61.64 57.15 25.46 60.21 3.18 53.06 10.64 3.66 54.63 11.95 coo 57.19 35.56 57.82 57.34 33.47 57.88 0.59 58.54 20.35 2.20 57.89 19.15 coo 53.24 34.19 58.78 54.08 32.31 58.44 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 3 3 # 3 C 202 HIS B 22 HIS~? -3.40 MN MN B 607s C 295 HIS B 67 HIS~? -4.45 CL CL B 609s C 296 HIS B 96 HIS~? -3.43 MN MN B 606s coo 56.07 24.38 61.64 57.15 25.46 60.21 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.19 35.56 57.82 57.34 33.47 57.88 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 53.24 34.19 58.78 54.08 32.31 58.44 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 4kbp_c02 PURPLE ACID PHOSPHATASE user 4 3 # 4 C 202 HIS B 22 HIS~? -3.40 MN MN B 607s C 295 HIS B 96 HIS~? -3.43 MN MN B 606s C 296 HIS B 67 HIS~? -4.45 CL CL B 609s coo 56.07 24.38 61.64 57.15 25.46 60.21 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 57.19 35.56 57.82 57.34 33.47 57.88 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 53.24 34.19 58.78 54.08 32.31 58.44 -13.16 78.27 11.53 -11.33 78.28 12.55 4kbp_c02 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c02 naa= 3 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 1 3 # 1 D 202 HIS A 22 HIS~? -3.40 MN MN A 604s D 295 HIS A 67 HIS~? -4.40 CL CL A 608s D 296 HIS A 96 HIS~? -3.41 MN MN A 605s coo 61.78 113.98 49.61 62.80 115.33 50.85 3.18 53.06 10.64 3.66 54.63 11.95 coo 63.27 125.61 50.94 63.59 123.54 51.16 0.35 54.22 20.29 -1.10 54.30 18.77 coo 63.24 124.12 46.99 63.79 122.40 48.02 0.59 58.54 20.35 2.20 57.89 19.15 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 2 3 # 2 D 202 HIS A 22 HIS~? -3.40 MN MN A 604s D 295 HIS A 96 HIS~? -3.41 MN MN A 605s D 296 HIS A 67 HIS~? -4.40 CL CL A 608s coo 61.78 113.98 49.61 62.80 115.33 50.85 3.18 53.06 10.64 3.66 54.63 11.95 coo 63.27 125.61 50.94 63.59 123.54 51.16 0.59 58.54 20.35 2.20 57.89 19.15 coo 63.24 124.12 46.99 63.79 122.40 48.02 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 3 3 # 3 D 202 HIS B 22 HIS~? -3.40 MN MN B 607s D 295 HIS B 67 HIS~? -4.45 CL CL B 609s D 296 HIS B 96 HIS~? -3.43 MN MN B 606s coo 61.78 113.98 49.61 62.80 115.33 50.85 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 63.27 125.61 50.94 63.59 123.54 51.16 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 63.24 124.12 46.99 63.79 122.40 48.02 -13.24 74.01 11.32 -12.76 74.71 9.40 ULMN 3 4kbp_c03 PURPLE ACID PHOSPHATASE user 4 3 # 4 D 202 HIS B 22 HIS~? -3.40 MN MN B 607s D 295 HIS B 96 HIS~? -3.43 MN MN B 606s D 296 HIS B 67 HIS~? -4.45 CL CL B 609s coo 61.78 113.98 49.61 62.80 115.33 50.85 -5.34 79.70 5.35 -6.67 78.07 5.35 coo 63.27 125.61 50.94 63.59 123.54 51.16 -13.24 74.01 11.32 -12.76 74.71 9.40 coo 63.24 124.12 46.99 63.79 122.40 48.02 -13.16 78.27 11.53 -11.33 78.28 12.55 4kbp_c03 source 4kbp PURPLE ACID PHOSPHATASE : 4 hits 4kbp_c03 naa= 3 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 A 158 ASP A 69 ASP~? 7.42 O1 BME A 601 A 161 ARG A 166 ARG~? 11.02 O1 BME A 601 A 186 HIS A 66 HIS~? 3.42 MN MN A 604s coo 18.62 26.83 58.17 18.48 28.64 57.08 7.88 51.22 19.98 7.64 49.14 20.25 coo 23.76 27.69 57.88 24.05 29.81 55.69 6.93 48.25 24.41 9.45 50.10 24.73 coo 16.67 31.22 54.64 18.74 31.15 54.14 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 4mdh_c02 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 A 158 ASP B 69 ASP~? 7.66 S2 BME B 602 A 161 ARG B 166 ARG~? 12.22 S2 BME B 602 A 186 HIS B 66 HIS~? 3.43 MN MN B 607s coo 18.62 26.83 58.17 18.48 28.64 57.08 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 23.76 27.69 57.88 24.05 29.81 55.69 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 16.67 31.22 54.64 18.74 31.15 54.14 -11.11 81.39 7.66 -9.84 80.27 6.41 4mdh_c02 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 2 hits 4mdh_c02 naa= 3 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 3 # 1 B 158 ASP A 69 ASP~? 7.42 O1 BME A 601 B 161 ARG A 166 ARG~? 11.02 O1 BME A 601 B 186 HIS A 66 HIS~? 3.42 MN MN A 604s coo 44.53 16.44 28.54 44.89 18.45 28.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 39.64 19.27 28.15 40.19 21.74 29.94 6.93 48.25 24.41 9.45 50.10 24.73 coo 48.32 20.00 31.44 46.45 20.91 31.50 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 3 # 2 B 158 ASP A 69 ASP~? 7.42 O1 BME A 601 B 161 ARG A 167 ARG~? -4.94 O1 BME A 601s B 186 HIS A 66 HIS~? 3.42 MN MN A 604s coo 44.53 16.44 28.54 44.89 18.45 28.77 7.88 51.22 19.98 7.64 49.14 20.25 coo 39.64 19.27 28.15 40.19 21.74 29.94 6.75 43.81 21.29 6.50 46.65 20.31 coo 48.32 20.00 31.44 46.45 20.91 31.50 3.21 51.23 16.81 3.87 52.43 15.22 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 3 # 3 B 158 ASP B 69 ASP~? 7.66 S2 BME B 602 B 161 ARG B 166 ARG~? 12.22 S2 BME B 602 B 186 HIS B 66 HIS~? 3.43 MN MN B 607s coo 44.53 16.44 28.54 44.89 18.45 28.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 39.64 19.27 28.15 40.19 21.74 29.94 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.11 81.39 7.66 -9.84 80.27 6.41 ULMN 3 4mdh_c03 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 3 # 4 B 158 ASP B 69 ASP~? 7.66 S2 BME B 602 B 161 ARG B 167 ARG~? 6.18 S2 BME B 602 B 186 HIS B 66 HIS~? 3.43 MN MN B 607s coo 44.53 16.44 28.54 44.89 18.45 28.77 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 39.64 19.27 28.15 40.19 21.74 29.94 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.11 81.39 7.66 -9.84 80.27 6.41 4mdh_c03 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c03 naa= 3 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 3 # 1 71 ARG A 94 ARG~? 6.60 C1 GOL B 603 127 ARG B 128 ARG~? 13.47 O1 GOL B 603 270 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.58 68.78 21.39 1.97 70.41 20.81 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 3 # 2 71 ARG A 94 ARG~? 6.60 C1 GOL B 603 127 ARG B 128 ARG~? 13.47 O1 GOL B 603 270 GLU B 123 GLU~? 13.36 O1 GOL B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 -0.58 68.78 21.39 1.97 70.41 20.81 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -3.66 71.26 23.11 -3.83 72.79 25.78 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 5.68 77.05 25.89 7.75 77.09 25.94 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 3 # 3 71 ARG A 128 ARG~? 18.10 CL CL A 608 127 ARG B 94 ARG~? 13.57 MN MN B 606 270 GLU A 109 GLU~? 22.92 CL CL A 608 coo -1.14 25.72 1.64 0.76 28.10 1.50 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.48 52.51 17.23 -21.47 52.95 17.83 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 4 3 # 4 71 ARG A 128 ARG~? 18.10 CL CL A 608 127 ARG B 94 ARG~? 13.57 MN MN B 606 270 GLU A 123 GLU~? 22.37 MN MN B 606 coo -1.14 25.72 1.64 0.76 28.10 1.50 -14.01 61.35 15.89 -16.27 59.78 17.30 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.99 55.60 8.30 -20.84 55.52 6.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 5 3 # 5 71 ARG A 166 ARG~? 11.02 O1 BME A 601 127 ARG A 167 ARG~? -4.94 O1 BME A 601s 270 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -1.14 25.72 1.64 0.76 28.10 1.50 6.93 48.25 24.41 9.45 50.10 24.73 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 6.75 43.81 21.29 6.50 46.65 20.31 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 6 3 # 6 71 ARG A 167 ARG~? -4.94 O1 BME A 601s 127 ARG A 166 ARG~? 11.02 O1 BME A 601 270 GLU A 161 GLU~? 18.40 O1 BME A 601 coo -1.14 25.72 1.64 0.76 28.10 1.50 6.75 43.81 21.29 6.50 46.65 20.31 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 6.93 48.25 24.41 9.45 50.10 24.73 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 19.17 45.23 21.71 20.94 45.20 22.85 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 7 3 # 7 71 ARG B 94 ARG~? 13.57 MN MN B 606 127 ARG A 128 ARG~? 18.10 CL CL A 608 270 GLU A 123 GLU~? 22.37 MN MN B 606 coo -1.14 25.72 1.64 0.76 28.10 1.50 -13.47 63.76 12.41 -13.96 62.24 9.77 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -14.01 61.35 15.89 -16.27 59.78 17.30 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -19.99 55.60 8.30 -20.84 55.52 6.39 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 8 3 # 8 71 ARG B 128 ARG~? 13.47 O1 GOL B 603 127 ARG A 94 ARG~? 6.60 C1 GOL B 603 270 GLU B 109 GLU~? 18.95 O1 GOL B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.58 68.78 21.39 1.97 70.41 20.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -2.95 80.34 28.65 -2.60 79.82 30.64 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 9 3 # 9 71 ARG B 128 ARG~? 13.47 O1 GOL B 603 127 ARG A 94 ARG~? 6.60 C1 GOL B 603 270 GLU B 123 GLU~? 13.36 O1 GOL B 603 coo -1.14 25.72 1.64 0.76 28.10 1.50 -3.66 71.26 23.11 -3.83 72.79 25.78 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -0.58 68.78 21.39 1.97 70.41 20.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 5.68 77.05 25.89 7.75 77.09 25.94 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 10 3 # 10 71 ARG B 166 ARG~? 12.22 S2 BME B 602 127 ARG B 167 ARG~? 6.18 S2 BME B 602 270 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -1.14 25.72 1.64 0.76 28.10 1.50 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -16.44 88.73 6.31 -15.58 85.88 6.16 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -21.45 87.83 -5.08 -22.54 87.54 -6.89 ULMN 3 5cpa_c01 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 11 3 # 11 71 ARG B 167 ARG~? 6.18 S2 BME B 602 127 ARG B 166 ARG~? 12.22 S2 BME B 602 270 GLU B 161 GLU~? 19.04 O1 BME B 602 coo -1.14 25.72 1.64 0.76 28.10 1.50 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -19.40 84.27 7.18 -20.75 82.43 4.97 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 -21.45 87.83 -5.08 -22.54 87.54 -6.89 5cpa_c01 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 11 hits 5cpa_c01 naa= 3 ULMN 3 5rsa_c01 RIBONUCLEASE A user 1 3 # 1 12 HIS A 67 HIS~? -4.40 CL CL A 608s 41 LYS A 24 LYS~? 4.08 C2 BME A 601 119 HIS A 136 HIS~? 3.48 MN MN A 605s coo 28.18 18.67 11.43 28.83 17.39 9.89 0.35 54.22 20.29 -1.10 54.30 18.77 coo 25.33 8.32 6.30 27.86 13.90 7.82 -0.91 46.54 9.97 2.66 42.32 12.44 coo 33.68 19.99 5.35 34.98 18.36 5.19 -0.57 59.60 14.33 0.78 59.36 15.93 ULMN 3 5rsa_c01 RIBONUCLEASE A user 2 3 # 2 12 HIS A 136 HIS~? 3.48 MN MN A 605s 41 LYS A 24 LYS~? 4.08 C2 BME A 601 119 HIS A 67 HIS~? -4.40 CL CL A 608s coo 28.18 18.67 11.43 28.83 17.39 9.89 -0.57 59.60 14.33 0.78 59.36 15.93 coo 25.33 8.32 6.30 27.86 13.90 7.82 -0.91 46.54 9.97 2.66 42.32 12.44 coo 33.68 19.99 5.35 34.98 18.36 5.19 0.35 54.22 20.29 -1.10 54.30 18.77 ULMN 3 5rsa_c01 RIBONUCLEASE A user 3 3 # 3 12 HIS B 67 HIS~? -4.45 CL CL B 609s 41 LYS B 24 LYS~? -3.00 C2 BME B 602s 119 HIS B 136 HIS~? 3.50 MN MN B 606s coo 28.18 18.67 11.43 28.83 17.39 9.89 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 25.33 8.32 6.30 27.86 13.90 7.82 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 33.68 19.99 5.35 34.98 18.36 5.19 -7.23 73.04 10.16 -9.24 73.26 9.58 ULMN 3 5rsa_c01 RIBONUCLEASE A user 4 3 # 4 12 HIS B 136 HIS~? 3.50 MN MN B 606s 41 LYS B 24 LYS~? -3.00 C2 BME B 602s 119 HIS B 67 HIS~? -4.45 CL CL B 609s coo 28.18 18.67 11.43 28.83 17.39 9.89 -7.23 73.04 10.16 -9.24 73.26 9.58 coo 25.33 8.32 6.30 27.86 13.90 7.82 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 33.68 19.99 5.35 34.98 18.36 5.19 -13.16 78.27 11.53 -11.33 78.28 12.55 5rsa_c01 source 5rsa RIBONUCLEASE A : 4 hits 5rsa_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 42 ASN~? 28.57 S2 BME A 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 -23.24 41.26 4.00 -22.40 41.46 2.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 45 ASN~? 26.07 S2 BME A 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 -22.70 37.87 8.15 -21.07 38.55 6.95 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 73 ASN~? 13.47 MN MN A 605 coo 5.80 63.03 55.85 5.52 65.03 56.45 12.56 53.31 22.50 12.18 52.20 24.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 102 ASN~? 12.24 CL CL A 608 coo 5.80 63.03 55.85 5.52 65.03 56.45 -10.29 57.70 17.47 -10.13 59.75 17.06 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 117 ASN.? 27.48 C1 BME A 601 coo 5.80 63.03 55.85 5.52 65.03 56.45 -26.22 40.51 14.77 -24.81 39.30 15.85 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN A 148 ASN~? 13.72 MN MN A 604 coo 5.80 63.03 55.85 5.52 65.03 56.45 16.41 56.02 8.06 15.52 54.12 8.34 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 42 ASN~? 23.97 O1 GOL B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 10.75 91.50 27.13 12.28 91.20 25.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 45 ASN~? 25.33 O1 GOL B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 6.71 94.93 28.03 7.25 94.18 26.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 -12.53 86.72 19.85 -11.70 86.05 21.72 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 73 ASN~? 13.50 MN MN B 606 coo 5.80 63.03 55.85 5.52 65.03 56.45 -19.90 79.31 1.05 -21.42 80.32 2.14 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 102 ASN~? 10.95 O1 GOL B 603 coo 5.80 63.03 55.85 5.52 65.03 56.45 -6.42 74.86 20.35 -6.05 72.80 20.02 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 13 1 # 13 A 461 ASN B 117 ASN.? 27.09 C1 BME B 602 coo 5.80 63.03 55.85 5.52 65.03 56.45 1.79 92.43 33.70 0.32 93.69 32.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 14 1 # 14 A 461 ASN B 148 ASN~? 13.72 MN MN B 607 coo 5.80 63.03 55.85 5.52 65.03 56.45 -7.72 77.03 -8.08 -7.79 78.86 -6.95 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 14 hits 1kbk_p00 naa= 1 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 38 TYR~? 24.60 S2 BME A 601 A 108 ASN A 117 ASN.? 27.48 C1 BME A 601 A 135 ASN A 45 ASN~? 26.07 S2 BME A 601 coo 17.59 4.66 17.88 15.38 5.96 18.97 -19.15 43.63 4.59 -19.32 40.84 4.29 coo 12.36 16.24 15.27 12.06 14.29 16.05 -26.22 40.51 14.77 -24.81 39.30 15.85 coo 18.05 11.56 12.71 17.57 10.75 14.60 -22.70 37.87 8.15 -21.07 38.55 6.95 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 119 TYR.? 27.19 CL CL A 608 A 108 ASN A 45 ASN~? 26.07 S2 BME A 601 A 135 ASN A 117 ASN.? 27.48 C1 BME A 601 coo 17.59 4.66 17.88 15.38 5.96 18.97 -25.91 48.64 16.91 -24.81 51.15 17.51 coo 12.36 16.24 15.27 12.06 14.29 16.05 -22.70 37.87 8.15 -21.07 38.55 6.95 coo 18.05 11.56 12.71 17.57 10.75 14.60 -26.22 40.51 14.77 -24.81 39.30 15.85 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR B 38 TYR~? 21.27 O1 GOL B 603 A 108 ASN B 117 ASN.? 27.09 C1 BME B 602 A 135 ASN B 45 ASN~? 25.33 O1 GOL B 603 coo 17.59 4.66 17.88 15.38 5.96 18.97 8.78 89.03 23.51 9.07 91.81 23.56 coo 12.36 16.24 15.27 12.06 14.29 16.05 1.79 92.43 33.70 0.32 93.69 32.69 coo 18.05 11.56 12.71 17.57 10.75 14.60 6.71 94.93 28.03 7.25 94.18 26.08 ULMN 3 1uy2_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 119 TYR.? 22.89 O1 GOL B 603 A 108 ASN B 45 ASN~? 25.33 O1 GOL B 603 A 135 ASN B 117 ASN.? 27.09 C1 BME B 602 coo 17.59 4.66 17.88 15.38 5.96 18.97 -0.36 84.32 34.43 -1.33 81.81 33.61 coo 12.36 16.24 15.27 12.06 14.29 16.05 6.71 94.93 28.03 7.25 94.18 26.08 coo 18.05 11.56 12.71 17.57 10.75 14.60 1.79 92.43 33.70 0.32 93.69 32.69 1uy2_p00 source 1uy2 ENDO-1,4-BETA-XYLANASE A : 4 hits 1uy2_p00 naa= 3 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 1 3 # 1 A 51 TYR A 38 TYR~? 24.60 S2 BME A 601 A 108 ASN A 117 ASN.? 27.48 C1 BME A 601 A 135 ASN A 45 ASN~? 26.07 S2 BME A 601 coo 17.50 4.57 17.85 15.28 5.88 18.97 -19.15 43.63 4.59 -19.32 40.84 4.29 coo 12.22 15.98 15.24 11.94 14.05 16.09 -26.22 40.51 14.77 -24.81 39.30 15.85 coo 17.94 11.43 12.65 17.42 10.61 14.53 -22.70 37.87 8.15 -21.07 38.55 6.95 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 2 3 # 2 A 51 TYR A 119 TYR.? 27.19 CL CL A 608 A 108 ASN A 45 ASN~? 26.07 S2 BME A 601 A 135 ASN A 117 ASN.? 27.48 C1 BME A 601 coo 17.50 4.57 17.85 15.28 5.88 18.97 -25.91 48.64 16.91 -24.81 51.15 17.51 coo 12.22 15.98 15.24 11.94 14.05 16.09 -22.70 37.87 8.15 -21.07 38.55 6.95 coo 17.94 11.43 12.65 17.42 10.61 14.53 -26.22 40.51 14.77 -24.81 39.30 15.85 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 3 3 # 3 A 51 TYR B 38 TYR~? 21.27 O1 GOL B 603 A 108 ASN B 117 ASN.? 27.09 C1 BME B 602 A 135 ASN B 45 ASN~? 25.33 O1 GOL B 603 coo 17.50 4.57 17.85 15.28 5.88 18.97 8.78 89.03 23.51 9.07 91.81 23.56 coo 12.22 15.98 15.24 11.94 14.05 16.09 1.79 92.43 33.70 0.32 93.69 32.69 coo 17.94 11.43 12.65 17.42 10.61 14.53 6.71 94.93 28.03 7.25 94.18 26.08 ULMN 3 1uy4_p00 ENDO-1,4-BETA-XYLANASE A user 4 3 # 4 A 51 TYR B 119 TYR.? 22.89 O1 GOL B 603 A 108 ASN B 45 ASN~? 25.33 O1 GOL B 603 A 135 ASN B 117 ASN.? 27.09 C1 BME B 602 coo 17.50 4.57 17.85 15.28 5.88 18.97 -0.36 84.32 34.43 -1.33 81.81 33.61 coo 12.22 15.98 15.24 11.94 14.05 16.09 6.71 94.93 28.03 7.25 94.18 26.08 coo 17.94 11.43 12.65 17.42 10.61 14.53 1.79 92.43 33.70 0.32 93.69 32.69 1uy4_p00 source 1uy4 ENDO-1,4-BETA-XYLANASE A : 4 hits 1uy4_p00 naa= 3 ULMN 4 2cl8_p00 DECTIN-1 user 1 4 # 1 A 145 ARG A 94 ARG~? 6.60 C1 GOL B 603 A 148 SER A 88 SER~? 4.20 C3 GOL B 603 A 152 ALA A 85 ALA~? 9.47 C3 GOL B 603 A 194 GLU A 140 GLU~? -2.42 MN MN A 605s coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -0.58 68.78 21.39 1.97 70.41 20.81 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 6.33 67.41 15.47 7.25 67.93 13.23 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 11.62 67.36 15.14 11.92 65.86 14.96 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 5.06 58.75 13.41 3.74 57.63 14.59 ULMN 4 2cl8_p00 DECTIN-1 user 2 4 # 2 A 145 ARG B 94 ARG~? 13.57 MN MN B 606 A 148 SER B 88 SER~? 11.77 MN MN B 606 A 152 ALA B 85 ALA~? 12.60 MN MN B 606 A 194 GLU B 140 GLU~? -2.41 MN MN B 606s coo -29.52 -1.51 -10.80 -29.25 -1.07 -13.87 -13.47 63.76 12.41 -13.96 62.24 9.77 coo -35.30 0.90 -4.91 -36.19 -1.20 -5.57 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -37.81 4.22 -2.30 -36.99 5.43 -2.37 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo -43.25 5.44 -9.45 -44.36 4.89 -7.68 -8.44 74.11 4.59 -9.08 75.11 6.26 2cl8_p00 source 2cl8 DECTIN-1 : 2 hits 2cl8_p00 naa= 4 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 1 3 # 1 A 459 ASN A 42 ASN~? 28.57 S2 BME A 601 A 460 GLY A 43 GLY~? 29.48 S2 BME A 601 A 461 ASN A 45 ASN~? 26.07 S2 BME A 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 -23.24 41.26 4.00 -22.40 41.46 2.08 coo 19.48 94.04 5.03 19.26 94.00 5.78 -25.70 42.22 7.68 -24.92 42.27 7.40 coo 20.23 95.69 9.16 21.55 97.37 9.20 -22.70 37.87 8.15 -21.07 38.55 6.95 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 2 3 # 2 A 459 ASN A 45 ASN~? 26.07 S2 BME A 601 A 460 GLY A 43 GLY~? 29.48 S2 BME A 601 A 461 ASN A 42 ASN~? 28.57 S2 BME A 601 coo 15.00 94.38 6.97 13.00 93.59 6.99 -22.70 37.87 8.15 -21.07 38.55 6.95 coo 19.48 94.04 5.03 19.26 94.00 5.78 -25.70 42.22 7.68 -24.92 42.27 7.40 coo 20.23 95.69 9.16 21.55 97.37 9.20 -23.24 41.26 4.00 -22.40 41.46 2.08 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 3 3 # 3 A 459 ASN B 42 ASN~? 23.97 O1 GOL B 603 A 460 GLY B 43 GLY~? 25.26 O1 GOL B 603 A 461 ASN B 45 ASN~? 25.33 O1 GOL B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 10.75 91.50 27.13 12.28 91.20 25.69 coo 19.48 94.04 5.03 19.26 94.00 5.78 8.19 90.64 30.80 8.19 90.56 29.96 coo 20.23 95.69 9.16 21.55 97.37 9.20 6.71 94.93 28.03 7.25 94.18 26.08 ULMN 3 2qv4_p00 PANCREATIC ALPHA-AMYLASE user 4 3 # 4 A 459 ASN B 45 ASN~? 25.33 O1 GOL B 603 A 460 GLY B 43 GLY~? 25.26 O1 GOL B 603 A 461 ASN B 42 ASN~? 23.97 O1 GOL B 603 coo 15.00 94.38 6.97 13.00 93.59 6.99 6.71 94.93 28.03 7.25 94.18 26.08 coo 19.48 94.04 5.03 19.26 94.00 5.78 8.19 90.64 30.80 8.19 90.56 29.96 coo 20.23 95.69 9.16 21.55 97.37 9.20 10.75 91.50 27.13 12.28 91.20 25.69 2qv4_p00 source 2qv4 PANCREATIC ALPHA-AMYLASE : 4 hits 2qv4_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 102 ASN~? 12.24 CL CL A 608 A 384 ASN A 73 ASN~? 13.47 MN MN A 605 A 385 GLU A 72 GLU~? 12.86 MN MN A 605 coo 22.28 63.17 110.61 22.47 65.06 111.53 -10.29 57.70 17.47 -10.13 59.75 17.06 coo 7.06 50.07 96.17 8.50 48.54 96.31 12.56 53.31 22.50 12.18 52.20 24.34 coo 11.59 49.83 99.41 10.92 47.97 100.16 8.16 54.29 26.80 8.10 55.96 28.07 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN B 102 ASN~? 10.95 O1 GOL B 603 A 384 ASN B 73 ASN~? 13.50 MN MN B 606 A 385 GLU B 72 GLU~? 13.02 MN MN B 606 coo 22.28 63.17 110.61 22.47 65.06 111.53 -6.42 74.86 20.35 -6.05 72.80 20.02 coo 7.06 50.07 96.17 8.50 48.54 96.31 -19.90 79.31 1.05 -21.42 80.32 2.14 coo 11.59 49.83 99.41 10.92 47.97 100.16 -22.12 78.07 6.79 -23.41 76.46 7.29 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 2 hits 2v3r_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 133 TYR~? 5.56 CL CL A 608 I 306 VAL A 130 VAL~? 12.96 CL CL A 608 I 308 VAL A 32 VAL~? 15.69 CL CL A 608 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 23.55 29.53 9.81 23.15 27.39 10.24 -9.61 56.01 10.01 -10.45 54.86 8.31 coo 16.43 30.18 9.35 15.05 30.67 11.01 -12.88 49.71 9.41 -12.38 50.65 11.33 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR B 133 TYR~? 5.56 CL CL B 609 I 306 VAL B 130 VAL~? 6.17 O1 GOL B 603 I 308 VAL B 32 VAL~? 11.94 O1 GOL B 603 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 23.55 29.53 9.81 23.15 27.39 10.24 0.20 76.65 16.87 2.04 77.86 16.88 coo 16.43 30.18 9.35 15.05 30.67 11.01 1.98 82.91 19.59 0.02 82.04 19.86 1cqt_d00 source 1cqt GENE REGULATION/DNA : 2 hits 1cqt_d00 naa= 3 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 1 3 # 1 C 70 ARG A 26 ARG~? 9.60 MN MN A 604 C 71 LYS A 24 LYS~? 4.08 C2 BME A 601 C 72 VAL A 25 VAL~? 7.08 CL CL A 608 coo 23.89 33.54 29.21 26.59 34.86 28.68 -0.69 52.60 5.29 -0.15 55.65 5.60 coo 25.82 26.89 29.68 23.33 22.98 25.84 -0.91 46.54 9.97 2.66 42.32 12.44 coo 28.86 29.08 30.37 28.04 31.02 29.93 -2.56 49.80 11.08 -1.99 51.53 12.27 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 2 3 # 2 C 70 ARG A 27 ARG~? 11.42 S2 BME A 601 C 71 LYS A 24 LYS~? 4.08 C2 BME A 601 C 72 VAL A 25 VAL~? 7.08 CL CL A 608 coo 23.89 33.54 29.21 26.59 34.86 28.68 -3.68 43.51 6.20 -5.32 41.74 8.07 coo 25.82 26.89 29.68 23.33 22.98 25.84 -0.91 46.54 9.97 2.66 42.32 12.44 coo 28.86 29.08 30.37 28.04 31.02 29.93 -2.56 49.80 11.08 -1.99 51.53 12.27 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 3 3 # 3 C 70 ARG B 26 ARG~? 8.42 O2 GOL B 603 C 71 LYS B 24 LYS~? -3.00 C2 BME B 602s C 72 VAL B 25 VAL~? 7.14 CL CL B 609 coo 23.89 33.54 29.21 26.59 34.86 28.68 1.24 79.80 7.27 0.69 76.71 7.21 coo 25.82 26.89 29.68 23.33 22.98 25.84 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 28.86 29.08 30.37 28.04 31.02 29.93 -3.49 82.90 10.78 -4.85 81.17 10.78 ULMN 3 1hwt_d00 GENE REGULATION/DNA user 4 3 # 4 C 70 ARG B 27 ARG~? 11.60 C2 BME B 602 C 71 LYS B 24 LYS~? -3.00 C2 BME B 602s C 72 VAL B 25 VAL~? 7.14 CL CL B 609 coo 23.89 33.54 29.21 26.59 34.86 28.68 1.97 89.27 10.36 0.81 91.17 12.49 coo 25.82 26.89 29.68 23.33 22.98 25.84 -3.23 86.22 8.94 -7.29 90.78 7.55 coo 28.86 29.08 30.37 28.04 31.02 29.93 -3.49 82.90 10.78 -4.85 81.17 10.78 1hwt_d00 source 1hwt GENE REGULATION/DNA : 4 hits 1hwt_d00 naa= 3 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 458 GLU A 123 GLU~? 22.37 MN MN B 606 A 461 LYS A 127 LYS~? 18.61 MN MN B 606 A 462 ALA A 125 ALA~? 18.76 CL CL A 608 A 466 ARG A 128 ARG~? 18.10 CL CL A 608 coo 36.22 34.04 93.46 35.20 35.01 95.03 -19.99 55.60 8.30 -20.84 55.52 6.39 coo 29.92 31.01 94.11 31.45 36.50 96.08 -14.62 57.47 9.74 -19.33 59.04 5.94 coo 28.62 33.12 91.21 29.52 33.84 90.21 -16.97 56.66 14.75 -17.54 55.68 15.76 coo 25.27 34.07 87.35 27.76 35.81 87.05 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 4 1lat_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 458 GLU B 123 GLU~? 13.36 O1 GOL B 603 A 461 LYS B 127 LYS~? 11.03 O1 GOL B 603 A 462 ALA B 125 ALA~? 14.10 O1 GOL B 603 A 466 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 36.22 34.04 93.46 35.20 35.01 95.03 5.68 77.05 25.89 7.75 77.09 25.94 coo 29.92 31.01 94.11 31.45 36.50 96.08 2.32 75.24 21.44 7.34 73.34 24.59 coo 28.62 33.12 91.21 29.52 33.84 90.21 -1.46 75.97 25.50 -2.22 76.93 26.41 coo 25.27 34.07 87.35 27.76 35.81 87.05 -3.66 71.26 23.11 -3.83 72.79 25.78 1lat_d00 source 1lat TRANSCRIPTION/DNA : 2 hits 1lat_d00 naa= 4 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 1 3 # 1 A 40 LYS A 153 LYS~? 20.22 C2 BME A 601 A 41 LYS A 155 LYS~? 22.50 MN MN A 604 A 42 ILE A 151 ILE~? 15.53 MN MN A 604 coo 36.07 63.73 124.22 32.72 60.75 122.39 23.06 52.60 13.46 22.53 47.10 11.88 coo 38.49 66.12 125.64 35.69 66.71 131.25 21.85 53.55 18.73 24.16 56.83 22.72 coo 41.08 63.27 123.17 40.13 62.43 122.44 19.13 57.58 14.74 18.08 57.35 15.69 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 2 3 # 2 A 40 LYS A 155 LYS~? 22.50 MN MN A 604 A 41 LYS A 153 LYS~? 20.22 C2 BME A 601 A 42 ILE A 151 ILE~? 15.53 MN MN A 604 coo 36.07 63.73 124.22 32.72 60.75 122.39 21.85 53.55 18.73 24.16 56.83 22.72 coo 38.49 66.12 125.64 35.69 66.71 131.25 23.06 52.60 13.46 22.53 47.10 11.88 coo 41.08 63.27 123.17 40.13 62.43 122.44 19.13 57.58 14.74 18.08 57.35 15.69 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 3 3 # 3 A 40 LYS B 153 LYS~? 21.64 S2 BME B 602 A 41 LYS B 155 LYS~? 22.59 MN MN B 607 A 42 ILE B 151 ILE~? 15.56 MN MN B 607 coo 36.07 63.73 124.22 32.72 60.75 122.39 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 38.49 66.12 125.64 35.69 66.71 131.25 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 41.08 63.27 123.17 40.13 62.43 122.44 -14.92 75.27 -8.03 -15.39 75.48 -6.71 ULMN 3 1pyi_d00 PROTEIN (PYRIMIDINE PATHWAY REGULATOuser 4 3 # 4 A 40 LYS B 155 LYS~? 22.59 MN MN B 607 A 41 LYS B 153 LYS~? 21.64 S2 BME B 602 A 42 ILE B 151 ILE~? 15.56 MN MN B 607 coo 36.07 63.73 124.22 32.72 60.75 122.39 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 38.49 66.12 125.64 35.69 66.71 131.25 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 41.08 63.27 123.17 40.13 62.43 122.44 -14.92 75.27 -8.03 -15.39 75.48 -6.71 1pyi_d00 source 1pyi PROTEIN (PYRIMIDINE PATHWAY REGULATOR 1) : 4 hits 1pyi_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 24 LYS~? 4.08 C2 BME A 601 A 564 VAL A 25 VAL~? 7.08 CL CL A 608 A 568 ARG A 26 ARG~? 9.60 MN MN A 604 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -0.91 46.54 9.97 2.66 42.32 12.44 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -2.56 49.80 11.08 -1.99 51.53 12.27 coo -12.31 74.86 52.32 -13.99 74.91 54.92 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS B 24 LYS~? -3.00 C2 BME B 602s A 564 VAL B 25 VAL~? 7.14 CL CL B 609 A 568 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo -6.60 80.79 55.64 -8.55 79.48 61.01 -3.23 86.22 8.94 -7.29 90.78 7.55 coo -9.25 78.14 55.31 -11.11 77.94 56.39 -3.49 82.90 10.78 -4.85 81.17 10.78 coo -12.31 74.86 52.32 -13.99 74.91 54.92 1.24 79.80 7.27 0.69 76.71 7.21 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 2 hits 1r4i_d00 naa= 3 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 131 ALA~? 14.03 CL CL A 608 A 87 GLU B 91 GLU~? 11.42 MN MN B 606 A 123 TYR A 133 TYR~? 5.56 CL CL A 608 A 182 ARG A 128 ARG~? 18.10 CL CL A 608 coo 33.66 63.14 16.62 34.95 63.46 15.91 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 28.97 64.99 12.92 27.92 64.06 11.28 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 38.40 63.73 13.00 38.79 62.53 10.47 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 29.35 67.59 19.60 30.93 68.47 17.09 -14.01 61.35 15.89 -16.27 59.78 17.30 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA A 131 ALA~? 14.03 CL CL A 608 A 87 GLU B 91 GLU~? 11.42 MN MN B 606 A 123 TYR A 133 TYR~? 5.56 CL CL A 608 A 182 ARG B 94 ARG~? 13.57 MN MN B 606 coo 33.66 63.14 16.62 34.95 63.46 15.91 -9.04 59.66 9.42 -10.10 60.80 9.30 coo 28.97 64.99 12.92 27.92 64.06 11.28 -9.23 65.09 9.44 -9.52 64.33 11.38 coo 38.40 63.73 13.00 38.79 62.53 10.47 -4.49 55.31 12.95 -3.78 54.23 15.43 coo 29.35 67.59 19.60 30.93 68.47 17.09 -13.47 63.76 12.41 -13.96 62.24 9.77 ULMN 4 2bgw_d00 HYDROLASE user 3 4 # 3 A 86 ALA B 131 ALA~? -3.51 O1 GOL B 603s A 87 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 123 TYR B 133 TYR~? 5.56 CL CL B 609 A 182 ARG A 94 ARG~? 6.60 C1 GOL B 603 coo 33.66 63.14 16.62 34.95 63.46 15.91 0.55 72.95 16.09 1.01 71.82 17.02 coo 28.97 64.99 12.92 27.92 64.06 11.28 0.70 67.61 16.19 -1.02 68.27 17.25 coo 38.40 63.73 13.00 38.79 62.53 10.47 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 29.35 67.59 19.60 30.93 68.47 17.09 -0.58 68.78 21.39 1.97 70.41 20.81 ULMN 4 2bgw_d00 HYDROLASE user 4 4 # 4 A 86 ALA B 131 ALA~? -3.51 O1 GOL B 603s A 87 GLU A 91 GLU~? 5.92 C1 GOL B 603 A 123 TYR B 133 TYR~? 5.56 CL CL B 609 A 182 ARG B 128 ARG~? 13.47 O1 GOL B 603 coo 33.66 63.14 16.62 34.95 63.46 15.91 0.55 72.95 16.09 1.01 71.82 17.02 coo 28.97 64.99 12.92 27.92 64.06 11.28 0.70 67.61 16.19 -1.02 68.27 17.25 coo 38.40 63.73 13.00 38.79 62.53 10.47 -4.49 77.34 13.29 -7.09 78.39 13.51 coo 29.35 67.59 19.60 30.93 68.47 17.09 -3.66 71.26 23.11 -3.83 72.79 25.78 2bgw_d00 source 2bgw HYDROLASE : 4 hits 2bgw_d00 naa= 4 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 B 122 ARG A 166 ARG~? 11.02 O1 BME A 601 B 148 LYS A 153 LYS~? 20.22 C2 BME A 601 B 151 LEU A 156 LEU~? 15.16 MN MN A 604 B 154 ILE A 15 ILE~? 10.71 MN MN A 604 coo 13.00 32.05 60.31 16.02 31.73 59.80 6.93 48.25 24.41 9.45 50.10 24.73 coo 11.05 44.13 44.68 12.77 44.45 49.56 23.06 52.60 13.46 22.53 47.10 11.88 coo 11.72 38.91 44.77 13.11 39.67 46.23 18.80 52.13 15.15 17.87 53.81 14.10 coo 7.03 36.97 46.99 7.83 37.90 47.52 13.30 52.76 11.49 13.60 54.20 11.36 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 B 122 ARG A 167 ARG~? -4.94 O1 BME A 601s B 148 LYS A 153 LYS~? 20.22 C2 BME A 601 B 151 LEU A 156 LEU~? 15.16 MN MN A 604 B 154 ILE A 15 ILE~? 10.71 MN MN A 604 coo 13.00 32.05 60.31 16.02 31.73 59.80 6.75 43.81 21.29 6.50 46.65 20.31 coo 11.05 44.13 44.68 12.77 44.45 49.56 23.06 52.60 13.46 22.53 47.10 11.88 coo 11.72 38.91 44.77 13.11 39.67 46.23 18.80 52.13 15.15 17.87 53.81 14.10 coo 7.03 36.97 46.99 7.83 37.90 47.52 13.30 52.76 11.49 13.60 54.20 11.36 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 3 4 # 3 B 122 ARG B 166 ARG~? 12.22 S2 BME B 602 B 148 LYS B 153 LYS~? 21.64 S2 BME B 602 B 151 LEU B 156 LEU~? 15.23 MN MN B 607 B 154 ILE B 15 ILE~? 10.80 MN MN B 607 coo 13.00 32.05 60.31 16.02 31.73 59.80 -19.40 84.27 7.18 -20.75 82.43 4.97 coo 11.05 44.13 44.68 12.77 44.45 49.56 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 11.72 38.91 44.77 13.11 39.67 46.23 -15.37 80.75 -7.44 -13.99 79.12 -7.06 coo 7.03 36.97 46.99 7.83 37.90 47.52 -9.96 80.21 -3.74 -9.87 78.81 -4.13 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 4 4 # 4 B 122 ARG B 167 ARG~? 6.18 S2 BME B 602 B 148 LYS B 153 LYS~? 21.64 S2 BME B 602 B 151 LEU B 156 LEU~? 15.23 MN MN B 607 B 154 ILE B 15 ILE~? 10.80 MN MN B 607 coo 13.00 32.05 60.31 16.02 31.73 59.80 -16.44 88.73 6.31 -15.58 85.88 6.16 coo 11.05 44.13 44.68 12.77 44.45 49.56 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 11.72 38.91 44.77 13.11 39.67 46.23 -15.37 80.75 -7.44 -13.99 79.12 -7.06 coo 7.03 36.97 46.99 7.83 37.90 47.52 -9.96 80.21 -3.74 -9.87 78.81 -4.13 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 5 4 # 5 B 122 ARG B 168 ARG.? 14.32 O1 BME B 602 B 148 LYS B 153 LYS~? 21.64 S2 BME B 602 B 151 LEU B 156 LEU~? 15.23 MN MN B 607 B 154 ILE B 159 ILE~? 13.94 MN MN B 607 coo 13.00 32.05 60.31 16.02 31.73 59.80 -21.58 94.57 3.17 -23.33 92.58 1.57 coo 11.05 44.13 44.68 12.77 44.45 49.56 -15.29 80.48 -11.91 -17.46 85.09 -12.54 coo 11.72 38.91 44.77 13.11 39.67 46.23 -15.37 80.75 -7.44 -13.99 79.12 -7.06 coo 7.03 36.97 46.99 7.83 37.90 47.52 -19.35 80.72 -2.60 -18.70 79.54 -2.68 ULMN 4 3odc_d00 DNA BINDING PROTEIN/DNA user 6 4 # 6 B 122 ARG B 168 ARG.? 14.32 O1 BME B 602 B 148 LYS B 155 LYS~? 22.59 MN MN B 607 B 151 LEU B 156 LEU~? 15.23 MN MN B 607 B 154 ILE B 159 ILE~? 13.94 MN MN B 607 coo 13.00 32.05 60.31 16.02 31.73 59.80 -21.58 94.57 3.17 -23.33 92.58 1.57 coo 11.05 44.13 44.68 12.77 44.45 49.56 -19.72 79.32 -9.05 -24.26 76.03 -9.81 coo 11.72 38.91 44.77 13.11 39.67 46.23 -15.37 80.75 -7.44 -13.99 79.12 -7.06 coo 7.03 36.97 46.99 7.83 37.90 47.52 -19.35 80.72 -2.60 -18.70 79.54 -2.68 3odc_d00 source 3odc DNA BINDING PROTEIN/DNA : 6 hits 3odc_d00 naa= 4 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 1 3 # 1 A 101 VAL A 32 VAL~? 15.69 CL CL A 608 A 102 PHE A 126 PHE~? 19.53 CL CL A 608 A 169 CYH A 44 CYH.? 25.03 C1 BME A 601 coo -0.48 2.03 12.21 0.64 0.32 12.97 -12.88 49.71 9.41 -12.38 50.65 11.33 coo 0.51 5.20 15.97 0.26 4.09 18.50 -16.94 52.44 11.80 -18.31 50.33 13.01 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -23.50 41.83 10.75 -22.38 42.24 13.24 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 2 3 # 2 A 101 VAL A 106 VAL~? 15.91 CL CL A 608 A 102 PHE A 110 PHE~? 17.56 S2 BME A 601 A 169 CYH A 29 CYH~? 9.71 CL CL A 608 coo -0.48 2.03 12.21 0.64 0.32 12.97 -14.92 52.25 17.67 -13.69 51.99 15.85 coo 0.51 5.20 15.97 0.26 4.09 18.50 -15.74 46.87 16.94 -14.14 47.51 14.73 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 -8.10 50.91 9.05 -6.68 52.72 10.63 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 3 3 # 3 A 101 VAL B 32 VAL~? 11.94 O1 GOL B 603 A 102 PHE B 126 PHE~? 14.41 O1 GOL B 603 A 169 CYH B 44 CYH.? 24.08 O1 GOL B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 1.98 82.91 19.59 0.02 82.04 19.86 coo 0.51 5.20 15.97 0.26 4.09 18.50 1.23 80.23 24.35 0.63 82.37 26.02 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 4.59 91.00 29.83 1.85 90.60 29.68 ULMN 3 3s57_d00 OXIDOREDUCTASE/DNA user 4 3 # 4 A 101 VAL B 106 VAL~? 14.82 O1 GOL B 603 A 102 PHE B 110 PHE~? 17.53 S2 BME B 602 A 169 CYH B 29 CYH~? 9.17 O1 GOL B 603 coo -0.48 2.03 12.21 0.64 0.32 12.97 -4.98 80.48 24.70 -3.71 80.64 22.91 coo 0.51 5.20 15.97 0.26 4.09 18.50 -4.01 85.90 25.00 -2.51 85.14 22.70 coo 4.56 -7.03 18.26 5.32 -4.76 16.88 0.50 81.71 15.06 -1.49 79.86 14.33 3s57_d00 source 3s57 OXIDOREDUCTASE/DNA : 4 hits 3s57_d00 naa= 3 ULMN 5 3sm4_d00 HYDROLASE/DNA user 1 5 # 1 B 53 MET A 17 MET?? 7.51 C2 BME A 601 B 73 VAL A 89 VAL~? 8.68 C3 GOL B 603 B 75 ALA A 85 ALA~? 9.47 C3 GOL B 603 B 77 ALA A 82 ALA~? 13.80 O2 GOL B 603 B 78 LEU A 79 LEU~? 12.68 C1 GOL B 603 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 9.57 47.38 12.49 9.88 44.07 13.11 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 7.06 64.88 18.21 8.73 63.81 19.10 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 11.62 67.36 15.14 11.92 65.86 14.96 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 17.31 65.77 15.13 16.53 64.91 14.16 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 14.41 64.63 20.29 12.39 65.35 19.91 ULMN 5 3sm4_d00 HYDROLASE/DNA user 2 5 # 2 B 53 MET A 163 MET?? 10.74 MN MN A 604 B 73 VAL A 89 VAL~? 8.68 C3 GOL B 603 B 75 ALA A 85 ALA~? 9.47 C3 GOL B 603 B 77 ALA A 82 ALA~? 13.80 O2 GOL B 603 B 78 LEU A 79 LEU~? 12.68 C1 GOL B 603 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 11.40 47.04 21.86 11.83 50.09 18.92 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 7.06 64.88 18.21 8.73 63.81 19.10 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 11.62 67.36 15.14 11.92 65.86 14.96 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 17.31 65.77 15.13 16.53 64.91 14.16 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 14.41 64.63 20.29 12.39 65.35 19.91 ULMN 5 3sm4_d00 HYDROLASE/DNA user 3 5 # 3 B 53 MET B 17 MET?? 9.16 S2 BME B 602 B 73 VAL B 89 VAL~? 9.02 MN MN B 606 B 75 ALA B 85 ALA~? 12.60 MN MN B 606 B 77 ALA B 82 ALA~? 16.27 MN MN B 606 B 78 LEU B 79 LEU~? 13.82 MN MN B 606 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 -9.95 85.51 0.33 -14.29 86.95 -0.32 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 -13.47 67.92 4.34 -14.99 68.90 3.08 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 -14.32 67.41 -6.56 -13.20 68.41 -6.29 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 -18.16 68.12 -1.74 -17.03 67.35 -0.14 ULMN 5 3sm4_d00 HYDROLASE/DNA user 4 5 # 4 B 53 MET B 163 MET?? 10.64 S2 BME B 602 B 73 VAL B 89 VAL~? 9.02 MN MN B 606 B 75 ALA B 85 ALA~? 12.60 MN MN B 606 B 77 ALA B 82 ALA~? 16.27 MN MN B 606 B 78 LEU B 79 LEU~? 13.82 MN MN B 606 coo 6.68 -12.20 6.91 4.65 -8.54 6.72 -18.85 85.55 2.15 -16.36 82.51 0.52 coo 4.09 -11.16 -10.83 4.39 -11.22 -8.63 -13.47 67.92 4.34 -14.99 68.90 3.08 coo -0.13 -5.63 -11.43 -0.24 -5.75 -9.91 -12.15 65.75 -1.09 -12.32 67.25 -1.34 coo 0.92 -0.50 -9.34 0.65 -0.74 -7.86 -14.32 67.41 -6.56 -13.20 68.41 -6.29 coo 4.14 -4.02 -10.28 4.18 -5.28 -8.49 -18.16 68.12 -1.74 -17.03 67.35 -0.14 3sm4_d00 source 3sm4 HYDROLASE/DNA : 4 hits 3sm4_d00 naa= 5 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 A 21 GLN A 57 GLN~? 9.37 C1 BME A 601 A 41 TYR A 58 TYR~? -4.88 S2 BME A 601s A 43 ASN A 60 ASN~? 13.23 C1 BME A 601 coo 22.03 6.35 12.16 20.71 6.08 10.54 -5.61 40.45 19.17 -5.50 40.19 21.27 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -3.46 45.81 15.49 -1.06 47.20 15.11 coo 14.90 7.30 8.78 14.25 8.14 6.97 -7.52 45.83 22.75 -9.56 46.47 22.75 ULMN 3 3ssc_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 A 21 GLN B 57 GLN~? 9.76 C1 BME B 602 A 41 TYR B 58 TYR~? -4.91 S2 BME B 602s A 43 ASN B 60 ASN~? 14.04 C1 BME B 602 coo 22.03 6.35 12.16 20.71 6.08 10.54 -10.06 92.05 16.54 -12.03 92.38 17.28 coo 18.67 0.21 9.03 16.70 -1.66 8.55 -7.48 86.83 13.23 -7.97 85.45 10.86 coo 14.90 7.30 8.78 14.25 8.14 6.97 -12.53 86.72 19.85 -11.70 86.05 21.72 3ssc_d00 source 3ssc DNA BINDING PROTEIN/DNA : 2 hits 3ssc_d00 naa= 3 ULMN 4 3thx_d00 DNA BINDING PROTEIN/DNA user 1 4 # 1 A 41 ASP A 122 ASP~? 22.01 MN MN B 606 A 42 PHE A 126 PHE~? 19.53 CL CL A 608 A 79 VAL A 32 VAL~? 15.69 CL CL A 608 A 81 SER A 36 SER~? 22.84 CL CL A 608 coo -11.49 -6.95 34.02 -12.16 -8.53 35.26 -21.79 55.48 15.36 -21.54 57.57 15.22 coo -8.04 -3.06 33.00 -7.11 -2.18 35.47 -16.94 52.44 11.80 -18.31 50.33 13.01 coo -5.58 1.49 30.28 -6.75 1.22 32.10 -12.88 49.71 9.41 -12.38 50.65 11.33 coo -10.21 -2.58 27.81 -11.76 -1.58 26.23 -20.55 50.27 7.47 -20.40 52.14 8.97 ULMN 4 3thx_d00 DNA BINDING PROTEIN/DNA user 2 4 # 2 A 41 ASP B 122 ASP~? 15.88 O1 GOL B 603 A 42 PHE B 126 PHE~? 14.41 O1 GOL B 603 A 79 VAL B 32 VAL~? 11.94 O1 GOL B 603 A 81 SER B 36 SER~? 14.84 O1 GOL B 603 coo -11.49 -6.95 34.02 -12.16 -8.53 35.26 -0.15 77.17 30.18 -0.01 75.13 29.61 coo -8.04 -3.06 33.00 -7.11 -2.18 35.47 1.23 80.23 24.35 0.63 82.37 26.02 coo -5.58 1.49 30.28 -6.75 1.22 32.10 1.98 82.91 19.59 0.02 82.04 19.86 coo -10.21 -2.58 27.81 -11.76 -1.58 26.23 6.57 82.37 26.01 5.17 80.48 26.47 3thx_d00 source 3thx DNA BINDING PROTEIN/DNA : 2 hits 3thx_d00 naa= 4 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 24 LYS~? 4.08 C2 BME A 601 B 443 VAL A 25 VAL~? 7.08 CL CL A 608 B 447 ARG A 26 ARG~? 9.60 MN MN A 604 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -0.91 46.54 9.97 2.66 42.32 12.44 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -2.56 49.80 11.08 -1.99 51.53 12.27 coo -14.58 4.58 36.41 -12.11 2.82 36.84 -0.69 52.60 5.29 -0.15 55.65 5.60 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS B 24 LYS~? -3.00 C2 BME B 602s B 443 VAL B 25 VAL~? 7.14 CL CL B 609 B 447 ARG B 26 ARG~? 8.42 O2 GOL B 603 coo -11.49 8.72 29.13 -11.20 3.78 25.16 -3.23 86.22 8.94 -7.29 90.78 7.55 coo -11.96 6.22 31.96 -10.74 4.61 32.81 -3.49 82.90 10.78 -4.85 81.17 10.78 coo -14.58 4.58 36.41 -12.11 2.82 36.84 1.24 79.80 7.27 0.69 76.71 7.21 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 2 hits 4hn5_d00 naa= 3 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 1 3 # 1 C 61 LYS A 127 LYS~? 18.61 MN MN B 606 C 90 HIS A 136 HIS~? 3.48 MN MN A 605s C 91 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 -14.62 57.47 9.74 -19.33 59.04 5.94 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 -0.57 59.60 14.33 0.78 59.36 15.93 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 2 3 # 2 C 61 LYS A 127 LYS~? 18.61 MN MN B 606 C 90 HIS B 96 HIS~? -3.43 MN MN B 606s C 91 GLN B 95 GLN~? 8.04 MN MN B 606 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 -14.62 57.47 9.74 -19.33 59.04 5.94 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 -13.24 74.01 11.32 -12.76 74.71 9.40 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 -8.78 68.50 12.35 -7.20 68.45 10.97 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 3 3 # 3 C 61 LYS B 127 LYS~? 11.03 O1 GOL B 603 C 90 HIS A 96 HIS~? -3.41 MN MN A 605s C 91 GLN A 95 GLN~? 6.65 C3 GOL B 603 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 2.32 75.24 21.44 7.34 73.34 24.59 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 0.59 58.54 20.35 2.20 57.89 19.15 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 -2.08 64.08 16.74 -1.36 64.23 14.73 ULMN 3 4hp3_d00 DNA BINDING PROTEIN/DNA user 4 3 # 4 C 61 LYS B 127 LYS~? 11.03 O1 GOL B 603 C 90 HIS B 136 HIS~? 3.50 MN MN B 606s C 91 GLN B 95 GLN~? 8.04 MN MN B 606 coo -19.62 -7.95 11.61 -14.74 -11.23 10.80 2.32 75.24 21.44 7.34 73.34 24.59 coo -14.60 -21.92 8.98 -13.75 -22.48 7.16 -7.23 73.04 10.16 -9.24 73.26 9.58 coo -19.27 -22.51 13.20 -20.06 -20.67 12.43 -8.78 68.50 12.35 -7.20 68.45 10.97 4hp3_d00 source 4hp3 DNA BINDING PROTEIN/DNA : 4 hits 4hp3_d00 naa= 3 ULMN 3 1ukf_o00 AVIRULENCE PROTEIN AVRPPH3 user 1 3 # 1 A 98 CYH A 21 CYH~? -2.28 S2 BME A 601s A 212 HIS A 66 HIS~? 3.42 MN MN A 604s A 227 ASP A 69 ASP~? 7.42 O1 BME A 601 coo 32.24 40.70 41.87 34.94 39.83 42.22 3.34 47.98 12.34 4.26 47.15 14.87 coo 35.63 37.64 46.24 33.55 37.41 46.24 3.21 51.23 16.81 3.87 52.43 15.22 coo 30.05 37.79 50.12 31.66 36.75 49.22 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 1ukf_o00 AVIRULENCE PROTEIN AVRPPH3 user 2 3 # 2 A 98 CYH B 21 CYH~? -2.10 S2 BME B 602s A 212 HIS B 66 HIS~? 3.43 MN MN B 607s A 227 ASP B 69 ASP~? 7.66 S2 BME B 602 coo 32.24 40.70 41.87 34.94 39.83 42.22 -7.07 84.75 5.98 -9.76 85.47 5.91 coo 35.63 37.64 46.24 33.55 37.41 46.24 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 30.05 37.79 50.12 31.66 36.75 49.22 -15.81 81.35 4.53 -16.00 83.45 4.93 1ukf_o00 source 1UKF AVIRULENCE PROTEIN AVRPPH3 : 2 hits 1ukf_o00 naa= 3 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 1 3 # 1 X1165 CYH A 21 CYH~? -2.28 S2 BME A 601s X1205 HIS A 67 HIS~? -4.40 CL CL A 608s X1220 ASP A 69 ASP~? 7.42 O1 BME A 601 coo -26.56 24.53 92.56 -24.57 23.58 94.36 3.34 47.98 12.34 4.26 47.15 14.87 coo -19.40 30.09 91.63 -20.33 29.86 93.49 0.35 54.22 20.29 -1.10 54.30 18.77 coo -21.03 32.79 97.44 -20.59 31.13 96.21 7.88 51.22 19.98 7.64 49.14 20.25 ULMN 3 2ebf_o00 DERMONECROTIC TOXIN user 2 3 # 2 X1165 CYH B 21 CYH~? -2.10 S2 BME B 602s X1205 HIS B 67 HIS~? -4.45 CL CL B 609s X1220 ASP B 69 ASP~? 7.66 S2 BME B 602 coo -26.56 24.53 92.56 -24.57 23.58 94.36 -7.07 84.75 5.98 -9.76 85.47 5.91 coo -19.40 30.09 91.63 -20.33 29.86 93.49 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -21.03 32.79 97.44 -20.59 31.13 96.21 -15.81 81.35 4.53 -16.00 83.45 4.93 2ebf_o00 source 2EBF DERMONECROTIC TOXIN : 2 hits 2ebf_o00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 67 HIS~? -4.40 CL CL A 608s A 208 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 296 SER B 88 SER~? 11.77 MN MN B 606 coo 12.72 17.48 24.71 12.80 19.37 23.81 0.35 54.22 20.29 -1.10 54.30 18.77 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.32 68.36 21.17 7.09 68.49 22.34 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.49 65.58 3.90 -8.66 65.20 2.38 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS A 100 HIS~? 8.88 CL CL A 608 A 208 ASP A 90 ASP~? 8.93 C1 GOL B 603 A 296 SER B 88 SER~? 11.77 MN MN B 606 coo 12.72 17.48 24.71 12.80 19.37 23.81 -4.62 56.01 23.20 -2.61 55.48 22.88 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.32 68.36 21.17 7.09 68.49 22.34 coo 6.89 17.22 46.63 5.08 16.21 47.91 -10.49 65.58 3.90 -8.66 65.20 2.38 ULMN 3 2odj_o00 PORIN D user 3 3 # 3 A 156 HIS B 67 HIS~? -4.45 CL CL B 609s A 208 ASP B 90 ASP~? 13.30 MN MN B 606 A 296 SER A 88 SER~? 4.20 C3 GOL B 603 coo 12.72 17.48 24.71 12.80 19.37 23.81 -13.16 78.27 11.53 -11.33 78.28 12.55 coo 18.47 29.19 29.68 19.30 29.17 27.75 -15.47 64.24 6.89 -17.14 64.04 5.63 coo 6.89 17.22 46.63 5.08 16.21 47.91 6.33 67.41 15.47 7.25 67.93 13.23 2odj_o00 source 2ODJ PORIN D : 3 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 67 HIS~? -4.40 CL CL A 608s B 208 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 296 SER B 88 SER~? 11.77 MN MN B 606 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 0.35 54.22 20.29 -1.10 54.30 18.77 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 5.32 68.36 21.17 7.09 68.49 22.34 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.49 65.58 3.90 -8.66 65.20 2.38 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 100 HIS~? 8.88 CL CL A 608 B 208 ASP A 90 ASP~? 8.93 C1 GOL B 603 B 296 SER B 88 SER~? 11.77 MN MN B 606 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 5.32 68.36 21.17 7.09 68.49 22.34 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 -10.49 65.58 3.90 -8.66 65.20 2.38 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 67 HIS~? -4.45 CL CL B 609s B 208 ASP B 90 ASP~? 13.30 MN MN B 606 B 296 SER A 88 SER~? 4.20 C3 GOL B 603 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -13.16 78.27 11.53 -11.33 78.28 12.55 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 -15.47 64.24 6.89 -17.14 64.04 5.63 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 6.33 67.41 15.47 7.25 67.93 13.23 2odj_o01 source 2ODJ PORIN D : 3 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 36 SER~? 22.84 CL CL A 608 A 166 PHE A 110 PHE~? 17.56 S2 BME A 601 A 182 PHE A 129 PHE~? 10.87 CL CL A 608 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -20.55 50.27 7.47 -20.40 52.14 8.97 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -15.74 46.87 16.94 -14.14 47.51 14.73 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 88 SER~? 4.20 C3 GOL B 603 A 166 PHE A 75 PHE~? 5.80 MN MN A 605 A 182 PHE A 144 PHE~? 5.39 MN MN A 604 coo -46.28 37.24 81.97 -44.96 39.32 82.40 6.33 67.41 15.47 7.25 67.93 13.23 coo -36.62 39.62 84.60 -38.76 41.24 85.25 8.51 60.03 19.19 6.27 59.59 17.55 coo -36.55 45.66 79.22 -38.34 43.94 80.53 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 107 SER~? 17.07 CL CL A 608 A 166 PHE A 59 PHE~? 9.30 CL CL A 608 A 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -6.57 49.40 16.71 -5.70 50.05 14.11 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 107 SER~? 17.07 CL CL A 608 A 166 PHE A 129 PHE~? 10.87 CL CL A 608 A 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -10.38 54.19 14.28 -8.39 52.30 14.83 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER B 36 SER~? 14.84 O1 GOL B 603 A 166 PHE B 110 PHE~? 17.53 S2 BME B 602 A 182 PHE B 129 PHE~? 10.86 CL CL B 609 coo -46.28 37.24 81.97 -44.96 39.32 82.40 6.57 82.37 26.01 5.17 80.48 26.47 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -4.01 85.90 25.00 -2.51 85.14 22.70 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER B 88 SER~? 11.77 MN MN B 606 A 166 PHE B 74 PHE~? 8.86 MN MN B 607 A 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER B 88 SER~? 11.77 MN MN B 606 A 166 PHE B 75 PHE~? 5.83 MN MN B 606 A 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER B 88 SER~? 11.77 MN MN B 606 A 166 PHE B 144 PHE~? 5.38 MN MN B 607 A 182 PHE B 74 PHE~? 8.86 MN MN B 607 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -7.78 76.84 0.08 -8.68 77.53 2.69 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER B 107 SER~? 17.45 CL CL B 609 A 166 PHE B 59 PHE~? 9.18 CL CL B 609 A 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -7.31 83.22 16.56 -5.26 82.55 14.74 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER B 107 SER~? 17.45 CL CL B 609 A 166 PHE B 129 PHE~? 10.86 CL CL B 609 A 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -46.28 37.24 81.97 -44.96 39.32 82.40 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 -3.48 78.42 19.16 -4.63 80.39 17.56 coo -36.55 45.66 79.22 -38.34 43.94 80.53 -2.63 86.84 14.28 -3.66 89.36 13.73 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 10 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 36 SER~? 22.84 CL CL A 608 B 166 PHE A 110 PHE~? 17.56 S2 BME A 601 B 182 PHE A 129 PHE~? 10.87 CL CL A 608 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -20.55 50.27 7.47 -20.40 52.14 8.97 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -15.74 46.87 16.94 -14.14 47.51 14.73 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 88 SER~? 4.20 C3 GOL B 603 B 166 PHE A 75 PHE~? 5.80 MN MN A 605 B 182 PHE A 144 PHE~? 5.39 MN MN A 604 coo -19.94 46.29 97.83 -22.38 46.56 97.60 6.33 67.41 15.47 7.25 67.93 13.23 coo -29.59 43.40 95.66 -28.22 45.54 94.50 8.51 60.03 19.19 6.27 59.59 17.55 coo -32.72 50.15 98.46 -30.32 48.85 97.77 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 107 SER~? 17.07 CL CL A 608 B 166 PHE A 59 PHE~? 9.30 CL CL A 608 B 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -6.57 49.40 16.71 -5.70 50.05 14.11 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 107 SER~? 17.07 CL CL A 608 B 166 PHE A 129 PHE~? 10.87 CL CL A 608 B 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -10.38 54.19 14.28 -8.39 52.30 14.83 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER B 36 SER~? 14.84 O1 GOL B 603 B 166 PHE B 110 PHE~? 17.53 S2 BME B 602 B 182 PHE B 129 PHE~? 10.86 CL CL B 609 coo -19.94 46.29 97.83 -22.38 46.56 97.60 6.57 82.37 26.01 5.17 80.48 26.47 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -4.01 85.90 25.00 -2.51 85.14 22.70 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER B 88 SER~? 11.77 MN MN B 606 B 166 PHE B 74 PHE~? 8.86 MN MN B 607 B 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER B 88 SER~? 11.77 MN MN B 606 B 166 PHE B 75 PHE~? 5.83 MN MN B 606 B 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER B 88 SER~? 11.77 MN MN B 606 B 166 PHE B 144 PHE~? 5.38 MN MN B 607 B 182 PHE B 74 PHE~? 8.86 MN MN B 607 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -7.78 76.84 0.08 -8.68 77.53 2.69 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER B 107 SER~? 17.45 CL CL B 609 B 166 PHE B 59 PHE~? 9.18 CL CL B 609 B 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -7.31 83.22 16.56 -5.26 82.55 14.74 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER B 107 SER~? 17.45 CL CL B 609 B 166 PHE B 129 PHE~? 10.86 CL CL B 609 B 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -19.94 46.29 97.83 -22.38 46.56 97.60 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 -3.48 78.42 19.16 -4.63 80.39 17.56 coo -32.72 50.15 98.46 -30.32 48.85 97.77 -2.63 86.84 14.28 -3.66 89.36 13.73 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 10 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 36 SER~? 22.84 CL CL A 608 C 166 PHE A 110 PHE~? 17.56 S2 BME A 601 C 182 PHE A 129 PHE~? 10.87 CL CL A 608 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -20.55 50.27 7.47 -20.40 52.14 8.97 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -15.74 46.87 16.94 -14.14 47.51 14.73 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 88 SER~? 4.20 C3 GOL B 603 C 166 PHE A 75 PHE~? 5.80 MN MN A 605 C 182 PHE A 144 PHE~? 5.39 MN MN A 604 coo -2.19 64.27 51.12 -3.34 62.10 50.60 6.33 67.41 15.47 7.25 67.93 13.23 coo -11.14 61.91 46.89 -9.88 60.30 48.76 8.51 60.03 19.19 6.27 59.59 17.55 coo -7.71 55.92 42.70 -7.18 57.60 44.85 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 107 SER~? 17.07 CL CL A 608 C 166 PHE A 59 PHE~? 9.30 CL CL A 608 C 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -6.57 49.40 16.71 -5.70 50.05 14.11 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 107 SER~? 17.07 CL CL A 608 C 166 PHE A 129 PHE~? 10.87 CL CL A 608 C 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -10.38 54.19 14.28 -8.39 52.30 14.83 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER B 36 SER~? 14.84 O1 GOL B 603 C 166 PHE B 110 PHE~? 17.53 S2 BME B 602 C 182 PHE B 129 PHE~? 10.86 CL CL B 609 coo -2.19 64.27 51.12 -3.34 62.10 50.60 6.57 82.37 26.01 5.17 80.48 26.47 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -4.01 85.90 25.00 -2.51 85.14 22.70 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER B 88 SER~? 11.77 MN MN B 606 C 166 PHE B 74 PHE~? 8.86 MN MN B 607 C 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER B 88 SER~? 11.77 MN MN B 606 C 166 PHE B 75 PHE~? 5.83 MN MN B 606 C 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER B 88 SER~? 11.77 MN MN B 606 C 166 PHE B 144 PHE~? 5.38 MN MN B 607 C 182 PHE B 74 PHE~? 8.86 MN MN B 607 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -7.78 76.84 0.08 -8.68 77.53 2.69 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER B 107 SER~? 17.45 CL CL B 609 C 166 PHE B 59 PHE~? 9.18 CL CL B 609 C 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -7.31 83.22 16.56 -5.26 82.55 14.74 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER B 107 SER~? 17.45 CL CL B 609 C 166 PHE B 129 PHE~? 10.86 CL CL B 609 C 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -2.19 64.27 51.12 -3.34 62.10 50.60 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 -3.48 78.42 19.16 -4.63 80.39 17.56 coo -7.71 55.92 42.70 -7.18 57.60 44.85 -2.63 86.84 14.28 -3.66 89.36 13.73 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 10 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 36 SER~? 22.84 CL CL A 608 D 166 PHE A 110 PHE~? 17.56 S2 BME A 601 D 182 PHE A 129 PHE~? 10.87 CL CL A 608 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -20.55 50.27 7.47 -20.40 52.14 8.97 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -15.74 46.87 16.94 -14.14 47.51 14.73 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -10.38 54.19 14.28 -8.39 52.30 14.83 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 88 SER~? 4.20 C3 GOL B 603 D 166 PHE A 74 PHE~? 8.88 MN MN A 604 D 182 PHE A 144 PHE~? 5.39 MN MN A 604 coo -32.42 55.27 46.18 -30.51 54.94 47.67 6.33 67.41 15.47 7.25 67.93 13.23 coo -23.62 58.20 50.84 -23.76 56.14 48.96 11.59 56.31 16.73 12.14 57.65 14.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 88 SER~? 4.20 C3 GOL B 603 D 166 PHE A 75 PHE~? 5.80 MN MN A 605 D 182 PHE A 144 PHE~? 5.39 MN MN A 604 coo -32.42 55.27 46.18 -30.51 54.94 47.67 6.33 67.41 15.47 7.25 67.93 13.23 coo -23.62 58.20 50.84 -23.76 56.14 48.96 8.51 60.03 19.19 6.27 59.59 17.55 coo -23.08 51.44 54.96 -24.43 52.71 52.88 8.99 56.15 11.10 6.96 55.33 12.85 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 88 SER~? 4.20 C3 GOL B 603 D 166 PHE A 144 PHE~? 5.39 MN MN A 604 D 182 PHE A 74 PHE~? 8.88 MN MN A 604 coo -32.42 55.27 46.18 -30.51 54.94 47.67 6.33 67.41 15.47 7.25 67.93 13.23 coo -23.62 58.20 50.84 -23.76 56.14 48.96 8.99 56.15 11.10 6.96 55.33 12.85 coo -23.08 51.44 54.96 -24.43 52.71 52.88 11.59 56.31 16.73 12.14 57.65 14.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 107 SER~? 17.07 CL CL A 608 D 166 PHE A 59 PHE~? 9.30 CL CL A 608 D 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -6.57 49.40 16.71 -5.70 50.05 14.11 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 107 SER~? 17.07 CL CL A 608 D 166 PHE A 129 PHE~? 10.87 CL CL A 608 D 182 PHE A 28 PHE~? 9.03 S2 BME A 601 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -14.58 49.59 20.39 -13.79 50.81 22.29 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -10.38 54.19 14.28 -8.39 52.30 14.83 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -6.17 45.72 11.50 -5.16 43.17 12.10 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER B 36 SER~? 14.84 O1 GOL B 603 D 166 PHE B 110 PHE~? 17.53 S2 BME B 602 D 182 PHE B 129 PHE~? 10.86 CL CL B 609 coo -32.42 55.27 46.18 -30.51 54.94 47.67 6.57 82.37 26.01 5.17 80.48 26.47 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -4.01 85.90 25.00 -2.51 85.14 22.70 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -3.48 78.42 19.16 -4.63 80.39 17.56 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER B 88 SER~? 11.77 MN MN B 606 D 166 PHE B 74 PHE~? 8.86 MN MN B 607 D 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -14.08 76.48 -0.22 -12.03 75.25 -1.62 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER B 88 SER~? 11.77 MN MN B 606 D 166 PHE B 75 PHE~? 5.83 MN MN B 606 D 182 PHE B 144 PHE~? 5.38 MN MN B 607 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -15.10 72.64 3.42 -12.79 73.08 4.96 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -7.78 76.84 0.08 -8.68 77.53 2.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER B 88 SER~? 11.77 MN MN B 606 D 166 PHE B 144 PHE~? 5.38 MN MN B 607 D 182 PHE B 74 PHE~? 8.86 MN MN B 607 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -10.49 65.58 3.90 -8.66 65.20 2.38 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -7.78 76.84 0.08 -8.68 77.53 2.69 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -14.08 76.48 -0.22 -12.03 75.25 -1.62 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER B 107 SER~? 17.45 CL CL B 609 D 166 PHE B 59 PHE~? 9.18 CL CL B 609 D 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -7.31 83.22 16.56 -5.26 82.55 14.74 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.63 86.84 14.28 -3.66 89.36 13.73 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER B 107 SER~? 17.45 CL CL B 609 D 166 PHE B 129 PHE~? 10.86 CL CL B 609 D 182 PHE B 28 PHE~? 9.03 C2 BME B 602 coo -32.42 55.27 46.18 -30.51 54.94 47.67 -7.70 83.12 25.20 -9.96 84.03 25.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 -3.48 78.42 19.16 -4.63 80.39 17.56 coo -23.08 51.44 54.96 -24.43 52.71 52.88 -2.63 86.84 14.28 -3.66 89.36 13.73 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 12 hits 2r11_o03 naa= 3 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 69 ASP~? 7.42 O1 BME A 601 A 86 HIS A 66 HIS~? 3.42 MN MN A 604s A 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 7.88 51.22 19.98 7.64 49.14 20.25 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 3.21 51.23 16.81 3.87 52.43 15.22 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP A 69 ASP~? 7.42 O1 BME A 601 A 86 HIS A 66 HIS~? 3.42 MN MN A 604s A 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo 18.89 -28.09 25.11 19.05 -26.61 23.60 7.88 51.22 19.98 7.64 49.14 20.25 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 3.21 51.23 16.81 3.87 52.43 15.22 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 A 49 ASP B 69 ASP~? 7.66 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s A 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 A 49 ASP B 69 ASP~? 7.66 S2 BME B 602 A 86 HIS B 66 HIS~? 3.43 MN MN B 607s A 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o00 naa= 3 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 B 49 ASP A 69 ASP~? 7.42 O1 BME A 601 B 86 HIS A 66 HIS~? 3.42 MN MN A 604s B 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 7.88 51.22 19.98 7.64 49.14 20.25 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 3.21 51.23 16.81 3.87 52.43 15.22 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 B 49 ASP A 69 ASP~? 7.42 O1 BME A 601 B 86 HIS A 66 HIS~? 3.42 MN MN A 604s B 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 7.88 51.22 19.98 7.64 49.14 20.25 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 3.21 51.23 16.81 3.87 52.43 15.22 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 B 49 ASP B 69 ASP~? 7.66 S2 BME B 602 B 86 HIS B 66 HIS~? 3.43 MN MN B 607s B 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o01 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 B 49 ASP B 69 ASP~? 7.66 S2 BME B 602 B 86 HIS B 66 HIS~? 3.43 MN MN B 607s B 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo -25.60 -8.15 41.87 -24.93 -7.05 43.55 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -24.87 -3.97 45.59 -22.79 -4.09 45.73 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -17.45 -4.02 46.78 -18.80 -4.41 47.26 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o01 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o01 naa= 3 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 C 49 ASP A 69 ASP~? 7.42 O1 BME A 601 C 86 HIS A 66 HIS~? 3.42 MN MN A 604s C 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 7.88 51.22 19.98 7.64 49.14 20.25 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 3.21 51.23 16.81 3.87 52.43 15.22 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 C 49 ASP A 69 ASP~? 7.42 O1 BME A 601 C 86 HIS A 66 HIS~? 3.42 MN MN A 604s C 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo 52.29 -8.84 6.54 53.45 -9.52 8.16 7.88 51.22 19.98 7.64 49.14 20.25 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 3.21 51.23 16.81 3.87 52.43 15.22 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 C 49 ASP B 69 ASP~? 7.66 S2 BME B 602 C 86 HIS B 66 HIS~? 3.43 MN MN B 607s C 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o02 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 C 49 ASP B 69 ASP~? 7.66 S2 BME B 602 C 86 HIS B 66 HIS~? 3.43 MN MN B 607s C 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo 52.29 -8.84 6.54 53.45 -9.52 8.16 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 56.78 -9.42 10.42 56.27 -11.41 10.02 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 56.74 -16.59 11.78 56.33 -15.18 12.23 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o02 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o02 naa= 3 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 D 49 ASP A 69 ASP~? 7.42 O1 BME A 601 D 86 HIS A 66 HIS~? 3.42 MN MN A 604s D 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 7.88 51.22 19.98 7.64 49.14 20.25 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 D 49 ASP A 69 ASP~? 7.42 O1 BME A 601 D 86 HIS A 66 HIS~? 3.42 MN MN A 604s D 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 7.88 51.22 19.98 7.64 49.14 20.25 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 3.21 51.23 16.81 3.87 52.43 15.22 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 D 49 ASP B 69 ASP~? 7.66 S2 BME B 602 D 86 HIS B 66 HIS~? 3.43 MN MN B 607s D 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o03 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 D 49 ASP B 69 ASP~? 7.66 S2 BME B 602 D 86 HIS B 66 HIS~? 3.43 MN MN B 607s D 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo 33.58 -54.23 -8.77 34.81 -54.76 -10.41 -15.81 81.35 4.53 -16.00 83.45 4.93 coo 36.78 -56.86 -12.59 37.95 -55.16 -12.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo 41.85 -51.50 -13.98 40.55 -52.02 -14.52 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o03 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o03 naa= 3 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 E 49 ASP A 69 ASP~? 7.42 O1 BME A 601 E 86 HIS A 66 HIS~? 3.42 MN MN A 604s E 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo -36.18 24.97 18.78 -36.93 26.11 17.11 7.88 51.22 19.98 7.64 49.14 20.25 coo -36.85 29.32 15.06 -38.90 29.14 15.48 3.21 51.23 16.81 3.87 52.43 15.22 coo -44.49 29.68 13.98 -43.47 28.67 13.52 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 E 49 ASP A 69 ASP~? 7.42 O1 BME A 601 E 86 HIS A 66 HIS~? 3.42 MN MN A 604s E 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo -36.18 24.97 18.78 -36.93 26.11 17.11 7.88 51.22 19.98 7.64 49.14 20.25 coo -36.85 29.32 15.06 -38.90 29.14 15.48 3.21 51.23 16.81 3.87 52.43 15.22 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 E 49 ASP B 69 ASP~? 7.66 S2 BME B 602 E 86 HIS B 66 HIS~? 3.43 MN MN B 607s E 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o04 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 E 49 ASP B 69 ASP~? 7.66 S2 BME B 602 E 86 HIS B 66 HIS~? 3.43 MN MN B 607s E 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo -36.18 24.97 18.78 -36.93 26.11 17.11 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -36.85 29.32 15.06 -38.90 29.14 15.48 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -44.49 29.68 13.98 -43.47 28.67 13.52 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o04 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o04 naa= 3 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 F 49 ASP A 69 ASP~? 7.42 O1 BME A 601 F 86 HIS A 66 HIS~? 3.42 MN MN A 604s F 250 ALA A 20 ALA~? 6.78 S2 BME A 601 coo -82.12 8.55 35.60 -81.93 9.84 37.19 7.88 51.22 19.98 7.64 49.14 20.25 coo -84.21 11.81 39.90 -82.43 12.70 39.26 3.21 51.23 16.81 3.87 52.43 15.22 coo -78.49 17.13 41.31 -79.25 15.85 41.61 5.75 47.12 9.54 6.62 45.86 9.91 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 F 49 ASP A 69 ASP~? 7.42 O1 BME A 601 F 86 HIS A 66 HIS~? 3.42 MN MN A 604s F 250 ALA A 62 ALA~? -3.33 C1 BME A 601s coo -82.12 8.55 35.60 -81.93 9.84 37.19 7.88 51.22 19.98 7.64 49.14 20.25 coo -84.21 11.81 39.90 -82.43 12.70 39.26 3.21 51.23 16.81 3.87 52.43 15.22 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -0.61 45.64 19.79 -0.68 44.97 18.47 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 3 3 # 3 F 49 ASP B 69 ASP~? 7.66 S2 BME B 602 F 86 HIS B 66 HIS~? 3.43 MN MN B 607s F 250 ALA B 20 ALA~? 6.16 C2 BME B 602 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -5.51 85.82 2.70 -6.35 87.03 2.21 ULMN 3 2wwt_o05 INTRACELLULAR SUBTILISIN PROTEASE user 4 3 # 4 F 49 ASP B 69 ASP~? 7.66 S2 BME B 602 F 86 HIS B 66 HIS~? 3.43 MN MN B 607s F 250 ALA B 62 ALA~? 4.29 C1 BME B 602 coo -82.12 8.55 35.60 -81.93 9.84 37.19 -15.81 81.35 4.53 -16.00 83.45 4.93 coo -84.21 11.81 39.90 -82.43 12.70 39.26 -11.11 81.39 7.66 -9.84 80.27 6.41 coo -78.49 17.13 41.31 -79.25 15.85 41.61 -12.56 86.77 12.36 -11.38 87.53 11.88 2wwt_o05 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 4 hits 2wwt_o05 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 16 GLU~? 14.76 S2 BME A 601 B 44 ASP A 145 ASP~? 14.76 MN MN A 604 B 50 THR A 149 THR~? 18.02 O3 GOL B 603 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 13.57 48.33 8.05 14.78 46.83 7.14 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 12.32 59.45 6.26 13.32 58.94 4.48 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 19.17 59.55 8.18 18.83 61.06 6.69 3hde_o01 source 3HDE LYSOZYME : 1 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 16 GLU~? 14.76 S2 BME A 601 C 44 ASP A 145 ASP~? 14.76 MN MN A 604 C 50 THR A 149 THR~? 18.02 O3 GOL B 603 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 13.57 48.33 8.05 14.78 46.83 7.14 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 12.32 59.45 6.26 13.32 58.94 4.48 coo 25.48 4.87 1.60 23.90 4.95 0.15 19.17 59.55 8.18 18.83 61.06 6.69 3hde_o02 source 3HDE LYSOZYME : 1 hits 3hde_o02 naa= 3 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 1 3 # 1 A 220 HIS A 100 HIS~? 8.88 CL CL A 608 A 250 ASP A 101 ASP~? 14.47 MN MN A 605 A 328 SER A 107 SER~? 17.07 CL CL A 608 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -14.58 49.59 20.39 -13.79 50.81 22.29 ULMN 3 3nwu_o00 SERINE PROTEASE HTRA1 user 2 3 # 2 A 220 HIS B 100 HIS~? 8.87 CL CL B 609 A 250 ASP B 101 ASP~? 14.48 MN MN B 606 A 328 SER B 107 SER~? 17.45 CL CL B 609 coo -31.63 42.33 -9.10 -32.09 43.47 -7.39 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -28.83 47.26 -8.07 -29.71 45.89 -9.37 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -31.38 44.75 -19.08 -33.61 43.88 -19.06 -7.70 83.12 25.20 -9.96 84.03 25.06 3nwu_o00 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o00 naa= 3 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 1 3 # 1 B 220 HIS A 100 HIS~? 8.88 CL CL A 608 B 250 ASP A 101 ASP~? 14.47 MN MN A 605 B 328 SER A 107 SER~? 17.07 CL CL A 608 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -14.58 49.59 20.39 -13.79 50.81 22.29 ULMN 3 3nwu_o01 SERINE PROTEASE HTRA1 user 2 3 # 2 B 220 HIS B 100 HIS~? 8.87 CL CL B 609 B 250 ASP B 101 ASP~? 14.48 MN MN B 606 B 328 SER B 107 SER~? 17.45 CL CL B 609 coo -60.95 64.74 -17.31 -62.53 64.43 -18.66 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -61.22 67.85 -22.15 -60.12 66.82 -20.67 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -50.80 64.58 -18.50 -51.05 62.31 -17.80 -7.70 83.12 25.20 -9.96 84.03 25.06 3nwu_o01 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o01 naa= 3 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 1 3 # 1 C 220 HIS A 100 HIS~? 8.88 CL CL A 608 C 250 ASP A 101 ASP~? 14.47 MN MN A 605 C 328 SER A 107 SER~? 17.07 CL CL A 608 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -4.62 56.01 23.20 -2.61 55.48 22.88 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -10.28 59.57 22.50 -9.46 60.36 24.30 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -14.58 49.59 20.39 -13.79 50.81 22.29 ULMN 3 3nwu_o02 SERINE PROTEASE HTRA1 user 2 3 # 2 C 220 HIS B 100 HIS~? 8.87 CL CL B 609 C 250 ASP B 101 ASP~? 14.48 MN MN B 606 C 328 SER B 107 SER~? 17.45 CL CL B 609 coo -51.93 36.48 -40.55 -50.74 34.79 -40.19 -13.86 76.47 17.25 -14.56 76.87 15.30 coo -46.79 36.05 -43.01 -48.32 37.22 -42.10 -10.99 72.82 22.17 -12.93 72.02 22.11 coo -50.01 46.48 -39.48 -50.98 46.14 -37.32 -7.70 83.12 25.20 -9.96 84.03 25.06 3nwu_o02 source 3NWU SERINE PROTEASE HTRA1 : 2 hits 3nwu_o02 naa= 3